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SUMMARY
Background
Acute myocardial infarction (AMI) is an important cause of morbidity and mortality in 
men and women. Much of the existing literature has either focussed on men or has 
examined men and women together. There is a growing evidence to suggest that men and 
women represent distinct entities in tenns of the epidemiology of AMI. This study 
therefore aims to examine and compar e the baseline characteristics, burden of disease and 
survival of men and women hospitalised between 1990 and 2000 following a first and 
second AMI and also to determine factors that influence survival in men and women.
Methods
The Scottish Linked Morbidity Record Database was used to identify all patients 
hospitalised with a first and a second AMI between 1990 and 2000. Baseline 
characteristics including demograpliics, comorbid diagnoses and the burden of disease 
(including incidence, length of stay and revascularisation rates) were examined in men and 
women. Sex specific case fatality was calculated at a number of time points firom 30 days 
to five years. Multivariate modelling was then used to examine factors affecting prognosis 
in different age groups and detennine trends over time in men and women sepai’ately.
Results
Between 1990 and 2000, a total of 110,226 individuals were hospitalised with a first AMI 
(41% women) and 9,664 individuals (40%) were hospitalised with a second AML 
Comorbid diagnoses were coded in almost half of all men and women with a first AMI and 
two thirds of those with a second AML
Between 1990 and 2000, first AMI incidence declined by about one half in men and by one 
third in women whilst hospitalisation rates for second AMI halved. Thus, burden of 
disease (incidence and length of stay) fell whilst revasculai’isation rates increased.
Unadjusted short and longer term survival was greater in men than in women. After 
adjusting for age and other factors women with a first AMI fared worse than men in the 
short teim but better than men in the longer term. Short term sex differences were 
restricted to younger age groups. In the multivariate analyses men and women had similar 
short and longer tenn outcomes following a second AMI.
x v i
Between 1990 and 2000, short term case fatality declined by approximately half in men 
and by one third in women over the study period. These improvements were more evident 
following a first AMI and in younger age groups.
Conclusions
Younger women hospitalised with a first AMI have high levels of comorbid disease and a 
worse short tenn prognosis than men. However women fare better than men in the longer 
term. Sex differences are not apparent in survival following a second AMI. This may 
reflect differences in treatment and in secondary prevention, and merits further research.
xvu
1 INTRODUCTION
This thesis will examine sex differences in the baseline characteristics, suivival and 
National Health Semce burden of individuals hospitalised with a first and second acute 
myocardial infarction (AMI) in Scotland. It will define a research question, review the 
relevant literature and report the results of a study examining sex differences in baseline 
characteristics and sui*vival in patients with a first and second acute myocardial infarction 
in Scotland between 1990 and 2000.
1.1 Acute Myocardial Infarction
Acute myocardial infarction (AMI) is a major public health problem, especially in 
developed countries with ageing populations. Acute myocardial infarction is an important 
cause of mortality and morbidity. Mortality rates attributable to AMI depend on both 
incidence and case-fatality. * Although case-fatality has declined over the past two 
decades, it remains high and approximately 50% of individuals die within an hour of 
onset.^ Consequently, a lai’ge proportion of people do not even reach hospital so that the 
potential impact of treatment on population mortality rates is limited. Mortality rates from 
coronary heart disease have also declined significantly in most developed countries.* The 
relative contributions of changing incidence and case-fatality to this decline have been 
examined but are not clearly understood.
Coronary heart disease has traditionally been considered to be more common in men than 
in women. However, whilst onset of disease is often later in women, coronary heart 
disease still accounts for approximately one fifth of all deaths in Scottish women.^ In 
2002, coronary hearf disease accounted for 22.3% and 18.1% of all deaths in men and 
women respectively. In individuals aged less than 65 years, these figures were 18.5% and 
10.3%.^
1.2 Definition of acute myocardial infarction
Acute coronary syndrome
Acute coronary syndrome refers to a range of acute myocardial ischaemic conditions that 
share a common underlying pathophysiological mechanism."* This includes ST segment 
elevation AMI, non-ST segment elevation AMI and unstable angina.
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Changing terminology
An acute myocardial infarction results in prolonged ischaemia and subsequent death of 
cardiac myocytes^ Almost all acute myocardial infarctions result from coronary 
atherosclerosis. Defining acute myocardial infarction is not simple and the definition can 
arise from a number of different perspectives, according to clinical, biochemical, 
pathological and electro cardiographie (ECG) characteristics. In the past, there was a 
general consensus for the meaning of the term ‘acute myocardial infarction.’ This 
consensus was based on the World Health Organisation (WHO) definition which required 
the presence of two of the following tliree features: symptoms of myocardial ischaemia for- 
more than 20 minutes, significant cardiac enzyme rise and typical ECG changes^ This 
basic system was widely used but variably interpreted, resulting in a lack of comparability 
within and between studies.
Development of new, more sensitive tests, such as cardiac troponins and creatine kinase 
(CK) " MB mass, have meant that it is now possible to identify patients who have had very 
small infarcts, that would not previously been considered an AMI. This means that people 
who were formally given a diagnosis of angina pectoris might today be diagnosed as 
having had an AMI.
The availability of new more sensitive technologies shed doubt on the validity of the WHO 
definition. A consensus conference was therefore convened by the European Cardiac 
Society and the American College of Cardiology in order to examine the definition of 
AMI. The report published by this committee in 2000 was intended to give guidance to 
clinicians faced with new diagnostic methods and scientific literature.^
The new definition requfres documentation of a rise and fall in troponin or CK-MB as well 
as ischaemic symptoms or coronary intervention (Table 1). The previous definition 
allowed a diagnosis to be made on the basis of serial ECG changes alone, or a combination 
of symptoms and ‘probable’ ECG changes and /or abnormal plasma enzymes.
Table 1 Definition of acute myocardial infarction
OLD: DEFINITE ACUTE MYOCARDIAL INFARCTION
1 Definite ECG or
2 Symptoms typical or atypical or inadequately described, together with probable 
ECG or abnonnal enzyme, or
3 Symptoms typical with abnormal enzymes with ischaemic or non-codable ECG or 
ECG not available, or
4 Fatal case, whether sudden or not, with naked eye appearance of fresh myocardial 
infarction and /or recent coronary occlusion found at necropsy
New. either one of the following criteria satisfies the diagnosis for an acute, 
evolving or recent MI
1 Typical rise and gradual fall (troponin) or more rapid rise and fall (CK-MB) of 
biochemical markers of myocardial necrosis with at least one of the following:
a Ischaemic symptoms;
b Development of pathological Q waves on the ECG;
c ECG changes indicative of ischaemia (ST segment elevation or depression); or
d Coronary artery intervention (coronary angioplasty)
2 Pathological findings of an acute MI
Implications of the new definition of myocardial infarction
The redefinition of myocardial infarction has implications for individuals, for clinical 
practice and for the study of the epidemiology of AMI. It is estimated that the new 
definition for AMI will increase the number of non-ST elevation acute coronary syndromes 
by about 40%.^ This lower diagnostic threshold will impact upon patients and their 
families and has implications for issues such as employment and health insurance. The 
new definition of AMI has not yet been adopted by all clinicians,^ and it is likely to take 
some time before the new diagnostic criteria are universally incorporated iato clinical 
practice. In theory, widespread use of a standardised definition should allow more valid 
epidemiological comparisons between different populations and within populations over 
time.
The new definition has been criticised and there are concerns that it is ‘not applicable to 
more than a proportion of coronary events in the real world’7 One of the main concerns is 
that it requires documentation of a rise and fall of troponin or CK-MB, which is not always 
available. The criteria therefore do not cover early and other fatal cases or non-fatal cases 
where tests are incomplete, delayed or missing.
The impact of the redefinition of AMI on the recorded incidence of AMI is not clear. It has 
been suggested that it may lead to an underestimation of disease incidence, because of the 
likelihood of missing biochemical data and relatively high proportion of fatal cases^ 
Alternatively, lowering the diagnostic tlireshold could increase the reported incidence of 
AMI.^
1.3 Pathophysiology of acute myocardial infarction
Almost all AMIs occur as a result of coronary atherosclerosis, usually with superimposed 
coronary thrombosis. Atherosclerosis is thought to begin in childhood as deposits of 
cholesterol and fatty streaks in the intima of arteries.^ '*** Aortic fatty streaks are believed to 
develop first, though there appears to be little or no relationship between aortic fatty 
streaks and clinically important atherosclerotic lesions.^ Fatty streaks begin to appear in 
the coronary arteries approximately five to ten years later than in the aorta.^ Over time, 
more lipid may accumulate and become covered in a fibromuscular cap to form a fibrous 
plaque. It would seem therefore that in some individuals, juvenile fatty streaks in the 
coronary arteries progress to advanced atherosclerotic lesions within a few decades. 
Rupture or fissuring of the fibrous plaques results in platelet aggregation and tlirombus 
formation and can lead to an acute coronary event. Exposure of constituents of the plaque 
such as lipid, smooth muscle and foam cells, leads to the production of thrombin and fibrin 
which promotes platelet aggregation and formation of thrombus.** In AMI, occlusion of 
the coronary artery is usually more complete than in unstable angina. ST segment 
elevation AMI is usually associated with red, fibrin-rich and occlusive tlirombus. Unstable 
angina and non-ST elevation AMI are closely related conditions which may be 
undistinguishable in their clinical presentation. The difference between them depends 
upon whether the ischaemia is severe enough to cause myocardial necrosis as demonstrated 
by release of cardiac markers, especially cardiac troponin I and T.*^
1.4 Clinical presentation
Ischaemic symptoms include chest, epigastric, arm, or jaw discomfort associated with 
exertion or occuiTing at rest. The pain associated with AMI usually lasts at least 20 
minutes but may be shorter in duration. The pain may develop in the arm, epigastrium, 
shoulder, wrist or jaw but not in the chest, though this is unusual. The pain is not made 
worse by movement or inspiration. Other symptoms include nausea and vomiting, 
shortness of breath, weakness, dizziness or syncope. The pain may not be severe, 
especially in the elderly, in whom other symptoms may predominate. AMI may also occur 
without symptoms, an unrecognised AMI. Evidence of umecognised AMI can be 
demonstrated on serial ECG or autopsy. Unrecognised AMIs are thought to account for 
between 20% and 40% of all AMIs and as such represent a significant public health 
problem. In terms of examination, there are no specific physical signs that are 
diagnostic of AMI. Patients may have evidence of autonomic nervous system activation 
such as sweating and pallor and hypotension. Other features may include pulse 
irregularities and a third heart sound or evidence of heart failure.
1.5 Management of Acute Myocardial Infarction
Management of acute myocaidial infarction has changed considerably over the last decade. 
Accurate, rapid diagnosis and early risk stratification of patients presenting with chest pain 
are essential in order to identify those patients in whom early interventions can improve 
outcome.*^ Initial management of patients therefore involves an assessment of risk and 
triage into different risk categories. Risk assessment is a continuous process and its 
primary aim is to identify or exclude life-tlireatening conditions such as myocardial 
infarction and unstable angina. Initial management of AMI with ST~segment elevation 
differs fiom that of AMI without ST-segment elevation because of the presence of 
occlusive thrombus.
1.5.1 Diagnosis and early risk stratification
Early diagnosis and risk stratification of individuals presenting with acute chest pain is 
important to identify those individuals who are likely to benefit from early intervention.^^ 
Assessment of patients with suspected acute coronary syndrome is based on thi*ee criteria; 
clinical symptoms, electrocardiographic findings and measurements of biochemical 
markers.*^ Clinical symptoms include a history of severe, ischaemic chest pain lasting 20
minutes or more and not responding to nitroglyerine. An electrocardiogram (ECG) should 
be obtained as soon as possible and is rarely nonnal, even in the early stages of AMl/^ ST 
segment elevation or new left bundle branch block would be an indication for immediate 
reperfusion therapy/^ The majority o f patients with ST segment elevation ultimately 
develop a Q-wave AMI whilst only a minority develop a non-Q wave AMI. The ECG 
often takes time to evolve and may be equivocal in the early hours. ECG monitoring 
should be initiated early to detect anhythmias. Blood sampling for biochemical markers is 
routinely done in the acute phase. Cardiac troponin I and T are the preferred markers as 
they are more specific and reliable than creatine kinase or its isoenzyme creatine kinase 
MB. Cardiac troponin has nearly absolute myocardial tissue specificity as well as high 
specificity. Two dimensional echocardiography and perfusion scintigraphy may be helpful 
to exclude myocardial infarction.
1.5.2Pre-hospital or early in-hospital care
General treatment measures
Analgesia is important in the management of AMI, for pain relief and also to reduce 
sympathetic activation. A wide variety of analgesic agents have been used to treat the pain 
associated with AMI, but morphine remains the drug of choice. Oxygen should also be 
administered, especially if the patient is breathless or in shock.
Aspirin
Aspii'in is effective and is therefore indicated across the entiie spectrum of acute coronary 
syndromes. Aspirin forms part of the initial management strategy of patients with 
suspected AMI. The aim of aspirin treatment is to prevent formation of thromboxane A2 in 
platelets by cyclooxygenase inhibition, and therefore inhibit platelet aggregation^^ 
Convincing evidence of the effectiveness of aspirin was demonstrated by the ISIS-2 trial, 
in which it was shown that the benefits of aspirin and streptokinase were additive.’® 
Aspirin should be given to all patients with an AMI as soon as possible after the diagnosis 
is thought probable.
Nitrates
Nitrates increase coronaiy blood flow by coronaiy vasodilation and decrease ventricular 
preload by increasing venous capacitance. A meta-analysis of ten trials of early 
intravenous nitrate therapy showed an apparent mortality reduction.’^  However each of the
trials was small and subsequent studies including GISSI-3 and ISIS-4 failed to show any 
significant reduction in mortality.^’’’^ ’ The routine use of nitrates in the initial phase of 
myocardial infarction is not therefore recommended unless there is ongoing chest pain or 
evidence of coronary vasospasm’^
Beta adrenoceptor blockers
Beta adrenoceptor blockers relieve pain, reducing the need for analgesics, and reduce 
infarct size and the incidence of fatal aiThythmias. Many trials of intravenous beta- 
blockade have been done in the acute phase of AMI because of these potential effects. 
Pooling of 28 trials of intravenous beta-blockade showed a significant reduction in 
mortality at seven days.^^ However, these studies were carried out before the use of 
fibrinolysis and studies carried out since the widespread use of fibrinolysis do not support 
the routine early intravenous use of beta blockers.^^’^ '’ The American College of 
Cardiology recommends that it is reasonable to administer intravenous beta blockers in the 
acute phase of infarction but their use in the immediate treatment of AMI is very low in 
most countries^^ Oral beta blockers are commonly prescribed after the first 24 hours to 
patients without contraindications as part of secondary prevention.
Reperfusion therapy
It is recommended that all ST elevation AMI patients should undergo rapid evaluation for 
reperfusion therapy and have a reperfiision strategy implemented q u i c k l y . A M I  is a 
dynamic process that does not occur instantly but evolves over a period of hours. 
Persistent thrombotic occlusion is present in the majority o f patients with ST elevation 
AMI whilst the myocardium is undergoing necrosis.’^  There is evidence to suggest that 
rapid restoration of flow in the obstructed infarct aitery is an important determinant of 
short and longer term outcome following AMI, and most benefit is seen in those treated 
soonest after the onset of symptoms.^^’^  ^ An occluded artery can be opened by two main 
methods; administering of a thrombolytic or fibrinolytic agent or by primary percutaneous 
transluminal coronary angioplasty.
Thrombolysis
Tlirombolysis is the commonest reperfusion method used in ST segment elevation AMI, 
and there is a substantial body of evidence regarding the benefits of its use. For patients 
within 12 hours of the onset of symptoms, the overall evidence for the benefit of 
fibrinolytic treatment is overwhelming.’^  The Fibrinolytic Therapy Trialist’ analysis
showed that approximately 20 deaths aie prevented per 1000 patients treated who present 
with ST segment elevation AMI within six hours of symptom onset.^® The ISIS-2 study 
demonstrated the important additional benefit of aspirin, with a combined reduction of 
approximately 50 lives per 1000 patients treated.’® Overall the largest absolute benefit is 
seen in patients with the highest risk. Streptokinase is the most commonly used 
thrombolytic agent, though the choice of fibrinolytic agent will depend on an individual 
assessment of risk and benefit as well as availability and cost.
Primary angioplasty
Results of some randomised clinical trials have shown better clinical outcomes in patients 
receiving mechanical reperfiision than in those receiving pharmacological reperfiision.^^’^ ” 
Primary angioplasty mechanically disrupts the occlusive thrombus and compresses the 
underlying stenosis, thereby restoring blood flow.”  A metaanalysis of 23 randomised 
trials showed a 27% reduction in short term mortality when primary angioplasty was 
compared to fibrinolytic therapy.^” Primary angioplasty was also associated with a lower 
incidence of myocardial infarction, stroke and intracranial haemorrhage when compared to 
fibrinolysis.
The selection of reperfusion strategy should take into account a number of different factors 
including the time fi'om onset of symptoms, the mortality risk, risk of bleeding and 
transport time. In practice, in the UK, the availability of primary angioplasty is an 
important detennining factor in the choice of reperfusion strategy.
Treatment of AMI also involves the management of complications as they occur. This 
might include heart failure, shock, mechanical complications including cardiac rupture and 
mitral regurgitation as well as arrhythmias.
1.5.3Subsequent care
Management later in the hospital phase will be determined by the size of the infarct and by 
the presence of other comorbid diagnoses. Patients who aie asymptomatic and with 
minimum myocardial damage may go home after a few days, whilst those with more 
extensive necrosis or complications may require a longer hospital stay.
1.5.4Prevention and long term treatment
After myocardial infarction it is important to stratify patients according to their risk of 
subsequent coronary events, and to intei*vene in order to reduce the risk of subsequent 
events occuixing. In high risk patients, coronary interventions should be considered.^’ 
Clinical indicators of high risk in the early stage include persistent heart failure, malignant 
arrhythmias, and persistent chest pain or angina. Prevention of subsequent events involves 
lifestyle change as well as long term medical management.
Aspirin
There is good evidence to recommend long term antiplatelet treatment in patients who 
have had an AMI. This evidence comes mainly from a metaanalysis of 25 trials of 
antiplatelet therapy prescribed m the secondary prevention of cardiovascular disease.^^ 
This Antiplatelet Trialists’ Collaboration demonstrated a 25% reduction in re-infarction 
and death in post-infarct patients.
Beta Adrenoceptor Blockers
A  number of trials and metanalyses have shown that beta blockers reduce mortality and 
reinfarction by 20-25% in people post myocardial infarction.®®'^  ^ A metanalysis of 82 
randomised trials produced strong evidence for the long term use of beta blockers to reduce 
morbidity and mortality following a myocardial infarction.^^ Data suggests that beta 
blockers should be continued indefinitely in these patients.
Angiotensin converting enzyme (ACE) inhibitors
Evidence supports the use of ACE inhibitors post-myocardial infarction.®^’^  ^ A number of 
clinical studies have shown that ACE inhibitors reduce the rates of reinfarction and 
decrease the risk of developing heart failure with a consequential reduction in mortality. 
The effect of ACE inhibitors is thought to be greatest in people who have experienced 
heart failure in the acute event or who have reduced left ventricular function.^®
Statins
It is recommended that lipid lowering agents should be prescribed in accordance with 
guidelines derived ftom a number of clinical trials.^ "^^  ^ The European Society of 
Cardiology recommends that patients are prescribed statins if, in spite of dietary measures,
total cholesterol levels are gi'eater than 4.9 inmol.l ’and or LDL eholesterol levels of 2.97 
mmol.r’ still persist. ”
Lifestyle changes
Stopping smoking is potentially the most effective of all secondary prevention measures. 
Evidence from observational studies suggests that following an AMI, people who stop 
smoking have more than a 50% reduction in mortality compaied to those who continue to 
smoke.'’^  Diet is also important and a Mediterranean type diet which is low in saturated fat 
and high in polyunsaturated fat and in fruit and vegetables, has been shown to reduce the 
rates of recurrent events in patients following thefr first AMI.'’'’ Fish oils are also 
associated with a reduction in mortality post AMI.'’^  Physical activity is also important and 
is thought to reduce mortality and to improve well-being and cardiorespfratoiy fitness.'’^ ’'’^
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2 LITERATURE REVIEW
2.1 Scope
A MEDLINE (1966-2004) seai'ch on appropriate subject headings yielded over 200,000 
items. The subject headings used were: acute myocardial infai'ction, population, 
epidemiology, diagnosis, prognosis, survival, incidence, prevalence, mortality, 
revascularisation, trends, length of stay, socioeconomic deprivation, heart failure, atrial 
fibrillation, renal failure, hypertension, diabetes, cancer, peripheral vascular disease, 
angina, coronary heait disease, sex factors, sex characteristics, and women’s health. 
Searches were combined and restricted to naiTow the search. The search strategy was then 
repeated in EMBASE (1980-2004), using the synonymous EMBASE subject headings, and 
was extended by using lateral references.
The scope of the literature review aimed to encompass the following areas:
1. The epidemiology of first and second AMI including the incidence of the diagnosis 
with an emphasis on sex differences.
2. Temporal trends in the incidence of first and second AMI.
3. Baseline characteristics of men and women who are hospitalised with first and second 
AMI.
4. Temporal trends in the baseline characteristics of men and women hospitalised with 
first and second AMI.
5. The aetiology and pathophysiology of acute myocardial infai'ction in men and women.
6. Short and longer term survival of men and women with a diagnosis of first and second 
acute myocardial infarction.
7. Factors affecting survival following hospitalisation with first and second AMI in men 
and women.
8. Temporal trends in survival following hospitalisation with first and second AMI.
9. The potential mechanisms behind sex differences in survival from acute myocardial 
infai'ction.
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2.2 Epidemiology of Acute Myocardial Infarction
The literature describing the epidemiology of acute myocardial infarction is extensive and 
varied. As in many ai*eas of clinical epidemiology, there is a lack of uniformity and 
consistency between studies. Consequently, it is often difficult to make valid comparisons 
between data. Sex-specific data aie not always reported in the literature, especially in 
older studies.
2.2.1 Study types and sources of data
Different studies have been designed to address particulai' questions. Data aie principally 
available ftrom four types of studies:
1. Population-based studies using hospital discharge data that are principally used to 
examine trends in hospitalisation.
2. Clinical trials and registries.
3. WHO MONICA Project studies caiiied out in 21 countries and within defined 
populations and set up to measure trends in CHD event rates, case-fatality, risk factors 
and acute coronary care over a 10 yeai* period.
4. Cohort Studies such as the Framingham Study.
Not all studies have involved men and women, and women are undoubtedly 
underrepresented in clinical trials as they tend to focus on younger, male patients. The 
results of such studies are not always generalisable therefore to the general population of 
myocardial infarction patients.
2.2.2 Incidence of Acute Myocardial Infarction in men and women
A considerable number of studies have described incidence of myocardial infarction. 
Many of these studies were designed to examine trends over time and therefore report 
incidence data ftom more than one time period. A significant proportion do not report sex- 
specific data.'’® The majority o f studies report on incidence of hospitalised AMI, though a 
growing number including many of the MONICA studies, include out of hospital events.'’^ " 
The definition of incident event varies according to the methodology employed. Many 
studies do not differentiate between first and subsequent events and report attack rates.
12
Some studies using routine data are able to link records belonging to the same individual 
and thereftre identify the first record belonging to that individual during a specified time 
period. Others involve examination of case notes or of electrocardiograms for evidence of 
previous events.
The Rochester Epidemiology Project used routine data to identify all individuals 
hospitalised with AMI between 1979 and 1994 (Table 2) '^’ The case notes of these 
individuals were then examined in order to validate the diagnosis and to identify incident 
events. Researchers identified 1820 incident AMIs between 1979 and 1994, 44% of 
incident infarctions occuned in women. Age adjusted incidence rates were reported. In 
1994, the age adjusted annual incidence was 260 per 100,000 in men and 180 per 100,000 
in women. Sex-specific median age was not reported. The Minnesota Heart Survey 
randomly selected a 50% sample of all case notes of individuals aged 30-74 years 
dischaiged ftom hospital with a diagnosis of acute CHD in the Twin Cities of Minneapolis 
and St Paul in 1985 and 1990.^  ^ Standardised criteria were use to validate a diagnosis o f 
AMI and first and recurrent events were distinguished by examining medical records. 
Over the course of 1985 and 1990, 4500 incident AMIs were identified. Of these, 
approximately 30% were in women. In 1990, the age adjusted annual incidence of first 
AMI was 298 per 100,000 in men and 107 per 100,000 in women. Neither the Rochester 
Epidemiology Project nor the Minnesota Heart Survey reported age specific incidence 
rates in men or in women. The Worcester Heait Attack Study examined temporal trends in 
the incidence of first AMI between 1975 and 1988.^’’ The study sample comprised all 
3,148 individuals hospitalised with validated first AMI in Worcester, Massachusetts. 39% 
were women. In 1988, the age-adjusted incidence rate of first AMI was 240 per 100,000 in 
men and 137 per 100,000 in women. The mean age of women was 71.7 years, 7.8 years 
older than men. The Atherosclerosis Risk in Communities Study (ARIC) examined 
incidence of CHD in four communities in the United States in individuals aged 35 to 74 
y e a rs .F irs t  events were identified and the diagnosis validated. In 1994, the age adjusted 
incidenee of first AMI was 180 per 100,000 in women and 410 per 100,000 in women. 
The Toulouse MONICA Study reported incidence rates for first AMI in individuals aged 
35 to 64 years living in the French department of Haut e-Garonne.^® In 1993, the age 
adjusted incidence rate for first AMI was 162 per 100,000 in men and 29 per 100,000 in 
women. These rates aie lower than those reported by other studies and this is likely to 
reflect a lower prevalence of coronary heart disease in this population as well as a younger 
population. These studies have been consistent in their findings that incidence of
13
hospitalised AMI is greater in men than in women and that women are on average older at 
the time o f  their first presentation with AML
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2.2.3 Trends in incidence of AMI in men and women
The majority of studies describing incidence of hospitalised AMI have attempted to 
determine whether incidence and often survival have changed over time. All of the studies 
described above have examined temporal trends in AMI incidence in men and in women. 
Most of the studies examining trends in incidence of AMI are fi'om the United States and 
there are few large British studies that have described temporal trends in men and women. 
Comparing the magnitude of changes between different studies is not straightforward as 
change is ftequently measured using different parameters and in different population 
groups. The majority of studies have reported declining incidence in first AMI, though the 
overall and the age and sex-specific estimated magnitude of change ai e not consistent. The 
Minnesota Heart Survey reported non-significant declines in incident AMI of 5% in men 
and 4% in women between 1985 and 1990 (Table 3).^  ^ Age-specific changes were not 
reported. Actual figures were not reported. In the Toulouse MONICA Study, there was a 
2% decline in the incidence of AMI in men and a 2.5% decline in women between 1985 
and 1993.^  ^ This decline did not reach significance in women and age specific changes 
were not reported, presumably because of relatively small numbers. A number of studies 
have reported differences between men and women in the temporal trends of first AMI 
i n c i d e n c e . I n  the Worcester Heart Attack Study, the age-adjusted incidence rates of 
initial AMI showed an overall decline of 26% in men and 22% in women between 1975 
and 1988.^  ^ Temporal trends varied according to age and sex, tending to increase in 
magnitude with increasing age. The Rochester Epidemiology Project reported different 
trends in AMI incidence fi'om 1979 to 1994 according to age and sex.^  ^ The age adjusted 
incidence of AMI increased in women by 2.1% per year between 1979 and 1994 
(significant increase of 36% over the study period). In men age adjusted incidence 
decreased by 0.5% per year (non-significant decrease of 8% over the study period). The 
dftection and magnitude of change vai ied according to age and sex. The greatest declines 
in incidence were seen in young men and the largest increases in elderly women. In the 
ARIC Study, the age adjusted incidence o f hospitalisation for fii'st AMI m men and women 
changed little between 1987 and 1994.^  ^ Analysis of age and sex-specific incidence rates 
revealed a significant increase of 4.6% per year in men aged 55-74 years, but not in any 
other age groups. The National Hospital Discharge Survey examined AMI hospitalisation 
rates in the United States between 1988 and 1997. The study reported stable age adjusted 
rates in men and women during this period although actual figures were not provided. In a 
recent report of the National Health and Nutrition Examination Survey Epidemiological 
Follow-up Study, the age standardised incidence of first AMI was non-significantly lower
16
among white and black men during 1982-1992 as compared with 1971-1982 but increased 
significantly by 21% among white women. Many of the MONICA Studies have described 
temporal trends in incidence of AMI. However the majority of studies have included out 
of hospital AMI deaths as well as hospitalised AMI and have excluded individuals aged 
greater than 64 years old.^^’^ ’^^* Although inclusion of out of hospital deaths is a more 
accurate reflection of the real incidence o f AMI, it is not comparable with many other 
studies that have included only hospitalised AMI.
17
III.a
I
1
I
I
I
.aI
IH
11
% 8 M t3
■gS’B
n11l'a11
« 'ë'
o
•S11#:'-"3 -g -a 
h  cj 3  j 3 .....................2 6 #  S §
§, é % 1 VD<f a 3; § 1 1 7nti! * o\ 2' ë ë i
g '% a .rg
o u a 1:3
! l l
Eliÿ> '^S g ÊA il
& . |li î l inlli
% Ji :ÜPi -O K C
i„s s
o,
IIII
bQ.
}l
a api
Os
J>§
a
l i l i
i s ^ 2
^  o  cTg^@2&
^ ‘S
l i î
5R
M- -=1- '51- M-•V 'tto lO lo >o oo(S lo  \ o  t ' '  AD « ni o 4> 61) tSp %  W) M
gg
iri
OJ) W) < <
w r- Aeo M 00 < < <
-ë
I
1
I
-gimIH
II
1) «+H
111
■c.a u‘-Q
“°III
§)|
II
ÎjI
III
.a
s
Ml
^ 8 iS <
tpi
Z
i l ï
îllll
§
a o —I (/) 3 --*
py fjH co
o>
Tl
2,3 Factors affecting incidence of AMI in men and women
2.3.1 Socioeconomic deprivation
There are many studies that have examined the relationship between socioeconomic 
deprivation and coronary heart disease. There are few studies that have examined the 
relationship between socioeconomic deprivation and incidence of coronary heart disease or 
AML The measurements used to determine socioeconomic deprivation vary and it is 
difficult to make valid comparisons between studies. A number of studies and reviews of 
the literature have focussed on psychosocial factors and coronary heart disease and the 
relationship between these factors and socioeconomic deprivation is c o m p l e x . S o m e  
studies have only included men.*"^ '^ ’ In addition many studies have looked at the 
relationship between socioeconomic deprivation and coronaiy heart disease mortality, 
rather than incidence and suivival.^^’^ *’^ ’^^  ^ It is therefore difficult to disentangle the 
different effects and to determine how socioeconomic deprivation might interact with these 
different indices. Different indicators of socioeconomic status including education, income 
and occupation as well as composite measures have been associated with coronary heart 
disease risk factors, morbidity and m o r t a l i t y . A  number of studies have looked at the 
association between socioeconomic status and coronary heart disease. The Minnesota 
Heart Suiwey described the distribution of coronary heart disease risk factors in different 
socioeconomic groups defined by education and income levels. "^^  It found that education 
was significantly and inversely related to blood pressure, cigaiette smoking and body mass 
index. Education was positively associated with physical activity and health knowledge. 
Women had healthier risk profiles overall. Associations with household income were less 
consistent in magnitude and diiection. The Glasgow MONICA Study investigated the 
relationship between socioeconomic group and incidence of AMI in men and women 
between 1985 and 1991.^  ^ Socioeconomic status was derived from the postcode of 
residence using the Carstairs and Morris deprivation score. They found that coronary 
event rates increased 1.7 fold in men and 2.4 fold in women horn the least to the most 
deprived socioeconomic quarter. The socioeconomic gradient was steeper in women. The 
INTERHEART Study used a case control design to examine the relationship between 
psychosocial factors and the risk of AMI in 24,767 men and women in 52 countries.^^ The 
study found that the presence of psychosocial stressors including financial stress was 
associated with an increased risk of AMI. The effects were similar in men and women. 
The FINMONICA Study examined the relationship between socioeconomic status and
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incidence of AMI in men and women aged 35 to 64 years/^ Age adjusted incidence of 
first AMI was higher in men and women with low incomes compared to those with higher 
incomes. The age adjusted incidence rate ratios were 1.67 (1.57-1.78) in men and 1.52 
(1.38-1.68) in women in the low income categoiy compared with the high income 
category.
2.3.2Age
The vast majority of studies that have examined incidence or survival following AMI have 
included a deseription o f the age distribution of the patients involved. Not all studies have 
included sex specific figures. In addition a number of studies have used inclusion or 
exclusion criteria, often based around age or coronary care admission, which introduce a 
selection bias into the age distribution of individuals included. The only studies that can be 
used to examine distribution of age in individuals hospitalised with AMI aie therefore 
population based studies. All studies have shown that women are on average older than 
men at the time of admission to hospital with an AMI. The National Registry of 
Myocardial Infarction 2 included all consecutive hospitalisations with AMI between 1994 
and 1998. The study excluded individuals aged less than 30 years or greater than 90 
years.^^ Within these confines, the mean age of men was 65.6 years compared to 72.4 
years in women. The Yorkshire AMI Study included all consecutive hospitalisations with 
AMI during a three month period in 1995. Women were on average seven years older than 
men with a mean age of 74.9 years (SD 10.9) compared to 68.0 years (SD 11.9) in men. In 
the Goteborg Study, which included consecutive hospitalisations with AMI between 1986 
and 1987, the median age of men was 69 years compared to 76 years in women.^^ The 
Alberta Health and Wellness database contains infonnation on 15,809 men and 7158 
women hospitalised with an AMI between 1993 and 2000.®° It is a population based study 
that includes all individuals admitted to hospital over the age of 18 years. The median age 
of women during this time was 73 years compared to 64 years in men. The Worcester 
Heart Attack Study is a population based study that involved the analysis of survival in all 
men and women hospitalised with a first AMI between 1975 and 1988.^  ^ The mean age of 
men was 71.7 years compared to 63.9 years in women who were therefore on average 7.8 
years older than men at the time of their first AML In the Framingham Study the incidence 
of cardiovascular disease increased more steeply with age in women than m men, so that 
the rates almost converged at 85-94 years.®* The rate of development of coronary heart 
disease in women increased three-fold from age 35-64 years to 65-94 yeai's, whereas in
2 1
men it increased 2.25 fold. Women lagged behind men in the incidence of cardiovascular 
disease by ten years.
Comorbidity
There is a substantial amount of data relating to the prevalence of comorbid conditions in 
individuals hospitalised with AMI. However there is a lack of consistency regarding these 
data. Different comorbid conditions have been included by different studies and the 
definition of these conditions is not standardised. For example, hypertension is frequently 
included as a comorbid condition but the parameters of this diagnosis are rarely included in 
the methods. It is not always clear whether the comorbid diagnosis preceded the AMI or 
developed subsequently to the index event, for example heart failure. Also few studies 
include only first events so that comparison is difficult. In addition a number of studies 
have looked at survivors, the definition of which vary and may introduce significant 
selection bias.
2.3.3 Diabetes
Many studies that have explored survival following AMI have looked at the prevalence of
diabetes (Table 4). There is wide vaiiation in repoifed prevalence of diabetes in
individuals hospitalised with AMI. In the Northern Sweden MONICA Project, 14.9% of
men and 19.7% of women hospitalised with AMI had a diagnosis of diabetes.®  ^ This sex
difference was statistically significant. These admissions were not necessarily first AMIs.
In the ISIS-3 Study, women hospitalised with AMI were more likely to have diabetes than
men.®® The prevalence of diabetes increased with age in both sexes. 14% of women aged
less than 60 years had a diagnosis of diabetes compared to 7% of men. This figure rose to
18% in women and 12% in men aged greater than 69 yeai*s. The National Registry of
Myocardial Infai'ction 2 is a prospective study that enrolled consecutive patients
hospitalised with AMI.^® Between 1994 and 1998, 229,313 men and 155,565 women were
included in this study. The mean age of men was 65.6 years compaied to 72.4 years in
women. Of these 25% of men and 33% of women had a history of diabetes ascertained on
case note review. Younger women were more likely than younger men to have a history of
diabetes. This sex based difference was not apparent in older age groups. The Gerona
Heart Registry (The REGICOR Study) recorded information on all individuals aged less
than 75 years hospitalised with a fii'st Q wave infarction between 1978 and 1997.®^ * Of
these, 18% of men and 46% of women had a history of diabetes. The prevalence of
diabetes varied with age in men and women so that 16% of men and 43% of women aged
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less than 65 years had a diagnosis of diabetes rising to 23% in men and 48% in women 
aged 65 to 74 yeai's. A prospective study examined risk factors and survival in 2196 
consecutive patients hospitalised with AMI in Yorkshire in 1995.®^  The cohort included 
2153 people of whom 60% were men. Of these, 11% of men and 16% of women had a 
diagnosis of diabetes, as detennined by case note review. The mean age of men was 68 
years compared to 75 years in women. This sex difference was statistically significant. 
The Goteborg Study examined baseline characteristics and survival in 300 women and 621 
men who were hospitalised in Goteborg, Sweden with an AMI between 1986 and 1987.^  ^
The median age of the patients was 69 years in men and 76 years in women. 11% of men 
and 15% of women had a histoiy of diabetes. This sex difference was not statistically 
significant. In the Alberta Health and Wellness Database, 16% of men and 22% of women 
hospitalised with an AMI had a diagnosis of diabetes on their discharge record.®** The 
median age of men was 64 years compared to 73 years in women. The TRACE Study 
examined baseline characteristics and survival in 2170 women and 4501 men admitted to 
coronary care units ion Denmark between 1990 and 1992.®^  Women were on average five 
years older than men with a median age of 72 years in women compared to 67 years in 
men. Overall 14% of women and 9% of men had a diagnosis of diabetes based on then 
medical histoiy derived through interview and case note analysis. The prevalence of 
diabetes increased with age in both sexes but remained higher in women than in men at all 
ages. The Worcester Heart Attack Study examined trends in incidence and survival of first 
AMI between 1975 and 1988.^  ^ Comorbid diagnoses were determined tlnough 
examination of case notes. 16% of men and 27% of women hospitalised with a first AMI 
had a history of diabetes. This sex difference was statistically significant.
2.3.4Heart failure
There is a lack of data examining the risk of AMI in men and women with heart failure. 
There are however numerous studies that have examined the prevalence of heai't failure in 
individuals hospitalised with AMI (Table 5). In the Northern Sweden MONICA Project, 
6.5% of men and 7.6% of women hospitalised with an AMI, had a clinical diagnosis of 
heai't failure at the time of discharge.®  ^ These proportions were not significantly different 
between men and women and heart failure was not defined using uniform diagnostic 
criteria. In the National Registry of Myocardial Infarction 2, 13% of men and 21% of 
women had a histoi-y of congestive cardiac failure.^® Again, younger women were more 
likely than younger men to have a diagnosis of heart failure though this difference was not 
apparent in older age groups. In the REGICOR Study which examined baseline
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characteristics in individuals hospitalised with a first AMI, 8% of men and 19% of women 
had a history of cardiac failure.®"* The prevalence increased substantially with age in both 
sexes so that 6% of men and 14% of women aged less than 65 yeai's had a history of 
cardiac failure, rising to 11% in men and 23% in women aged 65 to 74 years. In the 
Yorkshire AMI Study, 9% of men and 11% of women hospitalised with AMI had a 
previous history of heart failure (p=0.08).®  ^ In the Goteborg Study, 18% of men and 29% 
of women had a histoiy of congestive cardiac fa ilu re .T h e  diagnosis of heart failure was 
made on clinical histoiy. In the Alberta Health and Welhiess database, 26% of women and 
17% of men had a diagnosis of previous congestive heai't failure on their discharge 
record.®** This sex difference was statistically significant. In the TRACE Study 50% of 
men and 60% of women had a diagnosis of congestive heart failure.®  ^ The prevalence of 
this diagnosis increased with age so that only 24% of men and 27% of women aged <55 
years had a diagnosis of congestive heart failure rising to 73% of men and 74% of women 
aged greater than 75 years. This diagnosis included those individuals with a prior history 
of heaif failure as well as those who developed heart failure during the index admission.
2.3.5Hypertension
Blood pressure measurements have often been included in baseline measurements of 
individuals hospitalised following AMI. However the definition of hypertension is not 
consistent. The ISIS-3 Study included measurement of systolic blood pressure which was 
categorised into three groups, <100, 100-174 and M75 mm Hg.®® Only 6% o f men and 
women aged less than 60 years hospitalised with AMI had a systolic blood pressure greater 
or equal to 174 mm Hg. This figure increased with age rising to 10% of women and 9% of 
men aged greater than 69 years. The distribution of systolic blood pressure was similar in 
men and women (Table 6). In the Framingham Study the incidence of cardiovascular 
disease was noted to rise in men and women in relation to their blood pressure without any 
evidence of a critical value.®* In the Rochester Epidemiology Project, 89% of women and 
56% of men who survived 30 days following hospitalisation for theii' first AMI between 
I960 and 1979, had a diagnosis of hypertension.®^ The definition of hypertension was not 
described in the paper. In the National Registry of Myocardial Infarction 2 Study, 47% of 
men and 59% of women had a histoiy of hypertension as recorded in medical case notes.^® 
In the REGICOR Study, 40% of men and 61% of women had a history of hypertension.®"* 
The prevalence increased with age so that 38% of men and 53% of women aged less than 
65 years had a diagnosis of hypertension rising to 45% of men and 66% of women aged 
65-74 years. These sex differences were statistically significant. In the Yorkshire AMI
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Study, 25% of men and 36% of women had a diagnosis of hypertension (p<0.001).®® In 
the Goteborg Study 31% of men and 44% of women had a history of hypertension 
(p<0.001)7^ In the Alberta Health and Welhiess Database which used routine coding at 
discharge to identify comorbid diagnoses, 29% of men and 40% of women had a diagnosis 
of hypertension at discharge.®** In the TRACE Study 20% of men and 28% of women had 
a diagnosis of systemic hypertension.®^ In the Worcester Heart Attack study 54% of 
women and 40% of men hospitalised with a first AMI had a history of hypertension
(p<0.001).®^
2.3.6 Renal impairment
Few of the large epidemiological studies that have examined baseline characteristics and 
survival in individuals hospitalised with AMI have included renal impairment in their 
description of baseline characteristics of men and women. Different definitions have been 
used to measure renal impairment and most studies have categorised patients on the basis 
of renal function and have not provided sex specific data. The Medicare Study looked the 
independent effect of chronic kidney disease on case fatality in 559 hospital survivors of an 
AMI who had been admitted to hospital in 1998 (Table 8).®® Creatinine clearance was 
estimated using the Cockcrofl-Gault equation. Chronic kidney disease was defined on the 
basis of a creatinine clearance of less than 60ml/min. The mean age of this cohort was 
73.8 years and clironic kidney disease was present in 48.7% of men and 72.7% of women. 
The Cooperative Cardiovascular Project examined the association between renal 
insufficiency and case fatality following AMI in 130,099 individuals hospitalised with 
AMI between 1994 and 1995.®^  Renal impairment was defined according to creatinine 
clearance and women accounted for 48% of the study sample. Approximately 41% of men 
and 33% of women had mild or moderate renal impairment (figures are estimated as sex 
specific data were not reported). The Mayo Clinic Study examined survival in 3106 
individuals admitted to coronary care with an AMI between 1988 and 2000.**** Renal 
impairment was defined according to creatinine clearance which was estimated using the 
Cockcro fl-Gault equation. Overall, 47% of men and 76% of women had a degree of renal 
impairment, although the prevalence increased substantially with age. In the Alberta 
Health and Wellness Database 3% of men and 4% of women hospitalised with an AMI had 
a diagnosis of clironic renal disease made at discharge.®** This sex difference was 
statistically significant. A recent study of individuals admitted to Veterans Affairs 
Hospitals looked at the independent effect of renal insufficiency and seven month case 
fatality following hospitalisation with unstable angina and AMI.*** Sex specific figures
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were not reported and only a very small number of women were included in the study 
which comprised approximately 98% men. Of the 2706 individuals with acute coronary 
syndrome, only 16% had normal renal function, 43% had mild renal insufficiency and 41% 
had moderate or severe renal insufficiency. Renal insufficiency was based on the 
estimated glomerular filtration rate which was calculated using the abbreviated 
Modification of Diet in Renal Disease Study Equation. The study sample was older 
relative to other studies of AMI and the prevalence of renal insufficiency increased with 
age.
2.3.7 Previous AMI
The estimates for the proportion of men and women hospitalised with AMI who have a 
previous history of AMI vaiy substantially between different studies. Different methods 
and definitions have been used to determine which individuals have had a previous AMI. 
In some studies the diagnosis is based on case note review or on interview and in others on 
examination of ECGs. In the Northern Sweden MONICA Project 73.5% of men and 
75.0% of women who were hospitalised with an AMI were reported to have had a previous 
AMI (Table 9).®^  The study only included individuals aged 35 to 64 yeais and previous 
AMI was diagnosed tlrrough examination of case records and on inteiview with the patient 
when appropriate. Other studies have reported lower prevalence rates. In the National 
Registry of Myocardial Infai'ction 2 Study, 28% of men and 24% of women had a history 
of previous AMI.^® Men were more likely than women to have a history of previous AMI 
at all ages. In the Goteborg Study, 32% of men and 28% of women had a previous AMI.^ ** 
The study included an unselected cohort of all AMIs with a median age of 69 years in men 
and 76 years in women. In the Yorkshire AMI Study which again included all consecutive 
hospitalisations for AMI, 29% of men and 21% of women had a history of previous AMI.®® 
The mean age o f  men in this study was 68 years compared to 74.9 years in women. In the 
TRACE Study, 25% of men and 19% of women hospitalised with AMI had a previous 
history of AMI.®  ^ The prevalence of previous AMI increased with age especially in 
women in whom only 8% of those aged less than 55 yeai’s had a previous histoiy of AMI 
rising to 22% in those aged greater than 75 years.
2.3.8 Previous angina and coronary heart disease
A number of studies have included a previous histoiy of angina in their description of 
baseline characteristics of individuals hospitalised with AMI (Table 10). The estimates of
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prevalence vary, partly because studies have used different definitions of angina. Age 
specific figures are rarely reported. In the National Registry of Myocaidial Infarction 2 
Study, 18% of men and women had a previous history of angina on admission to hospital 
with an AMI.**® Women were slightly less likely than men to have a history of angina in 
the older age groups. The study excluded individuals aged 90 years and over as well as 
people transferred to other hospitals. In the Yorkshire AMI Study, 37% of men and 
women had a previous history of angina as documented in medical case notes.®® In the 
Goteborg Study, 45% of men and 51% of women had a history of angina reported at 
interview.^** Both the Yorkshire Study and the Goteborg Study included individuals of all 
ages in a non-selected cohort. In the REGICOR Study, 47% of men and 51% of women 
hospitalised with a first AMI and aged less than 75 yeai's had a history of angina.®"* The 
prevalence increased only slightly with age in both sexes. In the Established Populations 
for the Epidemiologic Studies of the Elderly project. (The EPESE Study) 43% of men and 
51% of women had a documented histoiy of a n g i n a . T h i s  study only included 
individuals aged 65 yeais or over. In the Framingham Study, 21% of men and 25% of 
women with a diagnosis of first AMI that included clinically unrecognised AMI, had a 
diagnosis of pre-existing angina.**® In the TRACE Study, 36% of men and 38% of women 
hospitalised with AMI had a diagnosis of angina.®  ^ This sex difference was not 
statistically significant.
2.3.9 Atrial fibrillation
There are a number of studies that have examined the prevalence and prognostic 
significance of atrial fibrillation in men and women hospitalised with AMI, including 
clinical trials (Table 12). As with many of the other comorbid diagnoses, it is not always 
clear from the literature whether the diagnosis preceded the index AMI or arose subsequent 
to it. It is also difficult to determine sex differences because sex specific data are rarely 
presented presumably because the data categorisation is usually based on the presence or 
absence of the comorbid condition. The Cooperative Cardiovasculai* Project examined 
prevalence and outcome of atrial fibrillation in 106,780 men and women aged greater than 
64 years who were hospitalised following an AMI.**'* Diagnosis of atrial fibrillation was 
based on the patient’s ECG report. A similai’ proportion of men and women, 
approximately 22%, had a diagnosis of atrial fibrillation. 47% of men and 51% of women, 
who had a diagnosis of atrial fibrillation, had this diagnosis on arrival to hospital. Women 
were therefore more likely to present with atrial fibrillation. This difference was 
statistically significant, p=0.001. The prevalence of atrial fibrillation increased with age,
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though analyses were not sex specific. The TRACE Study found a similar overall 
prevalence of atrial fibrillation in its study population which comprised 6676 consecutive 
patients hospitalised with AMI between 1990 and 1992.^ ® 23% of women and 20% of men 
had a diagnosis of atrial fibrillation, either aiising before or during hospitalisation. The 
Worcester Heart Attack Study reported a prevalence of atrial fibrillation of 14.7% in men 
and 18% in women following hospitalisation with AMI.^ ** This figure included new and 
chronic cases. In the Optimal Trial in Myocardial Infarction with the Angiotensin II 
Antagonist Los art an, 12.2% of men and 11.4% of women had atrial fibrillation at 
baseline.^^ These figures did not include new onset atrial fibrillation. The global use of 
strategies to open occluded coronary arteries (GUSTO III Trial) reported similar 
prevalence figures of 11.9% in men and 12.6% in women.**® A Japanese Study examined 
the prevalence of atrial fibrillation in 1039 individuals hospitalised with AMI between 
1985 and 1995.^ ** 10% of men and 9% of women either had a histoiy of atrial fibrillation or 
developed atrial fibrillation during theii" admission. The distribution of age in men and 
women was not described and sex specific data were not reported. Other studies have 
looked at the risk of developing atrial fibrillation in individuals hospitalised with AMI. 
The Gmppo Italiano per lo Studio della Sopravvivenza nellTnfarto Miocardico (GISSI-3 
Study) examined the incidence of new-onset atrial fibrillation in 17,749 individuals 
hospitalised with AMI.***** The study excluded those individuals who had a diagnosis of 
atrial fibrillation on admission to hospital. Overall 7.2% of men and 10% of women 
developed atrial fibrillation during theii* hospital admission (p<0.Q01).
2.3.10 Chronic obstructive Pulmonary Disease
Few studies have included chronic obstructive pulmonary disease (COPD) in then 
description of baseline characteristics of men and women hospitalised with AMI (Table 
11). The Yorkshire AMI Study reported a previous histoiy of COPD in 15% of men and 
14% of women who were hospitalised with AMI.®® In the SPRINT Trial, 7.5% of men and 
5.5% of women hospitalised with AMI had a diagnosis of COPD.**** The prevalence of 
COPD increased with age and was more common in men. The Cooperative 
Cardiovascular Project examined the prevalence of COPD and asthma in 54,962 patients 
hospitalised with AMI between 1994 and 1995 who did not have contraindications to beta- 
b locker therapy. ***^ 18.7% of women and 21 % of men had a diagnosis of COPD or asthma 
and this diagnosis was classified as being severe in 15% of women and 23% of men. The 
TRACE Trial examined the prevalence of COPD in 6676 individuals hospitalised with 
AMI between 1990 and 1992.***® Histoiy of COPD was obtained either fiom medical case
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notes or on inteiview of the patient. 12% of men and 11% of women hospitalised with 
AMI had a history of COPD. Sex specific data were not reported. A small study in 
Newcastle Upon Tyne in the UK, examined the prevalence of COPD in 60 consecutive 
admissions to coronaiy care with inferior AMI.***"* COPD as defined by forced expiratory 
volume and vital capacity was found in 46% of patients. Sex specific data were not 
provided.
2.3.11 Other vascular diseases
Few studies have included other vascular diseases in their description of baseline 
characteristics of men and women hospitalised following AMI. The Framingham Study 
reported long tenn survival and prevalence of pre-existing cardiovascular conditions in 532 
men and 296 women who experienced theii* fii*st AMI during the 34 year follow up period 
between 1948 and 1982.**® 9% of men and 11% of women had a diagnosis of intennittent 
claudication made on the basis of a standardised interview. Intermittent claudication was 
the most common pre-existing cardiovasculai* condition after angina. The average age of 
the individuals was not reported and the diagnosis of AMI included those individuals with 
a ‘silent’ AMI. These clinically uni*ecognised AMIs accounted for 30% of all AMI 
diagnoses in men and 38% in women. 5% of men and 8% of women had a history of 
stroke or TIA. The SPRINT Trial examined the prevalence and prognostic significance of 
peripheral vascular disease in 4258 individuals hospitalised with a fii'st AMI.***® The 
prevalence of PVD was similar in men and women with 6.4% of men and 6% of women 
having a diagnosis of PVD based on clinical histoiy and physical examination.
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2.4 Temporal trends in baseline characteristics of men and 
women
Age
There are few data describing trends in the baseline characteristic of men and women 
hospitalised with AMI. Many studies exclude individuals over a certain age or only 
include those admitted to coronary care units. This introduces bias and does not provide an 
accurate reflection of the AMI population age structure. Very few studies only include 
individuals with flist events so that they comprise a mix of first and recuiTent events which 
tend towards different age profiles. The Ontario Study described trends in the 
demographic and comorbidity chaiacteristics of 89,456 patients admitted to hospital 
between 1992 and 1996.^^  ^ In this study there was an overall trend towards an increasing 
proportion of older AMI patients. The median age of men and women rose from 68 years 
in 1992 to 69 years in 1996. Sex specific figures were not reported. In the Nottingham 
Heart Attack Register the mean age of men and women hospitalised following an AMI 
increased between 1982 and \992}^^ The mean age increased from 67.6 years in women 
and 60.7 years in men in 1982 to 69.7 years in women and 64.8 years in men in 1992. 
These trends were significant. The proportion of male patients also fell during this time. 
In 1992 men accounted for 79% of the total population fallmg to 63% in 1992. In the 
SPRINT Registry, the mean age on hospitalisation with AMI between 1981-3 and 1992-4, 
remained relatively stable in men whilst the mean age of women increased by 
approximately one year, from 67.3 years to 68.4 y e a r s . I n  the Worcester Heart Attack 
Study, the mean age of individuals hospitalised with AMI increased from 65.4 years in 
1975-1978 to 72.5 years in 2001.^^  ^ Sex specific data were not reported. None of these 
data distinguish between first and subsequent events.
Comorbid diagnoses
The SPRINT Registry examined trends in baseline characteristics of men and women with 
AMI admitted to coronary care in 1981-3 and 1992-4. The prevalence of diabetes 
increased in men and women. In 1981-3, 18% of men and 29% of women had a diagnosis 
of diabetes. By 1992-4, this figure had increased to 23% m men and 35% in women. The 
prevalence of hypertension remained relatively stable whilst the prevalence of previous 
angina decreased during the study period. In the Ontario Study the proportion of most 
patient comorbidities remained relatively stable between 1992 and 1996.'^^ The proportion
39
of individuals with a secondary diagnosis of diabetes with complications rose from 1.6% in 
1992 to 2.3% in 1996. The proportion of individuals with a congestive heart failure 
diagnosis rose slightly from 19.3% to 21.5% over the same time period. Neither the sex 
specific figures nor the statistical significance of these trends were reported. The National 
Hospital Discharge Survey examined the prevalence of comorbid diagnoses in hospital 
discharges for AMI between 1988 and 1997.^  ^ The study however reported data relating to 
episodes rather than individuals and reported few sex specific analyses. Overall it found 
that the prevalence of diagnosed hypertension increased by 62%, a mean annual increase of 
6%. By contrast the prevalence of diabetes remained stable. The Worcester Heart Attack 
Study examiued changes over time in the demographic characteristics of individuals 
hospitalised with AMI.*^  ^ The study found that with the exception of previous angina, the 
prevalence of comorbid diagnoses increased in hospitalised patients between 1975-1978 
and 2001. There was an increase in the prevalence of heart failure, diabetes, hypertension 
and stroke during this time. For example the prevalence of heart failui'e increased from 
13.9% in 1975-8 to 25.5% in 2001. Hypertension increased in prevalence from 41% to 
68.7%. Sex specific data were not reported. The Minnesota Heart Survey examined trends 
in coronary heart disease hospitalisations and deaths in residents of Minnesota between 
1985 and 1990.^  ^ It also looked at trends in coronary heart disease risk factors through 
surveys of the Minnesota population between 1985 and 1992. The study found that the 
coronary heaif disease risk factor profile improved over tlfrs time. In terms of comorbid 
diagnoses, only hypertension was included in the inteiwiew schedule. The proportion of 
individuals with a diagnosis of hypertension remained relatively stable in men but 
decreased significantly in women from 26% in 1985 to 18% in 1992. The study examined 
the risk factor profile of the general population and not those individuals hospitalised with 
AMI.
2,5 Short term Survival in men and women following first AMI
One month and in-hospital case fatality
Many studies have examined short teim survival following AMI (Table 13). Not all 
studies have clearly reported sex specific data or have analysed first AMI survival as 
oppose to first or r ecur ren t . ' *^ ' In  addition, comparison is hindered by a lack of 
consistency in the end points that aie used. Time periods vary from in-hospital case 
fatality to 28 day and 30 day case fatality. Variation in age between different study groups 
also limits the comparability o f results and age specific case fatality is not always reported.
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The Rochester (Minnesota) Epidemiology Project reported 28 day case fatality rates for 
incident hospitalised AMI between 1979 and 1994 in men and women of all ages.^ "^  In 
1994, 28 day case fatality was 7% in men and 15% in women. Age specific figures were 
not reported for men and women. The Worcester Heart Attack Study examined incidence 
and survival in 3,148 individuals hospitalised with a first AMI between 1975 and 1988.^  ^
Overall unadjusted in-hospital case fatality rates were significantly higher in women 
(21.7%) than in men (12.7%). After adjusting for age the sex difference naiTOwed and case 
fatality was 17.9% in women compared to 15.2% in men. It is not clear whether this 
difference was statistically significant and age specific rates were not reported. In the 
Minnesota Heart Suiwey in 1990, age adjusted 28 day case fatality was 10% in men and 
12% in w o m e n . S e x  differences were not explored and it is not clear whether this 
difference was statistically significant. Data from the Swedish National Acute Myocardial 
Infarction Register was used to examine sex differences in survival in men and women 
aged 30 to 89 years hospitalised with AMI between 1987 and 1995.*^  ^ The Register 
included all events, not just first events. Overall crude case fatality was 22.6% in men and 
27.5% in women. The overall age adjusted odds ratio in women compared to men was 
0.98 (95% Cl 0.96-1.00). The Northern Sweden MONICA Project reported 28 day case 
fatality in 2483 men and 669 women aged 35 to 64 years who were hospitalised with an 
AMI between 1989 and 1995.^  ^ Unadjusted case fatality was significantly lower in men 
than in women (12.7% versus 21.2% respectively). The MONICA Breman Study 
examined 28 day survival in 1710 men and 563 women aged 25-69 yeais who were 
admitted to hospital following a first AMI.’*^ The unadjusted 28 day case fatality rate was 
higher in women than in men (23.1% versus 16.1% respectively). Adjusting for age did 
not eliminate the difference entirely. The National Hospital Discharge Suiwey was used to 
examine age adjusted in-hospital case fatality in men and women aged 35 years and over 
between 1988 and 1997 across the United States of Amer ica .Overa l l  unadjusted case 
fatality was 13.9% in men and 9.3% in women. In 1997 age adjusted case fatality was 
4.4% in women and 3.4% in men. Case fatality was higher in women than in men in all 
age groups except in those aged greater than 84 years. The Myocardial Infarction Triage 
and Intervention (MITI) registry database recorded data on 4255 women and 8076 women 
who developed an AMI and were admitted to coronary care in 19 Seattle, Washington area 
hospitals between 1988 and 1994.'^^ In-hospital case fatality was 13.7% in women and 
7.8% in men. This difference persisted after adjusting for age and women were 20% more 
likely to die in the hospital than men. Age specific rates were not reported. In ISIS-3, 35- 
day case fatality was examined in 9600 women and 26,480 men who had been hospitalised 
with AMI between 1989 and 1991 and who had clear indications for fibrinolytic therapy.
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Overall case fatality was 14.8% in women and 9.1% in men, the unadjusted odds ratio was 
1.73. Adjusting for age reduced the odds ratio to 1.20 (1.11-1.29), but did not remove the 
sex difference in survival. The National Registry of Myocardial Infarction 2 collected data 
on 384,878 men and women admitted to hospital across the USA with an AMI between 
1994 and 1998.^  ^ Overall in-hospital case fatality was 16.7% in women and 11.5% in men. 
However, sex-based differences in case fatality varied according to age, so that the effect 
of sex could not be simply described. The REGICOR Study included all 2769 individuals 
aged less than 74 years admitted to hospitals in Gerona between 1978 and 1997 with a 
diagnosis of Q-wave AMI.^ "^  Unadjusted 28 day case fatality was 18.8% in women and 
9.3% in men. The unadjusted female to male odds ratio was 2.27 (1.72-2.99). In a fully 
adjusted multivariate model, sex differences in survival vaiied with age. In the Danish 
Verapamil Infarction Trial carried out between 1979 and 1981, 15 day case fatality was 
17% in women and 16% in men.^ '^* The trial included 738 women and 2335 men aged less 
than 76 years who had been admitted to hospital following an AMI. The EPESE Cohort 
included 2182 individuals aged 65 years and over who were living in New Haven in 
1982.^  ^ 103 women and 120 men were hospitalised with an AMI between 1982 and 1992. 
The overall 30 day case fatality was 21.4% in women and 25.0% in men. Unadjusted 
female to male relative risk was 0.85 (0.49-1.47). In the Goteborg Study, the in-hospital 
case fatality rate was 12% in men and 19% in women. The study included all AMIs and 
the median age was 69 years in men and 76 years in women. The unadjusted female to 
male relative risk was 1.54 (1.09-2.18).
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One year case fatality
There are fewer studies describing case fatality following AMI after 28 days, and even 
fewer doing so in men and women separately. In addition, methodologies are not 
consistent in terms of whether the analyses include or exclude deaths within the first 28 
days, one month or in-hospital time period. The study based on the Swedish National 
Acute Myocardial Infarction Register reported one year age specific case fatality rates in 
men and women after excluding deaths within the first 28 days (Table 14).“ ’ Age 
standardised case fatality in 1995 at one year was 35% in men and in women. Sex-based 
differences varied according to age. The Trandoloapril Cardiac Evaluation (TRACE) 
Study included 4501 men and 2170 women aged between 45 years and 86 yeai’s admitted 
to coronary care units in Denmaik following an AMI.^^ One year case fatality was 28% in 
women and 21% in men. These figures did not exclude early deaths and were not age 
adjusted. A study canned out on 1551 men and 538 women admitted to hospital in San 
Diego and Columbia with an AMI reported a one yeai' case fatality of 13% in men and 
11% in women. These figures were unadjusted and excluded early in-hospital deaths. 
The MITI Registry reported case fatality in men and women who admitted to coronaiy care 
units in Washington between 1988 and 1994.’“  In this registry, one year case fatality was 
24% in women and 16% in men. Case fatality was not age adjusted. In the EPESE 
Cohort, one year case fatality amongst those who survived the first 30 days was 21% in 
women and 34.4% in men.^  ^ The unadjusted female to male relative risk was 0.56 (0.31- 
1.02). In the Goteborg Study, one yeai' unadjusted case fatality was 36% in women and 
25% in men.^^ The unadjusted female to male relative risk was 1.54 (1.09-2.18),
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2.5.1 Trends in short term survival in men and women following AMI
Many of the studies that examined short term case fatality following AMI, have also 
described trends in survival rates over Although a number of studies have
demonstrated a decline in short term case fatality over time in men and in women, the 
results of these studies are not consistent. In addition, not all studies have presented sex 
specific results or have adjusted survival to take account of variation in baseline 
characteristics and other prognostic factors over time.^^  ^ Many of the studies have 
examined case fatality in all AMIs and do not distinguish between first and subsequent 
e v e n t s . O t h e r  studies, including many o f the MONICA Studies, have included deaths 
following AMI that have occuned in those individuals who die before reaching 
hospital. The Rochester (Minnesota) Epidemiology Project reported 28 day
unadjusted case fatality rates for incident AMI of 10% in men and 14% in women in 
individuals hospitalised in 1979 (Table 15).^ '^  In 1994 the equivalent figures were 7% and 
15%. No significant time trend was found in men or in women. The case fatality rate 
decreased over time in people aged less than 75 years old, but did not change in those aged 
greater than 75 years. Adjusted odds of death were not calculated for men and women 
separately. The Northern Sweden MONICA Project demonstrated a significant 
improvement between 1985 and 1994 in short tenn survival following an acute myocardial 
i n f a r c t i o n . A g e  standardised 28 day case fatality fell from 15% in men and 26% in 
women in 1989, to 10% in men and 18% in women in 1994. Previous analyses used 
multivariate modelling to explore sex differences in changing case fatality and found that 
after adjusting for other prognostic factors, the trends were only significant in men in 
whom adjusted odds of death declined by 56% in men between 1985 and 1994, 
p<0.0001.^^^ The adjusted odds ratio in women was 0.95, p=0.390. The Minnesota Heart 
Survey demonstrated a decline in 28 day case fatality in men and w o m e n . I n  men case 
fatality fell from 13% in 1985 to 10% in 1990 (adjusted relative risk 0.74, 95% Cl 0.58- 
0.96). In women the equivalent figures were 15% and 12% (adjusted relative risk 0.84, 
95% Cl 0.62-1.13). The National AMI Register in Sweden reported declines in 28 day 
case fatality in men and women between 1987 and 1995.^  ^ Age standardised case fatality 
declined from 30% to 23% in men and from 28% to 23% in women. Multivariate 
modelling was not earned out. Data derived from the National Hospital Discharge Survey 
demonstrated a significant decline in in-hospital case fatality following AMI in men and in 
w o m e n . A g e  adjusted in-hospital case fatality fell from 7% to 3.4% in men and from 
8.2% to 4.4% in women between 1988 and 1997. The average annual percentage decline 
in case fatality was greater in older men and women compared to younger men and
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women, although these figures were not reported. No clear trends in in-hospital case 
fatality between 1975 and 1988 were observed in men or women in the Worcester Heait 
Attack S t u d y . I n  the ARIC Study, the age adjusted 28 day case fatality rate fell by 4.1% 
per year in men and by 9.8% per year in women between 1987 and 1994.^  ^ This decline 
was statistically significant only among women. The Ontario Myocardial Infarction 
Database was used to describe 30 day and one year survival in 89,456 patients who were 
hospitalised between 1992 and 1997 following an AMI.'^^ There was a gradual decline in 
overall 30 day case fatality in men and women during this period. Case fatality fell from 
12.8% in men and 20,1% in women in 1992 to 11.6% in men and 19.1% in women in 
1996. This trend was significant only in men. The declines were also significant m 
younger and older age groups, though sex specific analyses were not reported. Risk 
adjusted rates were not reported for men and women separately.
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One year case fatality
Again there are few studies that have reported trends in one year case fatality. The study 
based on data from the National AMI Register in Sweden found that one year case fatality 
improved in men and women between 1987 and 1995.^  ^ Age standardised case fatality fell 
from 44% in men and 43% in women in 1987 to 35% in both sexes in 1995. Age specific 
rates were not reported. In the Ontario Myocardial Infai'ction Database there was a gradual 
decline in overall one year case fatality in men but not in women between 1992 and 
1996.^ *^^  Case fatality fell from 20.3% in 1992 to 19.1% in 1996 in men. In women case 
fatality remained relatively stable at 29.8% in 1992 and 29.9% in 1996. Vii tually all of the 
improvement in one year survival in men occurred within 30 days of the AMI.
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2.6 Longer term Survival in men and women following first 
AMI
There are many fewer studies examining the longer term prognosis in men and women 
following AMI than there are examining short tenn case fatality (Table 17). Those that do 
exist are not consistent in their chosen end points or in theh reporting of sex specific 
data.^ *^ ’*’^ ’*^  ^ For example the original Worcester Heart Attack Study looked at survival 
between one and 14 years but did not report these data in men and w o m e n . T h e  authors 
did however observe that no significant sex differences in either crude or age adjusted long 
teim case fatality were seen. The Worcester Heart Attack continued and later analyses 
have reported two year case fatality in men and women survived hospitalisation for AMI 
between 1975 and 1995.^^  ^ The overall two year case fatality rate was higher in women, 
28.9% than in men, 19.6%. The effect of sex varied with age. The Minnesota Heart 
Survey reported three year case fatality in men and women aged 30 to 74 years between 
1985 and 1990.^  ^ Tliree year age adjusted case fatality in individuals with a first AMI in 
1990 was 18% in men and 24% in women. The REGICOR Study examined three year 
case fatality in men and women who had survived the first 28 days following their first 
AMl.^ "^  Unadjusted three year case fatality was 22% in men and 10% in women. The 
study only included individuals aged 25 years to 74 years. The TRACE Study examined 
longer term survival in men and women admitted to coronary care units between 1990 and 
1992. Patients were enrolled in the study between 1990 and 1992 and were followed up 
until 1994.^  ^ Average length of follow up was not reported. After adjusting for age and 
excluding deaths occurring within the first 30 days, men had a 20% increased risk of death 
in the longer teim (hazard ratio 1.2, 95% Cl 1.1-1.3). A study was carried out using the 
Alberta Health and Wellness databases which included information on 7158 women and 
15809 men admitted to hospital following an AMI between 1993 and 2000.^^ At five years 
crude case fatality was 38.8% in women and 26.8% in men. A study using the Helsinki 
Coronaiy Registry examined five year case fatality in 388 men and 178 women with a first 
AMI occuiTing between 1970 and 1971.^^  ^ Five year age adjusted case fatality excluding 
the first 28 days was 17.3% in women and 26.3% in men. The sex difference was not 
statistically significant. In the Danish Verapamil Infarction Trial, patients were followed 
up for ten yeai's.^ "^^  Unadjusted case fatality at ten years excluding deaths within the first 
15 days was 58.7% in men and 60.9% in women. After adjustment for age, long tenn case 
fatality was similar in men and women.
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2.6.1 Trends in longer term survival in men and women following AMI
There are few studies describing trends in longer term case fatality following AMI. In 
addition, the time periods chosen are not consistent so that comparison between studies is 
not easy. The Minnesota Heart Suiwey reported three year' case fatality rates in men and 
women between 1985 and 1990 (Table 18).^  ^ Age adjusted case fatality following a fii*st 
AMI declined in men and women during this time. In men case fatality fell hom 21% in 
1985 to 18% in 1990 and in women from 29% to 24%. Neither of these falls was 
statistically significant as demonstrated by the relative risk ratios.
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2.7 Factors affecting survival following AMI in men and 
women
2.7.1 Age
Survival following AMI
The effect of age on sui*vival following AMI has been extensively discussed in the 
literature. Age is widely reported to be strongest predictor of suiwival following AMI in 
men and women and sex differences in survival have often been attributed to differences in 
the age distribution of men and women. However many studies adjust for age but do not 
examine the magnitude of effect of age in men and women.^^’*’^  Age is not always 
included in models as a categorical variable so that the interpretation of its effect may not 
be straightfomard. The Swedish National Myocardial Infarction Register Study reported 
age and sex specific 30 day case fatality r a t e s . ' C a s e  fatality was only 8% in men and 
14% in women aged less than 50 years but rose to 63% in men and 60% in women aged 
85-89 years. The TRACE Study examined prognostic factors for 30 day case fatality 
following AMI in men and women s e p a r a t e l y . I n  a multivariate model, a one year 
increase in age was associated with a 4% increase in the risk of death in men and women.
Detennining the effect of age on survival following AMI is hindered by a lack of 
consistency in the age categorisation applied to the study populations involved and also by 
the tendency towards describing the effect of age on survival in the whole study population 
rather than men and women separately. In addition, ruany studies have reported age 
adjusted results so that the effect of age cannot be determined or described ftorn the 
analyses performed.
Short term survival
A number of studies have reported short term age stratified case fatality rates in men and
women following In all these studies, case fatality rates rise
substantially with increasing age. For example in the National Registry of Myocardial
Infarction 2, 30 day case fatality rose steeply with increasing age from 2.9% in men aged
less than 50 years to 25.3% in men aged 85-89 years.^  ^ There was a corresponding
increase in women froru 6.1% to 24.2%. In the Swedish National Register, 28 day case
fatality rose ftom 5.7% in men aged 30-49 years to 43% in men aged 85-89 years."' The
corresponding figures in woruen were 10.1% and 40.2% respectively. Age has been
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consistently shown to have a powerful effect on prognosis, though the magnitude of that 
effect varies according to the study type and population. There are very few studies that 
have provided data regarding the independent effect of age on survival in men and women 
after adjusting for other baseline variables. The MONICA Breman Study reported the 
effect of age after adjusting for other baseline variables and found that every additional 
year led to an increased risk of 4% in 28 day case fatality."^ Separate models were not 
carried out in men and women. The Swedish MONICA Project also examined the 
independent effect of age on survival, but again not in men and women separately.
Longer term survival
There are few studies that have described the effect of age on longer term survival in men 
and women following AML Those that have examined longer term survival have usually 
presented their results using Kaplan Meier Survival Curves so that case fatality rates 
cannot be quantified easily. In the Worcester Heart Attack Study two year case fatality 
rates in men hospitalised with AMI who survived to discharge, increased ftorn 6.0% in 
those aged less than 50 years to 51.3% in those aged greater than 79 y e a r s . T h e  
equivalent figures in women were 8.9% and 46% respectively. There are no studies that 
report the effect of age on the adjusted risk of longer term case fatality following AMI in 
men and women.
2.7.2 Sex
Short term survival following AMI
Sex specific data are not always examined or reported. In addition, studies do not 
consistently examine the independent effect of sex on survival after adjusting for other 
prognostic factors, so that it may not be clear whether observed sex differences are due to 
sex differences in baseline characteristics such as age. In the Rochester (Minnesota) 
Epidemiology Project sex differences in short term survival were not modelled in 
multivariate analyses, making it difficult to make valid comparisons between men and 
w o m e n . M o s t  studies that have examined short term case fatality in men and women 
have reported higher unadjusted case fatality in wornen.^^’^ "'’^ ’^^ ’^^ ’^^ ’^' "  Studies that have 
gone on to adjust for sex differences in age and other prognostic factors have found 
conflicting results. It is not universally accepted that sex is an independent predictor of 
short term survival and a number of studies have attributed sex differences in survival to 
variation in baseline characteristics such as age and cornorbid diagnoses."^ The MITI
6 0
registry examined in-hospital survival in men and women admitted to coronary care."^ 
Multivariate modelling adjusted for age, sex, history of congestive cardiac failure and of 
previous AMI. Women were still more likely to die with an odds ratio of 1.22 (95% Cl 
1.06-1.39).
Studies that have found that sex is not an independent predictor o f short term survival
In the MONICA Bremen Study, 28 day case fatality was significantly higher in women 
(23.1%) than in men (16.1%)."^ Adjusting for sex differences in age reduced but did not 
eliminate the excess risk seen in women. Controlling for previous use of inotropic 
medicine and diuretics, during the event receipt of tlirombolysis and platelet inhibitors and 
age in logistic regression analyses resulted in a similar 28 day mortality risk after acute 
myocardial infarction for both sexes (female/ male odds ratio=1.13, 95% Cl 0.86-1.50). 
In the Worcester Heart Attack Study in hospital smvival was similar in men and women 
after adjusting for prognostic factors including age in a multivaiiate model (odds ratio 
0.90, 95% Cl 0.70-1.16).^^ The factors controlled for in the multiple regiession models 
included age, sex, year, medical history, AMI location and type, peak serum creatine 
kinase levels, congestive heait failure, cardiogenic shock as well as medication and 
surgical intervention. Age sex interaction terms were not explored in the models. In the 
Northern Sweden MONICA Project unadjusted case fatality was significantly lower in 
men than in women (12.7% versus 21.2% respectively). In a multivariate model, the sex 
difference in 28 day case fatality was largely determined by other variables so that sex was 
not an independent predictor of outcome. Age sex interactions were explored but none 
were found to be statistically significant. Multiple logistic regression models included sex, 
age, diabetes, time to admission, admission to coronary care, thrombolytic therapy and 
smoking. In the EPESE Study wliich only included individuals aged 65 years and over 
hospitalised with AMI, unadjusted 30 day case fatality was 21.4% in women and 25% in 
men.^^ After adjusting for demographic factors, comorbidity, functional status, 
psychosocial factors and clinical severity the female to male relative risk was 0.85 (0.41- 
1.76). Case fatality at 30 days did not therefore differ significantly between the sexes.
Studies that have found that sex is an independent predictor o f short term survival
In the National Hospital Discharge Survey, unadjusted and adjusted survival was higher in 
women than in men except in the very elderly. Multivariate logistic regression was 
carried out on the whole group and in two age groups; age 35-64 years and age 64 and 
older. The models included age, sex, hypertension, hyperlipidaemia, diabetes, cardiogenic
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shock, revascularisation, heart failure and length of stay. After adjusting for these factors, 
sex remained a significant predictor of in hospital case fatality with the odds of death 13% 
greater in women relative to men (odds ratio 1.13, 95% Cl 1.12-1.13). The sex difference 
in survival was greater in younger than in older individuals. In the age group 35 to 64 
yeai's, the odds of death were 28% greater in women than in men. In individuals aged 65 
and over, this figure declined to 9%. The MITI registry examined in-hospital survival in 
men and women admitted to coronary care.'" Multivariate modelling adjusted for age, 
sex, history of congestive cardiac failure and of previous AMI. Women were still more 
likely to die with an odds ratio of 1.22 (95% CÏ 1.06-1.39). In ISIS-3 the unadjusted odds 
ratio of death among women compared to men was 1.73 (95% Cl 1.61-1.86). Adjusting 
for age reduced this odds ratio to 1.20 (95% Cl 1.11-1.29). Adjustment for other 
differences in baseline characteristics further reduced the odds ratio to 1.14 (95% Cl 1.05- 
1.23). Multiple logistic regi'ession models included the variables: age, sex, time since 
onset of pain, systolic blood pressure, heart rate, previous AMI and stroke, diabetes, 
smoking and ECG findings.
Studies that have found an interaction between sex and age in short term survival
In the Swedish National Acute Myocardial Infarction Register the age adjusted odds ratio 
for 28 day case fatality for women compared to men was 0.98 (95% Cl 0.96-1,00). ''* 
This disguised variation between age groups in men and women. Women aged less than 
75 years had a worse prognosis than men. For example, the odds ratio in women aged 30 
to 49 years compared to men o f the same age was 1.84 (95% Cl 1.56-2.18). Conversely, 
women aged 75 years and over had a better prognosis than men. Formal testing of an age 
sex interaction was not reported. Case fatality was adjusted only for age and multivariate 
modelling was not caixied out. The National Registry of Myocardial Infarction 2 found 
that sex-based differences in case fatality varied according to age, and that younger women 
but not older women had higher case fatality rates than men of the same age.^  ^ Among 
patients less than 50 years the case fatality rates were twice as high in women as in men. 
The difference in the rates decreased with increasing age and was no longer significant 
after age 74 years. An age sex interaction temi was found to be highly significant, 
p<0.001. Multivaiiate analyses showed that the odds of death were 7% gieater in women 
than in men for every five years decrease in age. In the Danish Verapamil Infarction Trial 
there was a significant interaction between age and sex for case fatality at 15 days, 
p=0.02.'''' Case fatality was higher in younger women compared to younger men but was 
similar in men and women fi-om age 64 years. The REGI COR Study examined survival in
62
men and women following a first AMI, and found a significant interaction between age 
and sex. Unlike the other studies they found that women aged less than 65 years had a 
lower risk of death at 28 days than men.^'' The multivariable adjusted odds ratio for 
women relative to men was 0.45 (0.19-1.04) in individuals aged less than 65 years. 
Women aged 65 to 74 years however had a higher eaiiy risk of death than men of a similar 
age with an adjusted odds ratio of 1.62 (1.01-2.66). The difference in the results between 
this and other studies is attributed to differences in study design and methodologies and 
possibly because of differences in the incidence rate of AMI between Southern European 
Countries and American or Northern European Countries.
One year case fatality
In the Swedish Acute Myocardial Infarction Register, the effect of sex on case fatality at 
one year in those individuals who suivived the first 28 days, varied according to age.'" 
4.0% of women and 2,9% of men aged less than 50 years were dead within one year (odds 
ratio 1.37, 95% Cl 1.06-1.76). One year case fatality increased to 11% in men and women 
aged 65 to 69 years. After the age of 69 years, women had a small survival advantage. 
There was a significant interaction between age and sex (p<0.0001). In the MITI Registry, 
one year case fatality was similar in men and women after adjusting for age and other 
clinical and treatment variables."^ In the Goteborg Study, unadjusted one year case 
fatality was 25% in men and 36% in wo m e n . A f t e r  adjusting for age, sex was no longer a 
significant predictor of outcome with an age adjusted relative risk of 1.06 (0.82-1.37). 
Early deaths were not excluded and the authors concluded that the increased case fatality 
seen at one year could be accounted for by older age of women. In the EPESE Cohort 
Study, women were almost twice as likely to suivive one year compared to men both 
before multivariable adjustment (relative risk 0.56, 95% Cl 0.31-1.02) and after controlling 
for other prognostic factors (relative risk 0.44, 95% Cl 0.20-0.99).^^ One year survival 
excluded deaths within the first 30 days.
Longer term case fatality
hi the TRACE Study the effect of sex was examined using Cox’s Proportional Hazard 
models to the end of the study period, after excluding the first 30 days.^^ Average follow 
up was between two and four years. After adjusting for age, men had a significantly 
increased risk of death in the longer tenu, hazai’d ratio 1.20 (1.10-1.31). When other 
factors including body mass index, previous AMI or angina, creatinine, heart failure, 
diabetes, thrombolytic therapy and hypertension were taken into account, the risk of death
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remained elevated in men compared to women with a hazard ratio of 1.16 (1.03-1.31). The 
authors therefore concluded that men had an increased longer term mortality relative to 
women that was not explained by variation in age and other factors. In the Worcester 
Heart Attack Study, no significant sex differences in either crude or age adjusted long term 
suivival were seen.^  ^ Future analyses however on an extended database did however 
reveal sex differences in two year case fatality following dischai'ge with AMI."'' There 
was a significant interaction between age and sex and only women younger than 60 years 
had a higher mortality rate than men of a similar age. The age adjusted hazard ratio of 
death for women compared to men was 1.40 in those younger than 60 years of age, 1.05 in 
those aged 60-69 years and 0.95 in those at least 70 years old. This relationship was not 
altered by adjusting for other factors including demographic chai*acteristics, clinical history 
and treatment. The hazard of death for women compared to men increased by 15.4% for 
every ten year decrease in age. In the MITI Study the two years unadjusted case fatality 
rates were 29% in women and 20% in m en.'" The adjusted hazard ratio for death in 
women compared to men was 0.92 (0.84-1.00). After excluding early in-hospital deaths 
there was a trend towards improved suivival in women. The age adjusted hazard ratio was 
0.87 (0.79-0.96). In the Alberta Study which looked at five year survival, sex was not a 
significant predictor of five yeai" case fatality but did demonstrate a significant interaction 
with age so that its effect could not be simply described.®" Higher unadjusted case fatality 
in women was confined to those aged less than 65 years who were at a significantly higher 
risk even after adjustment. In the Danish Verapamil Infarction Trial the overall age 
adjusted hazard ratio for women versus men was 0.90 (0.80-1.01).'" There was no 
interaction between age and sex for long term case fatality.
2.7.3Socioeconomic deprivation
Short term case fatality
There are few studies that have examined the relationship between socioeconomic 
deprivation and survival following AMI in men and women and the literature that does 
exist is not consistent in its findings. Most studies that have examined the relationship 
between socioeconomic deprivation and survival following AMI have looked at short tenu 
case f a t a l i t y . M a n y  studies have not reported sex specific data or have excluded women 
firom the study population. A number of studies examining case fatality in men and 
women have included socioeconomic factors in multivariate models but have not reported 
theii' independent e f f e c t s . T h e  Glasgow MONICA Coronary Event Register examined
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the effect of socioeconomic group on short term survival on 2568 men and 1059 women 
aged 25 to 64 years admitted to hospital following an AMl/^ They found no social class 
variation in in-hospital case fatality in men or women. There was however a 
socioeconomic gradient in the proportion of men and women reaching hospital alive with a 
decreasing proportion of men and women in more deprived quarters reaching hospital 
alive. In the FINMONICA Myocardial Infarction Register Study the age adjusted 
mortality rate ratios for death within 28 days showed three times higher mortality rates in 
the low income category compared with the high income c a t e g o r y . T h e  findings were 
similar in women. Actual case fatality rates were not reported. Data fiom the Ontario 
Myocardial Infarction Database was used to examine the effect of socioeconomic status on 
one year case fatality following A M I.'" The study found that income was a consistent 
predictor of case fatality and that this effect was substantial. The effect was consistent 
amongst age groups. Although the study included men and woruen and adjusted for the 
effect of sex, it did not examine the effects of income in men and women separately.
2.7.4 Diabetes
There are a number of studies that have examined the impact of diabetes on survival 
following AMI in men and women. Most studies have looked at diabetes as a predictive 
variable in multivariate analyses examining survival following AMI, whereas a smaller 
number have only included those individuals with a diagnosis of diabetes and AMI.'^^
Short term case fatality
A limited number of studies have found that women are at an increased risk of death after
AMI compared to men with d i a b e t e s . N o t  all these studies have disentangled the
effects of sex and the effects of diabetes and any interaction between them, on case fatality.
The Worcester Heart Attack Study examined sex differences in short and longer term
survival following AMI in 1354 men and 1280 women between 1975 and 1999.'"
Unadjusted in-hospital case fatality rates were higher in women than in men. Average in-
hospital case fatality was 14.9% in men and 21.3% in women. Women with diabetes
remained at a significantly increased risk of in-hospital death compared to men with
diabetes after adjusting for age, comorbidities and AMI associated characteristics. The
adjusted odds ratio was 1.37 (1.08-1.75). Compared to the referent group of men without
diabetes, women without diabetes had an increased risk of in-hospital death with an
adjusted odds ratio of 1.06 (0.90-1.24). Women with diabetes had an increased risk of 1.24
(1.02-1.51) when compared to women without diabetes whilst men with diabetes had an
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increased risk of 1.05 (0.85-1.29) when compared to men without diabetes. In the 
Secondary Prevention Reinfarction Israeli Nifedipine (SPRINT) Study, diabetes was a 
significant predictor of in-hospital death after AMI in women but not in m en.'" After 
adjusting for age as well as clinical variables, the relative odds of death in women with 
diabetes compared to women without diabetes was 1.92 (1.4-2.55). In men there was an 
increased risk of 24% which was not significant. The MONICA Project in New South 
Wales examined 28 day case fatality in 3643 men and 1679 men admitted to hospital 
following a first AMI between 1985 and 1994. The age adjusted 28 day case fatality rate 
for women with diabetes (25%) was significantly higher than for women without diabetes 
(16%). The age adjusted relative risk was 1.56 (1.19-2.04). The difference in men was 
also significant (25% with diabetes and 20% without diabetes, relative risk 1.25, 1.02- 
1.53).'^'' However, after adjusting for age, year of diagnosis, smoking, 
hypercholesterolaemia and hypertension, the increased risk associated with diabetes was 
no longer statistically significant in men. The authors therefore concluded that the effect 
of diabetes on short tenu case fatality was therefore greater in women than in men. Other 
studies have found no significant difference in the effect of diabetes in men and women on 
suivival following AMI. In the National Registry of Myocardial Infaiction 2, women 
were at increased risk of in-hospital death after adjusting for clinical and treatment 
variables.'^' The adjusted odds of death in women compaied to men was similar in people 
with diabetes, odds ratio 1.25 (1.17-1.35) and people without diabetes, odds ratio, 1.32 
(1.25-1.39). Diabetes had a similar effect on case fatality in men, odds ratio 1.45 (no Cl), 
and in women, odds ratio 1.38 (no Cl). In the Diabetes Mellitus Insulin Glucose Infusion 
in Acute Myocardial Infaiction (DIGAMI) Study which examined one year case fatality in 
men and women with diabetes, sex was not an independent predictor of outcome after 
adjusting for other factors.
Longer term case fatality
There are far fewer studies that have examined the impact of diabetes on long term
suivival following AMI in men and women. These studies have not been consistent in
theft results but have generally shown a greater impact of diabetes in women than in men
on long term case fatality following A M I.'" ''" ''"  In the Framingham Study men and
women who had survived an AMI were followed up for 34 y e a r s . D i a b e t e s  was an
important factor in determining survival. In individuals with diabetes, the age adjusted risk
of fatal coronary heart disease was increased more in men than in women. The age
adjusted relative risk for fatal coronary heart disease was 1.8 (1.2-2.9) in men and 2.6 (1.4-
4.7) in men. The Deteiininants of Myocardial Infarction Onset Study included 1935 men
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and women hospitalised with AMI between 1989 and 1993."^ During an average follow 
up period of approximately four years, the risk of dying in patients with diabetes compared 
with patients without diabetes was almost two times higher among women compared to 
men. In the Worcester Heart Attack Study the differences in post-discharge survival 
between men and women with diabetes declined during the ten year follow up period."^ 
There were no significant differences in long term survival rates between men and women 
with diabetes after adjusting for other prognostic factors. In the SPRINT Study the risk of 
death up to ten years after an AMI was higher among women with diabetes who were 
treated with insulin than men with diabetes who were treated with insulin."® However 
long tenn case fatality was similar in men and women treated with oral hypoglycaemic 
agents. One study has shown that the effect of diabetes is stronger on long term than short 
term case fatality, and that the impact accelerates over time."'' Sex specific results were 
not reported.
Diabetes is the most widely studies cornorbid condition in relation to AMI survival. There 
are fewer studies that have examined the independent effects of other comorbid conditions 
on the prognosis following AMI in men and women.
2.7.5Heart failure
Short term case fatality
There are far more studies that have looked at the development of heart failure following 
AMI than there are that have examined the association between pre-existing heart failure 
and AMI suivival. The occurrence of heart failure in patients with AMI has been 
consistently recognised as a significant and powerful predictor of prognosis, with 
individuals who develop heart failure experiencing poorer suivival than those who do not. 
The National Registry of Myocardial Infarction database 2 and 3 included data on 605,500 
patients hospitalised with AMI between 1994 and 2000. Patients with a previous history of 
heart failure were excluded from the study. Of those hospitalised with AMI, 29% 
developed heart failure during their admission. The unadjusted in-hospital case fatality 
rate for patients with AMI complicated by heart failure was 24% compared to 6.2% in 
patients without heart failure. After adjusting for clinical and demographic factors, the 
odds of dying remained significantly elevated in patients with heart failure (adjusted odds 
ratio 3.8, 95% Cl 3.7-3.9), compared to those without heart failure. Sex specific data were 
not presented and gender effects were not examined. In the Worcester Heart Attack Study, 
heart failure developed in approximately 38% of patients with AMI over the 20 year study
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period."^ In 1993 to 1995 the in-hospital case fatality rate in patients with heart failure 
was 17.7% compared to 7% in those without heart failure. The multivariable adjusted odds 
of dying in those with heart failure was 2.71 (2.31-3.18) compared to those without heart 
failure. Again sex specific analyses were not reported, although sex was included in the 
multivariate models. Both of these studies included first and recurrent AMIs.
Longer term case fatality
The Rochester Epidemiology Project examined the development of new onset heart failure 
in 1915 individuals with a first AMI and no prior histoiy of heart failure."® Of these, 41% 
developed new onset heart failure during an average of over six years follow up. Survival 
was examined at one and five years after the onset of heart failure. In those patients who 
developed heart failure, male sex was associated with a 38% increase in the risk of death 
compared to female sex after adjusting for age and other prognostic factors. Survival was 
not compared between those who did and did not develop heart failure.
2.7.6Chronic obstructive pulmonary disease
There are few studies that have included COPD in theft description of baseline
characteristics or in theft analysis of prognostic factors following hospitalisation for AMI.
No studies have examined the prognostic significance of a COPD diagnosis on outcome in
men and women separately. The Cardiovascular Cooperative Project examined one year
case fatality in 54,962 patients hospitalised with AM I.'" Of these, 21% of men and 18.7%
of women had a diagnosis of COPD or asthma. In 23% of men and 15% of women the
diagnosis of COPD or astlima was severe. Unadjusted one year case fatality was 23.3%
amongst those with a diagnosis of severe COPD or asthma compared to 10% in those
without COPD or asthma. Sex specific figures were not reported. The TRACE Study
examined the relationship between COPD and survival following AM I.'" Unadjusted case
fatality was 13.7% at 30 days, 27.8% at one year and 57.1% at five years in patients with a
diagnosis of COPD compared to 12% at 30 days, 22.5% at one year and 42.5% at five
years in those without a diagnosis of COPD. The overall unadjusted relative risk of COPD
was 1.49 (1.35-1.65). In multivariate analyses, COPD was an independent predictor of
long term case fatality after adjusting for other factors. The relative risk was 1.15 (1.04-
1.28). Sex specific analyses were not cai'ried out. Sub-analyses were perfoimed to
examine the interaction of a COPD diagnosis with congestive heart failure. These analyses
revealed that COPD was a predictor of long tenn case fatality following AMI only in those
patients without a diagnosis o f congestive heart failure. The SPRINT Study examined the
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relationship between COPD and outcome and found that it was not a significant predictor 
of five year survival after adjusting for other factors.
2.7.7Atrial fibrillation
Many of the studies that have described the incidence or prevalence as well as the 
prognostic significance of atrial fibrillation are clinical trials. The study populations of 
clinical trials tend to be younger and fitter and aie rarely generalisable to the general 
population. A number of studies, such as GISSI-3, have distinguished between new-onset 
atrial fibrillation and chronic atrial fibrillation. Previous studies have reported 
conflicting findings regaiding the prognostic significance of atrial fibrillation and AMI and 
there is some evidence to suggest that this may depend upon the time of atrial fibrillation 
onset. Both the GUSTO I Trial and the Cooperative Cardiovascular Project found that 
patients with atrial fibrillation on arrival to hospital had only a small risk of mortality 
whereas those who developed atrial fibrillation during hospitalisation had a substantially 
increased risk of d e a t h . A  Japanese Study that examined 1039 patients hospitalised 
with AMI also found that the onset time of atrial fibrillation was a important parameter in 
determining the impact of atrial fibrillation on prognosis.^'' None of these studies have 
reported sex specific analyses.
Short term case fatality
The Cooperative Cardiovascular Project examined the prevalence and prognostic 
significance of atrial fibrillation in AMI." The study was confined to individuals aged 
greater than 64 years. Patients with atrial fibrillation had higher in-hospital, 30 days and 
one year case fatality. Overall case fatality was 29.3% at 30 days and 48.3% at one year in 
patients with atrial fibrillation compared to 19.1% and 32.7% in those without atrial 
fibrillation. Sex specific data were not reported. When adjusted for other prognostic 
factors, atrial fibrillation increased the odds of death by 20% at 30 days and by 34% at one 
year. The TRACE Study examined the occurrence and prognostic significance of atrial 
fibrillation following AMI." Unadjusted in-hospital case fatality was 18% in patients with 
atrial fibrillation which was significantly higher than in patients without atrial fibrillation. 
After adjustment for baseline characteristics, the presence of atrial fibrillation increased in 
hospital case fatality by 50% (odds ratio 1.5, 95% Cl 1.2-1.8).
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Longer term case fatality
There are fewer studies examining the association between atrial fibrillation and longer 
term survival following AMI. In the TRACE Study, five year case fatality excluding in- 
hospital deaths was elevated in individuals with atrial fibrillation when compared to those 
without this diagnosis (hazai'd ratio 1.3, 95% Cl 1.2-1.4)." Again, sex specific analyses 
were not reported. The SPRINT Trial examined the relationship between paroxysmal 
atrial fibrillation and long term survival following AMI."" Patients with paroxysmal atrial 
fibrillation who suiwived hospitalisation had approximately two-fold higher five year case 
fatality rates when compared to those without pai'oxysmal atrial fibrillation (43.5% versus 
25.4% at five years). The multivariate adjusted relative risk associated with paroxysmal 
atrial fibrillation was estimated to be 1.28 (95% Cl, 1.12-1.46).
2.7.8 Hypertension
Many of the studies that have examined prognosis following AMI have included 
hypertension in their description of baseline chaiacteristics and analysis of potential 
independent prognostic factors. However, as for other baseline characteristics, few of 
these studies have reported sex specific analyses. In addition the definition of hypertension 
varies, may be based on different criteria and is not always described.
Short term case fatality
The Rochester, Minnesota Study examined the relationship between hypertension and 
survival following AMI in 1321 individuals diagnosed with first AMI between I960 and 
1975."' 30 day case fatality rates were elevated in individuals with hypertension. The age 
adjusted 30 day case fatality rate was 13% in normotensive and treated hypertensive, 16% 
in borderline and 19% in untreated hypertensive patients. Sex specific data were not 
reported.
Longer term case fatality
The Framingham Heart Study examined the relationship between pre-existing hypertension 
and the risk of adverse outcomes after initial AM I.'" Mean follow up was 7.85 years. 
Median suiwival was 12.19 years, 8.8 years and 4.18 years among normotensive, untreated 
hypertensives and treated hypertensives respectively. After excluding deaths within 30 
days, and adjusting for other prognostic factors, untreated and treated hypertensives had an 
increased risk of death (hazard ratios relative to normotensive group, 1.19 and 1.69
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respectively). The Survival and Ventricular Enlaigement (SAVE) Clinical Trial examined 
and compared outcomes in 906 patients with hypertension and 1325 patients without 
hypertension."® All patients had suiwived an AMI and had left ventricular’ systolic 
dysfunction. Mean follow up was 42 ± 10 months. Case fatality was higher in patients 
with hypertension than in those who were normotensive, 27.4% versus 19.3%. After 
adjusting for known risk factors, patients with hypertension had a significant increase in 
the risk of death (hazard ratio 1.25, 95% Cl 1.02-1.53). Sex specific results were not 
reported.
2.7.9RenaI impairment
It is only relatively recently that studies have examined the relationship between renal 
impairment and outcome following AMI. Survival of patients with renal failure is 
considerably worse than sur'vival of patients without renal failure and patients with other 
cornorbid diagnoses. There is however a lack of data describing the impact of renal 
impairment on survival following AMI in men and women separately as studies have 
usually categorised risk in terms of the degree of renal impairment rather than on the basis 
of sex. In addition many of the multivariate models that have been used to examine the 
prognostic significance of factors thought to affect survival have included sex. For renal 
failure, the interpretation of these findings is complicated by the fact that sex is 
incorporated into the estimation and definition of glomemlai’ filtration rate, creatinine 
clearance and elevated creatinine levels. This may bias the results of any multivariate 
analyses that further adjust for the effects of sex.
Short term case fatality
Data from the Mayo Clinic and the Veterans Affairs Hospital at the University of San
Francisco illustrated the significant excess mortality risk faced by those with renal
impairment who had experienced an AMI." Renal function was estimated according to
creatinine clearance and stratified into five groups. In-hospital case fatality rates were 2%
in patients with normal renal function, 6% in those with mild renal failure, 14% in those
with moderate renal failure and 21% in those with severe renal failure. The adjusted risk
of death followed a similar gradation of risk with mild renal failure being associated with
an odds ratio of 1.9 (1.1-3.1) and severe renal failure an odds ratio of 5.1 (2.2-12.1) relative
to normal renal fiinction. Sex specific data were not reported. Data pooled from the
Thrombolysis In Myocardial Infarction (TIMI) trial 10A, lOB, and 14 trials, were used to
examine the association between impaired renal function and 30 day case fatality in
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individuals hospitalised following an AMI who had been treated with thrombolysis."'' The 
study found that impaired renal function was associated with increased case fatality after 
adjusting for other prognostic factors. Renal impairment was measured using creatinine 
levels and creatinine clearance. For both measures there was a stepwise increase in case 
fatality among patients with normal, mildly and severely impaired renal function. The 
odds ratio for death in individuals with severe renal impairment relative to nonnal renal 
function was 3.81 (95% Cl 2.57-5.65), as measured by creatinine clearance. No sex 
specific data were reported. Renal impairment has also been shown to relate to one year 
case fatality. The Cooperative Cai’diovascular Project also found that renal impairment 
was an independent predictor of death following an AMI. Unadjusted one year case 
fatality was 24% in those with normal renal function, 46% in those with mild renal 
impairment and 66% in those with moderate renal impairment.®'' A study earned out in 
Boston and Framingham, Massachusetts, examined one year case fatality in 562 
individuals hospitalised following AMI between 1991 and 1992.'" 22% of these
individuals had a raised creatinine level. One year case fatality was 46% in these 
individuals compared to 15% in those with a noinial creatinine level. After multivariate 
adjustment, one year case fatality remained elevated in individuals with raised creatinine 
with a hazard ratio of 2.40 (1.55-3.72).
Longer term case fatality
There are few studies that have examined the longer term prognosis of individuals 
hospitalised with AMI who also have renal failure. The United States Renal Data System 
was used to identify those individuals on renal replacement therapy who were hospitalised 
with a first AMI between 1977 and 1995.'''^ Case fatality in these individuals was 51.8% 
at two years and 70.2% at five years. The Mayo Study followed-up individuals 
hospitalised with AMI for up to five years and found an increased long tenn risk of death 
in individuals with renal dysfunction who were hospitalised with AMI." The adjusted 
hazard ratio was 5.4 in patients with end stage renal disease compared to those with normal 
renal function. Again there was a gradation of risk of death associated with the degree o f 
renal impairment and individuals with mild renal insufficiency had 2.4 times the risk of 
death compared to those individuals with normal renal function.
2.7.10 Other vascular diseases
As for COPD there is a lack of data describing the prevalence and prognostic significance
of other vascular diseases in men and women following hospitalisation with AMI. The
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SPRINT Trial, which was carried out between 1981 and 1983, reported a peripheral 
vascular disease prevalence of approximately 6% in men and women hospitalised with a 
fii'st AM I.'" In-hospital, one year and five year case fatality rates were significantly 
higher amongst those with a diagnosis of PVD compared to those without a diagnosis of 
PVD. One year and five year case fatality rates excluded in-hospital deaths. Case fatality 
in those individuals with a diagnosis of PVD was 24% in-hospital, 12% at one year and 
33% at five years. The same figures in those without a diagnosis of PVD were 13%, 7% 
and 22% respectively. The multivariate adjusted odds of death for in-hospital case fatality 
following AMI in patients with PVD relative to those without PVD were 1.37 (1.03-1.83). 
PVD was not independently associated with longer tenn (mean follow-up 5.5 years) case 
fatality. Sex specific figures were not reported.
2.7.11 Previous coronary heart disease 
Short term case fatality
A number of studies have included a previous history of angina in their description of
baseline characteristics of individuals hospitalised with AMI and analysis of prognostic
factors. Studies have tended to use different definitions of angina and age and sex specific
figures aie rarely reported. It has been estimated that approximately one half o f
individuals hospitalised with AMI have a histoiy of angina pectoris.'" Studies examining
the prognostic significance of previous angina in individuals hospitalised with AMI have
reported conflicting results.'''®"'" A number of studies have suggested that myocardial
preconditioning may occur.'®'"'" Myocardial preconditioning is a phenomenon in which
brief episodes of ischaemia and reperfusion protect the myocardium against prolonged
ischaemic damage.'®® In the Thrombolysis in Myocardial Infarction (TIMI) 4 Study,
previous angina was found to have a beneficial effect on in-hospital outcome after AMI,
although this effect was not statistically significant and sex specific figures were not
reported.'®^ The Japanese Acute Coronary Syndrome Study found that preinfarction
angina had a beneficial effect on in-hospital outcome, but only in individuals with anterior
AMI,'®'' In the Goteborg Study, the in-hospital case fatality rate was similar in individuals
with and without a previous history of angina and angina was not an independent predictor
of death during the in-hospital period.'" However individuals with previous chronic
angina did have a worse one year prognosis than individuals without previous chronic
angina. In the SPRINT Registry a history of previous chronic angina was associated with a
higher in-hospital case fatality rate in individuals hospitalised with a first AMI (16%
versus 12%, p<0.0001).'" The literature regarding the effect of previous angina on short
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term case fatality following AMI is therefore conflicting. There is evidence to suggest that 
the effect of previous angina on short term survival may depend upon how long the 
individual has had angina for, the site of infarct as well as the age of the patient.'®*’" ''’'®®
Longer term case fatality
Fewer studies have examined the relationship between previous angina and longer teim 
prognosis following AMI. In the TIMI 4 Study, although previous angina improved in- 
hospital outcome, there was no long term benefit of this diagnosis.'®^ In the SPRINT 
Registiy a history of previous angina was associated with higher five year case-fatality 
rates (26% versus 19%, p<0.0001).'" The Framingham Study also reported higher long 
term case fatality rates in individuals with a previous histoiy of angina.^® After adjusting 
for the effect of age, this association was significant only in men in whom the risk of 
coronary death was increased by 49% in individuals with a previous history of angina. It is 
therefore apparent that there is very little literature that has examined the relationship 
between previous angina and short and long teim in individuals hospitalised with a first 
AMI.
2.7.12 Previous AMI
Short term case fatality
Many studies have described the prevalence of a previous AMI and have also adjusted for 
the potential effects of a previous AMI on prognosis following a subsequent 
AMI.^®’®^’®®’®®’' " ’'®' However few studies have examined the independent effect of a 
previous AMI on survival in men and women following hospitalisation with a subsequent 
AMI. The Northern Sweden MONICA Project included previous AMI in its multivariate 
analyses of in-hospital survival which were carried out in men and women sepaiately.®  ^
Previous AMI was not a significant independent predictor of outcome although the p-value 
and odds ratio were not reported.
Longer term case fatality
Very few studies have examined the prognostic effect of previous AMI on suivival 
following a subsequent AMI. A Japanese Study carried out between 1981 and 1990 
examined prognosis in 350 individuals hospitalised with an anterior AMI and found that 
previous AMI was not a significant predictor of outcome at five years.'®'
74
2.8 Incidence of and trends in incidence of second acute 
myocardial infarction
Whilst there is a considerable literature examining the incidence of first AMI, there is little 
known about trends in the incidence of and prognosis after second infarction. No studies 
have reported the incidence rates of second AMI in men and women. A number of studies 
have looked at of the risk of re-infarction during an in-hospital stay,®®’"®’"'"’"^ and the 
short-tenn incidence of re-infarction has been examined in some clinical trials."^'"" The 
GUSTO I and III trials described re-infarction rates in 52,662 men and women with an ST- 
segment elevation AMI who received fibrinolysis."^ It reported an in-hospital re­
infarction rate of 4.3% (Table 19). The GISSI-2 Study analysed re-infarction rates 
amongst hospital survivors of AMI treated with thiombolysis."" The post-discharge to 
six-month incidence rate of AMI was 2.9% overall. None of the trials reported sex- 
specific figures though the independent effect of sex examined in multivariate models 
looking at predictors of subsequent AMI. The Framingham Heart Study compared one, 
five and ten-year re-infarction rates in subjects with Q-wave and non-Q-wave 
infarctions. The study included 227 men and 136 women with a first AMI and a mean 
duration of follow-up of 5.1 years. The five-year re-infarction rates were 20.6% in Q-wave 
and 32.4% in non-Q-wave infarctions. The numbers of re-infarctions was small and sex- 
specific figures were not reported. The First Danish Verapamil Infarction Trial Database 
examined ten year reinfarction rates in 5993 patients hospitalised with AMI who survived 
to day 15."" The ten year re-infarction rate was 49.8% in men and 45.6% in women. This 
difference was not statistically significant. The Rochester Study examined reinfarction 
rates in 1013 men and women hospitalised with a first AMI, who survived the first 30 
days, between 1960 and 1979.®^  The rates of reinfarction were higher in men than in 
women. The five year age adjusted reinfarction rate per 100 person-years was 7.3% in 
men and 5.9% in women in the 1970-1979 cohort. The Goteborg Study reported one year 
reinfarction rates in 621 men and 300 women hospitalised with AMI between 1986 and 
1987." 17% of men and 15% of women were hospitalised with a recunent AMI in the 
year subsequent to theft index admission.
All of these studies have looked at re-infarction rate within a defined and usually short 
time period, rather than incidence rate of subsequent AMI. The numbers are consequently 
small and sex-specific data rarely reported. A number of studies including many of the 
MONICA Studies and the ARIC Study have looked at population incidence of recunent 
events (Table 20). The ARIC Study examined trends in incidence of recurrent AMI in men
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and women between 1987 and 1996." They reported significant declines in the incidence 
of recuiTent events in residents aged 35-74 years. The incidence rate fell by 1.9% in men 
and 2.1% in women. The Toulouse MONICA Study described the AMI recurrence rates, 
between 1985 and 1993, in individuals aged 35 to 64 years.®® In men, age-standardised 
rates for recurrent AMI declined by 1.9%, and m women, increased by 1.4%. Neither 
trends reached statistical significance. The National Health and Nutrition Examination 
Survey Epidemiological Follow-up Study examined trends in incidence and recurrence 
rates of AMI in two cohorts, between 1971 and 1992.^" They reported a 21.9% decline in 
recuiTent AMI rate in white men but a 35.2% increase in white women. Both trends were 
statistically significant.
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2.9 Factors predicting a subsequent AMI
A number of studies, including clinical trials, have attempted to examine the independent 
predictors of re-infarction. Many of these have looked at in-hospital r e - i n f a r c t i o n . I n  
the GUSTO I and III Trials, the most important predictors of in-hospital re-infarction were 
age, time to fibrinolysis, previous coronary heart disease and anterior Sex was
also a significant predictor with women being more likely to experience re-infarction, after 
adjusting for other factors. In the SPRINT Trial, women were again more likely to 
experience a recurrent AMI by one year, though this increased risk did not reach statistical 
significance in a multivariate model. Significant predictors of re-infarction included 
age, previous angina, diabetes, heart failure and peripheral vascular disease. In the 
Maximum Individual Therapy in Acute Myocardial Infarction (MITRA) and the 
Myocardial Infarction Registry (MIR), female sex was independently associated with an 
increased risk of re-infarction during the in-hospital period (odds ratio 1.14, 95% Cl 1.05- 
1.32).^^  ^ Other predictive factors included age and previous AMI. None of these studies 
examined predictive factors in men and women separately and in general the predictive 
ability of the multivariate models were low, for example 63% of re-infarctions in the 
GUSTO I and III Studies were correctly identified. The Rochester Study was unable to 
identify any factors that were significant predictors of subsequent infarction.
2.10Survival following a second or recurrent AMI
There are few data describing prognosis following a recurrent AMI and no data looking 
specifically at prognosis following second AML Some of the MONICA Studies have 
looked at survival following a recurrent AMI, however these have mainly included out-of­
hospital deaths and have not reported the prognosis of recurrent hospitalised AMI.^^’^ ^^  
Other studies have examined a prior history of AMI or ischaemic heart disease as an 
independent predictor of prognosis. These studies provide an estimate of the excess risk 
associated with previous AMI, but do not provide an estimate of absolute risk or of how 
this risk might vary according to age, sex and socio-economic deprivation status. The 
SPRINT Trial examined the in-hospital case fatality of individuals who experienced a 
second AMI within one year of theft first AMI.*^  ^ The overall in-hospital case fatality rate 
was 31%. In those individuals with a second AMI who suiwived hospitalisation, the one 
year case fatality rate was 11.8% and the five year case fatality rate was 40.1%. Sex 
specific data were not reported. In the MITRA and MIR Study, the authors examined in-
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hospital case fatality in those individuals hospitalised with an AMI who experienced a 
recurrent AMI during their index hospital a d m i s s i o n / S e x  specific data were not 
reported. The overall in-hospital case fatality rate for individuals who experienced a re­
infarction was 41.2%. The Study by Gilpin et al examined case fatality at one year* in 
3,666 individuals hospitalised with an AMI.*^  ^ Of these, 171 (4.7%) experienced a 
recurrent AMI within a one year time period. Case fatality was higher in this group, and at 
one year was 16.4% compared to those who had not experienced a recurrent AMI. The 
one year* follow up was taken from the time of the index admission and not from 
hospitalisation with the recuiTent AMI. Sex specific data were not reported. The GUSTO 
I and III Studies carried out similar analyses and compared 30 day case fatality in those 
individuals hospitalised with an AMI who did and did not experience hospitalisation with a 
recurrent AMI.^^  ^ Overall 30 day case fatality was 11.3% in those with reinfarction 
compared to 3.5% in those without reinfaiction. Sex specific data were again not reported.
2.11Factors affecting survival following a second AMI
Very few studies have examined factors that predict suiwival following a second or 
recurrent AMI. The 60 Minutes Myocardial Infarction Project examined in-hospital case 
fatality in 2854 individuals hospitalised with reinfaiction between 1992 and 1994, and 
compared it to tlie in-hospital case fatality observed in 12,126 individuals hospitalised with 
first AMI.’^ "^ Case fatality was higher in individuals hospitalised with a recunent AMI 
compared to those hospitalised with a first AMI (23% versus 15% respectively). 
Multivariate analyses were not used and sex specific figures were not reported. A number 
of studies have however looked as subsequent AMI as a predictor of death following a first 
event, hi the SPRINT Trial which examined case fatality in individuals hospitalised with a 
second AMI, multivariate modelling was used to detennine whether re-infarction was an 
independent predictor of case fatality following a first AMI.^^  ^ However, the study did not 
examine the independent predictors of case fatality following a second AMI.
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3 AIMS AND OBJECTIVES
3.1 Aims
In the light of the findings of the literature review, a study was developed with the 
following aim:
• To compare the baseline characteristics, survival and health service burden of men and 
women hospitalised with a first and second acute myocardial infarction in Scotland 
between 1990 and 2000.
The aim translated into the following objectives:
3.2 Objectives
• To describe and compaie the age and socio-economic characteristics of men and 
women admitted to hospital with a first and a second acute myocardial infarction 1990-
2000.
# To describe the incidence of hospitalisations for first and second AMI in men and 
women between 1990 and 2000.
To determine and compare the nature and extent of comorbidity in men and women 
admitted to hospital with a first and a second acute myocardial infarction 1990-2000.
To analyse, describe and compare short and longer term survival and trends in survival 
in men and women following an admission to hospital with a first and a second acute 
myocardial infarction 1990-2000.
To examine and compare the independent effect of sex on short and longer tenn 
suiwival in different age groups in individuals admitted to hospital with a first and a 
second acute myocardial infarction 1990-2000.
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• To detennine and compare the independent effect of factors thought to influence 
survival in men and women following an admission to hospital with a first and a 
second acute myocardial infarction 1990-2000.
• To describe the burden of first and second acute myocardial infarctions on the Scottish 
National Health Service in men and in women 1990-2000.
4 METHODS 
4.1 Data sources
Data were obtained from the Information and Statistics Division of the National Health 
Service in Scotland (ISD Scotland). ISD Scotland manage the Scottish Record Linkage 
System on behalf of NHS Scotland. This system links together computerised hospital 
records (Scottish Morbidity Records) and death registration records that belong to the same 
patient.
4.1.1 Scottish Morbidity Records
The Scottish Morbidity Record (SMR) schemes record hospital discharge data at an 
individual level. The main records kept under these schemes include all discharges from 
acute hospitals (SMROl), maternity units (SMR02), psychiatric units (SMR04) and 
neonatal discharges (SMRll). This study involved the analysis of SMROl data. SMROl 
data is generated when a patient is discharged firom hospital; changes consultant, is 
transfeiTcd to another hospital or dies. SMROl relates to both inpatients and day cases who 
are discharged fr om non-psychiatric, non-obstetric wai'ds in Scottish hospitals. It includes 
data on both emergency and elective admissions. The data is abstracted from case notes 
and then transcribed onto an SMROl form. The Infonnation and Statistics Division of the 
Common Seiwices Agency (CSA) hold this information on computer at a National level. 
The data collected includes a principal diagnosis and up to five secondary diagnoses as 
well as up to four operative procedures. The World Health Organisation (WHO) 
International Classification of Diseases (ICD) system is used to classify both principal and 
secondary discharge diagnoses. The tenth revision (ICD-10) has been available since 
the mid-1990's and was introduced by the CSA in April 1996. The data in this study are 
therefore based on diseases coded using the ninth revision (ICD-9) from January 1st 1990
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to March 31®‘ 1996 and the tenth revision (ICD-10) from April 1996 to 3C‘ December
2001.
4.1.2Death certificate data
The General Register Office for Scotland records the causes of death for all Scottish 
r e s i d e n t s . T h e  codes used to classify these deaths are allocated using the WHO 
International Classification of Diseases. Prior to 1996, a team of trained nosologists 
coded the causes of death manually. They selected the underlying cause and up to three 
other causes considered to have contributed to death as outlined on the death certificate.
4.1.3Linked Database
In Scotland, computerised hospital records, cancer registration records and death 
registration records belonging to the same patient aie linked together in the Scottish 
Record Linkage System. Heasman first demonstrated the potential for linking individual 
patient records together in 1968. As record linkage had to be carried out for each analysis, 
it was initially expensive and slow. A joint project between ISD and the CSA started in 
May 1989 and led to the development of a new record linkage system. The linked data set 
holds hospital discharge records for non-psychiatric, non-obstetric specialties (SMRl) 
together with Cancer Registry records (SMR6) and Registrar General’s death records fr'om 
1981 until the present day. Ad hoc linkages can also be carried out dating back to 1968.^^^
Methods of linking
Methods of probability matching have been developed and refined in Oxford, Scotland and 
Canada over the last thiity yeais, and are used by the Record Linkage System to allow for 
inaccuracies in the identifying information. When records are linked, two records are 
compared and a decision is made as to whether they belong to the same individual. A 
computer algorithm calculates a score for each pair of records that is proportional to the 
likelihood that they belong to the same person. The common core of identifying items 
includes: surname, first initial, sex, year, month and day of birth and postcode. Surnames 
are changed to coded format in order to avoid the effects of differences in spelling. The 
huge volume o f data would mean that it would be impossible to compare every record with 
all the other records and blocking is used to cut down the number of compai'isons required. 
Only those records that have a minimum level of agreement in identifying items are
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compai'ed. Probability matching then allows mathematically precise assessment of the 
implications of the levels of agreement and disagreement between records
4.1.4 Accuracy of data
The linkage process is largely automatic as a tlireshold score based on probability 
matching dictates the decision as to whether the records belong together. Clerical checking 
has shown that both the false positive rate and the false negative rate are around one per 
cent. It is the responsibility of the Quality Assessment and Accreditation Unit (QAA) of 
ISD to monitor the quality of SMR data, by assessing accuracy, completeness, consistency 
and fitness for purpose. The QAA have carried our regular audits that have involved 
sample sizes of between 7,500 and 9,500 records. Between 2000 and 2002, the national 
average accuracy at a thiee-digit level was 88% for the main diagnosis. Acute myocardial 
infarction was coded with an accuracy rate of 84%. Coding of secondary diagnoses was 
less accurate with an overall accuracy rate of 77%. The most frequently observed 
omissions included diabetes, hypertension, cardiac dysrythmias, asthma, angina and 
clii'onic ischaemic heart disease. The accuracy of recording data for non-clinical data items 
was 97%. A number of other studies have looked at the accuracy of SMRl data with 
variable results. Kohli et al compared SMRl data and case-notes of patients discharged 
with upper gastro-intestinal diagnoses from Greater Glasgow Health Board hospitals in 
1987, In a sample of 778 cases, they found a crude agreement of 73.6% between primary 
diagnosis and the case-note diagnosis. Coding of secondary diagnoses was much poorer 
and there was a significant underestimation of artliritis.
4.1.50rgaiiisation and Extraction of data
At present the linked data is stored as a conventional flat file of records. The records for 
each individual are stored adjacently in clnonological order and marked with a unique 
personal identifier. Different types of record are stored in their original unlinked format 
and are preceded by several fields of linkage information. This increases the range of 
analyses that are possible. The dataset is complex and requires tailored FORTRAN 
programs to access the data. The staff in ISD use FORTAN programming to produce 
specific data sets. In collaboration with staff at ISD, a data spec was written which 
detailed the nature of the data requfred for this study. This is included as Appendix 1.
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4.2 Data extracted for present study
Information available
For this study, all adults (aged 16 and over) with a first and second principal diagnosis of 
acute myocardial infarction admitted to Scottish hospitals between 1986 and 2000, were 
identified along with any subsequent deaths related to these admissions occuiring up until 
December 31®^ 2001.
The ICD9 code used to identify acute myocaidial infarction patients included: 410- acute 
myocardial infarction. The ICDIO diagnoses used included: 121 and 122 .
This information available allowed patients to be followed up for a minimum of one year 
to the end of the study (31st December 2001). Only the first and second episode of acute 
myocardial infai'ction leading to a hospital admission per patient was analysed. Each 
patient record provided information on age, sex, postcode of residence, date of admission 
and death, if it occuiTed.
Postcode sectors were used to derive Carstairs soeio-economic deprivation scores, which 
were used to categorise patients into deprivation categories. Resident postcodes were used 
to assign a Carstaiis deprivation category from one (least deprived) to five (most deprived) 
to each individual. These categories aie derived from 1991 census data on four variables: 
overcrowding, the proportion of residents unemployed, who do not have a cai', or belong to 
a low occupational social class.
Secondary diagnoses in positions two to six were examined in order to detennine the most 
fr'equent co-diagnoses. These were then recoded into categorical variables. Information on 
prior hospital admission came from retrospective linkage back to 1981. This identified 
those patients who had been admitted to hospital for any other reason, within five years 
prior to their admission for acute myocardial infarction. In order to consistently obtain a 
five-year history of prior admission to hospital for each patient, the principal analyses in 
this study were confined to patients admitted between January 1990 and December 2000. 
A new comorbidity variable was created which combined prior admission and secondary 
diagnosis so that the final variable indicated either a prior admission or a secondary 
diagnosis or both for the following diagnoses:
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Atrial fibrillation, cancer, cerebrovascular disease, coronary heart disease (excluding 
AMI), diabetes, hypertension, peripheral vascular disease, renal failure and respiratory 
disease. Coronary heart disease excluding AMI was not extracted as a secondary 
admission but was included as a comorbidity variable from prior admission because it was 
a relatively common co-diagnosis. The ICD9 and ICDIO codes used to define these 
diagnoses are also detailed in Appendix 1.
Definition of first admission
A "first admission" was defined as the first admission with a principal diagnosis of AMI 
between 1990 and 2000. These individuals had no admission with AMI in the previous ten 
years. Patients with a hospitalisation related to AMI in the previous ten years were 
excluded fr om these analyses.
Definition of second admission
A ‘second admission’ was defined as an admission to hospital with a principal diagnosis of 
AMI in an individual who had been admitted only once in the previous ten years with the 
same diagnosis.
4.3 Statistical analyses
All tests of statistical significance were two tailed. All analyses were undertaken using the 
Statistical Package for Social Scientists (SPSS Inc, Chicago, Illinois 60611) and 
Confidence Inteiwal Analysis for Windows (CIA, 1998).
4.3.1 Descriptive analyses
Baseline data relating to men and women were compared using chi square tests and chi 
square tests for trend for categorical data and t tests for continuous data. Population data 
were used to derive population-based discharge rates per 100,000 individuals for first and 
second AMI stratified by sex, age group and year of admission. Annual age and sex 
specific population denominators were obtained from the General Registrar for Scotland. 
Linear regression was used to test the significance of the obseiwed trends in population 
discharge rates and numbers. Length of stay was examined in men and women between 
1990 and 2000. Mean and median length of stay was also calculated along with 
interquartile range. Occupied bed days per 1000 population were calculated for men and
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women between 1990 and 2000. For each year the number and proportion of men and 
women who underwent in-hospital revascularisation was calculated. In-hospital 
revascularisation was subdivided into coronary artery bypass graft surgery and coronary 
angioplasty. The annual proportion of all emergency medical admissions in Scotland 
accounted for by first and second AMI was also calculated for men and women. In order 
to examine temporal trends in the baseline characteristic of men and women hospitalised 
with a first and second AMI, the overall time period was divided into tliree approximately 
equal time periods, 1990-1992, 1993-1196 and 1997-2000. This categorisation was chosen 
on the basis that the number of men and women admitted to hospital with a first AMI was 
roughly equivalent in the thi*ee time periods because of a decline in the annual number and 
rate of admissions over time. Age distribution and distribution of comorbid diagnoses was 
then examined and compared in these thr ee time periods. The annual mean age of men and 
women was also determined. The chi square test for trend was used to determine the 
presence of any significant association between time period and the proportion of men and 
women with each comorbid diagnosis.
4.3.2Survival analyses
Case fatality rates at 30 days, six months, one year, two years and five years were 
compared in men and women who were categorized into five age groups. The age 
categories chosen were consistent with previous studies. Suiwival time was calculated as 
the time firom either first or second admission for AMI, to death from any cause; or 
censored at 31/12/2001. Age and sex specific survival rates were calculated for the follow 
up periods using the actuarial life table method. This takes account of admission dates and 
periods of follow-up, which differ between patients. Cmde survival rates were stratified 
by sex, by age and sex, by deprivation category and sex, and by co-morbidity and sex. 
Kaplan-Meier suivival curves were drawn in order to graphically illustrate the probability 
of survival for men and women. Stratified analyses were also performed in order to 
compare survival of men and women in different age groups, deprivation quintiles and for 
men and women with each comorbid diagnosis. The log rank test was used to test the null 
hypothesis that men and women are samples from the same population as regards survival 
experience. This involves calculating the observed and expected number of deatlis in both 
groups at separate time intervals and summing these. Median survival was also calculated 
using the Kaplan-Meier survival method.
4.3.3 Cox’s proportional hazards
Cox’s proportional hazard models were then used to determine whether sex, age, socio­
economic deprivation and comorbidity were independently associated with survival at one 
year and five years excluding those deaths that occuned during the fii'st 30 days following 
admission. The Cox’s proportional hazards model compares the hazard functions for each 
level of the model. This was carried out using a foiward stepwise Cox regression. The 
method started by including sex only and added in the most significant variable at each 
step until there were no other significant vaiiables that could be added. This was carried 
out by keeping sex, the variable of interest, in the model. Cox proportional hazard models 
were also caiTied out in men and women separately in order to examine any sex differences 
in the independent effect of variables on survival. Interaction terms between sex and year 
of admission were tested and found to be non-significant. Interaction terms between sex 
and other variables were included in the models and tested for significance. Because there 
was a significant interaction between age and sex, age was then recoded into three age 
categories, <65 year olds, 65-74 year olds and >74 year olds and Cox’s proportional hazard 
models were then carried out in these three groups. Sex was kept in the models and 
forward stepwise Cox regression caiTied out. As no significant departure from linear trend 
was found, age was modelled as a continuous variable within these age group models. For 
each variable entered into a model, the lowest class was set at unity. After fitting the final 
model, the assumptions were checked. The assumptions underlying a Cox’s proportional 
hazards model are:
1. Proportional hazards, the ratio of hazard ftinctions for two individuals with different 
CO variâtes does not vary with time.
2. Linearity, the relationship between the covariates and the hazard function should be 
linear in the log space.
3. Survival times should be independent, as should survival times and censoring times 
and the censoring should not be affected by the covariates.
These were checked by looking at a log-log plot for each categorical covariate in the 
model, which should demonstrate parallel lines if the hazards ar e proportional.
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4.3.4Logistic regression
Multiple logistic regression was used to calculate the adjusted odds ratio for the probability 
of death within 30 days of a first and second admission for AMI. As for Cox proportional 
hazards, foiward stepwise regression was performed. Sex was kept in the model and other 
significant variables were added sequentially. Age was included as a categorical variable 
and categorised into the five groups used in the descriptive and survival analyses. Logistic 
regression was also carried in men and women separately and in the three different age 
groups used in the Cox proportional hazards. In these age group models, age was 
modelled as a continuous variable, as no significant departure from linear trend was found. 
For each variable entered into a model, the lowest class was set at unity.
Adequacy of fit was assessed using the Hosmer Lemeshow Goodness-of Fit-Test.
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5 FIRST AMI: BASELINE CHARACTERISTICS
5.1 Results of descriptive analyses
This section describes the baseline characteristies of men and women who ai e admitted to 
hospital following a fii'st acute myoeardial infarction. In order to examine differences in 
survival between men and women, it is essential to have a clear understanding of then age, 
socio-economic status and co-existing medical conditions. Differences in these variables 
may contribute to discrepancies in survival between men and women. It is therefore 
difficult to examine the independent effect of sex on suivival without first accounting for 
any differences in baseline characteristics that might influence survival.
S.l.lOverall
Between January 1®^ 1990 and December 3V^  2000, a total of 110,226 individuals aged 16 
years and over, were admitted to Scottish hospitals following a first acute myocardial 
infarction. 45,600 were women who comprised 41.4% of the total cohort.
5.1.2Age
Table 22 shows the distribution of age in men and women admitted to hospital following 
their first AMI. Mean age on admission to hospital was 72.1 years in women and 64.6 
years in men. Women were on average seven and a half yeai's older than men at the time 
of first admission to hospital. A two-sample t-test to compare the mean ages of men and 
women was highly significant, p<0.001. The age distribution of men and women differed 
significantly with almost twice the proportion of men aged less than 65 years compared to 
women (47.6% versus 24.2%, p<0.001). The distribution of age was relatively normal in 
men and women and can be summarised using a histogram as seen in Figure 1 and by the 
median, quartiles and extremes shown in Table 22. There was a marked variation in age 
which ranged from 18 to 104 years in both men and women. The distribution of age was 
clustered around the median with 50% of women aged between 65 and 81 years and 50% 
of men aged between 56 and 74 yeai's.
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Table 22 Descriptive statistics for age of men and women following a first hospital
admission for acute myocardial infarction
i. Age group distribution
Number of cases (%) MEN WOMEN BOTH
Age-group <55 years 13897 (21.5%) 3592 (7.9%) 17489 (15.9%)
55-64 years 16866 (26.1%) 7454(16.3%) 24320 (22.1%)
65-74 years 19283 (29.8%) 13639 (29.9%) 32922 (29.9%)
75-84 years 11940 (18.5%) 14538 (31.9%) 26478 (24.0%)
>84 years 2640 (4.1%) 6377 (14.0%) 9017 (8.2%)
Total 64626 (58.6%) 45600 (41.4%) 110226 (100%)
ii. Summary Statistics
Mean (95%CI) SD MEDIAN MIN MAX RANGE IQR
Men 64.6 (64.5-64.7) 12.2 65 18 104 86 18
Women 72.1 (72,0-72.2) 11.6 73 18 104 86 16
iii. Percentiles
PERCENTILE
5 10 25 50 75 90 95
Men 44 48 56 65 74 80 84
Women 51 56 65 73 81 86 89
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Figure 1 Histograms showing age distribution in men and women with a first
admission for acute myocardial infarction
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5.1.3Deprivation and sex
Overall 41.9% of individuals admitted to hospital with a first AMI came fr om the two most 
deprived deprivation categories. Table 23 and Figure 2 show the distribution of deprivation 
in men and women. There was a socioeconomic gradient in men and women and the 
proportion of individuals in more deprived categories was higher than the proportion in 
less deprived categories. A chi square test for trend was highly significant, p<0.001 after 
excluding the relatively small number of individuals not assigned to a deprivation 
category. Figure 3 shows the distribution of deprivation in men and women in the Scottish 
population at the time of the population census in 1991. Unlike the AMI cohort, the 
proportion of men and women in each deprivation category is roughly similar.
Table 23 Distribution of deprivation in men and women
MEN WOMEN ALL
Deprivation
categories
I- least deprived 10,799 (16.7%) 7,318 (16,0%) 18,117(16.4%)
II 12,668 (19.6%) 8,624 (18.9%) 21,292(19.3%)
III 12,764 (19.8%) 9,064 (19.9%) 21,828 (19.8%)
IV 12,954 (20.0%) 9,439 (20.7%) 22,393 (20.3%)
V- most deprived 13,560 (21.0%) 10,275 (22.5%) 23,835 (21.6%)
uncoded 1,881 (2.9%) 880 (1.9%) 2,761 (2.5%)
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Figure 2 Distribution of deprivation in men and women hospitalised with first AMI
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5.1,4Deprivation and age
There was a marked difference in the distribution of age groups between deprivation 
categories in individuals admitted to hospital following a first AML As shown in Table 
24, the most deprived individuals were younger than the least deprived individuals. 32.9% 
of those in the least deprived eategoiy were aged less than 65 years, compared to 43.7% of 
those in the most deprived category. There was a significant trend of decreasing age with 
increasing deprivation and this was statistically significant (Chi square test for trend
p<0.001).
Table 24 Age distribution within deprivation quintiles
Deprivation category
Age group 1-least
deprived
2 3 4 5-most
deprived
imcoded
<55 years 2403
(13.3%)
3025
(14.2%)
3399
(15.6%)
3585
(16.0%)
4539
(19.0%)
538
(19.5%)
55-64 years 3556
(19.6%)
4378
(20.6%)
4652
(21.3%)
5154
(23.0%)
5877
(24.7%)
703
(25.5%)
65-74 years 5238
(28.9%)
6443
(30.3%)
6624
(30.3%)
6770
(30.2%)
7029
(29.5%)
818
(29.6%)
75-84 years 4929
(27.2%)
5477
(25.7%)
5325
(24.4%)
5219
(23.3%)
4948
(20.8%)
580
(21.0%)
>84 years 1991
(11.0%)
1969
(9.2%)
1828
(8.4%)
1665
(7.4%)
1442
(6.0%)
122
(4.4%)
Total 18117
(100%)
21292
(100%)
21828
(100%)
22393
(100%)
23835
(100%)
2761
(100%)
5.1.5Deprivation, age and sex
Table 25 shows the distribution of age by sex and deprivation category. The difference in 
the distribution of age according to deprivation category was seen in both men and women, 
although women were on average older than men. The socio-economic gradient seen 
across age groups was greater in women than in men. Individuals aged 55 years and under 
accounted for only 5.5% of women in the least deprived eategoiy compared to 11% of 
women in the most deprived category. In men the figures were 18.5% and 25.1%. There 
was a trend across deprivation categories so that more deprived men and women were 
younger than less deprived men and women. The differences were significant (Chi squai'e 
test for trend p<0.001 in men and women). Figure 4 shows the distribution of deprivation 
categories by age group and by sex. The interaction between deprivation and sex seen in
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all patients was seen in all age gi'oups but was more marked in younger age groups. The 
excess of women in deprived categories was not therefore confined to certain age groups.
Table 25 Age distribution by sex and deprivation category
Deprivation category
Men Age
group
1-least
deprived
2 3 4 5-most
deprived
uncoded
<55 years 1996
(18.5%)
2467
(19.5%)
2732
(21.4%)
2816
(21.7%)
3407
(25.1%)
479
(25.5%)
55-64
years
2657
(24.6%)
3134
(24.7%)
3224
(25.3%)
3530
(27.3%)
3794
(28.0%)
527
(28.0%)
65-74
years
3248
(30.1%)
3920
(30.9%)
3898
(30.5%)
3839
(29.6%)
3851
(28.4%)
527
(28.0%)
75-84
years
2293
(21.2%)
2541
(20.1%)
2405
(18.8%)
2284
(17.6%)
2112
(15.6%)
305
(16.2%)
>84 years 605
(5.6%)
606
(4.8%)
505
(4.0%)
485
(3.7%)
396
(2.9%)
43
(2.3%)
Women Age
group
<55 years 407
(5.5%)
558
(6.5%)
667
(7.4%)
769
(8.1%)
1132
(11.0%)
59
(6.7%)
55-64
years
899
(12.3%)
1244
(14.4%)
1428
(15.8%)
1624
(17.2%)
2083
(20.3%)
176
(20.0%)
65-74
years
1990
(27.2%)
2523
(29.3%)
2726
(30.1%)
2931
(31.1%)
3178
(30.9%)
291
(33.1%)
75-84
years
2636
(36.0%)
2936
(34.0%)
2920
(32.2%)
2935
(31.1%)
2836
(27.6%)
275
(31.3%)
>84 years 1386
(18.9%)
1363
(15.8%)
1323
(14.6%)
1180
(12.5%)
1046
(10.2%)
79
(9.0%)
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Figure 4 Distribution of deprivation categories by age group and sex
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5.1.6Co-morbidity
Almost a half (47.3%) of all individuals admitted to hospital following theh first AMI had 
either a hospital admission in the five years prior to their AMI admission, or had a 
secondary diagnosis falling into one or more of the categories listed (Table 26). Previous 
coronary heart disease excluded AMI and was based solely on previous admissions and did 
not include secondary diagnoses. A higher proportion of women had a recorded 
comorbidity than men (51.5% versus 44.3%). Heart failure was the most commonly 
recorded comorbidity and was more frequently coded in women than in men. All 
individual comorbid conditions other than coronary heart disease and peripheral vascular 
disease were more commonly recorded in women than in men.
Table 26 Distribution and comparison of comorbid diagnoses by sex
Comorbidity Men Women All
Any 28615 (44.3%) 23474 (51.5%) 52089 (47.3%)
Diabetes 5178 (8.0%) 4350 (9.5%) 9528 (8.6%)
Cancer 3729 (5.8%) 2929 (6.4%) 6658 (6.0%)
Respiratory 6119(9.5%) 4698 (10.3%) 10817(9.8%)
Cerebrovascular
disease
4248 (6.6%) 3456 (7.6%) 7704 (7.0%)
Peripheral 
vascular disease
4455 (6.9%) 2914 (6.4%) 7369 (6.7%)
Atrial fibrillation 3736 (5.8%) 3378 (7.4%) 7114(6.5%)
Hypertension 5978 (9.3%) 5432 (11.9%) 11410(10.4%)
Renal failure 1641 (2.5%) 1515(3.3%) 3156 (2.9%)
Heart failure 9340 (14.5%) 8810(19.3%) 18150(16.5%)
Coronary heart 
disease
4507 (7.0%) 3158 (6.9%) 7665 (7.0%)
5.1.7Comorbidity, age and sex
Each comorbid condition was examined according to age group and sex. Figure 5 shows 
the distribution of age group by comorbid condition in men and in women and Table 27 
shows the results of the chi square tests of association between age group and sex within 
each comorbid diagnosis.
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Comorbid diagnoses that decreased in prevalence with increasing age
The prevalence of diabetes was greatest in the middle aged groups and declined in the 
elderly. Prevalence of diabetes was gi'eater in women than in men in all age groups. The 
observed trends were significant in men and in women, p<0.001. Hypertension showed a 
marked reduction in the elderly, especially in men. Again, hypertension was more 
common in women than in men of all ages.
Comorbid diagnoses that increased in prevalence with increasing age
The prevalence of a previous or co-existing heart failure diagnosis increased significantly 
with age in men and in women, p<0.001. Only 5.6% of men and 6.7% of women aged less 
than 55 yeai's had a heart failure diagnosis coding compared to 27.6% of men and 30.4% of 
women aged 85 years and over. Heart failure was more common in women than in men in 
all age groups, except in individuals aged 75-84 years. The prevalence of atrial fibrillation 
increased with age in men and in women and was slightly more common in men than in 
women apart from in the very elderly age group. Cerebrovascular disease increased in 
prevalence with age in men and women up to the age of 75-84 years and declined 
thereafter. The proportion of individuals with a previous histoiy of coronary heart disease 
increased only marginally with age and was slightly greater in men than in women except 
in those aged less than 55 years.
Comorbid diagnoses that displayed an interaction between age and sex
A  cancer diagnosis displayed an interaction between age and sex. Cancer was more 
commonly coded in younger women than in younger men and less commonly coded in 
older women than in older men. For example, 3.8% of women aged less than 55 years 
were coded for cancer compared to 1.7% of men. However, 12.6% of men aged >84 yeai's 
were coded for cancer compared to 6.8% of women. Respiratory disease showed a similar 
pattern and increased more with age in men than in women. 16.1% of men aged greater 
than 84 years had a resphatory diagnosis compared to 11.3% of women. Peripheral 
vascular disease increased dramatically in prevalence with age in men but not in women 
leading to an age sex interaction. 12.9% of men aged greater than 84 years had a diagnosis 
of peripheral vascular disease compared to 7.1% of women. Renal failure displayed a 
similar pattern although the differences between men and women were less marked in all 
age groups.
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Figure 5 Distribution of comorbid diagnosis by age and sex
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Table 27 Tests of association between sex and age group within comorbid diagnoses
CHI SQUARE TEST CHI SQUARE TEST FOR 
TREND
Comorbidity Men Women Men Women
Diabetes P<0.001 P<0.001 P<0.001 P<0.001
Cancer P<0.001 P<0.001 P<0.001 P<0.001
Respiratory
disease
P<0.001 P<0.001 P<0.001 P<0.001
Cerebrovascular
disease
P<0.001 P<0.001 P<0.001 P<0.001
Peripheral 
vascular disease
P<0.001 P<0.001 P<0.001 P<0.001
Atrial fibrillation P<0.001 P<0.001 P<0.001 P<0.001
Hypertension P<0.001 P<0.001 P=0.001 P<0.001
Renal failure P<0.001 P<0.001 P<0.001 P<0.001
Heart failure P<0.001 P<0.001 P<0.001 P<0.001
Coronary heart 
disease
P<0.001 P=0.038 P<0.001 P=0.039
5.1.8 Comorbidity, deprivation and sex
Describing the distribution of deprivation categories for each comorbid diagnosis in men 
and in women provided more information about the relationship between deprivation and 
specific comorbid diagnoses (Figure 6). Table 28 shows the results of the chi squai'e tests 
of association between sex and deprivation within comorbid diagnoses. Individuals who 
had not been assigned to a deprivation category were excluded from these tests. Variation 
by deprivation category was not as marked as that obseived between age groups.
The proportion of women with a comorbid diagnosis of diabetes varied by deprivation 
category (p<0.001). There was a clear socio-economic gradient so that 8.2% of women in 
the least deprived categoi'y had a comorbid diagnosis of diabetes, rising to 10.6% in the 
most deprived eategoiy. This trend was highly significant, p<0.001. There was no 
difference across the deprivation categories in men. Cancer and respiiatory disease also
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displayed a relationship with deprivation and were more commonly coded in more 
deprived categories in men and women. These trends were highly significant, p<0.001.
Coronary heart disease displayed significant variation across deprivation categories in men 
and in women. The most deprived were more likely to have a coding for previous 
coronary heait disease and this gradient was similar in men and women. For example, 
6.5% of men and 6.3% of women in the least deprived category were coded for coronary 
heai't disease compared to 8.0% of men and 8.1% of women in the most deprived eategoiy. 
In men, cerebrovasculai' disease was more commonly coded in more deprived categories 
than in least deprived categories. This trend was not seen in women. Peripheral vascular 
disease showed no evidence of trend or variation according to deprivation category m men 
or in women. Hypertension showed a reverse pattern compared to other comorbid 
diagnoses and was more likely to be coded in least deprived men compared to most 
deprived men, P<0.001. This pattern was not evident in women.
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Figure 6 Distribution of deprivation categories by comorbid diagnosis and sex 
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Table 28 Tests of association between sex and deprivation within comorbid diagnoses
Chi Square Test Chi Square Test for Trend
Comorbidiiy Men Women Men Women
Diabetes P=0.759 P<0.001 P=0,825 P<0.001
Cancer P-0.001 P<0.001 P<0.001 P<0.001
Respiratory
disease
P<0.001 P=0.001 P<0.001 P<0.001
Cerebrovascular
disease
P<0.001 P=0,772 P<0.001 P=0.909
Peripheral 
vascular disease
P=0.442 P^O.273 P=0.104 P=0.169
Atrial fibrillation P=0.001 P=0.002 P-0.001 P=0.011
Hypertension P=0.002 P ^ O J l l P-0.001 P=0,473
Renal failure P=0,508 P=0.006 P=0.880 P^O .300
Heart failure P<0.001 P=0.018 P<0.001 P=0.036
Coronary heart 
disease
P<0.001 P<0.001 P<0.001 P<0.001
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5.2 Discussion of first AMI baseline characteristics
There is a large literature surrounding the epidemiology of AML Despite this there is a 
lack of data relating to the comparison of men and women with AMI. Most of the 
literature that does exist compares survival rates between the sexes and examines possible 
explanations for differences in these. There are very few studies that have examined the 
baseline characteristics including comorbid diagnoses in men and women hospitalised with 
AMI in an unselected population cohort. Many of those studies that have carried out 
detailed comparisons between men and women hospitalised with AMI include clinical 
trials such as I S I S - 3 , S P R I N T , T I M I  II^™or GUSTO IIb^^‘ or studies that have 
excluded older^ '^^ ^^ '^ ^^ '^ ^^  or younger individuals.^^’ All of these studies are subject to 
selection bias and the individuals are not therefore typical of AMI patients in the general 
population. There is consequently difficulty regarding the generalisability of their results. 
In addition the vast majority of studies include first and recurrent AMI and do not 
differentiate between these. The baseline characteristics including age and prevalence of 
comorbid diagnoses differ between individuals with first and recurrent events and this 
issue is rarely, if ever, explored. This discussion is therefore caixied out with reference to 
those studies that have examined the distribution of comorbid diagnoses in men and 
women hospitalised with AML It is not restricted to first AMI for which there is a very 
limited literature.
5.2.1 Age and sex
Between 1990 and 2000, 45,600 women were hospitalised in Scotland with a first AMI, 
accounting for 41.4% of all hospitalisations. This diffei^ from clinical trials where women 
tend to be enmlled in small numbers if at all but is consistent with other population based 
studies. In the Worcester Heait Attack Study and the Rochester Epidemiology Project, 
women accounted for 39% and 44% respectively of the study cohorts of first AMIs, which 
is similar to this Scottish c o h o r t . T h e  mean age of Scottish men and women on 
admission to hospital was 64.6 years and 72.1 years respectively. Again this is consistent 
with other studies in which women hospitalised with an AMI are generally six to ten years 
older than men. hi the Worcester Heart Attack Study men and women were 63.9 years and 
71.7 years respectively at the time of hospitalisation wiÜi their first AMI.^^ It was not 
possible to determine the mean age of men and women in the Rochester Epidemiology 
Project firom the published repoi-t.^ "^  In the Ontario Myocardial Infarction Database,
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women accounted for 36% of all individuals hospitalised with an The study
included all AMIs as oppose to first AMIs. The mean age of these individuals was 69 
years in 1996, though again it was not possible to detennine the mean age of men and 
women from the published report. Some of the other large studies like ARIC and 
NHANES-I excluded patients over the age of 74 years and do not therefore allow a valid 
comparison of age with population based s t u d i e s . T h e  age and sex characteristics of 
the patients in this study compare well to smaller studies carried out in the UK. In the 
Yorkshire AMI Study, 39% of the study population were women with a mean age of 74.9 
years compaied to 68 years in men.^^ In the Nottingham Heart Attack Register, women 
accounted for 37% of the study cohort in 1992 and had a mean age of 69.7 years compared 
to 64.8 years in men.^^  ^ The current study and other studies have therefore consistently 
shown that women develop clinical manifestations of coronary artery disease later than 
men. The male to female ratio of coronary artery disease declines with increasing age, 
possibly due to women undergoing the menopause and acquiring an increasing burden of 
cardiovascular risk factors, hi the Framingham Study AMI incidence in women was 
roughly half that of men in individuals aged greater than 65 y ears. The proportion of 
men and women in an AMI cohort will then depend upon file age and sex structure of the 
population of origin.
5.2.2Socioeconomic characteristics
There was a socioeconomic gradient in bofii men and women, with increasing number's of 
admissions seen in the luore deprived categories, especially in women. An interaction was 
observed so tliat there were more men than women observed in the least deprived 
categories but more women fiian men in the most deprived categories. This interaction 
was also present witiiin each age group. A similar interaction is seen in the whole Scottish 
population but is not apparent within age groups. There are few publications with which to 
compare these data. This is because there are few population based studies that examine 
first AMI and those that do exist have not examined the distribution of socioeconomic 
deprivation in men and women and in different age groups. The studies that have included 
some measure of socio-economic depr*ivation, have used different classification systems 
and are not therefore directly comparable to the Scottish data. In the National Registry of 
Myocardial Infarction 2, women, especially younger women were substantially more likely 
to be receiving Medicaid than men.^  ^ Medicaid is a program that pays for medical 
assistance for people with low incomes. In the North Karelia and Kupio Study income was 
associated with an adverse cardiovascular' risk but only in women. hicome was the only
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socioeconomic factor that seemed to differentiate between men and women in terms of 
cardiovascular risk. There has been very little analysis or discussion in Üie literature 
around the relationship between socioeconomic deprivation and coronary heart disease in 
men and women. Young women have a relatively low risk of developing the disease and 
those that do develop coronary heart disease are therefore likely to have a particularly 
adverse risk profile, which in turn is related to the level of socioeconomic deprivation. 
Diabetes for example has been found to be more common in people fiom areas of high 
socioeconomic deprivation.*^^ Diabetes has also been shown to have a greater impact on 
the relative risk of developing coronary heart disease in men than in women.^*’*^ ’^*^ ^
5.2.3Comorbid diagnoses
Few studies have examined the prevalence of comorbid diagnoses in men and women of 
all ages. Wliilst a number of studies have looked at the prevalence of other cardiovascular 
diagnoses in men and women separately, they have generally excluded individuals in older 
age groups and have not included other comoibid diagnoses in their description of baseline 
characteristics. Very few studies have described tlie distribution of risk factors and 
comorbid diagnoses by age group within men and women separately. Slightly more 
women than men had either a prior admission within five years of the index event, or a 
secondary diagnosis falling into one or more of the chosen categories (51.5% of women 
versus 44.3% of men). This is not surprising given tlrat women were on average seven and 
a half years older than men. However not all comorbid diagnoses increased in prevalence 
with age and younger patients had a relatively high rate of coded comorbid diagnoses.
Diabetes
Overall 8.0% of men and 9.5% of women in this study had a diagnosis of diabetes. This is 
lower than the rates reported by most other studies. In the current study, it is likely that 
diabetes is under recorded as a secondary diagnosis in hospital discharge forms and that 
those individuals with a primary diagnosis of diabetes in a prior admission represent the 
more severe end of a spectrum. However the reported prevalence of diabetes in men and 
women hospitalised with AMI varies substantially between different studies. In the 
National Registry of Myocardial Infarction 2 Study, 25% of men and 33% of women had a 
diagnosis of d i abe tes .This  is higher than the rates reported by most other studies. For 
example 11% of men and 16% of women in the Yorkshire AMI Study had a diagnosis of 
d i a b e t e s . T h e  overall prevalence of diabetes reported by different studies is higher in
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women than in men hospitalised with AMI, which is in keeping with the results fiom this 
study/**"^ **'^ '^^  ^ The prevalence of diabetes in the general population is not significantly 
different in white men and women. In this study women were more likely to have a 
diagnosis of diabetes in all age groups though the prevalence was greatest in the middle 
age groups and declined in the elderly. The sex difference was greatest in younger age 
groups. Few studies have looked at age specific prevalence of diabetes in men and women 
hospitalised with AMI. Those that have are mainly clinical trials, the results of which are 
difficult to extend to the general population. The National Registry of Myocardial 
Infarction 2 Study found that younger women were more likely than younger men to have 
a histoiy of diabetes, but that this sex difference was minimal in older age groups.^^ This 
is in keeping with the results of this study. Diabetes is linked to obesity which is more 
common in women and might contribute to the increased prevalence seen in women. As 
mentioned previously young women have a relatively low risk of developing coronary 
heart disease and those that do are likely to have particularly adverse risk profiles. In 
addition diabetes has a greater impact on the relative risk of coronary heart disease in 
women than in men.^*’*^ ^
Heart failure
Heart failure was the most commonly recorded comorbid diagnosis in this study. More 
women than men had a recorded diagnosis of heart failure (19.3% versus 14.5%), This 
finding is in keeping with the rates reported by other studies, for example in the National 
Registiy of Myocardial Infarction 2 Study, 21% of women and 13% of men had a histoiy 
of congestive cardiac failure. Prevalence of heart failure varies between different studies 
but has been found to be consistently higher in women than in Some of the
variation in reported prevalence rates is likely to arise as a result of the different criteria 
used to define heart failure and also because prevalence is measured at different time 
points during the index admission. In the current study the prevalence rate is likely to 
include in the numerator those individuals who develop heart failure in the post-infarct 
period, prior to discharge or death. The prevalence of heart failure increased significantly 
with age in men and women, which again is in-keeping with other studies. In the 
REGICOR Study, 11% of men and 23% of women aged 65-74 years hospitalised with an 
AMI between 1990 and 1992 had a diagnosis of heart failure. '^* In the current study the 
equivalent figures were 16% and 17% in men and women respectively. Given that the age 
specific prevalence rates of heart failure in the cuiient study were similar in men and 
women it is likely that the overall excess in women can be explained by the fact that
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women were on average older than men and that the prevalence of heart failure increases 
with age.
Hypertension
More men than women had a recorded diagnosis of hypertension (11.9% versus 9.3%). 
This is substantially lower than the rates reported by other studies and is likely to have 
arisen as a result of poor coding in hospital discharge fonns and medical case notes. 
Prevalence rates reported by other studies vary considerably. It is often difficult to 
determine fiom these studies whether the diagnosis of hypertension was based on a history 
of hypertension or on clinical examination of the AMI patient. Hypertensive patients can 
become normotensive after developing an AMI and this would decrease the estimated 
prevalence. In the REGICOR Study, 61% of women and 40% of women had a diagnosis 
of hypertension based on clinical examination following hospitalisation with an AMI.^ "* 
Hypertension was more commonly coded in women than in men and this is in keeping 
with the results of other s t u d i e s . H y p e r t e n s i o n  is believed to develop at similar rates 
in men and women in the general population, and to exert similar effects on the risk of 
coronary ardeiy disease in both sexes. Elderly hypertensive women outnumber 
hypertensive men because men die at a younger age than women. In the current study 
the prevalence of hypertension reached a peak in middle age groups and declined in the 
elderly. Few other studies have examined prevalence of hypertension in different age 
groups and those that have, have largely excluded the very elderly. This finding may 
reflect a greater likelihood of diagnosing and treating cardiovascular risk factors like 
hypertension in younger people compared to older people rather than a real difference in 
the prevalence of this diagnosis.
Renal impairment
Renal failure was coded in a small proportion of men and women (2.5% of men versus 
3.3% of women). There are few studies with which to compare these figures. In 
NHANES III the population prevalence rate of chi'onic renal insufficiency was 2.2% in 
men and 2.7% in women aged 20-74 years. In the current study a renal failure diagnosis 
is likely to represent individuals with relatively severe renal disease. In the Framingham 
Offspring Study, 8.9% of men and 8.0% of women had an elevated serum creatinine level 
and the prevalence increased steeply with age.*^ * 20% of this Framingham cohort had pre­
existing cardiovascular disease. In the current study prevalence of renal failure also 
increased substantially with age, especially in men, 6.9% of whom had a diagnosis of renal
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failure over the age of 84 years. There is a growing literature regarding renal failure and 
AMI, but few studies have reported sex specific data. Furthennore the diagnostic criteria 
used are not consistent and the reported prevalence rates vary markedly between studies. 
For example, the Mayo Clinic Study found that 47% of men and 76% of women 
hospitalised with AMI had a degree of renal impairment.^** These figures were based on 
creatinine clearance which is a sensitive marker and likely to pick up mild cases. In 
contrast, the Alberta Health and Wellness Database found that only 3% of men and 4% of 
women hospitalised with AMI had a diagnosis of renal failure based on discharge coding.^ ** 
These figures are comparable to those found in this study and are likely to represent 
individuals with severe disease.
Previous angina and coronary heart disease
In this study a previous diagnosis of coronary heart disease was present in 7.0% of men 
and 6.9% of women hospitalised following a first AMI. The prevalence was slightly 
higher in men than in women in all age groups, except in those aged less than 55 years. 
Prevalence remained relatively stable with age in both sexes. The prevalence of previous 
angina in individuals hospitalised with AMI reported by other studies varies considerably. 
In the Worcester Heart Attack Study, 17% of men and 22% of women hospitalised with a 
fii'st AMI had history of angina based on review of medical notes.^*’ Other studies, 
especially those looking at all AMIs as oppose to first AMI, have reported higher rates of 
previous angina in individuals hospitalised with AMI. '^*’^ *^’^  ^ For example the Goteborg 
Study found a prevalence of previous angina of 45% in men and 51% in wo men. Some 
of these differences may be the result of the different methodologies employed by studies. 
It is likely that the prevalence of previous angina will be higher in those studies where 
description of baseline characteristics is based on interview and case notes, compared to 
those where prevalence is based solely on discharge coding or case notes.
Atrial fibrillation
Overall, 5.8% of men and 7.4% of women in this study had a diagnosis of atrial 
fibrillation. The prevalence of atrial fibrillation increased substantially with age and was 
slightly more common in men than in women except in the very elderly. Overall the 
prevalence of atrial fibrillation was gi*eater in women than in men because of the relatively 
small number of men compared to women in the older age groups. These figures are lower 
than those reported by most studies. In the Worcester Heart Attack Study, 14.7% of men 
and 18% of women had a diagnosis of atrial fibrillation following admission to hospital
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with As in the cun*ent sstudy, the prevalence of atrial fibrillation increased
significantly with age. In the Worcester Heart Attack Study, AMI patients with atrial 
fibrillation were more likely to develop heart fa i lure.People with heait failure are more 
likely to develop atrial fibrillation and the association between heart failure and atrial 
fibrillation is clearly complex and has not been explored in this study.^^’*****’*^^
Chronic obstructive airways disease
In this study, the prevalence of respiratory disease which comprised mainly chronic 
obstmctive airways disease was similar in men and women (9,5% in men versus 10.3% in 
women). There was an interaction between age and sex so that respiratory disease was 
more common in younger women than in men but more common m older men than in 
older women. There are very few data with which to compare these findings. In the 
SPRINT Trial, 7.5% of men and 5.5% of women hospitalised with AMI had a diagnosis of 
COPD. The prevalence increased with age but the analyses were not sex specific. The 
relatively higher prevalence of COPD in younger women may reflect the stronger 
association in women than in men between cigarette smoking and the risk of developing 
coronary artery disease. The incidence of coronary heart disease is relatively low in 
younger women and those that do develop the disease are likely to have particularly 
adverse risk profiles.
Cancer
Slightly more women than men had a diagnosis of cancer (6.4% versus 5.8%). The 
prevalence of a cancer diagnosis was greater in younger women than in younger men. This 
is likely to represent breast cancer. Rates increased substantially with age, more so in men 
than m women so that the diagnosis was more common in men than in women in older age 
groups. This is likely to represent the lung and bowel tumours seen in these age gioups.
Other vascular diseases
Overall the rates of PVD and CVD were similar in men and women in the current study 
(6.9% of men and 6.4% of women had a diagnosis of PVD and 6.6% of men and 7.6% of 
women had a diagnosis of CVD). The prevalence of PVD and CVD increased with age, 
especially PVD in men. This was coded in 12.9% of men and 7.1 % of women aged greater 
than 84 years. CVD was coded in 9.2% of men and 8.9% of women. There are very few 
data with which to compare these results, especially for CVD. The prevalence of PVD 
seen in this study was similar to that reported by the SPRINT Trial which found that 6.4%
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of men and 6% of women hospitalised with AMI had a diagnosis of PVD.***^  The 
Framingham Study also reported prevalence of intermittent claudication and stroke or TIA 
in men and women, though their study included those individuals with a diagnosis of 
‘silent’ AMI, which inflated the denominator, especially in women.^^ In the Framingham 
Study 9.4% of men and 10.5% of women presenting with a first AMI had a diagnosis of 
intermittent claudication, and 5.3% of men and 8.1% of women had a history of stroke or 
TIA. These prevalence figures were not age adjusted and the excess prevalence in women 
may have been largely or wholly explained by older age of the women. In the cunent 
study the prevalence of PVD and CVD was higher in younger women than in men but 
greater in older men than in women. This finding is again in keeping with other comorbid 
diagnoses and the hypothesis that as younger women have a relatively low risk of 
developing coronaiy heart disease compared to men, they are likely to have particularly 
adverse risk profiles and high prevalence rates of comorbid disease.
5.2.4 Summary
In the current study women were on average more than seven years older than men at the 
time of hospitalisation with theft first AMI. They accounted for approximately 40% of all 
hospitalisations for first AMI. Both men and women were more likely to come firom a 
more deprived than from a less deprived area, though this was especially true of younger 
women. Almost half of all men and women had one or more comorbid diagnosis and this 
prevalence rate increased dramatically with age. Younger women had high levels of 
comorbid disease relative to men. This is relevant to theft hospitalisation with AMI which 
would be relatively unusual in the absence of cardiovascular risk factors and comorbid 
disease that serve to counteract the protective effects of the premenopause.^*’*^ ’^*^^
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6 Temporal trends in baseline characteristics of individuals 
admitted to hospital following a first AMI 1990-2000 
6.1 Results
When examining temporal trends in survival following AMI, it is important to consider the 
baseline characteristics of men and women which may vary over time. Variation over time 
in baseline characteristics such as age and comorbid diagnoses may contribute to or even 
explain, observed changes in survival. This section therefore describes the distribution of 
age and comorbid diagnoses in men and women between 1990 and 2000.
6,l.lAge
For ease of comparison, yeai* of admission was categorised into three time periods as 
described in the methods. The age distribution of men and women admitted to hospital 
following a first AMI has experienced modest changes (Table 29). The proportion of 
younger individuals aged less than 65 years has decreased and the proportion of older 
individuals aged 75 year's and over has increased. Tliis pattern is present in men and 
women. In men for example, the proportion of individuals aged 55 to 64 years fell from 
27.3% in 1990-1992 to 24.5% in 1997-2000, whilst the proportion of individuals aged 
greater than 84 years increased from 3.3% to 5.1%. In women the proportion of 
individuals aged 55 to 64 years fell from 17.4% in 1990-1992 to 14.8% in 1997-2000, 
whilst the proportion of individuals aged greater than 84 years increased fr om 11.7% to 
16.2% in 1997-2000. These trends were all highly significant, p<0.001. The average age 
of men and women on admission also increased between 1990-1992 and 1997-2000 In 
men the median age increased from 65 to 66 years and in women from 72 to 74 years. 
Figure 7 shows a scatterplot of mean age on admission m men against year of admission. 
A linear trend line has been fitted to the data. The sample correlation coefficient 
suggests that 67% of the variability in mean age can be explained by its relationship with 
year of admission, so that there is a strong relationship between the two variables. The 
strength of the relationship is even greater in women in whom the R  ^is 80%.
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Table 29 Temporal trends in age distribution of men and women
iv. Age group distribution
Number of cases 
(%)
Men Women
Year of 1990- 1993- 1997- 1990- 1993- 1997-
admission 1992 1996 2000 1992 1996 2000
Age-group <55 4293 5072 4532 1166 1283 1143
years (21.2%) (21.2%) (22.2%) (8.1%) (7.5%) (8.0%)
55-64 5535 6316 5015 2495 2848 2111
years (27.3%) (26.4%) (24.5%) (17.4%) (16.7%) (14.8%)
65-74 6021 7325 5937 4425 5140 4074
years (29.7%) (30.6%) (29.0%) (30.9%) (30.1%) (28.6%)
75-84 3748 4264 3928 4556 5393 4589
years (18.5%) (17.8%) (19.2%) (31.8%) (31.6%) (32.3%)
>84 664 931 1045 1667 2398 2312
years (3.3%) (3.9%) (5.1%) (11.7%) (14.1%) (16.2%)
Total 20261 23908 20457 14309 17062 14229
V. Summary Statistics
Men Women
Year of 
admission
1990-1992 1993-1996 1997-2000 1990-1992 1993-1996 1997-2000
Mean age 
(years)
64.4
(64.2-
64.6)
64.6
(64.4-
64.7)
64.9
(64.8-
65.1)
71.5
(71.3-
71.7)
72.2
(72.0-
72.4)
72.7
(72.5-
72.9)
Standard
deviation
11.9 12.2 12.5 11.4 11.6 11.9
Median age 
(years)
65 65 66 72 73 74
Interquartile
range
17 17 18 16 16 16
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Figure 7 Mean age on admission to hospital following a first AMI in men 1990-2000
65.2
S2S 64.8 
'o  64.6 
C 64.4S
E 64.2 ♦ men
64
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000
year of admission
Figure 8 Mean age on admission to hospital following a first AMI in women 1990- 
2000
=  0.801
♦ women
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 
year of admission
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Comorbidity
Overall the proportion of men and women coded with each comorbid diagnosis, increased 
between 1990-1992 and 1997-2000. These trends were all significant, p<0.001. In 1990- 
1992, 37.1% of men and 43.6% of women had at least one comorbid diagnosis. By 1997- 
2000 this figure had increased to 51.6% of men and 59.8% of women.
The magnitude of change over time varied by diagnosis and by sex. Hypertension, renal 
failure, atrial fibrillation, respiratoiy disease and diabetes exhibited the greatest relative 
increases. The proportion of individuals with a secondary or prior diagnosis of atrial 
fibrillation almost doubled in men and women. In 1990-1992, only 3.8% of men and 5.1% 
of women had a comorbid diagnosis of atrial fibrillation. By 1997-2000 this had increased 
to 7.7% and 10.2% in men and women respectively. The proportion of individuals coded 
with hypertension more than doubled during the study period, rising from 5.4% in men and 
7.4% in women in 1990-1992 to 14.1% in men and 18.2% in women in 1997-2000. 
Cancer and coronary heart disease exhibited the most modest rises over the study period. 
In 1990-1992, 6.0% of men and 5.9% of women had experienced a previous admission 
with coronary heart disease. By 1997-2000 this had increased to 7.9% of men and 8.3% of 
women.
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Table 30 Temporal trends in prevalence of comorbid diagnoses in men and women
hospitalised with a first AMI
Proportion of individuals with comorbid diagnosis (%)
Men Women
Comorbidity 1990-
1992
1993-
1996
1997-
2000
1990-
1992
1993-
1996
1997-
2000
Diabetes 5.8 7.6 10.7 8.0 9.4 11.3
Cancer 4.7 5.6 7.0 4.7 6.5 8.0
Respiratory
disease
7.5 9.5 11.3 7.6 10.3 13.0
Cerebrovascular
disease
5.5 6.6 7.6 6.6 7.3 8.9
Peripheral 
vascular disease
5.7 7.0 7.9 5.6 6.4 7.2
Atrial fibrillation 3.8 5.8 7.7 5.1 7.1 10.2
Hypertension 5.4 8.3 14.1 7.4 10.5 18.2
Renal failure 1.6 2.2 3.9 2.2 3.1 4.7
Heart failure 11.6 14.5 17.2 16.2 19.8 21.8
Coronary heart 
disease
6.0 7.1 7.9 5.9 6.7 8.3
Any comorbidity 37.1 44.1 51.6 43.6 51.2 59.8
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Age group
The proportion of men and women with comorbid conditions increased over the time 
period for most diagnoses and in most age groups. The changes were broadly similar in 
men and women and were more likely to be significant in older age groups. Figure 9 
shows the distribution of comorbid diagnoses by age group and time period for men and 
women.
The proportion of men with a diagnosis of diabetes increased across all the age groups 
between 1990-1992 and 1997-2000. 4.2% of men aged less than 55 years had a diagnosis 
of diabetes but by 1997-2000 this had risen to 7.2%. Other age groups demonstrated 
similar relative increases. The increase was gi*eatest in the 65-74 year old age group in 
whom the prevalence was highest. In 1990-1992 the proportion of men aged 65-74 years 
with a diabetes diagnosis was 6.3% but by 1997-2000 this had risen to 13%. These trends 
were all highly significant. Relative increases were not as great in women in whom the 
prevalence of diabetes was higher. In 1990-1992 the prevalence of diabetes in women 
aged 65-74 years was 8% and by 1997-2000 this had risen to 13.3%. Prevalence of 
diabetes did not increase significantly in women aged less than 55 years.
The proportion of men and women with a diagnosis of cancer increased significantly in all 
individuals aged 55 years and over, except in men aged greater than 84 years in whom 
there was no clear trend, p=0.762. Relative increases were greater in women in whom the 
prevalence of cancer almost doubled in some age groups. The proportion of women aged 
55-64 years with a cancer diagnosis increased from 3.5% in 1990-1992 to 7.4% in 1997- 
2000. In men the increases in prevalence were significant but were smaller in magnitude.
Cerebrovascular disease and peripheral vascular disease demonstrated similar and more 
modest changes which were not significant in the younger age groups in men or in women. 
For example the proportion of men aged 75-84 years with a diagnosis of cerebrovascular 
disease increased from 9.2% in 1990-1992 to 12.3% in 1997-2000. The equivalent figures 
in women were 6.2% and 8.6%.
The prevalence of heart failure increased substantially in men and women during the study 
period. 21.3% of women aged 75-84 years had a diagnosis of heart failure in 1990-1992 
and by 1997-2000 this had risen to 27.1%. A similar ircrease was seen in men in whom
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the equivalent figures were 20.3% and 28.4%. All these trends were highly significant 
(Table 31).
Coding for atrial fibrillation also increased substantially during the study time. In 1990- 
1992 only 4.4% of women aged 65-74 years had a diagnosis of atrial fibrillation but by 
1997-2000 this had risen to 8.2%. Again increases were seen across all age groups and in 
men and women. Relative increases were greater in older age groups so that in men aged 
85 years and over the prevalence increased from 5.4% in 1990-1992 to 14.4% in 1997- 
2000.
Hypertension also demonstrated substantial increases in prevalence between 1990-1992 
and 1997-2000. These changes were apparent across all the age groups and in men and 
women. For example the proportion of women aged 75-84 years with a diagnosis of 
hypertension increased fr'om 6.6% in 1990-1992 to 20.1% in 1997-2000. The equivalent 
figures in men were 4.3% and 14.8%.
The prevalence of men and women with a diagnosis of renal failure was relatively small 
but increased during the study period, especially in the elderly age groups. In 1990-1992 
3.8% of men aged greater than 84 years had a diagnosis of renal failure but by 1997-2000 
this had increased to 10%. The equivalent figures in women were 4.4% and 7.8%. Trends 
in previous coronaiy heart disease were smaller in magnitude when compared to other 
diagnoses, especially in the younger age groups. The prevalence of previous coronary 
heart disease declined slightly in younger women, falling from 6.9% in 1990-1992 to 5.4% 
in 1997-2000 in individuals aged less than 55 years. Modest increases were seen in older 
age groups. In men the prevalence of previous coronary heart disease increased across all 
the age gi'oups though these trends were only significant in individuals aged greater than 
64 years.
Overall the proportion of men and women with at least one comorbid diagnosis increased 
substantially in men and women of all ages across the study period. In 1990-1992 20.8% 
of men aged less than 55 years had at least one comorbid diagnosis but by 1997-2000 this 
had increased to 30.8%. The equivalent figures in women were 31.2% and 39.3%. In the 
elderly age groups the increases were gieater in magnitude. 54.2% of men aged greater 
than 84 years had at least one comorbid diagnosis in 1990-1992 but by 1997-2000 this 
figure had risen to 70.1%. The equivalent figures in women were 50.9% and 67.7%.
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Figure 9 Distribution of comorbid diagnoses by age group and time period for men
and women
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6,2 Discussion regarding temporal trends in baseline 
characteristics of first AMI
Whilst many studies have looked at temporal trends in AMI survival, there are very few 
studies that have examined temporal trends in baseline characteristics of individuals 
hospitalised following AMI and none that have included only fu'st AMIs and have reported 
sex specific analyses in a population based study. Tln'ee of the studies that have examined 
trends in the incidence of first AMI are ARIC, NHANES 1 Epidemiological Follow-up 
Study and the Minnesota Heart Survey, all of which have an upper age limit of 74 years. 
Given that age and comorbid diagnoses are significant predictors of outcome, it is 
important to consider whether the baseline characteristics of men and women have 
changed over time and whether this may have contributed to any observed changes in 
survival.
6.2.1Age
In this study the average age of men and women at the time of hospitalisation with their 
first AMI, increased significantly between 1990 and 2000. The median age of men 
increased ifom 65 yeai's to 66 years and the median age of women from 72 yeai's to 74 
years. CoiTespondingly the proportion of individuals aged 65 years and over increased, in 
men from 51.5% in 1990 to 53.3% in 2000 and in women from 74.4% in 1990 to 77.1% in
2000. More than half of all men and three quarters of all women are now aged 65 years or 
over at the time of hospitalisation with thefr first AMI. Just less than a quarter of men and 
one half of women are aged greater than 74 years. There are very few studies with which 
to compare these data. In the Nottingham Fleart Attack Register, mean age on admission 
increased from 67.6 years m women and 60.7 years in men in 1982 to 69.7 years in women 
and 64.8 years in men in 1992. The age of men in Nottingham was similar to men in 
this study, whilst the women in Nottingham were younger than women in this study. 
These hospitalisations included first and recuirent AMI events and you might therefore 
expect the average age of men and women to be greater than in a cohort of only first AMI 
admissions. The only other study that has reported temporal trends in mean age of men 
and women hospitalised with AMI is the SPRINT Study. In this study the mean age of 
men remained relatively stable between 1981-3 and 1992-4, whilst the mean age of women 
increased slightly from 67.3 years in 1981-3 to 68.4 years in 1992-4.^®  ^ The SPRINT 
Registry only included those individuals who were admitted to coronary care units who are
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likely to be younger than an unselected cohort. The Ontario Study reported an increase in
median age for individuals hospitalised with an AMI between 1992 and 1996 but did not
report sex specific data.*^^
6.2.2 Comorbidity
In this study, the proportion of men and women who had at least one comorbid diagnosis 
increased in men and women of all ages between 1990 and 2000. In 1990-1992, 37% of 
men and 44% of women had one or more comorbid diagnoses. By 1997-2000, this figure 
had risen to 52% in men and 60% in women. Absolute changes were greatest in older age 
groups in men and women. The diagnoses that demonstrated the greatest relative increase 
in prevalence were hypertension, atrial fibrillation and renal failure. The proportion of 
men and women with comorbid conditions increased over the time period for all diagnoses 
except previous coronary heart disease. There are a number of possible explanations for 
this. A comorbid diagnosis of coronary heart disease was based on different coding 
criteria than the other comorbid diagnoses. It was based on a principal diagnosis of 
coronary heart disease that occun ed within five yeai's prior to the index admission. Unlike 
other comorbid diagnoses it did not include secondary diagnoses coded in the index 
admission. Some of the trends observed therefore could be due to changes in coding 
practice and an increasing likelihood that secondaiy diagnoses are accurately recorded. 
The audit reports relating to Scottish Morbidity Data however do not support this 
hypothesis. Alternatively, the observed changes could reflect real differences in the 
characteristics of individuals hospitalised with first AMI, who may be becoming older and 
sicker over time. If that is the case then it is not clear why the proportion of individuals 
with a previous diagnosis of coronary heart disease would remain stable in younger age 
groups. Interestingly the Worcester Heait Attack Study has recently reported a similar 
f i n d i n g . I n  this study, which included individuals hospitalised with AMI between 1975 
and 2001, those who were hospitalised during recent study years were older and had a 
higher prevalence of comorbid diagnoses, with the exception of previous angina. Sex 
specific data were not reported. The SPRINT Study reported a decline in the prevalence of 
prior angina in men and women hospitalised with AMI between 1981-2 and 1992-4.^®^
As for temporal changes in age, there are few studies that have described trends in 
comorbid diagnoses in men and women hospitalised with AMI. Of those that have, none 
of them have reported age and sex specific analyses following hospitalisation with first 
AMI. Only the SPRINT Study has reported the results of sex specific analyses and this is
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in a study population comprising individuals with first and recurrent AMIs who were
admitted to coronary care units.
In this Scottish study, the prevalence of diabetes increased in men and women across all 
age groups. The prevalence of diabetes increased in men from 5.8% in 1990-1992 to 
10.7% in 1997-2000 and in women from 8.0% to 11.3%. The relative increases were 
greater in younger individuals compared to older individuals and in men compared to 
women. There are a number of possible explanations for these changes. The increase in 
prevalence may not reflect a real change in the prevalence of the disease and may have 
arisen as a result of a change in coding practice, improved recognition, or because of the 
lower diagnostic tlireshold for diabetes that was introduced by the American Diabetes 
Association in 1997.^ "^^ '^ ^^  Alternatively the increase in prevalence may reflect a real 
change in prevalence that has in part arisen because of increasing levels of obesity that are 
now found in S c o t l a n d . A  number of other studies have demonstrated an increase in the 
prevalence of diabetes in individuals hospitalised with AMI, including the Worcester Heart 
Attack Study, the SPRINT Study and the Ontario S t u d y . T h e  SPRINT Study 
reported an increase in the prevalence of diabetes in men from 18% in 1981-3 to 23% in 
1992-4. In women the prevalence rose from 29% in 1981-3 to 35% in 1992-4.^^®
In this study, the prevalence of hypertension more than doubled in men and women during 
the study period. In men the prevalence of hypertension increased from 5.4% in 1990- 
1992 to 14.1% in 1997-2000, and in women from 7.4% in 1990-1992 to 18.2% in 1997-
2000. As with diabetes, it is not clear whether these changes reflect an underlying change 
in population disease prevalence or whether they are due to better coding and diagnosis. 
The literature regarding changing prevalence of hypertension has not been consistent in its 
findings. The Worcester Heart Attack Study also reported an increase in the prevalence of 
hypertension in individuals hospitalised with AMI, from 41% in 1975-8 to 68.7% in
2001.*^  ^ However, in the SPRINT Study the prevalence of hypertension remained 
relatively stable in men and women.
Between 1990-1992 and 1997-2000, the prevalence of heart failure in the cuiTent study 
increased substantially in men and women hospitalised in Scotland with a first AMI. The 
prevalence increased from 11.6% in men and 16.2% in women in 1990-1992 to 17.2% in 
men and 21.8% in women in 1997-2000. These figures are similar to those observed in the 
Ontario Study in which 19.3% of individuals hospitalised with AMI in 1992 had a 
diagnosis of congestive heart failure. This figure rose to 21.5% in 1996. The Worcester
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Heart Attack Study also reported an increasing prevalence of heart failure in those patients 
who were hospitalised in recent study years compared to those hospitalised during the 
early study y e a r s / T h e  overall prevalence of heart failure increased from 13.9% in 1975- 
1978 to 25.5% in 2001. In this study the prevalence was based on secondary coding as 
well as prior admission and it is therefore likely that a proportion of the heart failure cases 
developed subsequent to the first AMI. In this report from the Worcester Heart Attack 
Study however, the prevalence was based on past medical history. Further analyses carried 
out by the Worcester Heart Attack Study reported a modest decline in the incidence rate of 
heart failure between 1975 and 1995 in individuals hospitalised with AMI.^^  ^ In the 
curr'ent study a true increase in the prevalence of heart failure may have arisen as a result 
of a number of factors. These would include increasing age and increasing numbers of 
women as well as an increasing prevalence of hypertension and diabetes, both of which 
would increase the likeliliood of developing heart failure.
6.2.3 Summary
In the curTent study the average age of men and women hospitalised with a first AMI 
increased by over a year between 1990 and 2000. Over the same period the prevalence of 
comorbid illness also increased. Whilst some of these changes may reflect changes in 
coding and diagnostic thr eshold, it seems likely that they will also reflect a real increase in 
certain diagnoses. An improvement in the detection and treatment of disease is probably 
also important and may contribute to a reduction in the severity of disease in individuals 
hospitalised with AMI and an improvement in their survival rates.
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7 FIRST AMI : BURDEN OF DISEASE
7.1 Results
The aim of this section is to describe the changing burden of first AMI in men and in 
women on the hospital sector of the National Health Seiwice in Scotland over the period 
1990-2000. ‘Burden’ includes numbers of hospitalisations, population hospitalisation 
rates, length of stay and bed days as well as in-hospital revascularisation rates. Analysis of 
temporal trends in these measures allows us to place AMI in context to the overall burden 
on the National Health Service in Scotland and also to examine and compare the 
contribution of AMI in men and women over time.
7.1.1 Population rates for admission to hospital following a first AMI 
1990-2000
Sex
Between 1990 and 2000, the population discharge rate for first AMI fell by 28% in men, 
fi'om 361 to 260 per 100,000, and by 30% in women, fi’om 225 to 157 per 100,000 (Table 
32). These trends were highly significant in men and women, p<0.001.
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Table 32 Annual number of eases and population rates per 100,000 for men and
women admitted to hospital following a first AMI
Number of cases Population rates (per 100,000)
Men Women Men Women
1990 6687 4657 361 225
1991 6730 4715 363 227
1992 6844 4937 368 238
1993 6630 4686 356 225
1994 5913 4313 317 207
1995 5848 4208 313 202
1996 5517 3855 296 185
1997 5365 3772 288 181
1998 5293 3645 284 175
1999 4958 3531 266 169
2000 4841 3281 260 157
Crude % change -28 -30 -28 -30
Average annual 
change (95% Cl)
"217 (-260-175) ■ 181 ( “ 214- 
“ 149)
" 12.7 ( “ 15- 
-10)
" 8.8 ( “ 10- 
"7)
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Figure 10 Population rates in men and women for admission to hospital following a
first AMI
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Age and sex
Examination of age and sex specific temporal trends in population rates revealed important 
differences between age groups and between men and women. These are shown in, Table 
33, Table 34, Table 35, Table 36, Table 37 and Figure 11. The greatest absolute changes 
in the number of individuals admitted to hospital following a first AMI occuiTed in those 
aged 55 to 74 years, and were greater in men than in women. Between 1990 and 2000, the 
number of men aged 55-64 year's with a discharge diagnosis of first AMI decreased by 656, 
a relative decline of 36%. In women the number of first AMI diagnoses in individuals 
aged 55-64 years, declined by 404, a relative decline of 50%. These trends were all highly 
significant.
Smaller absolute and relative changes were seen in men and women aged <55 years. In 
this age group, population rates for AMI hospitalisation declined by 24% in men and 28% 
iu women. These trends were all significant. Men and women aged greater than 84 years 
displayed an increase in the absolute number of hospitalisations. This did however 
translate into a modest decline in population rates of 10% in women and 25% in men.
The sex differences in population rates for first AMI hospitalisation declined with 
increasing age so that the large discrepancy seen in younger people was no longer as 
apparent in men and women aged 75 and over.
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Table 33 Annual number of cases and population rates per 100,000 for men and
women aged <55 years admitted to hospital following a first AMI
Aged <55 years Number of cases Population rates (per 100,000)
Men Women Men Women
1990 1432 383 110 29
1991 1447 386 111 29
1992 1414 397 108 30
1993 1460 355 112 27
1994 1279 326 98 24
1995 1173 315 90 24
1996 1160 287 89 22
1997 1155 285 89 21
1998 1220 307 95 23
1999 1082 273 84 21
2000 1075 278 84 21
Crude % change -25 -27 -24 -28
Average annual 
change (95% Cl)
- 44 ( - 60- ■ 
27)
" 1 3 ( “ 17-”
9)
“ 3 ( “ 4- “ 2) " 1 ( “ 1.3-~ 
0.7)
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Table 34 Annual number of cases and population rates per 100,000 for men and
women aged 55-64 years admitted to hospital following a fh st AMI
Number of cases Population rates (per 100,000)
Men Women Men Women
1990 1816 814 711 286
1991 1862 825 732 292
1992 1857 856 731 304
1993 1758 795 690 283
1994 1543 747 606 266
1995 1591 670 624 239
1996 1424 636 561 229
1997 1360 609 535 220
1998 1261 589 490 211
1999 1234 503 473 178
2000 1160 410 441 145
Crude % change -36 -50 -38 -49
Average annual 
change (95% Cl)
"77 ( " 9 1 - “ 
64)
" 4 2 ( " 5 1 - “
33)
~ 32 ( " 37- “ 
26)
"15 ( " 1 8 - "  
11)
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Table 35 Annual number of cases and population rates per 100,000 for men and
women aged 65-74 years admitted to hospital following a first AMI
Number of cases Population rates (per 100,000)
Men Women Men Women
1990 1963 1435 1038 578
1991 2027 1459 1056 586
1992 2031 1531 1045 610
1993 2059 1409 1044 555
1994 1855 1348 926 525
1995 1725 1261 868 499
1996 1686 1122 852 449
1997 1605 1081 813 435
1998 1581 1087 799 439
1999 1378 973 696 395
2000 1373 933 690 379
Crude % change -30 -35 -34 -34
Average annual 
change (95% Cl)
"72  ( " 9 1 - "  
54)
"61 ( " 7 4 - "
47)
- 41 ( - 48- - 
33)
"24 ( " 2 8 - "  
19)
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Table 36 Annual number of cases and population rates per 100,000 for men and
women aged 75-84 years admitted to hospital following a first AMI
Number o f cases Population rates (per 100,000)
Men Women Men Women
1990 1242 1511 1359 894
1991 1202 1489 1316 888
1992 1304 1556 1441 941
1993 1144 1487 1296 923
1994 997 1306 1155 830
1995 1118 1384 1241 859
1996 1005 1216 1084 744
1997 1002 1212 1053 733
1998 974 1104 1009 666
1999 981 1193 998 718
2000 971 1080 970 649
Crude % change -22 -29 -29 -27
Average annual 
change (95% Cl)
" 32 ( ■ 46- " 
18)
" 49 ( " 62- “ 
35)
" 46 ( " 59- " 
33)
" 29 ( " 39- ” 
19)
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Table 37 Annual number of cases and population rates per 100,000 for men and
women aged >84 years admitted to hospital following a first AMI
Number of cases Population rates (per 100,000)
Men Women Men Women
1990 234 514 1538 986
1991 192 556 1201 1024
1992 238 597 1422 1071
1993 209 640 1199 1117
1994 239 586 1323 1000
1995 241 578 1267 956
1996 242 594 1230 967
1997 243 585 1192 939
1998 257 558 1203 880
1999 283 589 1286 918
2000 262 580 1157 892
Crude % change +12 +13 -25 -10
Average annual 
change (95% Cl)
+6 (+2-+9) +2 ( " 5-+9) ~ 21 ( " 42- ~ 
0.4)
" 1 7 ( " 2 a - -
6)
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Figure 11 Age and sex specific population rates for admission to hospital following a
first AMI
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7.1.2Length of stay and bed days occupied following admission to
hospital with a first AM I 1990-2000
Length of stay in days in men and women
Length of stay declined steadily in men and women between 1990 and 2000. In 1990 the 
mean length of stay was 11.8 days in men and 20.7 days in women. This difference was 
highly significant. By 2000 the mean length of stay had declined to 8.9 days in men and 
11.8 days in women. Again these changes were highly significant. Median length of stay 
differed substantially from mean and was therefore a more appropriate summaiy measure. 
The median length of stay was 8 days in men and women in 1990 and declined to 6 days in 
men and 7 days in women by 2000. The interquartile range was greater in women than in 
men in each year suggesting that the distribution of length of stay was more widely spread.
Table 38 Length of stay in men and women following a first AMI 1990-2000
Men Women
year of 
admission
Mean Median IQ range Mean Median IQ range
1990 11.8 8 6-10 20.7 8 6-13
1991 12.6 7 6-10 18.3 8 6-12
1992 11.3 7 6-9 18.8 8 6-12
1993 10.6 7 6-9 16.6 8 5-12
1994 9.7 7 5-9 14.9 8 6-12
1995 9.3 7 5-9 13.3 7 5-12
1996 9.1 7 5-9 12.1 7 5-12
1997 8.6 6 5-8 11.3 7 5-11
1998 8.3 6 5-8 10.8 7 5-11
1999 8.6 6 5-8 11.8 7 5-11
2000 8.9 6 5-8 11.8 7 5-11
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Bed days in men and women
Figure 12 shows the bed days per 1000 population occupied by men and women following 
a first AMI between 1990 and 2000. Bed days declined substantially in men and in 
women. In men the number of bed days occupied per 1000 head of population fell from 
42.5 in 1990 to 23.2 in 2000, a decline of 46%. The fall was even greater in women in 
whom the bed days declined fi'om 46.6 in 1990 and 18.5 in 2000, a fall o f 60%. Since 
1995, the occupied bed days per 1000 population has been consistently greater in men than 
in women.
Figure 12 Bed days occupied by men and women following a first AMI 1990-2000
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Total occupied bed days in men and women hospitalised with a first AMI between 1990 
and 2000 are shown in Table 39. The total number of occupied bed days has declined 
substantially in men and women during the study period. In 1990, occupied bed days were 
similar in men and women, the lower numbers of admissions in women being ofifeet 
against a longer length of stay. By 2000 the number of occupied bed days more than 
halved in men and women and women accounted for 46% of all bed days.
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Table 39 Total occupied days In men and women hospitalised with first AMI 1990- 
2000
Year o f admission Men (%) Women (%) Total (%)
1990 43121 (49.9) 43254 (50.1) 86375 (100)
1991 38080 (49.4) 39073 (50.6) 77153 (100)
1992 37931 (51.4) 35825 (48.6) 73756(100)
1993 32964 (50.6) 32220 (49.4) 65184(100)
1994 2797 (49.0) 29127 (51.0) 31924(100)
1995 27979 (51.4) 26402 (48.6) 54381 (100)
1996 23620 (52.8) 21157 (47.2) 44777 (100)
1997 21226 (52.5) 19228 (47.5) 40454 (100)
1998 19923 (53.2) 17500 (46.8) 37423 (100)
1999 18952 (51.3) 17975 (48.7) 36927(100)
2000 18401 (53.6) 15923 (46.4) 34324 (100)
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7.1.3In-hospital revascularisation rates in men and wom en following a
first AM I 1990-2000
Table 40 shows the number and proportion of men and women witli a first AMI 
undergoing a revascularisation procedure during their inpatient stay. The numbers and 
proportions are relatively small, but increased substantially over time in men and women (
146
Figure 13). In 1990, only two men and four women undeiivent a revascularisation 
procedure during their inpatient stay. By 2000 this had mcreased to 208 men and 71 
women. The proportion of men and women undergoing a coronary artery bypass graft 
operation was similar in men and women whilst a higher proportion of men than women 
had a percutaneous angioplasty procedure. The proportion of individuals undergoing a 
revascularisation procedure varied with age and younger men and women were more likely 
to undergo in-hospital revascularisation than older men and women (Table 41). This trend 
was highly significant in men and in women, p<0.001.
Table 40 Numbers and rates of men and women with a first AMI undergoing 
revascularisation during their index hospital admission 1990-2000
Men . Women
Revasc CABG PTCA Revasc CABG PTCA
1990 2 (0%) 1 (0%) 1 (0%) 4(0.1%) 3 (0.1%) 1 (0%)
1991 17 (0.3%) 7(0.1%) 10(0.1%) 3(0.1%) 1 (0%) 2 (0%)
1992 16 (0.2%) 5(0.1%) 11 (0.2%) 7(0.1%) 1 (0%) 6 (0.1%)
1993 26 (0.4%) 10 (0.2%) 16 (0.2%) 16 (0.3%) 3 (0.1%) 13 (0.3%)
1994 25 (0.4%) 7(0.1%) 19 (0.3%) 25 (0.6%) 7 (0.2%) 18 (0.4%)
1995 44 (0.8%) 8 (0.1%) 37 (0.6%) 33 (0.8%) 9 (0.2%) 25 (0.6%)
1996 63 (1.1%) 14 (0.3%) 50 (0.9%) 38(1.0%) 8 (0.2%) 30 (0.8%)
1997 94(1.8%) 17 (0.3%) 79(1.5%) 44(1.2%) 7 (0.2%) 37(1.0%)
1998 127 (2.4%) 15 (0.3%) 112(2.1%) 64(1.8%) 8 (0.2%0 56(1.5%)
1999 154 (3.1%) 10 (0.2%) 145 (2.9%) 76 (2.2%) 5 (0.1%) 71 (2.0%)
2000 208 (4.3%) 12 (0.2%) 198 (4.1%) 71 (2.2%) 6 (0.2%) 66 (2.0%)
Total 776 (0.1%) 106 (0.2%) 678 (1.0%) 381 (0.8%) 58 (0.1%) 325 (0.7%)
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Figure 13 Proportion of men and women undergoing a revascularisation procedure
during admission following a first AMI 1990-2000
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Table 41 Proportion of men and women in different age groups undergoing a 
revascularisation procedure during admission following a first AMI
Age group Men Women
<55 years 264(1.9%) 77 (2.1%)
55-64 years 241 (1.4%) 111 (1.5%)
56-74 years 227(1.2%) 139(1.0%)
75-84 years 39 (0.3%) 51 (0.4%)
>84 years 5 (0.2%) 3 (0.05%)
148
7.1.4First AMI as a proportion of all emergency medical admissions
In 1990 hospitalisations for first AMI accounted for 9% of all emergency medical 
admissions in men and 7% of all emergency medical admissions in women. By 2000 these 
figures had fallen to 4% and 3% in men and women respectively. First AMI accounted for 
a higher proportion of medical admissions in men than in women and this sex difference 
remained relatively stable between 1990 and 2000 (Figure 14).
Figure 14 Barchart showing admissions for first AMI as a proportion of all 
emergency medical admissions in men and women 1990-2000
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1 2  Discussion regarding burden of disease for first AMI
7.2,1 Population discharge rates in men and women 1990-2000
In Scotland between 1990 and 2000, the population dischai*ge rate for first AMI fell by 
28% ill men, firom 361 to 260 per 100,000 and by 30% in women, fi.*om 225 to 157 per 
100,000. The fall in hospitalisation rates for AMI is in keeping with numerous reports 
from many countries. ‘^s>50-54;57;58;i89-i9i the Worcester Heait Attack Study, the age 
adjusted incidence of first AMI declined by 26% in men (from 323 per 100,000 in 1975 to 
240 per 100,000 in 1988) and by 22% in women (from 176 per 100,000 in 1975 to 137 per 
1000,000 in 1988).^ *"' Similar declines were also seen in tiie Stockholm Study in which age 
adjusted incidence of first AMI fell by 18% in men and by 13% in women.^^ In the 
Minnesota Heart Sui-vey there were more modest declines in the incidence of first AMI in 
men and women between 1985 and 1990.^  ^ Age adjusted incidence fell by 5% in men and 
4% in women during the study period. Not all studies have reported sex specific analyses. 
Those that have reported sex specific findings have not been consistent in their findings. A 
number of studies have reported more modest changes in incidence in women than in men. 
For example NHANES 1, tlie Rochester Epidemiology Project and the OXMIS Study all 
reported an increasing incidence of AMI in women and a decreasing incidence of AMI in 
men over time. '^^’^ ’^^  ^ In contrast to this and other studies, the ARIC Study reported an 
increasing incidence of AMI in men and women, although fire findings were statistically 
non-significant.^^ The reasons for the conflicting findings regai’ding trends in AMI 
incidence, especially in women are not cleai’. Trends have varied across different 
populations and across different study types and consequently there is no obvious 
geographical or methodological explanation. Definition of AMI varies between studies 
and one obsei-vation is that those studies that have employed a narrower definition of AMI, 
such as the MONICA studies, aie more likely to have reported a decline in incidence than 
those studies that have used a broader definition, such as ARIC, possibly including 
probable as well as definite AMI.
7.2.2Population discharge rates in men and women and different age 
groups 1990-2000
Overall changes masked substantial variation within subgroups and this study has found 
that there are important differences in temporal trends in AMI incidence between men and
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women in different age groups. Greatest relative changes were seen in men and women 
aged 55-64 years. In this age group men demonstrated a 38% decline and women a 49% 
decline in incidence rates between 1990 and 2000. Falls were more modest in the very 
elderly. In individuals aged greater than 84 years, men experienced a 25% decline in 
incidence compared to a 10% decline in women. Few studies have reported age and sex 
specific trends in AMI incidence. The Worcester Heart Attack Study, the OXMIS Study 
and the Rochester Epidemiology Project all examined age and sex specific trends in 
incidence of AMI, and found conflicting r e s u l t s . I n  the Worcester Heart Attack 
Study, the greatest declines were seen in the veiy elderly in whom incidence rates declined 
by approximately 55% between 1975 and 1988.^  ^ The overall decline also disguised 
increasing incidence in women aged 65-74 years in whom incidence rates increased by 
15%. The Rochester Epidemiology Project also reported differing secular trends in AMI 
incidence according to age and sex. They also reported increasing incidence in women 
aged 60 years and greater but declining rates in men of all ages. The reasons for the 
observed dispaiities between studies are not cleai*. There would appear to be consistent 
evidence for declining AMI incidence in men in all age groups, but conflicting evidence 
regarding secular trends in women. It is likely that differences in methodology including 
definition of AMI may account for some of the variation in findings. It is apparent that 
those population-based studies that have analysed routine data sets, such as the Swedish 
National AMI Register and the Ontario Myocardial, Infarction Database, have been more 
consistent in their findings than studies involving more select populations and specific 
diagnostic criteria.
7.2.3Length of stay and bed days in men and women
In this study the average length of stay in men and women hospitalised with AMI declined 
significantly between 1990 and 2000. Median length of stay declined fiom eight days in 
men and women in 1990, to six days in men and seven days in women in 2000. Total bed 
days also declined dramatically in both sexes, presumably a reflection of declining 
incidence and shorter lengths of stay. In 1990-1991, overall bed usage was slightly greater 
in women than in men, despite the fact that they accounted for only 41.1% of all 
admissions. This was a reflection of the longer average length of stay seen in women than 
in men. This is likely to be due to fire older average age of women hospitalised with a first 
AMI and also because of the higher prevalence of comorbid disease seen in women 
compai'ed to men. By 2000 however, total bed usage had declined by 57% in men and by 
63% in women so that overall bed usage was greater in men than in women (18401 bed
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days in men versus 15923 in women). Women still accounted for only 41.4% of all 
admissions so presumably reduction in length of stay has had a greater impact in women 
than in men. There are few existing data on the health seiwice burden of AMI with which 
to compare these findings. The National Hospital Discharge Suiwey found that median 
lengtli of stay declined by 38% between 1998 and 1997, fiom eight days to five days. 
This is similar to tire results of this study though sex specific results were not reported, hr 
the Minnesota Heart Suiwey the median length of stay for individuals hospitalised with 
AMI between 1985 aird 1990 decreased fiom 8.5 days to 6.2 days in men aird fi'om 8.9 
days to 6.9 days among women. This study however excluded individuals over the age of 
74 years. This would bias the average length of stay analyses as length of stay increases 
with age. The burden placed on the hospital sector by AMI has fallen substantially 
because of decliiriirg incidence and a reduction in lengtlr of stay in botlr men and women.
7.2.4In-hospital revascularisation rates in men and women
In contrast to tire falling incidence and length of stay, there has been a dramatic increase in 
the proportion of men and women hospitalised witir a first AMI who underwent a 
revascularisation procedure during their inpatient stay. In 1990 less than 0.1% of 
individuals underwent a revascularisation procedure during their admission. By 2000 this 
had iircreased to 4.3% of men and 2.2% of women. The in-hospital intervention rate 
declined with increasiirg age in men aird women, hr 2000, the individuals who underwent 
revascularisation during their hospital stay were much more likely to have a percutaneous 
angioplasty procedure than a coronaiy artei'y bypass graft operation. In 2000, 
percutaneous angioplasty was carried out in 2.0% of women and 4.1% of men whereas 
coronary artei'y bypass grafting was earned out iir only 0.2% of women and 0.2% of men. 
Again there are veiy few population-based data with which to compaie these findings. The 
intervention rates are much lower than those reported by any other study. This is in part 
likely to reflect selection bias in existing surveys and studies which tend to include a high 
proportion of teaching hospitals with on-site revascularisaton facilities. In the EURO
Heart Survey, percutaneous angioplasty was cairied out in 40.4% of individuals, and 
coronaiy artery bypass grafting in 3.4% of individuals diagnosed with ST-elevation 
AMI.^^  ^ The relatively low levels of intervention are likely to be more representative of 
population based rates and also to reflect differing clinical practice. It also seems likely 
that the low intei'vention rates ai*e in part due to deficiencies in coding in the routine data 
set analysed in the current study. The majority of revascularisation interventions are 
carried out in teaching hospitals and patients are transferred from district general hospitals
152
to these facilities. It is possible that tlie data extract used in the current study has not 
included all revascularisation procedures that are carried out in a hospital that is different 
from the admission hospital.
7.2,5Proportion of all emergency medical admissions
In 1990, fii'st AMI accounted for 9% of all emergency medical admissions in men and for 
7% of all emergency medical admissions in women. By 2000 these figures had declined to 
4% and 3% respectively. There are no other studies with which to compaie these data.
7.2.6Summary
The burden placed on the health service in Scotland by individuals hospitalised with first 
AMI has declined between 1990 and 2000. This has arisen as a result of declining 
incidence and length of stay. There has however been a substantial increase in coronary 
revascularisation procedures which will offset some of the benefits gained as a result of 
changing incidence and length of stay. It is also important to remember that these 
individuals represent first AMIs only and are only a proportion of individuals hospitalised 
with an AMI diagnosis. In addition, whilst AMI hospitalisation rates are declining, there 
has been a substantial rise increase in the number of hospital admissions for suspected 
acute coronary syndrome over the past decade. This has been accounted for by a striking 
increase in admissions with angina and chest pain, which have more than doubled during 
this p e r i o d . T h e  overall pattern of suspected acute coronary syndrome has therefore 
changed with rapidly rising numbers of admissions with chest pain.
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8 SURVIVAL FOLLOWING ADMISSION TO HOSPITAL 
WITH A FIRST AMI
8.1 Results of unadjusted survival analyses
This section describes the unadjusted case fatality of men and women hospitalised in 
Scotland with a first AMI. Case fatality is described at 30 days, six months, one year, two 
year and five years in men and women. Analyses in men and women have been stratified 
into different age groups, socioeconomic categories, years of admission and according to 
the presence of particular comorbid diagnoses. The aim is to provide actual mortality data 
and to gain fiirther insight into suivival differences tliat may exist between men and 
women that may be explored further in multivariate analyses.
8.1.1 Unadjusted case fatality from life tables
The overall unadjusted case fatality rates were higher in women than in men at all o f the 
time periods examined (Table 42). In men the overall case fatality rates at 30 days, six 
months, one year, two years and five years were 16.3%, 20.7%, 23.5%, 28.0% and 39.0% 
respectively. In women the equivalent rates were 25.6%, 31.9%, 35.3%, 40.6% and 
52.8%. These sex differences were all statistically significant. Prognosis following a fiist 
AMI was therefore relatively poor, especially in women, with almost one half of all 
women dead within 5 yeais of admission.
Table 42 Unadjusted case fatality rates in men and women following admission to 
hospital with a first AMI
Case fatality %
Men : Women
30 days 16.3 25.6
Six months 20.7 31.9
One year 23.5 35.3
Two years 28.0 40.6
Five years 39.0 52.8
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8.1.1.1 Age
30 day and six months case fatality
The effect of age on case fatality was powerful in men and in women. 30 day case fatality 
was 3.7% in men and 5.9% in women aged less than 55 years. It increased to 42.6% in 
men and 44.7% in women aged greater than 84 years (Table 43). By six months case 
fatality had risen to 4.8% in men and 7.0% in women aged <55 years (Table 44). Case 
fatality was higher in women than in men of all ages at 30 days and six months.
One, two and five years case fatality
By one year case fatality increased to 23.5% in men and 35.3% in women. Again case 
fatality was higher in women than in men m all age groups (Table 45). By two years the 
difference in case fatality between men and women was less apparent in the older age 
groups but remained a similar magnitude in the younger age groups (Table 46). At five 
years there was an interaction between age and sex so that the effect of sex could not be 
simply described and depended upon age (Table 47). Young women continued to have a 
higher case fatality than young men but in men aged 65 to 74 years and 75-84 years, case 
fatality was greater in men than in women. In men aged 75-84 years, case fatality was 
70% compared to 68.4% in women.
8.1.1.2 Socioeconomic deprivation
30 day and six months case fatality
Socio-economic deprivation appeared to have a minimal effect on short-term case fatality. 
There was a reverse socioeconomic gradient, especially in women so that case fatality was 
higher m the least deprived groups and lower in the most deprived groups. This gi'adient 
was not as appaient in men. Case fatality was higher in all groups in women than in men 
at 30 days and at six months.
One, two and five years case fatality
Socio-economic deprivation had a similar effect m the longer term. Again, there was a 
reverse socioeconomic gradient in women but not in men, in whom the effect of 
socioeconomic deprivation was less consistent. For example, five yeai' case fatality in 
women decreased fiom 54.8% m the least deprived group to 51% m the most deprived
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group. In men, case fatality was similar in the different deprivation categories and there 
was no evidence of any significant differences or of trends.
8.1.1.3 Comorbidity
30 day and six months case fatality
At 30 days and six months the effect of prior and concurrent diagnoses had a marked effect 
on case fatality. The presence of one or more diagnoses increased six month case fatality 
fiom 13.4% to 30% m men and from 25.5% to 37.9% in women. The greatest effects were 
seen with renal failure, cancer, cerebrovascular disease, peripheral vasculai- disease and 
heart failure. For example, case fatality was 56.1% in men and 63.6% in women with a 
codmg for renal failure, compared to an overall rate of 20.7% in men and 31.9% m women. 
Cancer was associated with a six month case fatality rate of 46.3% in men and 47.1% in 
women. Case fatality was generally higher in women, although this effect varied in its 
magnitude. Hypertension had a small effect on case fatality which increased to 20.7% in 
men and 28.7% in women at six months. None of the comorbidies coded appeared to have 
a protective effect and to reduce case fatality.
One, two and five years case fatality
Similar patterns to those seen at 30 days and six months were seen at one, two and five 
years. Cancer, renal failure, heart failure and cerebrovascular and peripheral vascular 
disease again caii'ied the worst prognosis. 87.2% of women and 82.2% of men with renal 
failure and 75.3% of women and 74.2% of men with cancer were dead within five years. 
The presence of any coded comorbidity approximately doubled case fatality at five years in 
men. Five yeai* case fatality was 54.6% with any comorbidity compared to 26.5% with 
none. The effect was not quite as marked in women; 63.1% compared to 41.5%. Again, 
hypertension, diabetes and coronary heart disease appeared to have the least effect on case 
fatality, especially in men. For example, men with a previous admission for coronary heart 
disease had a five year case fatality of 52% compared to 61.3% in women.
8.1.1.4 Trends in unadjusted case fatality in men and women 
30 day and six months case fatality
In men, 30 day case fatality fell from 18.1% in 1990 to 14.6% in 2000, a decline of 19%. 
In women, case fatality declined by 8%, falling fiom 27.2% in 1990 to 25.1% in 2000
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(Table 48). Smaller declines were also seen at six months, and again the fall was greater in 
men than in women, 9% compared to 6%.
One, two and five years case fatality
At one year case fatality in men declined from 25.3% in 1990 to 21.9% in 2000, a decline 
of 13% (Error! Reference source not found.). In women one year case fatality fell by 
6%, from 37% to 34.8%. At two years however, case fatality fell by approximately 7% in 
men and women. Five years case fatality fell by 9% in men, from 41.8% to 38.2% and by 
5% in women, from 54.2% to 51.7% (Table 49).
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Table 43 Unadjusted 30 day case fatality rates in men and women following
admission to hospital with a first AMI
30 day case fatality
MEN WOMEN
Overall 16.3 25,6
Age group
<55 3.7 5.9
55-64 8.9 11.6
65-74 18.7 20.8
75-84 31.4 33.8
>84 42.6 44.7
Deprivation quintile
1-least deprived 16.4 26.8
2 13.8 27.1
3 16,6 26.4
4 16.2 25.4
5-mo St deprived 15.4 23.2
Comorbidity
Any CO morbidity 22.8 29.3
No comorbidity 11.1 21.7
Diabetes 20.5 27.8
Cancer 34.2 36.0
Respiratory disease 27.3 32.5
Cerebrovascular disease 31.6 38.4
Peripheral vascular disease 28.5 32.7
Atrial fibrillation 20.6 27.8
Hypertension 15.0 22.3
Renal failure 44.2 52.0
Heart failure 27.7 33.2
Coronary heart disease 22.6 27.4
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Table 44 Unadjusted six month case fataUty rates in men and women following
admission to hospital with a first AMI
Six month case fatality
MEN WOMEN
Overall 20.7 31.9
Age group
<55 4.8 7.0
55-64 11.4 14.0
65-74 24.1 25.5
75-84 39.6 42.1
>84 54.1 57.3
Deprivation quintile
1-least deprived 20.5 33.7
2 22.0 33.9
3 21.0 32.9
4 20.8 31.5
5-most deprived 20.3 29.1
Comorbidity
Any comorbidity 30.0 37.9
No comorbidity 13.4 25.5
Diabetes 27.9 36.1
Cancer 46.3 47.1
Respiratory disease 35.8 41.4
Cerebrovascular disease 42.1 49.9
Peripheral vascular disease 38.1 43.0
Atrial fibrillation 30.2 40.0
Hypertension 20.7 28.7
Renal failure 56.1 63.6
Heart failure 37.5 44.7
Coronary heart disease 28.9 35.4
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Table 45 Unadjusted one year case fatality rates in men and women following
admission to hospital with a first AMI
One year case fatality
MEN WOMEN
Overall 23.5 35.3
Age group
<55 5.7 8.2
55-64 13.1 15.6
65-74 27.2 28.5
75-84 44.7 46.7
>84 60.3 62.4
Deprivation quintile
1-least deprived 23.4 37.0
2 24.5 37.5
3 23.9 36.5
4 23.7 34.8
5-most deprived 23.3 32.6
Comorbidity
Any comorbidity 34.2 42.7
No comorbidity 15.0 27.5
Diabetes 32.5 41.1
Cancer 52.2 53.0
Respiratory disease 40.8 46.6
Cerebrovascular disease 47.4 55.3
Peripheral vascular disease 43.4 48.2
Atrial fibrillation 36.0 46.2
Hypertension 24.2 32.7
Renal failure 61.1 68.4
Heart failure 43.0 50.8
Coronary heart disease 33.3 40.2
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Table 46 Unadjusted two years case fatality rates in men and women following
admission to hospital with a first AMI
Two year case fatality
MEN WOMEN
Overall 28.0 40.6
Age group
<55 7.2 10.3
55-64 16.2 18.7
65-74 32.4 33.3
75-84 52.6 53.4
>84 68.7 69.8
Deprivation quintile
1 -least deprived 27.9 42.4
2 28.8 42.6
3 28.4 41.3
4 28.4 40.5
5-most deprived 28.1 38.0
Comorbidity
Any comorbidity 40.6 49.3
No comorbidity 17.9 31.4
Diabetes 38.8 49.0
Cancer 60.2 60.8
Respiratory disease 48.1 54.1
Cerebrovascular disease 55.5 62.1
Peripheral vascular disease 51.2 55.4
Atrial fibrillation 43.8 54.4
Hypertension 29.3 38.8
Renal failure 69.4 76.1
Heart failure 51.0 58.4
Coronary heart disease 38.9 47.3
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Table 47 Unadjusted five years case fatality rates in men and women following
admission to hospital with a first AMI
Five year case fatality
MEN WOMEN
Overall 39.0 52.8
Age group
<55 11.5 14.8
55-64 25.1 27.0
65-74 45.5 45.1
75-84 70.0 68.4
>84 85.8 86.0
Deprivation quintile
1-least deprived 38.3 54.8
2 40.1 54.2
3 39.7 53.4
4 39.6 53.2
5-most deprived 39.9 51.0
Comorbidity
Any CO morbidity 54.6 63.1
No eomorbidity 26.5 41.5
Diabetes 53.2 63.5
Cancer 74.2 75.3
Respiratory disease 62.9 68.6
Cerebrovascular disease 69.9 74.1
Peripheral vascular disease 65.3 68.6
Atrial fibrillation 60.9 70.9
Hypertension 42.8 51.8
Renal failure 82.2 87.2
Heart failure 66.9 73.1
Coronary heart disease 52.0 61.3
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Table 48 Trends In unadjusted 30 day and six months case fatality rates in men and
women following admission to hospital with a first AMI
30 day case fatality % Six months case fatality %
MEN WOMEN MEN WOMEN
1990 18.1 27.2 21.5 33.5
1991 17.3 26.2 22,6 32.9
1992 17.0 26.4 21.9 32.2
1993 16.7 26.8 21.1 33.2
1994 16.0 24.7 20.9 31.1
1995 15.9 24.7 20.1 31.1
1996 15.9 24.7 19.9 31.2
1997 15.5 25.4 19.9 31.3
1998 14.8 23.9 19.3 30.2
1999 15.8 25.5 20.3 32.1
2000 14.6 25.1 19.5 31.5
% change 19% 8% 9% 6%
vbwomen following admission to hospital with a first AMI 1990-2000
One year case fatality % Two years case fatality %
MEN WOMEN MEN WOMEN
1990 25.3 37.0 29.2 42.6
1991 24.4 36.4 29.9 42.2
1992 25.0 36.1 29.8 41.4
1993 23.8 36.7 28.2 42.2
1994 23.5 34.4 28.1 39.6
1995 22.8 34.2 27.0 39.6
1996 23.0 34.3 27.3 38.9
1997 22.6 34.5 26.9 41.5
1998 21.9 33.7 26.2 38.7
1999 22.9 35.2 27.1 39.6
2000 21.9 34.8 - -
% change 13% 6% 7% 7%
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Table 49 Trends in unadjusted five year case fatality rates in men and women
following admission to hospital with a first AMI 1990-2000
Five years case fatality %
MEN WOMEN
1990 41.8 54.2
1991 40.2 54.5
1992 40.8 52.6
1993 40.0 54.1
1994 38.8 52.4
1995 37.2 52.0
1996 38.2 51.7
% change 9% 5%
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8,1.2 Kaplan-Meier Survival Curves and median survival time
8.1.2.1 Overall
The Kaplan Meier survival curve for men and women showed a progressive decline in 
cumulative survival in both men and women (Figure 15). Survival was consistently higher 
in men and this difference was statistically significant (p<0.001). The results of the log 
rank tests are shown in Table 52. Median survival times for men and women are shown in 
Table 50 and Table 51. The median survival of men admitted to hospital with a first AMI 
was 8.8 years in men compared to 4.3 years in women.
8.1.2.2 Age
Figure 15 shows the Kaplan Meier survival curves for men and women in different age 
groups. As demonstrated in the life table, age had a powerfiil effect on prognosis. Median 
survival was greater than 10 years in both men and women aged <65 years, but decreased 
to 0.3 years in men and 0.2 years in women aged >84 years. Prognosis was better for men 
than for women, especially in the younger age groups. In individuals aged 65 and over, 
women appeared to have a worse prognosis than men in the short term, but a better 
prognosis than men in the longer term. Overall therefore, the suivival curves were only 
significantly different in men and women aged less than 65 yeai's. The effect of sex on 
prognosis seemed to change as survival time increased.
8.1.2.3 Socio-economic deprivation
Figure 16 shows Kaplan Meier survival curves in men and women within deprivation 
categories. The effect of sex on suiwival was similar in each of the deprivation categories. 
Survival was significantly worse in women in all groups (p<0.001). In men, median 
suiwival was significantly longer in the least deprived category (9.5 years) when compared 
to other deprivation groups (8.2 years in most deprived group). There was little variation 
in median survival in the other categories. In women, median survival was significantly 
longer in the most deprived category (4.8 years) when compared to other deprivation 
categories.
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Figure 15 Survival by sex for all ages and by age group for first AMI
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Figure 16 Survival by sex within deprivation categories
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Table 50 Median survival time in years in men and women following a first AMI
Median survival in years (95% Cl)
MEN WOMEN
Overall 8.8 (8.6-9.0) 4.3 (4.2-4.5)
Age group
<55 >10 >10
55-64 >10 >10
65-74 6.2 (6.0-6.4) 6.4 (6.2-6.7)
75-84 1.6 (1.5-1.8) 1.4(1.3-1.6)
>84 0.3 (0.2-0.4) 0.2 (0.1-0.2)
Deprivation quintile
1 -least deprived 9.5 (9.0-10.0) 3.8 (3.4-4.1)
2 8.3 (8.0-8.7) 4.0 (3.7-4.3)
3 8.5 (8.2-S.9) 4.1 (3.S-4.4)
4 8.3 (8.0-8.7) 4.2 (4.0-4.5)
5-most deprived 8.2 (7.S-8.5) 4.8 (4.6-5.1)
Comorbidity
Any comorbidity 3.9 (3.7-4.0) 2.1 (2.0-2.2)
No comorbidity >10 7.8 (7.5-8.0)
Diabetes 4.2 (3.9-4.Ô) 2.2 (1.9-2.4)
Cancer 0.8 (0.6-0.9) 0.7 (0.6-0.9)
Respiratory disease 2.3 (2.1-2.5) 1.4(1.2-1.6)
Cerebrovascular disease 1.3 (1.1-1.5) 0.5 (0.4-0.6)
Peripheral vascular disease 1.8(1.6-2.0) 1.2 (0.9-1.4)
Atrial fibrillation 2.8 (2.6-3.1) 1.4(1.2-1.6)
Hypertension 7.1 (6.6-7.5) 4.5 (4.1-4.9)
Renal failure 0.2 (0.1-0.3) 0.1 (O.O-O.l)
Heart failure 1.9(1.7-2.0) 0.9 (0.8-1.0)
Coronary heart disease 4.5 (4.1-4.9) 2.5 (2.1-2.8)S
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Table 51 Trends in median survival time in years in men and women following a first
AMI
Median survival in years (95% Cl)
MEN ■ . ' . WOMEN
1990 7.7 (7.3-S.2) 3.8 (3.4-4.2)
1991 8.5 (8.1-8.9) 3.8 (3.4-4.2)
1992 8.1 (7.7-8.5) 4.3 (3.9-4.7)
1993 >8 3.9 (S.5-4.3)
1994 >7 4.5 (4.1-4.9)
1995 >6 4.6
1996 >5 >5
1997 >4 >4
1998 >3 >3
1999 >2 >2
2000 >1 >1
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Table 52 Results of log rank tests from Kaplan Meier Survival comparing men and 
women
Log rank test, p-value
Sex P<0.0001
Age group
<55 P<0.0001
55-64 P=0.0022
65-74 P=0.3666 NS
75-84 P=0.6990 NS
>84 P=0.4148 NS
Deprivation quintile
1-least deprived P<0.0001
2 P<0.0001
3 P<0.0001
4 P<0.0001
5-most deprived P<0.0001
Comorbidity
Any comorbidity P<0.0001
No comorbidity P<0.0001
Diabetes P<0.0001
Cancer P=0.36 NS
Respiratory disease P<0.0001
Cerebrovascular disease P<0.0001
Peripheral vascular disease P=0.0002
Atrial fibrillation P<0.0001
Hypertension P<0.0001
Renal failure P<0.0001
Heart failure P<0.0001
Coronary heart disease P<0.0001
Continued over.
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Table 53 continued
Log rank test, p-value
1990 P<0.0001
1991 P<0.0001
1992 P<0.0001
1993 P<0.0001
1994 P<0.0001
1995 P<0.0001
1996 P<0.0001
1997 P<0.0001
1998 P<0.0001
1999 P<0.0001
2000 P<0.0001
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8.1.2.4 Comorbidity
The presence of any comorbid diagnosis substantially reduced median sui-vival in men and 
women following a first AMI (Table 50). Median survival was >10 years in men and 7.8 
years in women who had no comorbid diagnosis but only 3.9 years in men and 2.1 years in 
women who had one or more comorbid diagnoses. Each of the comorbid diagnoses 
appeared to substantially reduce median survival. As seen in the life table analyses, the 
strongest effects were with renal failure, cancer, heait failure, cerebrovascular and 
peripheral vascular disease. Median survival was longer in men than in women with these 
comorbid diagnoses. Survival with all of these diagnoses except cancer was significantly 
different between men and women. Hypertension and coronary heart disease again had a 
lesser effect on median survival, especially in men.
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Figure 17 Kaplan Meier Survival Curves by sex within comorbid diagnoses
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8.2 Results of adjusted survival analyses
The aim of this section is to deteraiine the independent effect of sex on the risk of short 
and longer tenn case fatality in individuals hospitalised with a first AMI after adjusting for 
the effects of other prognostic variables. The analyses also arm to examine the 
independent effects of the baseline characteristics including age, comorbid diagnoses 
socioeconomic deprivation and year* of hospitalisation on the risk of death in men and 
women.
8.2.1 Logistic regression at 30 days in men and women following a first 
AMI
8.2.1.1 Overall
Table 53 shows the effect of other factors on sex as a predictor of prognosis at 30 days 
following a first AMI. The model started with sex and added other variables, in order of 
decreasing significance. Without adjusting for any factors, women’s odds of death at 30 
days were 77% greater than for men. Accounting for age differences between men and 
women removed much of this sex difference so that women’s odds of death were 16% 
greater than that of men. There was a significant interaction between age and sex so that 
the effect of sex on short term survival could not be simply described and varied according 
to age (p<0.0001). Addition of other variables into the model slightly increased the sex 
difference in the odds of dying at 30 days. After all the variables had been included in the 
model, men had a survival advantage of 20% in the odds of death at 30 days. Again, after 
adjusting for other factors, there was a significant interaction between age and sex 
(p=0.005).
Table 54 shows the logistic regression models carried out in men and women separately. 
Age was the most powerful predictor of outcome at 30 days and appeared to have a 
stronger efiect in men than in women. Men aged 85 and over had a fifteen fold increase in 
the risk of death when compaied to men aged < 55 years (odds ratio 15.31, 95%CI 13.57- 
17.29). In women the equivalent odds ratio was 12.13 (95% Cl 10.44-14.08). 
Socioeconomic deprivation appeared to have a more marked effect on the odds of death in 
men than in women. In men the most deprived deprivation category had a 9% increased 
risk of death relative to the least deprived categoiy. In general, the effect of comorbid
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conditions was greater in men than in women. For example a diagnosis of heart failure 
carried a 48% increase in the odds of death in men compared to a 15% increase in women. 
Previous coronaiy heart disease increased the odds of death in men but not in women. A 
number of diagnoses had a protective effect on sui-vival, and these effects were of a similar 
magnitude in men and women. Atrial fibrillation and hypertension both decreased the 
odds of death at 30 days. Atrial fibrillation was associated with a 24% reduction in the 
odds of death in men and in women. The adjusted odds of death at 30 days decreased in 
men and women between 1990 and 2000 (Table 55). In men the odds of death fell by 38% 
and in women by 24%. These changes were all significant.
Table 53 Effect on sex of stepwise addition of other significant variables in logistic 
regression at 30 days
Step Variable in model Odds ratio (95%CI)
MEN,-; . y WOMEN._
Enter Sex ' 1.00 1.77 (1.71-1.82)
1 _ ' + age group 1.00 1.16(1.12-1.90)
2 + renal failure 1.00 1.17(1.13-1.20)
3 : _ , + cerebrovascular disease 1.00 1.17(1.30-1.20)
4 + cancer 1.00 1.18(1.14-1.22)
5 + year of admission 1.00 1.18(1.14-1.22)
6 + heart failure 1.00 1.18(1.14-1.22)
7 . T. t  hyjpertension 1.00 1.19(1.15-1.23)
8 + respiratory disease 1.00 1.19(1.15-1.23)
9 + atrial fibrillation 1.00 1.19(1.15-1.23)
10 + peripheral vascular 
disease
1.00 1.20 (1.16-1.23)
11 + diabetes 1.00 1.20 (1.16-1.24)
12 + coronary heart disease 1.00 1.20(1.16-1.24)
.3 + deprivation quintile 1.00 1.20(1.16-1.24)
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Table 54 Adjusted odds of death at 30 days in men and women admitted to hospital
following a first AMI
Odds ratio (95% Cl)
MEN WOMEN
Sex 1.00 1.20(1.12-1.23)
Age group
<55 1.00 1.00
55-64 2.33 (2.10-2.58) 2.01 (1.72-2.35)
65-74 5.07 (4.60-5.58) 3.96 (3.42-4.58)
75-84 9.47 (8.58-10.46) 7.60 (6.58-8,79)
>84 15.31 (13.57-17.29) 12.13 (10.44-14.08)
Deprivation quintile
1-least deprived 1.00 1.00
2 1.12(1.04-1.20) 1.09 (1.01-1.17)
3 1.09(1.01-1.17) 1.10(1.02-1.18)
4 1.08 (1.00-1.16) 1.08 (1.00-1.16)
5-mo St deprived 1.09(1.02-1.18) 1.04 (0.96-1.11)
Comorbidity
Diabetes 1.17(1.08-1.26) 1.17(1.09-1.27)
Cancer 1.63 (1.51-1.77) 1.45 (1.33-1.58)
Respiratory disease 1.29(1.21-1.39) 1.23 (1.14-1.32)
Cerebrovascular disease 1.67 (1.55-1.81) 1.61 (1.49-1.74)
Peripheral vascular disease 1.30(1.20-1.40) 1.21 (1.11-1.31)
Atrial fibrillation 0.76 (0.70-0.83) 0.76 (0.70-0.82)
Hypertension 0.74 (0.68-0.81) 0.76 (0.70-0.81)
Renal failure 2.63 (2.35-2.93) 2.74 (2.45-3.06)
Heart failure 1.48 (1.39-1.56) 1.15 (1.09-1.22)
Coronaiy heart disease 1.26 (1.16-1.37) 1.02 (0.93-1.11)
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Table 55 Trends in adjusted odds of death at 30 days in men and women admitted to
hospital following a first AMI
Odds ratio (95% Cl)
' MEN WOMEN
Year o f admission
1990 1.00 1.00
1991 0.94 (0.86-1.04) 0.96 (0.87-1.06)
1992 0.90 (0.82-0.99) 0.94 (0.86-1.04)
1993 0.90 (0.81-0.99) 0.94 (0.85-1.03)
1994 0.82 (0.74-0.90) 0.85 (0.76-0.94)
1995 0.78 (0.70-0.86) 0.80 (0.72-0.89)
1996 0.77 (0.69-0.85) 0.79 (0.71-0.88)
1997 0.73 (0.66-0.81) 0.82 (0.74-0.91)
1998 0.68 (0.61-0.76) 0.77 (0.69-0.86)
1999 0.70 (0.63-0.78) 0.79 (0.71-0.88)
2000 0.62 (0.56-0.69) 0.76 (0.68-0.85)
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8.2.1.2 L og istic  reg ress ion  a t  30 days follow ing a f irs t A M I age <65 years
Sex had a stronger effect on prognosis at 30 days in individuals aged <65 years (Table 56). 
Women had a 29% increase in the odds o f death after adjusting for other factors. 
Socioeconomic deprivation also appeared to have a stronger effect in this younger age 
group. Men in the most deprived category had a 33% increase in the odds of death when 
compared to the least deprived category. A similar effect was seen in women with a 30% 
increase in the odds o f death. The presence o f comorbid conditions also had a more 
marked effect on 30 day survival in this younger age group. For example a diagnosis of 
diabetes increased the odds o f death by 39% in men and by 65% in women. Men with 
renal failure were more than four times likely to die at 30 days (odds ratio in men 4.5, 
95%CI 3.47-5.84). Atrial fibrillation and hypertension continued to have a protective 
effect. Odds o f dying at 30 days fell by 59% in men and 47% in women between 1990 and 
2000 in this younger age group (Table 57). These falls were therefore greater than those 
seen in the overall analyses.
8.2.1.3 Log istic reg ress ion  a t  30 days follow ing a f irs t A M I age 65-74 years
Sex remained a significant predictor o f outcome but had a lesser effect on outcome. 
Women had a 13% increase in the odds o f death at 30 days when compared to men o f a 
similar age (Table 58). Socio-economic deprivation eontinued to have a significant effect, 
but only in men. This effect was smaller in magnitude than that seen in individuals aged 
<65 years. For example, men in the most deprived deprivation category had a 20% 
increase in the odds o f death relative to men in the most affluent deprivation eategory. The 
effect o f comorbid diagnoses differed according to the nature o f the diagnosis and sex. A 
number o f conditions had a lesser effect on the odds o f death in this age group than in the 
younger age group. This included peripheral vascular disease, cerebrovaseular disease, 
heart failure and coronary heart disease. Diabetes was no longer a significant predictor o f 
outcome in men or women. A previous diagnosis o f coronary heart disease, excluding 
AMI, significantly increased the odds of death in men by 28% but not in women. 
Hypertension and atrial fibrillation continued to have a protective effect and to lower the 
odds o f death in men and women at 30 days. Between 1990 and 2000 the odds o f death at 
30 days declined by 27% in men and by 35% in women (Table 59). These declines were 
significant and were smaller than those observed in younger men and women.
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8.2.1,4 Logistic regression at 30 days following a first AMI age >74 years
Sex remained a significant predictor o f outcome at 30 days with women carrying a 12% 
excess risk of death. Socio-economic deprivation no longer had a significant effect on 
outcome in men or in women in this older age group. In general the presence o f comorbid 
conditions had a lesser effect on the odds o f death in this older age group than in the two 
younger groups. For example, heart failure increased the odds o f death by 45% in men 
aged 65-74 years and by 23% in men aged >74 years. Heart failure no longer had a 
significant effect on outcome in women in this age group. Hypertension and atrial 
fibrillation continued to have a protective effect and to lower the odds o f death at 30 days 
in men and women.
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Table 56 Adjusted odds of death at 30 days in men and women aged < 65 years
admitted to hospital following a first AMI 1990-2000
Odds ratio (95% Cl)
MEN- WOMEN
Sex 1.00 1.29 (1.19-1.4)
Deprivation quintile
1-least deprived 1.00 1.00
2 1.23 (1.04-1.46) 1.26 (0.97-1.63)
3 1.20 (1.01-1.42) 1.17(0.91-1.51)
4 1.30(1.11-1.54) 1.34(1.05-1.71)
5-mo St deprived 1.33 (1.13-1.56) 1.30(1.02-1.64)
Comorbidity
Diabetes 1.39(1.19-1.63) 1.65 (1.37-1.98)
Cancer 1.74(1.41-2.15) 1.88 (1.46-2.42)
Respiratory disease 1.51 (1.28-1.79) 1.13(0.90-1.41)
Cerebrovascular disease 1.94(1.63-2.32) 2.27 (1.79-2.89)
Peripheral vascular disease 1.47(1.21-1.79) 1.17 (0.90-1.53)
Atrial fibrillation 0.86 (0.66-1.11) 0.85 (0.57-1.27)
Hypertension 0.67 (0.56-0.80) 0.83 (0.67-1.01)
Renal failure 4.50 (3.47-5.84) 5.15 (3.66-7.23)
Heart failure 2.29 (2.01-2.61) 1.64(1.35-1.97)
Coronary heart disease 1.58 (1.35-1.85) 1.17(0.92-1.49)
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Table 57 Trends in adjusted odds of death at 30 days in men and women aged <65
years admitted to hospital following a first AMI
. W O M E N
Year o f  admission
1990 : ^ 1.00 1.00
1991 0.83 (0.69-1.00) 0.89 (0.68-1.16)
1992 0.74 (0.61-0.90) 0.84 (0.64-1.09)
1993 0.79 (0.65-0.96) 0.88 (0.67-1.15)
1994 0.73 (0.60-0.89) 0.73 (0.55-0.97)
1995 0.67 (0.54-0.82) 0.59 (0.43-0.79)
1996 0.67 (0.54-0.82) 0.60 (0.44-0.82)
1997 0.62 (0.50-0.77) 0.62 (0.45-0.83)
1998 0.60 (0.48-0.75) 0.70 (0.52-0.94)
1999 0.55 (0.43-0.69) 0.61 (0.44-0.84)
2000 0.41 (0.32-0.53) 0.53 (0.37-0.76)
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Table 58 Adjusted odds of death at 30 days in men and women aged 65-74 years
admitted to hospital following a first AMI 1990-2000
Odds ratio (95% Cl)
M E N W O M E N
Sex LOO 1.13 (1.07-1.20)
Deprivation quintile
1-least deprived 1.00 1.00
2 1.22(1.08) 1.04 (0.90-1.21)
3 1.22 (1.08-1.38) 1.10(0.95-1.28)
4 1.14(1.01-1.29) 1.18 (1.02-1.36)
5-most deprived 1.20 (1.06-1.37) 1.04 (0.90-1.20)
Comorbidity
Diabetes 1.08 (0,96-1.23) 1.10(0.96-1.26)
Cancer 1.85 (1.62-2.11) 1.58 (1.34-1.86)
Respiratory disease 1.22(1.09-.36) 1.26(1.10-1.44)
Cerebrovascular disease 1.69(1.50-1.91) 1.85 (1.60-2.15)
Peripheral vascular disease 1.31 (1.16-1.49) 1.19(1.01-1.41)
Atrial fibrillation 0.76 (0.65-0.88) 0.76 (0.63-0.91)
Hypertension 0.76 (0.67-0.86) 0.73 (0.64-0.84)
Renal failure 2.51 (2.08-3.02) 3.01 (2.42-3.74)
Heart failure 1.45 (1.31-1.59) 1.36(1,22-1.52)
Coronary heart disease 1.28 (1.13-1.46) 0.95 (0.80-1.12)
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Table 59 Trends in adjusted odds of death at 30 days in men and women aged 65-74
years admitted to hospital following a first AMI
O dds ra tio  (95%  C l)
. : M E N  ;. . W O M E N
Year o f  admission
1990 1.00 1.00
1991 0.98 (0.83-1.15) 0.95 (0,79-1.14)
1992 1.01 (0.86-1.19) 0.96 (0.80-1.15)
1993 0.92 (0.78-1.08) 0.92 (0.77-1.11)
1994 0.85 (0.72-1.01) 0.76 (0.63-0.92)
1995 0.83 (0.70-0.99) 0.76 (0.63-0.92)
1996 0.85 (0.71-1.01) 0.74 (0.63-0.92)
1997 0.85 (0.71-1.01) 0.92 (0.76-1.12)
1998 0.74 (0.61-0.88) 0.71 (0.57-0.86)
1999 0.71 (0.58-0.85) 0.67 (0.54-0.82)
2000 0.73 (0.61-0.88) 0.65 (0.52-0.81)
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Table 60 Adjusted odds of death at 30 days in men and women aged >74 years
admitted to hospital following a first AMI 1990-2000
Odds ratio (95% Cl)
M E N W O M E N
Sex 1.00 1.12(1.07-1.18)
Deprivation quintile
1 -least deprived 1.00 1.00
2 1.03 (0.93-1.15) 1.10(1.01-1.21)
3 0.98 (0.88-1.10) 1.11(1.01-1.21)
4 0.99 (0.88-1.10) 1.02(0.93-1.12)
5-most deprived 0.93 (0.83-1.05) 1.03 (0.94-1.13)
Comorbidity
Diabetes 1.05 (0.93-1.20) 1.10(1.00-1.23)
Cancer 1.45 (1.29-1.62) 1.31 (1.17-1.46)
Respiratory disease 1.23 (1.12-1.36) 1.20 (1.10-1.32)
Cerebrovascular disease 1.45 (1.29-1.62) 1.42(1.29-1.57)
Peripheral vascular disease 1.16(1.04-1.29) 1.19(1.07-1.33)
Atrial fibrillation 0.73 (0.65-0.83) 0.75 (0.68-0.82)
Hypertension 0.77 (0.67-0.88) 0.75 (0.68-0.82)
Renal failure 2.15(1.85-2.51) 2.29 (2.00-2.62)
Heart failure 1.23 (1.13-1.33) 1.02 (0.95-1.09)
Coronary heart disease 1.03 (0.90-1.17) 1.01 (0.90-1.13)
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Table 61 Trends in adjusted odds of death at 30 days in men and women aged >74
years admitted to hospital following a first AMI
O dds ra tio  (95%  C l)
M E N W O M E N
Year o f admission
1990 1.00 1.00
1991 0.99 (0.85-1.16) 0.98 (0.86-1.12)
1992 0.90 (0.77-1.05) 0.95 (0.84-1.08)
1993 0.93 (0.80-1.09) 0.95 (0.83-1.08)
1994 0.82 (0.70-0.97) 0.90 (0.79-1.03)
1995 0.79 (0.67-0.93) 0.86 (0.76-0.98)
1996 0.76 (0.64-0.89) 0.85 (0.75-0.98)
1997 0.70 (0.59-0.83) 0.83 (0.72-0.95)
1998 0.69 (0.58-0.82) 0.82 (0.72-0.95)
1999 0.79 (0.67-0.93) 0.88 (0.77-1.01)
2000 0.66 (0.56-0.78) 0.85 (0.74-0.98)
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8.2.2 Cox’s Proportional Hazards Regression in men and women at one 
year excluding 30 days
8.2.2.1 O v e ra ll
When no other variables were included in the model, sex was a significant predictor o f 
outcome at one yeai' following a first AMI (p<0.0001). The unadjusted hazard o f death 
was 1.54 in women relative to men. Adjusting for age alone accounted for all o f this sex 
difference and sex was no longer a significant independent predictor o f outcome. Addition 
of other variables into the model had little effect on the hazai'd o f death and did not 
therefore appear to account for initial sex differences. In the final model, the risk of death 
was similar in men and women. The adjusted hazard o f death was 1.02 (0.97-1.06) so that 
there was no significant difference in survival between the sexes. All other variables 
remained significant and were included in the final model. An age sex interaction term 
was included in the model and was found to be significant, p=0.04.
Table 62 shows the Cox Proportional Hazard regiession models carried out in men and 
women separately. As at 30 days, age had a powerful effeet on prognosis so that the 
hazard o f death was 11.6 times greater in men aged >84 when compared to men age <55 
years. A similar effect was seen in women. Socioeconomic deprivation was an 
independent predictor o f outcome in men but not in women. Men in the most deprived 
categoiy had a 28% increase in the hazai'd of death than men in the least deprived category. 
The presence o f comorbid conditions increased the hazard o f death in men and women 
though the magnitude of effect varied according to the diagnosis and by sex. Cancer, heart 
failure, renal failure and cerebrovascular disease had the greatest effect. For example, the 
hazard o f death was 93% greater in men and 84% greater in women who had a diagnosis of 
heart failure. Hypertension and previous coronary heart disease did not have a significant 
effect on prognosis. None o f the comorbid conditions had a protective effect. Between 
1990 and 2000 the adjusted hazard o f death at one year fell by 33% in men and by 31% in 
men. This difference was not significant, p=0.813.
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Table 62 Hazard ratios for death at one year excluding 30 days in men and women
admitted to hospital following a first AMI
Hazard ratio (95% Cl)
MEN W OMEN
Sex 1.00 1.02 (0.97-1.06)
Age group
<55 1.00 1.00
55-64 1.98 (1.72-2.28) 1.73 (1.36-2.21)
65-74 4.01 (3.52-4.56) 3.51 (2.81-4.40)
75-84 6.91 (6.07-7.88) 6.85 (5.49-8.54)
>84 11.61 (9.97-13.52) 11.82 (9.44-14.80)
Deprivation quintile
1-least deprived 1.00 1.00
2 1.08 (0.98-1.19) 1.12(1.01-1.23)
3 1.11 (1.01-1.22) 1.08 (0.98-1.19)
4 1.15(1.04-1.26) 1.03 (0.93-1.13)
5-most deprived 1.28 (1.17-1.41) 1.08 (0.98-1.19)
Comorbidity
Diabetes 1.48 (1.35-1.61) 1.38 (1.26-1.51)
Cancer 1.85 (1.69-2.03) 1.74(1.58-1.92)
Respiratory disease 1.34(1.24-1.45) 1.30(1.19-1.42)
Cerebrovascular disease 1.70 (1.55-1.85) 1.81 (1.65-1.98)
Peripheral vascular disease 1.57 (1.44-1.71) 1.51 (1.37-1.67)
Atrial fibrillation 1.29 (1.18-1.42) 1.30(1.19-1.42)
Hypertension 0.98 (0.89-1.08) 0.88 (0.80-0.96)
Renal failure 1.92(1.69-2.18) 1.67 (1.46-1.91)
Heart failure 1.93 (1.81-2.07) 1.84 (1.73-1.97)
Coronary heait disease 1.10(1.00-1.21) 1.09 (0.98-1.21)
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Table 63 Trends in hazard ratio for death at one year excluding 30 days in men and
women admitted to hospital following a first AMI
H a z a rd  ra tio  (95%  C l)
■ M E N W O M E N
Year o f  admission
1990 1.00 1.00
1991 0.98 (0.86-1.11) 1.02 (0.89-1.16)
1992 1.04 (0.92-1.18) 0.91 (0.80-1.04)
1993 0.89 (0.78-1.02) 0.94 (0.82-1.07)
1994 0.91 (0.80-1.04) 0.86 (0.75-0.99)
1995 0.80 (0.70-0.92) 0.79 (0.69-0.91)
1996 0.77 (0.67-0.88) 0.78 (0.68-0.89)
1997 0.74 (0.65-0.85) 0.73 (0.63-0.84)
1998 0.74 (0.64-0.84) 0.77 (0.67-0.89)
1999 0.71 (0.62-0.82) 0.72 (0.62-0.83)
2000 0.67 (0.59-0.78) 0.69 (0.59-0.80)
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5.2.2.2 C ox’s P ro p o rt io n a l H a z a rd s  R egress ion  a t  one y e a r  fo llow ing a  f irs t  A M I 
age <65 y ears  exclud ing  30 days
SuiTival was similar in men and women aged less than 65 years and sex was not an 
independent predictor o f prognosis at one year in this age group (Table 64). The adjusted 
hazard o f death in women relative to men was 0,92 (0.81-1,03). Socioeconomic 
deprivation was a significant predictor o f outcome in men but not in women, p=0.013. 
Men in the most deprived category had a 44% increase in the hazard o f death relative to 
men in the least deprived category. The effect o f some o f  the comorbid diagnoses on 
prognosis appeared greater in this age group than in the overall cohort. For example, 
cancer was associated with 2.71 times the risk of death in the under 65 year old men 
compared to an increased risk o f 85% in the whole cohort. Peripheral vasculai' disease and 
heart failure were also associated with substantial increases in the risk o f death in men and 
in women. Between 1990 and 2000 the adjusted hazard of death fell by 44% in men and 
by 51% in women (Table 65). This sex difference was not significant, p=0.301.
5.2.2.3 C ox’s P ro p o rt io n a l H a z a rd s  R egress ion  a t  one y e a r  follow ing a f irs t A M I 
age 65-74 years  exclud ing  30 days
Sex was a significant predictor o f one year survival in this age group (Table 66). The 
hazard o f death was 8% lower in women relative to men. Socioeconomic deprivation 
remained a significant predictor o f  death in men but not in women. Men in the most 
deprived categoiy had a 23% in the risk o f death when compared to men in the least 
deprived category. Comorbid diagnoses had a similai* effect to that seen in the younger age 
group, although the magnitude o f these effects varied slightly. Heart failure, renal failure 
and cancer had the strongest impact on prognosis, especially in men. For example, heart 
failure was associated with more than twice the risk o f death (hazard ratio 2.06 in men and 
2.35 in women). Between 1990 and 2000 the risk of death fell by 42% in men and by 45% 
in women (Table 63). This difference reached statistical significance, p=0.04.
5.2.2.4 C ox ’s P ro p o rt io n a l H a z a rd s  R egress ion  a t one y e a r  follow ing a f irs t  A M I 
age >74 years  exclud ing  30 days
As in the younger age group, sex was not a significant predictor o f outcome at one year 
excluding 30 days in men and women following a first AMI, p-0.47. Unlike in the two 
younger age groups, socioeconomic deprivation was a significant predictor o f outcome in 
men and in women, although the effect was not as great in magnitude as that seen in 
younger men (Table 68). For example, men in the most deprived categoiy had a 29%
194
increased risk o f death and women a 15% increased risk o f death when compared to men 
and women in the least deprived categories. Comorbid diagnoses continued to have a 
significant effect on prognosis, though the magnitude o f these effects was generally less 
than that seen in younger age groups. For example, heart failure was associated with a 
60% in the risk of death in women aged >74 years compared to an excess risk of 2.45 
times in women aged <65 years. Hypertension appeared to have a protective effect in 
women but not in men. Hypertension was associated with an 12% reduction in the hazard 
o f death in women.
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Table 64 Hazard ratios for death at one year excluding 30 days in men and women
aged < 65 years admitted to hospital following a first AMI 1990-2000
Hazard ratio (95% Ç1)
MEN , W OMEN
Sex 1.00 0.92 (0.81-1.03)
Deprivation quintile
1-least deprived 1.00 1.00
2 1.20 (0.96-1.52) 0.56 (0.36-0.85)
3 1.19(0.95-1.50) 1.05 (0.73-1.49)
4 1.32 (1.06-1.65) 0.89 (0.62-1.26)
5-most deprived 1.44(1.16-1.78) 0.96 (0.69-1.34)
Comorbidity
Diabetes 1.44(1.19-1.75) 2.40(1.88-3.07)
Cancer 2.71 (2.16-3.40) 2.21 (1.59-3.06)
Respiratory disease 1.37(1.11-1.68) 1.11 (0.82-1.52)
Cerebrovascular disease 1.84 (1.47-2.30) 2.34 (1.69-3.25)
Peripheral vascular disease 2.00 (1.61-2.50) 2.10(1.52-2.89)
Atrial fibrillation 1.37(1.05-1.79) 1.56 (1.01-2.40)
Hypertension 1.02 (0.84-1.24) 0.90 (0.68-1.20)
Renal failure 1.59(1.09-2.32) 2.65 (1.67-4.22)
Heart failure 2.66 (2.27-3.13) 2.45(1.90-3.15)
Coronary heart disease 1.17(0.95-1.45) 1.18 (0.85-1.65)
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Table 65 Trends in hazard ratios of death at one year excluding 30 days in men and
women aged <65 years admitted to hospital following a first AMI
H a z a rd  ra tio  (95%  C l)
. M ^  . W O M E N
Year o f admission
1990 1.00 1.00
1991 0.92 (0.70-1.21) 1.10(0.75-1.62)
1992 0.97 (0.75-1.27) 0.86 (0.57-1.28)
1993 0-91 (0.69-1.19) 0.70 (0.45-1.08)
1994 0.82 (0.62-1.09) 0.57 (0.36-0.89)
1995 0.77 (0.57-1.02) 0.71 (0,46-1.10)
1996 0.75 (0.56-1.01) 0.59 (0.37-0.93)
1997 0.79 (0.59-1.06) 0.36 (0.21-0.63)
0,82 (0.62-1.10) 0.65 (0.40-1.03)
1999 0.90 (0.67-1.19) 0.69 (0.43-1.10)
2000 0.56 (0.40-0.78) 0.49 (0.28-0.85)
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Table 66 Adjusted hazard ratios for death at one year excluding 30 days in men and
women aged 65-74 years admitted to hospital following a first AMI 1990-2000
Hazard ratio (95% Cl)
M E N W O M E N
Sex 1.00 0.92 (0.85-0.99)
Deprivation quintile
1 -least deprived 1.00 1.00
2 1.00 (0.85-1.19) 1.12(0.90-1.38)
3 1,05 (0.89-1.23) 1.01 (0.82-1.25)
4 1.12 (0.96-1.32) 1.11 (0.90-1.36)
5-most deprived 1.23 (1.05-1.44) 1.02 (0.84-1.26)
Comorbidity
Diabetes 1.54(1.34-1.77) 1.47 (1.24-1.74)
Cancer 2.15 (1.85-2.49) 1.72(1.41-2.10)
Respiratory disease 1.29(1.12-1.48) 1.53 (1.28-1.82)
Cerebrovascular disease 1.72(1.49-1.98) 1.48 (1.21-1.80)
Peripheral vascular disease 1.47(1.27-1.70) 1.93 (1.58-2.34)
Atrial fibrillation 1.48 (1.28-1.72) 1.53 (1.27-1.86)
Hypertension 0.98 (0.84-1.14) 0.94 (0.79-1.12)
Renal failure 2.08 (1.68-2.57) 1.64(1.23-2.20)
Heart failure 2.06 (1.84-2.31) 2.35 (2.05-2.69)
Coronary heart disease 1.03 (0.88-1.22) 1.16(0.94-1.43)
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Table 67 Trends in adjusted hazard ratios for death at one year excluding 30 days in
men and women aged 65-74 years admitted to hospital following a first AMI
H a z a rd  ra tio  (95%  O )
:  ^ M E N  ' ■ W O M E N
Year p f  admission ■
1990 1.00 1.00
1991 0.92 (0.74-1.13) 0.93 (0.72-1.21)
1992 0.99 (0.81-1.21) 0.80 (0.62-1.03)
1993 0.86 (0.70-1.06) 0.81 (0.62-1.03)
1994 0.91 (0.74-1.12) 0.79 (0.61-1.02)
1995 0.68 (0.54-0.86) 0.68 (0.52-0.90)
1996 0.74 (0.59-0.92) 0.57 (0.42-0.76)
1997 . 0.56 (0.44-0.71) 0.67 (0.50-0.89)
1998 0.63 (0.50-0.80) 0.72 (0.54-0.94)
1999 0.55 (0.43-0.71) 0.54 (0.40-0.74)
2000 0.58 (0.45-0.74) 0.55 (0.41-0.75)
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Table 68 Adjusted hazard ratios for death at one year excluding 30 days in men and
women aged >74 years admitted to hospital following a first AMI 1990-2000
Hazard ratio (95% Cl)
M E N W O M E N
Sex LOO 1.04 (0.96-1.08)
Deprivation quintile
1-least deprived 1.00 1.00
2 1.13 (0.98-1.30) 1.21 (1.08-1.35)
3 1.17(1.02-1.34) 1.11 (0.99-1.25)
4 1.13 (0.98-1.31) 1.04 (0.93-1.17)
5-most deprived 1.29(1.12-1.48) 1.15(1.02-1.29)
Comorbidity
Diabetes 1.41 (1.23-1.62) 1.22(1.08-1.37)
Cancer 1.52 (1.33-1.72 1.71 (1.51-1.92)
Respiratory disease 1.35 (1.20-1.51) 1.21 (1.09-1.35)
Cerebrovascular disease 1.55 (1.37-1.76) 1.88 (1.69-2.09)
Peripheral vascular disease 1.48 (1.31-1.67) 1.31 (1.16-1.49)
Atrial fibrillation 1.13 (1.00-1.29) 1.22(1.20-1.35)
Hypertension 0.97 (0.83-1.13) 0.88 (0.78-0.98)
Renal failure 1.82(1.53-2.17) 1.56 (1.33-1.83)
Heart failure 1.62(1.48-1.79) 1.60(1.48-1.73)
Coronary heart disease 1.06 (0.93-1.25) 1.05 (0.93-1.20)
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Table 69 Trends in adjusted hazard ratios for death at one year excluding 30 days in
men and women aged >74 years admitted to hospital following a first AMI
H a z a rd  ra t io  (95%  C l)
■ M E N ' W O M E N
Year o f admission
1990 LOO LOO
1991 1.08 (0.88-1.30) 1.01 (0.86-1.19)
1992 1.13 (1.02-1.34) 0.97 (0.83-1.14)
1993 0.90 (0.98-1.31) 1.01 (0.86-1.19)
1994 0.93 (0.75-1.14) 0.92 (0.78-1.09)
1995 0.92 (0.75-1.13) 0.83 (0.70-0.98)
1996 0.82 (0.66-1.01) 0.88(0.74-1.04)
1997 0.88 (0.72-1.09) 0.79 (0.67-0.94)
1998 0.80 (0.65-0.99) 0.81 (0.68-0.97)
1999 0.76 (0.61-0.94) 0.80 (0.67-0.95)
2000 0.83 (0.671.02) 0.75 (0.63-0.90)
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8.2.3C ox’s Proportional Hazards In men and wom en at five years
excluding 30 days
8.2.3.1 O v e ra ll
Before adjusting for any other prognostic factors, women had an increased risk o f death at 
five yeai’s (hazaid ratio 1.42). Accounting for the age differences between men and 
women revealed women to be at a survival advantage and then risk o f death was 6% less 
than that o f men (hazard ratio 0.94). Addition o f other variables into the model had a 
marginal effect on this hazard ratio, and women continued to have a better prognosis than 
men after adjusting for other prognostic factors. All the variables were retained in the final 
model.
Table 70 shows the result o f the Cox Proportional Hazai'd regression models carried out in 
men and women sepaiately. Age had a similar effect in men and women and again was the 
most powerful predictor of outcome. Socioeconomic deprivation had a highly significant 
effect on outcome, and the magnitude o f this effect seemed to be slightly greater in men 
than in women. Men in the most deprived category had a 27% increase in the hazard o f 
death at five years than men in the least deprived category. The presence o f comorbid 
diagnoses had a similar effect in men and women, more so than at any other time periods. 
Renal failure had the most powerful effect and increased the hazard o f death by 2.13 tunes 
in men and by 73% in women. Hypertension was the only diagnosis which did not have a 
significant effect on outcome in men or women. No comorbid diagnoses had a protective 
effect. Between 1990 and 1996, the five year hazard o f death declined by 27% in men and 
23% in women (Table 71). This sex difference was not significant, p=0.10.
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Table 70 Hazard ratios for death at five years excluding 30 days in men and women
admitted to hospital following a first AMI
Hazard ratio (95% Cl)
MEN WOMEN
Sex 1.00 0.94 (0.91-0.96)
Age group
<55 1.00 1.00
55-64 2.04 (1.87-2.22) 1.75 (1.52-2.03)
65-74 3.97 (3.67-4.30) 3.19(2.79-3.66)
75-84 7.21 (6.64-7.83) 6.16 (5.38-7.05)
>84 11.38 (10.22-12.66) 10.98 (9.54-12.63)
Deprivation quintile
1-least deprived 1.00 1.00
2 1.06 (0.99-1.13) 1.06 (0.98-1.13)
3 1.10(1.03-1.18) 1.03 (0.96-1.11)
4 1.14(1.07-1.22) 1.07(1.00-1.15)
5-mo St deprived 1.26(1.18-1.34) 1.27(1.09-1.25)
Comorbidity
Diabetes 1.52(1.42-1.63) 1.54 (1.44-1.65)
Cancer 1.68 (1.56-1.82) 1.68 (1.55-1.83)
Respiratory disease 1.38 (1.29-1.46) 1.39(1.30-1.49)
Cerebrovascular disease 1.67 (1.56-1.79) 1.67 (1.54-1.80)
Peripheral vascular disease 1.44(1.35-1.54) 1.44 (1.33-1.56)
Atrial fibrillation 1.33 (1.24-1.43) 1.24(1.16-1.34)
Hypertension 1.02 (0.95-1.10) 1.00 (0.93-1.07)
Renal failure 2.13 (1.90-2.39) 1.73 (1.53-1.96)
Heart failure 1.90 (1.81-2.00) 1.73 (1.64-1.82)
Coronary heart disease 1.11(1.03-1.20) 1.17(1.08-1.27)
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Table 71 Trends in hazard ratio for death at five years excluding 30 days in men and
women admitted to hospital following a first AMI
H a z a rd  ra tio  (95%  C l)
M EN ' W O M E N
Year o f admission
1990 LOO 1.00
1991 0.94 (0.88-1.01) 1.02(0.94-1.10)
1992 0.94 (0.88-1.01) 0.88(0.81-0.95)
1993 0.89 (0.83-0.96) 0.92 (0.85-0.99)
1994 0.85 (0.78-0.91) 0.89 (0.82-0.96)
1995 0.74 (0.69-0.80) 0.81 (0.75-0.88)
1996 0.73 (0.68-0.79) 0.77 (0.71-0.84)
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5.2.3.2 C ox’s P ro p o rt io n a l H a z a rd s  R egress ion  a t  five y ea rs  fo llow ing a f irs t A M I 
age <65 y ears  exclud ing  30 days
Sex remained a significant independent predictor of outcome at five years in individuals 
aged less than 65 years, p=0.04. Hazard o f death was 7% lower in women relative to men 
(Table 72). The effect o f socioeconomic deprivation was gieater in men than in women. 
For example, in men the hazard o f death was 70% greater in the most deprived category 
than in the least deprived category. In women, the hazard o f death was 24% greater in the 
most deprived categoiy than in the least deprived categoiy. The magnitude o f the effect in 
men was also significantly greater than that seen in the whole cohort at five years. As seen 
in shorter teiin survival, the presence o f comorbid conditions had a marked impact on 
prognosis at five years in this younger age group. Men and women with renal failure, 
cancer and heart failure all had more than twice the increased risk o f death at five years. 
All o f the diagnoses carried an adverse effect, although hypertension was not a significant 
predictor of outcome in men or women in this age group. The risk o f death fell by 40% in 
men and 44% in women between 1990 and 1996 (Table 73). This sex difference was not 
significant.
5.2.3.3 C ox’s P ro p o rt io n a l H a z a rd s  R egress ion  a t  five y ea rs  follow ing a f irs t A M I 
age 65-74 years  exclud ing  30 days
Hazard of death at five years was 14% lower in women than in men in this age group 
(Table 74). This sex effect was highly significant, p<0.001. The effect of socioeconomic 
deprivation was significant and was similai' in magnitude in men and women. Both men 
and women in the most deprived category had a 32% increase in the hazard o f death 
relative to individuals in the least deprived category. The presence o f comorbid diagnoses 
had an adverse effect on outcome which was similar in men and women. Heart failure and 
renal failure again carried the worst prognosis. Neither hypertension nor previous 
coronary heart disease were independent predictors of outcome in men. Previous coronary 
heart disease did however have a significant effect on suiwival in women, whose hazard o f 
death at five years was increased by 19% when they were coded with this diagnosis. 
Between 1990 and 1996 the decline in the risk of death at five years was similar in men 
and women, (hazard ratio 0.74 in men and 0.75 in women) (Table 75),
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S.2.3.4 C ox’s P ro p o rt io n a l H a z a rd s  R egress ion  a t  five y ea rs  fo llow ing a f irs t A M I 
age >74 years  exclud ing  30 days
In this age group, as in the two younger age groups, sex remained a significant predictor of 
outcome at five years and the hazard o f death was 8% lower in women than in men (Table 
76). Socioeconomic deprivation did not have a significant effect on prognosis in men or 
women in this age group. All comorbid diagnoses except hypertension had a significant 
and adverse effect on prognosis at five yeai’s. The magnitude of these effects varied and in 
general was not as great as that observed in the younger age groups. For example, cancel- 
increased the hazar d o f death by 47% in men and by 58% in women in this age group, 
compared to an increased risk of more than two fold in the younger age groups. The 
decline in the risk of death between 1990 and 1996 was 13% in men and 20% in women, 
which again was less than that observed in younger age groups (Table 77). This sex 
difference was not significant.
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Table 72 Hazard ratios for death at five years excluding 30 days in men and women
aged < 65 years admitted to hospital following a first AMI 1990-2000
Hazard ratio (95% Cl)
MEN WOMEN
Sex LOO 0.93 (0.86-0.99)
Deprivation quintile
1 -least deprived 1.00 1.00
2 1.28 (1.10-1.48) 0.92 (0.72-1.18)
3 1.34 (1.16-1.55) 1.11 (0.88-1.40)
4 1.46 (1.27-1.68) 1.15 (0.92-1.44)
5-most deprived 1.70 (1.49-1.94) 1.24(1.00-1.53)
Comorbidity
Diabetes 1.68 (1.48-1.90) 2.33 (1.99-2.73)
Cancer 2.05 (1.73-2.43) 2.11 (1.69-2.64)
Respiratory disease 1.44(1.25-1.65) 1.41 (1.16-1.72)
Cerebrovascular disease 1.82(1.57-2.12) 1.97 (1.56-2.49)
Peripheral vascular disease 1.62 (1.39-1.89) 1.69 (1.36-2.11)
Atrial fibrillation 1.35 (1.12-1.63) 1.39(1.02-1.89)
Hypertension 1.07 (0.93-1.22) 0.92 (0.76-1.11)
Renal failure 2.73 (2.14-3.49) 2.95 (2.08-4.18)
Heart failure 2.40 (2.15-2.67) 2.14(1.81-2.53)
Coronary heart disease 1.17 (1.02-1.35) 1.08 (0.87-1.07)
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Table 73 Trends in hazard ratios of death at five years excluding 30 days in men and
women aged <65 years admitted to hospital following a first AMI
H a z a rd  ra t io  ( ^ %  C l)
V M E N / : ■ W O M E N
Year o f admission
1990 1.00 1.00
1991 0.89 (0.78-1.01) 0.98 (0.80-1.21)
1992 0.87 (0.77-1.00) 0.86 (0.69-1.06)
1993 0.82 (0.71-0.93) 0.81 (0.65-1.01)
1994 0.67 (0.58-0.77) 0.70 (0.56-0.88)
1995 0.64 (0.55-0.74) 0.75 (0.60-0.94)
1996 0.60 (0.51-0.69) 0.56 (0.44-0.72)
208
Table 74 Adjusted hazard ratios for death at five years excluding 30 days in men and
women aged 65-74 years admitted to hospital following a first AMI 1990-2000
Hazard ratio (95% Cl)
MEN WOMEN
Sex 1.00 0.86 (0.81-0.90)
Deprivation quintile
1 “least deprived 1.00 1.00
2 1.09 (0.97-1.21) 1.18(1.01-1.37)
3 1.15 (1.03-1.28) 1.17(1.01-1.35)
4 1.16(1.04-1.29) 1.24(1.07-1.44)
5-most deprived 1.32 (1.18-1.47) 1.32(1.14-1.52)
Comorbidity
Diabetes 1.45 (1.30-1.62) 1.71 (1.52-1.93)
Cancer 1.81 (1.60-2.04) 1.79(1.54-2.08)
Respiratory disease 1.41 (1.27-1.55) 1.61 (1.42-1.83)
Cerebrovascular disease 1.76 (1.58-1.97) 1.28 (1.10-1.49)
Peripheral vascular disease 1.37 (1.23-1.53) 1.75 (1.50-2.03)
Atrial fibrillation 1.55 (1.39-1.73) 1.56 (1.35-1.81)
Hypertension 0.97 (0.86-1.08) 1.08 (0.95-1.23)
Renal failure 2.20 (1.82-2.67) 2.25 (1.80-2.82)
Heart failure 2.08 (1.92-2.25) 1.88 (1.70-2.08)
Coronary heart disease 0.99 (0.88-1.12) 1.19(1.03-1.11)
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Table 75 Trends in adjusted hazard ratios for death at five years excluding 30 days in
men and women aged 65-74 years admitted to hospital following a first AMI
H a z a rd  ra tio  (95%  Ç I)
. M EN ' \W O M E N
Year of admission
1990 LOO 1.00
1991 0.91 (0.81-1.03) 1.07 (0.92-1.24)
1992 0.93 (0.82-1.04) 0.92 (0.79-1.07)
1993 0.90 (0.80-1.01) 0.88 (0.75-1.02)
1994 0.83 (0.73-0.93) 0.85 (0.73-0.99)
1995 0.71 (0.62-0.81) 0.77 (0.66-0.90)
1996 0.74 (0.65-0.84) 0.75 (0.63-0.88)
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Table 76 Adjusted hazard ratios for death at five years excluding 30 days in men and
women aged >74 years admitted to hospital following a first AMI 1990-2000
Hazard ratio (95% Cl)
MEN WOMEN
Sex 1.00 0.92 (0.88-0.96)
Deprivation quintile
1-least deprived 1.00 1.00
2 0.91 (0.89-1.09) 1.07 (0.98-1.16)
3 1.00 (0.90-1.11) 0.99 (0.91-1.09)
1.03 (0.93-1.15) 1.04 (0.95-1.14)
5-most deprived 1.01 (0.91-1.12) 1.14(1.04-1.25)
Comorbidity
Diabetes 1,46 (1.30-1.64) 1.30(1.18-1.43)
Cancer 1.47 (1.32-1,64) 1.58 (1.42-1.76)
Respiratory disease 1.30(1.18-1.43) 1.26 (1.15-1.38)
Cerebrovascular disease 1.45 (1.30-1.62) 1.77(1.61-1.95)
Peripheral vaseular disease 1.38 (1.24-1.53) 1.27(1.14-1.41)
Atrial fibrillation 1.12(1.00-1.24) 1.14(1.05-1.25)
Hypertension 1.05 (0.92-1.19) 0.98 (0.88-1.08)
Renal failure 1.71 (1.42-2.06) 1.42(1.21-1.67)
Heart failure 1.54 (1.43-1.66) 1.58 (1.49-1.68)
Coronary heart disease 1.12(0.99-1.27) 1.17(1.06-1.08)
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Table 77 Trends in adjusted hazard ratios for death at five years excluding 30 days in
men and women aged >74 years admitted to hospital following a first AMI
Hazard ratio (95% Cl)
MEN WOMEN
Year o f  admission
1990 LOO 1.00
1991 1.03 (0.91-1.16) 0.99 (0.90-1.10)
1992 LOO (0.89-1.13) 0.86 (0.78-0.96)
1993 0.93 (0.82-1.06) 0.94 (0.84-1.04)
1994 1.00 (0.89-1.13) 0.91 (0.82-1.02)
1995 0.84 (0.74-0.95) 0.82 (0.73-0.91)
1996 0.87 (0.77-0.98) 0.80 (0.72-0.90)
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8.3 Discussion regarding unadjusted and adjusted survival in 
men and women following a first AMI
The prognosis of men and women hospitalised with a first AMI in Scotland is much worse 
than indicated by clinical trials. One fifth of the patients in this study died within one 
month of admission and almost one half died by five years. Unadjusted short and longer 
survival was considerably better in men than in women. Median survival was 8.8 years in 
men and only 4.3 years in women. Short and longer tenn survival has improved in men 
and women between 1990 and 2000, though the degree of improvement varied according 
to age and sex. There are many factors affecting prognosis following AMI and most of the 
baseline characteristics examined in this study were strong independent predictors of 
outcome, although their relationship with outcome varied according to age and sex and the 
follow-up period examined.
8.3.1 Sex
Short term unadjusted case fatality
In this study overall 30 day case fatality was 16.3% in men and 25.6% in women. These 
figures are higher than those reported by most other population-based studies. There is 
however considerable variation in 30 day case fatality rates reported by different studies. 
For example in the Rochester Epidemiology Project, 28 day case fatality in 1994 was 7% 
in men and 15% in women hospitalised with a first AMI.^ "^  The Worcester Heart Attack 
Study also examined survival in men and women hospitalised with a fust AMI between 
1975 and 1988 and reported 30 day case fatality rates of 12.7% in men and 21.7% in 
w o m e n . I n  the Ontar io Myocardial Infar ction database, 30 day case fatality in 1996 was 
11.6% in men and 19.1% in women. The Ontario database is similar to the one analysed 
in the current study. 30 day case fatality rates in men and women in the cunent study are 
more consistent with reports fiorn other British studies. For example, in-patient case 
fatality in 1995 in the Yorkshire AMI Study was 19% in men and 30% in women and in 
1992 in the Nottingham Heart Attack Register in-patient case fatality was 21.7% 
o v e r a l l . N e i t h e r  of these studies were restricted to first AMI and the average age of 
individuals was greater in the Yorkshire AMI Study which may account for the higher case 
fatality rates. The reason for the differences in 30 day case fatality between countries is 
not clear-, although in general the average age of individuals is greater in the British studies 
than in the American studies. Numerous studies have reported a more favourable short
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term prognosis in men following hospitalisation with ]^y[i_56;78;85;i07;ii3;i70,i95,i96 the
literature is consistent in reporting higher unadjusted short term case fatality rates in 
women than in men, the magnitude of these differences varies considerably between 
studies.
In this study one year case fatality was 23.5% in men and 35.3% in women. This is again 
higher than the rates reported by most other studies, though again there ai'e few population 
based data available with which to make useful comparisons. In the Goteborg Study, one 
year case fatality was 25% in men and 36% in women.
Age adjusted case fatality
Much of the sex difference seen in short term suiwival following AMI is thought to be 
explained by differences in the baseline characteristics between men and women. Age is 
thought to be the most important prognostic factor in survival. Controlling for age through 
age adjusted or age stratified analyses should therefore reduce these sex differences. In 
this study controlling for age through age stratification did reduce sex differences in 
suiwival. It did not however remove them, and women of all ages continued to have a 
higher case fatality than men. The sex difference in case fatality was greater in younger 
individuals than in older individuals. The finding that controlling for age reduces sex 
differences in survival is consistent with a number of other studies, although the age 
categories used did vary and hinder comparison between studies.^^’*'^ ’^ ^^ ’*^  ^ Controlling 
for age completely removed sex differences in survival in a number of studies.^^’'^ ’^^ *^ ’*^  ^
The literature is therefore divided into those studies that have found a residual excess risk 
of death in women compared to men after adjusting for age differences, and those that have 
not. In the cunent study there was an excess risk of death at 30 days of 16% in women 
compared to men after adjusting for age differences. This figure is consistent with a 
number of other studies which have carried out similar a n a l y s e s . F o r  example in 
the National Registry of Myocardial Infarction 2 Study the age adjusted odds of death were 
1.18 in women relative to men.^^ In a number of studies it is not possible to discern fiom 
the methodology whether age adjusted case fatality differs significantly between men and 
women.
Multivariate adjusted case fatality
In the current study adjusting for age and other variables mcluding socio-economic
differences as well as comorbid diagnoses did not remove the excess risk of death seen in
women at 30 days following an AMI. Women remained at a 20% increased risk of death
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at 30 days when compared to men. Inclusion of the additional prognostic variables slightly 
increased the excess risk in women. This would therefore suggest that the distribution of 
these variables did not account for much if any of the excess risk seen in women after 
adjusting for age differences between men and women. The results of other studies that 
have controlled for factors other than age are conflicting. The comparison of results is 
difficult because factors that were controlled for varied across studies and very few studies 
controlled for comorbid diseases other than previous coronary heart disease and coronary 
heart disease risk factors. The results from the current study are in agreement with a 
number of other studies including ISIS-3, the National Hospital Discharge Suiwey and the 
MITI Registiy.^^’^ ’^^ *^  In the National Hospital Discharge Survey the risk of in-hospital 
death was 13% greater in women than in men.^  ^ In the current study, at one year and 
excluding 30 days, sex was no longer a significant predictor of outcome and all o f the 
differences in case fatality seen at one year could be explained by differences in the age 
distribution of men and women.
Age sex interaction
Many of these studies have not examined the effect of sex on survival in any detail and
have often failed to consider the varying effects of sex according to age. This may
disguise differences in survival rates and lead to inaccurate assessment of risk. In this
study age stratified analyses revealed important suiwival differences between men and
women. Sex differences in short term survival were much greater in younger age groups
and decreased with increasing age. Unadjusted 30 day case fatality in women aged less
than 55 years was ahnost 60% greater than in men (5.9% versus 3.7%). By 65 years this
excess risk in women had fallen to around 11%. At 30 days, there was an age sex
interaction in the unadjusted analyses which was highly significant in a logistic regression
model. Wlien the study population was divided into three subgroups on the basis of age,
sex continued to be a significant predictor of 30 day survival in all three groups. The effect
of sex on survival did vary and was greatest in the youngest age group. In individuals aged
less than 65 years, women had a 29% excess risk of death compared to men but by age
greater than 74 years this excess risk had decreased to 12%. The age sex interaction
remained significant after adjusting for differences in the distribution of baseline
characteristics. These findings are in keeping with a number of other studies that have also
reported age sex interactions in short term survival following Almost all o f
these studies have reported similar findings, namely an excess risk of death in younger
women compared to men and decreasing sex differences in survival with increasing age.
In the National Registry of Myocardial Infarction 2 Study, case fatality rates were twice as
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high in women as in men in those aged less than 50 years/^ The sex difference was no 
longer apparent by 74 years.
The fact that women are older at the time of their first AMI seems to account for much of 
the sex difference that exists in short term case fatality rates following hospitalisation with 
AMI. In the current study, adjusting for age reduced much of the excess risk seen in 
women but did not remove it completely. Controlling for other baseline characteristics had 
a marginal effect on the effect of sex on survival. The presence of an age sex interaction in 
short tenn survival following AMI suggests that the excess mortality risk in women seen in 
women following hospitalisation with AMI is greater in younger women. Various 
mechanisms have been put forward to explain the apparent excess short term risk in 
women following AMI.^^’’^  ^ These include sex based differences in pathophysiology 
including different plaque types, clotting mechanisms and coaguability. Possible 
explanations for the higher risk of death seen in younger women may include a lower rate 
of use of established treatments for AMI in women than in men, and sex based differences 
in these treatments have been reported.^^ '^^^  ^ It is also possible that differences in short 
term survival may be due to differences in baseline characteristics between men and 
women that have not been adjusted for. This is especially true of non-cardiac diagnoses 
which are rarely included in description of baseline characteristics. This study does not 
include deaths following AMI that occur in individuals who do not survive to reach 
hospital. It has been suggested that women are more likely to survive to reach hospital and 
that including these deaths in the analysis of short term case fatality may remove or reduce 
any sex differences in survival observed following hospitalisation.^^'* There is some 
evidence that women are more likely to survive an out of hospital cardiac arrest which 
would support these findings.^ **^
Longer term unadjusted case fatality
In the current study 28% of men and 40.6% of women were dead at two years following 
their first AMI. By five yeai's case fatality had increased to 39% in men and 52.8% in 
women. Overall unadjusted longer term case fatality was therefore higher in women than 
in men. The literature is not consistent in its description of longer term case fatality in men 
and women following AMI. The findings from the current study are in broad agreement 
with a number of other studies. For example, in the Worcester Heart Attack Study two 
year case fatality was 19.6% in men and 28.9% in w o m e n . T w o  year case fatality in the 
current study was 28% in men and 40.6% in women. In the Alberta Health and Welhiess 
database, five year case fatality was 26.8% in men and 38.8% in w o m e n . F i v e  year case
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fatality in the current study was 39% in men and 52.8% in women. The mean age of 
individuals in these studies was less than in the current study that did not exclude older 
individuals. A number of other studies that have included the very elderly have reported 
similar unadjusted case fatality rates in men or women.
Age adjusted case fatality
At two years, age stratified case fatality in this study was still higher in women than in men 
in all age groups. As for short term case fatality, the greatest sex differences were seen in 
the younger age groups. By five years however case fatality was very similar in men and 
women within age groups. At five years, adjusting for age after removing the deaths that 
occurred within the first 30 days accounted for all of the excess risk seen in women in the 
crude analyses and the risk of death in women was less than that seen in men. There are 
few studies with which to compare these data. Most studies that have examined longer 
term case fatality in AMI in men and women have reported either a similar case fatality in 
men and women* or a trend towards a lower case fatality in women.
Multivariate adjusted case fatality
In the current study after adjusting for age and other baseline variables, the risk of death at 
five years after excluding deaths in the first 30 days, was greater in men than in women. 
The risk of death was 6% less in women than in men. This female survival advantage was 
present in all age groups. There are a number of studies with which to compare these data, 
although useful comparison in hindered by variation in the follow-up periods that have 
been examined. In addition, the studies have controlled for different baseline 
characteristics when modelling survival and few have taken into account non-cardiac 
morbidity. The results of the cun ent study are in broad agreement with most other studies 
that have examined adjusted longer temi survival following AMI. In general improved 
survival in women was observed particularly when the length of follow-up was greater 
than one year. In the Worcester Heart Attack Study and the Perth Coronary Register, men 
had significantly poorer long term survival than women after adjusting for age and other 
f a c t o r s . I n  a number of other studies including TRACE, the MITI Registry, the Danish 
Verapamil Infarction Trial and the Yorkshire AMI Study, there was a trend towards better 
long term survival in women than in men although this trend was not statistically 
significant.»':'":**':**"
The reasons for the better longer term survival following AMI in women compared to men
are not clear. The lower long term case fatality in women does not appear to be due to
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theii' excess short term case fatality, which is not large enough to be responsible for such a 
bias?"" It is possible that the better long term suiwival in women reflects the overall 
survival advantage of women in the general population. The effects of the infarct are 
greatest on short term case fatality. For those individuals who survive this period, it maybe 
that woman then have a better survival than men as occurs in the general population. 
Competing causes of death are also important. Causes of death in individuals in the 
current study have not been examined and it maybe that such an analysis would provide 
further evidence for this theory.
8.3.2Age
ShoHterm case fatality
Age was the most powerful predictor of survival in men and women. The effect of age on 
survival was consistent with other studies, although comparison with other studies is 
limited by use of different age categories and the tendency for studies to look at the effect 
of age on survival in men and women together. In the current study 30 day case fatality 
rose from 3.7% in men aged less than 55 years to 42.6% in men aged greater than 84 years. 
The equivalent figures in women were 5.9% and 44.7% respectively. In the Swedish 
National Register case fatality rose fr om 6% in men aged 30-49 years to 43% in men aged 
85-89 years. In women the equivalent figures were 10% and 40% respectively. In the 
multivariate analyses age had a powerful effect and in women approximately doubled the 
risk of death for each additional decade. The effect of age on 30 day case fatality in the 
multivariate analyses was similai’ in men and women. There are no data with which to 
compare these findings.
Longer term case fatality
There are even less data available describing longer term case fatality in men and women 
of different ages. In the current study two year case fatality rose from 7.2% in men aged 
less than 55 years to 68.7% in men aged greater than 84 years. The equivalent figures in 
women were 10.3% and 69.8%. In the Worcester Heart Attack Study two year case 
fatality increased from 6.0% in men aged less than 50 years to 51.3% in men aged greater 
than 79 y e a r s . I n  women the equivalent figures were 8.9% and 46% respectively. Age 
continued to have a powerfiil effect in the multivariate analyses with each additional 
decade resulting in a doubling in the risk of death at five years.
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8.3.3Socioeconomic deprivation
There is a limited literature describing the relationship between socioeconomic deprivation 
and survival following first AML in men and in women. The situation is complicated 
further by a lack of consistency regarding the definition and measurement of 
socioeconomic deprivation. There are therefore few studies with which to compare the 
results of this study.
Short term case fatality
Unadjusted 30 day case fatality decreased as the level of socioeconomic deprivation 
increased. This can be at least partly explained by the younger age of men and women in 
more deprived groups compared to those in less deprived groups. The difference in the 
distribution of age across deprivation categories means that it is difficult to draw any 
conclusions from unadjusted analyses. In the multivariate analyses, socioeconomic 
deprivation had a more powerfiil effect on the risk of death at 30 days in men than in 
women, although overall it was a significant independent predictor of outcome in both 
sexes. In men the most deprived deprivation category had a 9% increased risk of death 
relative to the least deprived category. The results from the current study are in-keeping 
with the FINMONICA MI Register Study who found that the adjusted risk of death in low 
income men compared to high income men was 2.01 for deaths occunmg between 2 and 
27 days post-AMI in individuals aged 35-64 yeai's.^"  ^ As with the current study the effect 
of socioeconomic deprivation was greatest hi men and the adjusted risk in low income 
women compared to high income women was 1.25. When multivariate modelling was 
carried out within age groups, socioeconomic deprivation had the greatest effect in 
younger men and women. In individuals aged less than 65 years, men in the most deprived 
category had a 33% hicrease in the risk of death compared to those m the least deprived 
category. The magnitude of effect was similar m women. The effect of socioeconomic 
deprivation on short tenn survival declined with increasing age and it was no longer a 
significant independent predictor of outcome in women aged 65 year's and above or m men 
aged 75 years and over. There are no other studies with which to compare these data 
though the FINMONICA MI Study only included individuals aged 35-64 years. It is not 
clear why socioeconomic deprivation should adversely affect short term prognosis 
following AMI, especially in younger age groups and in men. A possible contributing 
factor could be var ying access to medical care and the quality of this care. There is some 
evidence that socioeconomic status may affect access to specialised cardiac services, 
though studies that have examined this have not been consistent in their findings. If this
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effect was predominately caused by lack of access to specialised cardiac services then you 
might expect the effect to be greater in women and the elderly who have been shown to 
have reduced access to these services.
Longer term case fatality
Longer term case fatality was again higher in individuals in the least deprived categories 
compared to those in the most deprived categories, who were on average younger in age. 
At five years and excluding 30 days, socioeconomic deprivation had a powerfiil effect on 
prognosis in men and women. As for short term survival, the magnitude of this effect was 
greater in men than in women. Men in the most deprived categoiy had a 27% increased 
risk of death compared to those in the least deprived category. There are few studies with 
which to compare these data. It is unclear why socioeconomic deprivation should exert a 
greater effect on longer term prognosis than on short term prognosis following AMI, and 
why this effect should be greater in men than in women. Again it could be due to 
competing risks and a reflection of the survival advantage of women in the general 
population. It has been suggested that the longer tenn effects of socioeconomic 
deprivation may arise as a result o f less efficient secondary prevention in these 
individuals. ‘'^ ,^207,209 jg however difficult to know how much of the effect is due to the 
greater longevity of individuals in less deprived categories compared to those in more 
deprived groups. This might also partly explain the greater effect in men than in women. 
The effect of socioeconomic deprivation on five year survival was much greater in younger 
age groups than in the older age groups. Men aged less than 65 years in the most deprived 
category had a 70% increased risk of death at five years compared to those in the least 
deprived categoiy. The magnitude of effect was greater in men than in women. As for 
short term suivival, socioeconomic deprivation was not an independent predictor of 
outcome in the elderly.
8.3.4 Comorbid diagnoses
8.3.4.1 D iabetes
Short term case fatality
In this study 30 day case fatality following a first AMI in men and women with a diagnosis 
of diabetes was approximately twice that of individuals with no comorbid diagnoses. After 
adjusting for the effect of other variables, men and women with diabetes had a 17% 
increase in the risk of death at 30 days compared to those without a diagnosis of diabetes.
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The effect was greatest in the younger age groups, especially in women. For example, 
women aged less than 65 years with diabetes had a 65% increased risk of death compared 
to those with no diagnosis of diabetes. Diabetes was not however a significant 
independent predictor of short term survival in men or women over the age of 65 years. A 
number of other studies have found that diabetes has a greater adverse effect in women 
than in men on short term case fatality following The reasons for this are
not clear though it is thought that the presence of diabetes in women may negate the 
protective effect of oestrogen, and that women with diabetes may have more comorbid 
conditions and coronary arteiy disease risk factors than men.»*’*^ ' These studies have not 
however shown that this effect is greater in younger individuals. In this study diabetes 
had a greater effect on one year survival following a first AMI after adjusting for other 
factors than on 30 day survival. Again this was more marked in younger age groups and in 
women. Women aged less than 65 years with a diagnosis of diabetes were 2.4 times more 
likely to die by one yeai' than those who did not have a diabetes diagnosis.
Longer term case fatality
Unadjusted case fatality in men and women with a diagnosis of diabetes remained elevated 
in the longer term compared to those individuals with no comorbid diagnoses. The five 
years case fatality rate was 53.2% in men and 63.5% in women hospitalised with a first 
AMI who had a diagnosis of diabetes. In the multivariate analyses diabetes remained a 
significant independent predictor of five year survival after adjusting for other variables. 
The effect of diabetes on suiwival was again greater in younger age gioups, especially in 
women although diabetes remained a significant and powerfiil predictor of five year 
suiwival in all age groups. These findings are consistent with reports from other 
studies. Overall the risk of death at five years was increased by 52% in men and
by 54% in women coded with diabetes compared to those with no diabetes coding.
S.3.4.2 H e a r t  fa ilu re  
Short term case fatality
In this study in the unadjusted analyses almost one third of men and women hospitalised 
with a fii'st AMI who had a diagnosis of heart failure were dead within 30 days of their first 
AMI. By one year tliis had risen to almost one half. In the multivariate analyses heart 
failure was a powerful predictor of short tenn survival after adjusting for the effects of 
other factors. The risk of death at 30 days was increased by 48% in men and by 15% in 
women with heart failure compared to those without a diagnosis of heart failure. The
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effect of heart failure was greatest in younger age groups and in men. Men aged less than 
65 years with a diagnosis of heart failure were 2.29 times were more likely to die at 30 
days than men without heart failure. The equivalent risk in women was 64%. The effect 
of a heart failure diagnosis was even more marked on one year suiwival and was again 
greater in younger age groups but similar in men and women. There are few data with 
which to compare these findings. A number of studies have reported elevated short term 
case fatality in men in individuals hospitalised with AMI but not in men and women and in 
different age groups.*'"’*'^  The increased case fatality in men hospitalised with AMI with a 
comorbid diagnosis of heart failure may relate to the higher rate of systolic dysfunction 
seen in men with heart failure and the fact that women who develop heart failure are more 
likely to have preserved left ventricular systolic function.^
Longer term case fatality
By five years two thii'ds of men and thi*ee quarters of women hospitalised with a first AMI 
who had a diagnosis of heart failure were dead. Median survival was less than two years in 
men and less than one year in women. Heart failure continued to have a significant 
adverse effect on longer term survival in the adjusted analyses. Overall men hospitalised 
with a first AMI who had a diagnosis of heart failure were 90% more likely to die than 
men without a diagnosis of heart failure. Again the risk was greatest in younger age 
groups.
S.3.4.3 H y pertens ion  
Short term case fatality
In the unadjusted analyses hypertension had a small effect on short term suiwival m men 
and women hospitalised with a fast AMI relative to other comorbid diagnoses. In the 
multivariate analyses hypertension was a significant independent predictor of outcome 
after adjusting for other variables. A diagnosis of hypertension reduced the risk of death at 
30 days in men and women in different age groups. Overall the risk of death at 30 days 
was reduced by 26% in men and by 24% in women in individuals hospitalised with a first 
AMI who had a diagnosis of hypertension. The effect of hypertension on survival was 
similar in all age groups. Previous studies have not provided consistent results on the 
importance of hypertension on suiwival following an AMI. A number of other studies that 
have demonstrated that hypertension adversely affects case fatality after AMI.*"^ '^ *^ "^ *" A 
number of possible explanations have been put forward to explain this finding including 
increased coronary vascular resistance, decreased coronary reserve and muscle fibre
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hyperplasia."^ In addition, hypertension is causally related to heart failure which has a 
high mortality and it is possible that individuals with a diagnosis of hypertension are more 
likely also to have a diagnosis of heart failure. Some of the inconsistency in findings 
between studies may relate to the importance of a change in blood pressure that may arise 
as a result of an AMI.^*  ^ A drop in blood pressure may reflect a badly damaged 
myocardium and be associated with a poor prognosis. It is possible that these individuals 
are not recorded as being hypertensive. Another possibility is that individuals in the 
current study who have a coding of hypertension are a biased sample of all individuals 
with the diagnosis and that they are likely to be receiving appropriate secondary prevention 
treatments which would improve then prognosis.
Longer term case fatality
As for short term suiwival, hypertension had a small effect on unadjusted longer term 
survival relative to other comorbid diagnoses. Median survival was reduced however in 
men and women with a diagnosis of hypertension. Median survival in men hospitalised 
with a first AMI was 7.1 years in those with a diagnosis of hypertension compared to over 
10 years in those with no comorbid diagnoses. After adjusting for other factors in the 
multivariate analyses hypertension was not a significant independent predictor of longer 
term survival. It is not clear why hypertension should be associated with decreased case 
fatality in the short term but not in the longer term. A lack of association between 
hypertension and longer term survival following AMI has been reported previously.^I t  
has been suggested that hypertension is important in the prognosis AMI but only in 
younger patients and not among older patients.^*" The effects of hypertension on longer 
term case fatality therefore may have been masked by the presence of an interaction 
between age and hypertension which were not fully accounted for in previous studies.^’" 
In the current study however, the effect of hypertension did not vaiy with age.
S.3.4.4 C h ro n ic  o b stru c tiv e  p u lm o n a ry  d isease 
Short term case fatality
In the current study 27.3% of men and 32.5% of women hospitalised with a first AMI who 
had a comorbid diagnosis of respiratoiy disease were dead within 30 days. Overall the risk 
of death at 30 days was increased by 29% in men and by 23% in women after adjusting for 
other factors in the multivariate analyses. In individuals aged less than 65 years, 
respii'atory disease was only a significant predictor of outcome in men and not in women. 
In other age groups however, respftatoiy disease was a significant independent predictor of
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suivival and its effect was similar in men and women. In the SPRINT Study unadjusted 
in-hospital case fatality was raised in individuals with COPD compared to those with no 
COPD (23.9% versus 17,2%).*"* Individuals with COPD were also more likely to have a 
diagnosis of heart iailure and atrial fibrillation. After adjusting for other factors COPD 
was not a significant independent predictor of outcome. In the TRACE Study COPD was 
not a significant predictor of survival at 30 days in individuals hospitalised with AMI.*"' 
COPD is an important confounding factor for the diagnosis of heart failure. Both TRACE 
and SPRINT collected detailed clinical information so that individuals were more likely to 
be given an accurate diagnosis of COPD or heart failure. The apparently significant 
independent effect of COPD on suivival may be partly explained by an under recording of 
heart failure so that it was inadequately controlled for in the multivariate analyses.
Longer term case fatality
Approximately half of all men and women hospitalised with a first AMI who had a 
comorbid diagnosis of respftatory disease were dead within two years of admission. 
Median survival was less than 2.5 years in men and 1.5 years in women. Respiratory 
disease had a more powerful effect on longer term than on short term survival and at five 
years the risk of death in individuals with a comorbid diagnosis of respiratoiy disease was 
increased by 38% in men and by 39% in women. The effect of this comorbid diagnosis on 
survival was again greater in younger age gioups than in the elderly but was similar in men 
and women. In the SPRINT Study COPD was not a significant predictor of five year 
survival after adjusting for other faetors in the multivariate analyses.*"* In the SPRINT 
Study, individuals with COPD were more likely to have a diagnosis of heart failure. In the 
TRACE Study COPD was found to be a significant independent predictor of outcome but 
only in those individuals without a diagnosis of heart failure.*"' Potential interactions 
between these two comorbid diagnoses have not been explored in the current study and 
further examination of this issue could provide more information as to the relative 
importance of these diagnoses and the relationship between them.
8.3.4.5 A tr ia l  f ib r illa tio n
Short term case fatality
In the current study, unadjusted short tenn case fatality was increased in men and women 
hospitalised with a fir st AMI who had a diagnosis of atrial fibrillation. The prevalence of 
atrial fibrillation increases with age and individuals with a comorbid diagnosis of atrial 
fibrillation are on average older than individuals with no comorbid diagnosis of atrial
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fibrillation. You would therefore expect these individuals to have an increased unadjusted 
case fatality and this finding is consistent with other studies.^":^^’^ *» After adjusting for 
other factors in the multivariate analyses, atrial fibrillation had a protective effect and 30 
day case fatality was significantly lower in those individuals with a comorbid diagnosis of 
atrial fibrillation. Overall the risk of death at 30 days was reduced by 24% in men and 
women. The effect was only present in individuals aged 65 years and over and was similar 
in magnitude in men and women. By one year and after exeluding 30 day deaths, case 
fatality was increased in individuals with a comorbid diagnosis of atrial fibrillation. The 
magnitude of this effect was much greater in younger and middle aged men and women so 
that the risk of death in individuals aged less than 65 years was increased by 37% in men 
and by 56% in women. These findings have not been reported previously, although the 
prognostic significance of atrial fibrillation complicating AMI is controversial. It is not 
clear why a diagnosis of atrial fibrillation might decrease short tenn case fatality, 
especially in older people, and increase longer tenn case fatality. Most studies have found 
that the presence of atrial fibrillation increases short term case fatality, however none o f 
the studies have looked at the effect in different age groups. The Worcester Heart Attack 
Study found that atrial fibrillation was not a significant independent predictor of outcome 
after adjusting for other factors.*"^ There is some evidence to suggest that the temporal 
relationship between AMI and atrial fibrillation is important when considering prognosis 
and that pre-existing atrial fibrillation is less likely to be associated with an adverse short 
tenn outcome than atrial fibrillation that develops as a complication of an AMI.^»’^ ’^*'^  
The current study does not differentiate between those individuals with pre-existing atrial 
fibrillation and those who develop atrial fibrillation subsequent to their AMI. Bias in 
coding towards those individuals with a pre-existing diagnosis of atrial fibrillation might 
contribute to the observed findings.
Longer term case fatality
Longer tenn case fatality rates were increased substantially in men and women hospitalised
with a first AMI who had a comorbid diagnosis of atrial fibrillation. Five years case
fatality in these individuals was 61% in men and 71% in women whilst median suivival
was only 2.8 yeai's in men and 1.4 years in women. After adjusting for other factors in the
multivariate analyses atrial fibrillation remained a significant predictor of outcome. The
risk of death in individuals aged 65-74 years was increased by 55% in men and by 56% in
women. As for short term case fatality, the effect of atrial fibrillation was greater in
younger and middle aged groups. This finding is new and has not been reported
previously. As with short term case fatality, controversial results have been reported in
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patients surviving hospitalisation with respect to long tenn case fatality?"’^ "’^**^ Atrial 
fibrillation may act as a marker for left ventricular dysfunction and a compromised 
myocardium which may explain the association with reduced longer term survival.
8.3,4.6 R en a l im p a irm en t
Short term case fatality
In the current study renal failure more than doubled the risk of death at 30 days in the 
unadjusted analyses. Almost half of all men and women hospitalised with a first AMI who 
had a diagnosis of renal failure were dead within 30 days. Median suivival was less than 
three months in men and less than two months in women. After adjusting for the effect of 
other factors, renal failure was a significant predictor of short term outcome and had the 
most powerful effect on suivival of all comorbid diagnoses. The effect of renal failure was 
greatest m younger age groups so that men aged less than 65 years were 4.5 times more 
likely to die at 30 days and women 5.2 times more likely to die than individuals aged less 
than 65 years with no comorbid diagnosis of renal failure. The magnitude of effect 
decreased with increasing age but remained significant in all age groups and was similar in 
men and women. Impaired renal function has consistently been found to be independently 
associated with poor outcome following AMI, and the effect on prognosis seems to be 
dependent on the degree of renal impairement.»^’^ "’*"":'^ " Several potential mechanisms 
have been suggested to explain the association between impaired renal function and 
survival following AMI.*"' These mechanisms include high levels of homocysteine and 
reduced nitric acid production which may result in accelerated atherosclerosis. There are 
no sex-specific data with which to compare the findings of this current study m which 
renal failure had a similar effect on suivival in men and women. Sex has been included in 
some of the multivariate modelling and women with impaired renal function have been 
found to be at a decreased risk of death following AMI than men."":*"" interpretation of 
these findings is complicated by the fact that sex is incorporated into the esthnation and 
definition of glomerulai- filtration rate, creatinine clearance and elevated creatinine levels. 
This may bias the results of any multivariate analyses that further adjust for the effects of 
sex. Prevalence of impaired renal function in individuals hospitalised with AMI varies 
according to the definition of renal impaiiment used and the study type and population 
involved. There is concern that the increasing prevalence of hypertension, obesity and 
diabetes among an ageing population will lead to a higher prevalence of renal failure.^^"
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Longer term case fatality
Five year case fatality was 82.2% in men and 87.2% in women hospitalised with a first 
AMI who had a comorbid diagnosis of renal failure. At five years renal failure remained a 
significant predictor of outcome and the risk of death was increased 2.1 times in men and
1.7 times in women with a comorbid diagnosis of renal failure. As for short term case 
fatality the effect of renal failure was greatest in younger age groups and was similar in 
men and women. The long term survival of patients with renal failure who have been 
hospitalised with AMI is much worse than survival in patients without renal failure and 
patients with other comorbid diagnoses. As for short tenn case fatality there are few data 
with which to compare these findings. One study found a small long tenn survival 
advantage in women with renal failure hospitalised with AMI, however this was in patients 
on dialysis which represent a minority of patients with impaii ed renal function. It seems 
clear that short and long term case fatality are significantly increased in men and women 
with impaired renal function but that the independent effect of sex on survival in this group 
of patients has not yet been established.
5.3.4.7 Other vascular diseases 
Short term case fatality
In the current study approximately one thkd of men and women hospitalised with a first 
AMI who had a comorbid diagnosis of cerebrovascular disease or peripheral vascular 
disease died within 30 days of admission. Both diagnoses were significant independent 
predictors of short tenn suivival though cerebrovascular* disease had a more powerful 
effect on survival than peripheral vascular disease after adjusting for the effect of other 
factors. The risk of death at 30 days was increased by 67% in men and by 61% in women 
with a comorbid diagnosis of cerebrovascular disease and by 30% in men and 21% in 
women with a diagnosis of peripheral vascular disease. As with many of the other 
comorbid diagnoses, the effect of these diagnoses was greater in younger age groups than 
in older age groups. Peripheral vascular disease had a greater effect on short term survival 
in men than in women, especially in younger age groups. More extensive coronary artery 
disease may contribute to the excess moitality seen in these individuals. Individuals with 
peripheral vascular disease may also have increased mortality due to sequelae of their non­
cardiac arterial disease including stroke.^^* There are few data with which to compare 
these findings and no sex-specific data. In the SPRINT Study, peripheral vascular disease 
increased the risk of in-hospital death by 37% in individuals hospitalised with AMI after 
adjusting for other factors.*"' In the SPRINT Study, patients with a diagnosis of peripheral
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vascular disease were also more likely to have heart failure and atrial fibrillation and it is 
possible that interactions exist between these diagnoses that have not been explored in the 
current or any other studies.
Longer term case fatality
Approximately two thhds of men and women with a comorbid diagnosis of peripheral 
vascular disease or cerebrovasculai* disease were dead within five years of hospitalisation 
with their first AML Median survival was only six months in women and 16 months in 
men who had a diagnosis of cerebrovascular disease. After adjusting for the effect of other 
factors, both diagnoses remained significant independent predictors of outcome at five 
years and the effect of cerebrovascular disease on case fatality was consistently greater 
than that of peripheral vascular disease. The effect of these diagnoses on case fatality was 
similar in men and women and was again gieater in younger than in older individuals. The 
only study to look at the significance of peripheral vascular disease as a prognostic 
indicator following AMI is the SPRINT Study. In this study peripheral vascular disease 
was not found to be a significant independent predictor of five year survival following 
AMI after adjusting for other factors. Another study looked at the effect of peripheral 
vascular disease on long tenn mortality following coronary arteiy bypass surgery.^^' It 
found that individuals with peripheral vascular disease had substantially increased long 
term mortality compared to those individuals without peripheral vascular disease. The 
reason for this dispaiity is unclear, although in the SPRINT Study only a small number of 
individuals with peripheral vascular disease were followed up for five years which would 
have limited the power of the study to detect differences in survival.
8.3.4.8 P rev ious co ro n a ry  h e a r t  d isease a n d  an g in a
Short term case fatality
In the current study unadjusted short term case fatality was increased in individuals with a 
previous diagnosis of coronary heart disease. 30 day case fatality was 22.6% in men and 
27.4% in women with a previous diagnosis of coronary heart disease hospitalised with a 
fii'st AMI. In the multivariate analyses, previous coronary heart disease was a significant 
predictor of 30 day outcome but only in men in whom the risk of death was increased by 
26%. The effect of previous coronaiy heart disease was greater in younger age groups and 
was not a significant predictor of outcome in either men or women aged 75 years and over. 
There are few studies with which to compare these findings and none that describe the 
effect of previous angina on prognosis in men and women of different ages who are
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hospitalised with a first AMI. As discussed previously, studies have reported conflicting 
results regarding the effect of previous angina on prognosis following AMI. The SPRINT 
Registiy found that in-hospital case-fatality was significantly increased in individuals 
hospitalised with a fli’st AMI who had a previous history of angina (16% versus 12%).*"" 
A Japanese Study analysed outcomes in 990 individuals hospitalised with AMI and 
reported better in-hospital and five year case fatality rates in patients aged less than 70 
years with a previous history of angina.^^  ^ There is evidence to suggest that the effect of 
previous angina on smwival following AMI may depend upon the site of the infarct, the 
length of histoiy of angina as well as the age of the individual.*'*:*'^:*'"’*"
Longer term case fatality
Unadjusted five year case fatality in individuals hospitalised with a first AMI with a 
previous diagnosis of coronary heart disease was 52% in men and 61.3% in women in the 
current study. In the multivariate analyses previous coronary heart disease was a 
significant independent predictor of five year outcome in men and women, although the 
effect was modest when compared to other comorbid diagnoses. Men had an 11% 
increased risk of death at five yeai's and women a 17% increased risk of death, though the 
risk varied with age. Previous coronary heart disease was only significant in men aged less 
than 65 years and in women aged greater than 65 years. In the Framingham Study, pre­
existing angina increased the long term risk of coronary death but not of all cause mortality 
in men but not in women."' The multivariate adjusted risk of coronary death was 
increased by 49% in men. Pre-existing angina is usually indicative of severe double or 
triple vessel coronaiy arteiy disease and it therefore reasonable to suggest that these 
individuals have more extensive coronary artery disease.
8.3.5Teinporal trends in case fatality in men and women following a first 
AMI
Short term case fatality
In the current study unadjusted 30 day case fatality in individuals hospitalised with a first 
AMI fell from 18.1% in men and 27.2% in women in 1990 to 14.6% in men and 25.1% in 
women in 2000. This represents a decline of 19% in men and 8% in women which 
occurred in the context of an increase in age in both sexes. One year case fatality fell by 
13% in men and 6% in women over the same time period. In the multivariate analyses 30 
day case fatality fell by 38% in men and by 24% in women. The magnitude of decline 
decreased with increasing age and was greatest in individuals aged less than 65 years.
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Adjusted one year case fatality fell by 33% in men and by 31% in women and again the 
declines were greater in younger than in older individuals. The falls observed in the 
current study were greater than those reported from European MONICA centres including 
Glasgow.^ However the MONICA Studies included individuals with all AMIs as oppose 
to first AMIs and were confined to younger patients. The sex difference in temporal trends 
in case fatality has been described previously and a number of studies including the 
Swedish MONICA Project, the Minnesota Heart Survey and the Ontario Study have 
reported significant reductions in short term case fatality in men but not in women.
No other studies have however described age and sex specific temporal trends. Possible 
explanations for this sex difference may include bias in treatment practices. It has been 
suggested that women are less likely to receive thrombolytic therapy which may be due to 
the fact that they are older and have more comorbid i l l n e s s . W o m e n  also tend to 
arrive at hospital later and have more atypical AMI presentations which would restrict their 
eligibility for acute therapy like tlnombolysis.^^"^’^ ^^  Age related trends in case fatality 
following AMI occurring between 1975 and 1995 were examined in the Worcester Heart 
Attack Study who found encouraging declines in case fatality in all age groups but greater 
changes in younger age groups.^^^ It is possible that differential receipt of therapies may in 
part explain age related differences in case fatality improvements over time. Older patients 
are less likely to be treated with effective therapies including beta blockers and 
thrombolysis. " The data from this cuiTent study are consistent with the suggestion that 
modern treatments are making an increasing population impact on survival following 
AMI.^^* The progressive improvements observed in short term case fatality may indicate 
the importance of immediate therapies for AMI such as ACE inhibitors, aspirin and 
tlirombo lys is.
Longer term case fatality
The decline in unadjusted longer tenn case fatality that occurred in the cuiTent study was 
smaller than the decline that occurred hi short term case fatality. Five year case fatality 
rates fell from 41.8% in men and 54.2% in women m 1990 to 38.2% m men and 51.7% in 
women. The declines observed in adjusted five yeai' case fatality were similar in men and 
women (27% m men versus 23% in women). The magnitude of the declines was similar in 
men and women and the greatest declines in case fatality were seen in younger individuals. 
The substantial improvements hi long tenu survival may be attributed to improvements in 
diet and smoking as well as secondary prevention therapies hicluding aspirin and beta- 
blockers.’^ ’^^ ^^ ’^ ^^ ’^ ^^  The similar trends hi long tenn case fatality seen in men and women
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may reflect the more equitable treatment once a diagnosis of coronary heart disease has 
been established.
8.3.6 Summary
In the cuiTent study, the prognosis of men and women hospitalised with a first AMI was 
much worse than indicated by clinical trials. One fifth of patients died within one month 
of admission and almost one half by five years. Unadjusted survival was substantially 
better in men than in women. Much but not all of the excess short term risk in women 
could be explained by the fact that women were older than men at the time of theft first 
AMI. Women however remained at a 20% increased risk of death at 30 days even after 
adjusting for age and other factors. There was an age sex interaction in short tenn survival 
and the excess short term risk seen in women compared to men was greater in younger 
women. This finding is in keeping with a growing literature that reports similar 
obseiwations. After excluding early deaths, adjusted longer tenn case fatality was slightly 
greater in men than in women. Age was the most powerful predictor of survival in men 
and women. Socioeconomic deprivation also had a powerful effect on survival, especially 
on longer term survival, in younger age groups and in men. Most comorbid diagnoses 
substantially increased the risk of death in the short and longer term. Heart failure, renal 
failure and cancer had the most powerful effects. Comorbid diagnoses tended to have a 
greater effect on longer tenn survival than on short term sui-vival and in younger men and 
women than in older individuals. Atrial fibrillation and hypertension reduced the risk of 
death in the short term but not in the longer term. Between 1990 and 2000, the risk of 
death at 30 days fell by more than one thftd in men and a quarter in women. Declines were 
greater in younger age groups.
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9 SECOND AMI: BASELINE CHARACTERISTICS
9.1 Results of descriptive analyses
This section describes the baseline chai'acteristics of men and women who are admitted to 
hospital following a second acute myocaidial infarction. Theft first AMI took place up to 
ten years previously. The distribution of age and socio-economic status as well as the 
presence of comorbid conditions may differ in men and women. It is therefore important 
to have a clear understanding of these factors which may contribute to differences in 
suiwival between men and women.
9.1.1 Overall
Between January 1990 and December 31®* 2000, a total of 9,664 individuals aged 16 
years and over, were admitted to Scottish hospitals following a second acute myocardial 
infarction. 3,849 were women. This comprised 39.8% of the cohort and was similar to the 
41.4% of women hospitalised with a first AMI.
9.1.2Age
Table 78 shows the distribution of age in men and women admitted to hospital following 
theft second AMI. Mean age on admission to hospital was 74.2 yeai's in women and 67.7 
years in men. Women were on average six and a half years older than men at the time of 
second admission to hospital and 2.1 years older than at the time of theft first admission to 
hospital. A two-sample t-test to compare the mean ages of men and women was highly 
significant, p<0.001. The age distribution of men and women differed significantly. 
82.6% of women were aged greater than 64 years compared to 62.3% of men (p<0.001). 
This represented a substantial shift from the age distribution described in individuals 
hospitalised following a first AMI, especially in men. In those individuals, 75.8% of 
women were aged greater than 64 years compared to 52.4% of men. The distribution of 
age was relatively normal in men and women and can be summarised using a histogram as 
seen in Figure 18 and by the median, quartiles and extremes shown in Table 78. Age 
ranged from 24 to 96 years in men and from 29 to 104 years in women. The distribution of 
age was clustered around the median with 50% of women aged between 68 and 82 years 
and 50% of men aged between 60 and 76 years.
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Table 78 Descriptive statistics for age of men and women following a second hospital
admission for acute myocardial infarction
Number of cases (%) Men Women Both
Age-group <55 years 790(13,6%) 168 (4.4%) 958 (9.9%)
55-64 years 1398 (24.0%) 499 (13.0%) 1897 (19.6%)
65-74 years 1910(32.8%) 1100 (28.6%) 3010(31.1%)
75-84 years 1402 (24.1%) 1499 (38.9%) 2901 (30.0%)
>84 years 315 (5.4%) 583 (15.1%) 898 (9.3%)
Total 5815 (60.2%) 3849 (39.8%) 9664 (100%)
vi. Summary Statistics
Mean (95%CI) MEDIAN SD MIN MAX RANGE IQR
Men 67.7 (67.4-67.8) 68 11.2 24 96 72 16
Women 74.2 (73.9-74.5) 76 10.4 29 104 75 14
vii. Percentiles
PERCENTILE
5 10 25 50 75 90 95
Men 48 52 60 68 76 82 85
Women 55 60 68 76 82 86 89
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Figure 18 Histograms showing age distribution in men and women admitted to
hospital with a second AMI
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9.1.3Deprivation and sex
Overall 42,2% of men and 44.5% of women admitted to hospital with a second AMI came 
from the two most deprived deprivation categories. Table 79 and Figure 19 show the 
distribution of deprivation in men and women. As for individuals admitted to hospital with 
a fri'st AMI, there was a socioeeonomic gradient in men and women with the number of 
individuals admitted with a second AMI increasing across the deprivation categories fi'om 
the least to the most deprived. A chi square test for trend was highly significant, p<0.001 
after excluding the relatively small number of individuals not assigned to a deprivation 
category. The socio-economic gradient appeared to be slightly steeper in individuals 
admitted with a second AMI compared to individuals admitted with a first AMI. Only 
15.2% of individuals with a second AMI were from the least deprived category compared 
to 16.4% of individuals with a fii st AMI (P<0.001).
Table 79 Distribution of deprivation in men and women with a second AMI
Men Women All
Deprivation
categories
I" least deprived 876 (15.1%) 595 (15.5%) 1471 (15.2%)
II 1133 (19.5%) 702(18.2%) 1835 (19.0%)
III 1289 (22.2%) 814(21.1%) 2103 (21.8%)
IV 1320 (22.7%) 861 (22.4%) 2181 (22.6%)
V- most deprived 1135 (19.5%) 849 (22.1%) 1984 (20.5%)
Uncoded 62 (1,1%) 28 (0.7%) 90 (0.9%)
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Figure 19 Distribution of deprivation in men and women hospitalised with a second
AMI
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9.1.4Deprivation and age
The distribution of age gi'oups varied between deprivation categories. As shown in Table 
80, the least deprived and more affluent individuals were older than the most deprived 
individuals. 78.1% of those in the least deprived category were aged 65 and over, 
compared to 65.3% of those in the most deprived category. There was a significant trend 
of decreasing age with increasing deprivation and this was statistically significant (Chi 
square test for trend p<0.001). The distribution of age within deprivation categories 
therefore displayed similar patterns in individuals admitted with a second AMI as for 
individuals admitted with a first AMI.
Table 80 Age distribution within deprivation quintiles in individuals with 
a second AMI
Deprivation category
Age group 1-least
deprived
2 3 4 5-most
deprived
uncoded
<55 years 103
(7.0%)
144
(7.8%)
208
(9.9%)
236
(10.8%)
256
(12.9%)
958
(9.9%)
55-64 years 218
(14.8%)
333
(18.1%)
418
(19.9%)
473
(21.7%)
432
(21.8%)
1897
(19.6%)
65-74 years 440
(29.9%)
570
(31.1%)
664
(31.6%)
727
(33.3%)
584
(29.4%)
3010
(31.1%)
75-84 years 505
(34.3%)
606
(33.0%)
622
(29.6%)
587
(26.9%)
560
(28.2%)
2901
(30.0%)
>84 years 205
(13.9%)
182
(9.9%)
191
(9.1%)
158
(7.2%)
152
(7.7%)
898
(9.3%)
Total 1471
(100%)
1835
(100%)
2103
(100%)
2181
(100%)
1984
(100%)
9664
(100%)
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9.1.5Deprivation, age and sex
Table 81 shows the distribution of age by sex and deprivation categoiy. There was a trend 
across deprivation categories so that more deprived men and women were younger than 
less deprived men and women. Women were on average older than men. The differences 
were significant. (Chi square test for trend p<0.001 in men and women). As for first AMI, 
the socio-economic gradient was greater in younger individuals aged <65 years. In the 
elderly, there was a reverse socioeconomic gradient so that elderly individuals were more 
likely to come from less deprived categories than from more deprived categories. 
Individuals aged 85 years and over accounted for only 11.4% of women in the most 
deprived categoiy compared to 21% of women in the least deprived categoiy. In men the 
figures were 4.8% and 9.1%. Figure 20 shows the distribution of deprivation categories by 
age group and by sex. The interaction between deprivation and sex seen in all patients was 
seen in all age groups but was more marked in younger age groups. The socio-economic 
gradient was stronger in women and in younger age groups.
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Table 81 Age distribution by sex and deprivation category in individuals with a
second AMI
Deprivation category
Men Age
group
1-least 
deprived
2 3 4 5-most
deprived
uncoded
<55 years 88
(10.0%)
117
(10.3%)
174
(13.5%)
195
(14.8%)
207
(18.2%)
9
(14.5%)
55-64
years
162
(18.5%)
259
(22.9%)
321
(24.9%)
353
(26.7%)
286
(25.2%)
17
(27.4%)
65-74
years
282
(32.2%)
381
(33.6%)
429
(33.3%)
451
(34.2%)
352
(31.0%)
15
(24.2%)
75-84
years
264
(30.1%)
314
(27.7%)
290
(22.5%)
284
(21.5%)
235
(20.7%)
15
(24.2%)
>84 years 80
(9.1%)
62
(5.5%)
75
(5.8%)
37
(2.8%)
55
(4.8%)
6
(9.7%)
Women Age
group
<55 years 15
(2.5%)
27
(3.8%)
34
(4.2%)
41
(4.8%)
49
(5.8%)
2
(7.1%)
55-64
years
56
(9.4%)
74
(10.5%)
97
(11.9%)
120
(13.9%)
146
(17.2%)
6
(21.4%)
65-74
years
158
(26.6%)
189
(26.9%)
235
(28.9%)
276
(32.1%)
232
(27.3%)
10
(35.7%)
75-84
years
241
(40.5%)
292
(41.6%)
332
(40.8%)
303
(35.2%)
325
(38.3%)
6
(21.4%)
>84 years 125
(21.0%)
120
(17.1%)
116
(14.3%)
121
(14.1%)
97
(11.4%)
4
(14.3%)
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Figure 20 Distribution of deprivation categories by age group and sex
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9.1.6 Co-morbidity
71.3% of women and 65.5% of men admitted to hospital following then second AMI had 
either an admission in the five years prior to their AMI admission, or had a secondary 
diagnosis falling into one or more of the categories listed (Table 82). These figures were 
higher than for first AMI for which 51.5% of women and 44.3% of men had a recorded 
comorbidity. As for first AMI, heart failure was the most commonly recorded comorbidity 
and was more frequently coded in men than in women (37.1% versus 27%), Previous 
admission for coronary heart disease (excluding AMI), increased dramatically in men and 
women, rising from 7% to 24,7% in men and from 6.9% to 23.4% in women. A diagnosis 
of atrial fibrillation also increased substantially, especially in women in whom the 
prevalence rose from 7.4% to 12.5%. Coronary heart disease, cancer, cerebrovascular 
disease and peripheral vascular disease were more commonly recorded in men than in 
women. All other comorbid conditions were more commonly recorded in women than in 
men.
Table 82 Distribution and comparison of comorbid diagnoses by sex in individuals 
with a second AMI
Comorbidity Men Women All
Any 3809 (65.5%) 2745 (71.3%) 6552 (67.8%)
Diabetes 672 (11.6%) 549 (14.3%) 1221 (12.6%)
Cancer 632 (10.9%) 397 (10.3%) 1029 (10.6%)
Respiratory 718 (12.3%) 516(13.4%) 1234 (12.8%)
Cerebrovascular
disease
673 (11.6%) 386 (10.0%) 1059 (11.0%)
Peripheral 
vascular disease
497 (8.5%) 283 (7.4%) 780 (8.1%)
Atrial fibrillation 516(8.9%) 480 (12.5%) 996 (10.3%)
Hypertension 659 (11.3%) 574 (14.9%) 1233 (12.8%)
Renal failure 265 (4.6%) 197 (5.1%) 462 (4.8%)
Heart failure 1568 (27%) 1427 (37.1%) 2995 (31.0%)
Coronary heart 
disease
1435 (24.7%) 899 (23.4%) 2334 (24.2%)
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9.1.7Com orbidity, age and sex
The prevalence of comorbid conditions varies substantially with age. In order to make 
more valid comparisons between men and women, each comorbid condition was then 
examined according to age group and sex. Figure 21 shows the distribution of age group 
by comorbid condition in men and in women and Table 83 shows the results of the chi 
square tests of association between age group and sex within each comorbid diagnosis.
Comorbid diagnoses that decreased in prevalence with increasing age
A previous admission for coronary heart disease was more common in younger individuals 
admitted to hospital following then second AMI. 34.5% of women and 29.5% of men 
aged <55 years had a previous admission for coronary heart disease (excluding AMI). 
These figures declined to 20.2% in women and 21.6% in men aged >84 years. The 
observed trends were significant in men and in women, p<0.001. These trends were in 
contrast to those seen in individuals admitted with a first AMI in whom coronary heart 
disease increased marginally with age. Diabetes decreased with increasing age, with the 
exception of men aged <55 years in whom prevalence was only 6.8% compared to the 
15.9% seen in women of the same age. These trends were significant in women, but not in 
men (p=0.092 in men and 0.003 in women). Hypertension remained relatively stable with 
age but showed a marked reduction in the very elderly, especially in women. Again, 
hypertension was more common in women than in men except in the >84 year old age 
group.
Comorbid diagnoses that increased in prevalence with increasing age
The prevalence of a previous or co-existing heart failure diagnosis increased significantly 
with age in men and in women, p<0.001. Heart failure was more commonly coded in 
women than in men in all age groups, although this female excess became more apparent 
in the elderly. 11.4% of men and 16.7% of women aged less than 55 years had a heart 
failure diagnosis coding compared to 39.7% of men and 53.2% of women aged 85 years 
and over. A similar pattern was seen in first AMI. The prevalence of atrial fibrillation 
increased substantially with age in men and in women and was slightly more common in 
women than in men. Only 2.4% of men and 3% of women aged <55 years had a diagnosis 
of atrial fibrillation. This rose to 17.8% of men and 20.9% of women aged >84 years. 
Peripheral vascular disease increased dramatically in prevalence with age in men but was 
less common in women in whom there was less of an age effect. There was no age sex
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interaction as observed for first AML 8.9% of men aged greater than 84 years had a 
diagnosis of peripheral vascular disease compared to 7.3% of women.
Comorbid diagnoses that displayed an interaction between age and sex
As for fir st AMI, a cancer diagnosis displayed an interaction between age and sex. Cancer 
was more commonly coded in younger women and less commonly coded in older women. 
For example, 7.1% of women aged less than 55 years were coded for cancer compared to 
4.9% of men. However, 16.2% of men aged >84 years were coded for cancer compared to 
9.9% of women. Respiratory disease showed a similar pattern and increased more with 
age in men than in women. 19.7% of men aged greater than 84 years had a resphatory 
diagnosis compared to 16.6% of women. Renal failure displayed a similar pattern 
although the differences between men and women were less marked in all age groups. 
This again was similar to patterns obseiwed for first AMI. Cerebrovascular disease also 
displayed an age sex interaction and was more common in younger women and in older 
men. For example, 9.5% of women and 4.3% of men aged <55 years had a diagnosis of 
cerebrovascular disease compaied to 7.2% of women and 15.2% of men aged >84 yeai*s.
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Figure 21 Distribution of comorbid diagnosis by age and sex
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Table 83 Tests of association between sex and age group within comorbid diagnoses 
in individuals with a second AMI
CHI SQUARE TEST c m  SQUARE TEST FOR 
TREND
Comorbidity Men Women Men Women
Diabetes P<0.001 P=0.004 P-0.092 P-0.003
Cancer P<0.001 P-0.631 P<0.001 P=0.990
Respiratory
disease
P<0.001 P-0.003 P<0.001 P<0.001
Cerebrovascular
disease
P<0.001 P=0.162 P<0.001 P-0.312
Peripheral 
vascular disease
P<0.001 P=0.006 P<0.001 P-0.003
Atrial fibrillation P<0.001 P<0.001 P<0.001 P<0.001
Hypertension P=0.527 P-0.039 P=0.917 P=0.192
Renal failure P<0.001 P=0.008 P<0.001 P=0.001
Heart failure P<0.001 P<0.001 P<0.001 P<0.001
Coronary heart 
disease
P<0.001 P=0.001 P<0.001 P<0.001
9.1.8Comorbidity, deprivation and sex
The distribution of deprivation categories within each comorbid diagnosis was examined 
(Figure 22). Table 84 shows the results of the ehi square tests of association between sex 
and deprivation within comorbid diagnoses. Individuals who had not been assigned to a 
deprivation category were excluded from these tests. Variation by deprivation category 
was not as marked as that observed between age groups, and there were minimal 
differences in the prevalence of comorbid diagnoses between deprivation categories. 
There appeared to be less variation between deprivation categories than observed for first 
AMI, and many of the associations seen previously were no longer evident.
The proportion of men and women with a comorbid diagnosis of cancer varied by
deprivation category. There was a socio-economic gradient so that 9.4% of men and 8.9%
of women in the least deprived category had a diagnosis of cancer, rising to 14.3% of men
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and 13.3% of women in the most deprived categoiy. This trend was significant in men and 
women (p=0.001 and 0.011 in men and women respectively).
Atrial fibrillation did display significant variation across deprivation categories in men. 
The most deprived were less likely to have a diagnosis of atrial fibrillation than the least 
deprived. 10.8% of men in the least deprived categoiy had a coding for atrial fibrillation 
compared to 6.7% in the most deprived category. This trend was significant, p=0.004.
In women, renal failure was more commonly coded in more deprived categories than in 
least deprived categories. This trend was significant, p=0.015 and was not observed in 
men.
Finally, coronary heart disease displayed significant variation across deprivation 
categories, but only in men. The most deprived were more likely to have a coding for 
coronary heart disease. For example, 24.3% of men in the least deprived category were 
coded for coronary heait disease compared to 26.4% in the most deprived category. A 
similai' pattern was seen in men and women following a fiist AMI.
The prevalence of respiratoiy disease, cerebrovascular disease and diabetes did not vary by 
deprivation categoiy, unlike in fii'st AMI.
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Figure 22 Distribution of deprivation categories by comorbid diagnosis and sex in
individuals following a second AMI
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Table 84 Tests of association between sex and deprivation within comorbid diagnoses
in individuals with a second AMI
CHI SQUARE TEST CHI SQUARE TEST FOR 
TREND
Comorbidiiy Men Women Men Women
Diabetes P^O .574 P=0.768 P= 0.447 P=0.284
Cancer P=0.002 P=0.029 P=0.001 P=0.011
Respiratory
disease
P=0.651 P=0.532 P=0,580 P= 0.117
Cerebrovascular
disease
P==0.239 P=0,524 P=0.328 P=0.522
Peripheral 
vascular disease
P=0.578 P=0.484 P=0.985 P=0.419
Atrial fibrillation P=0.016 P= 0.666 P=0.004 P=0.931
Hypertension P=0.716 P=0,114 P--0.853 P=0,066
Renal failure P=0.090 P-0.027 P=0.108 P-0.015
Heart failure P —0,666 P=0.605 P=0.889 P=0.494
Coronary heart 
disease
P=0.027 P=0,259 P=0.014 P=0.121
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9.1.9Tim e since first AM I
The median time since the first AMI was 2.3 years in men and 1.8 years in women (Table 
85). This time was consistently greater in men than in women. Median time since first 
AMI varied by age group but did not demonstrate any clear trend. As with age, there was 
some variation according to socioeconomic deprivation but no obvious trend. Median time 
since first AMI appeared to increase in men and women between 1990 and 1996 / 1997, 
and then decrease. Overall however, the median time since previous AMI did increase 
from one year in men and women in 1990 to 2.5 years in men and 1.7 years in women in 
2000.
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Table 85 Median time since first AMI in men and women with second AMI
MEDIAN TIME SINGE FIRST AMI (YEMIS)
MEN' WOMEN
Overall 2.3 1.8
Age
<55 years 2.0 1.9
55-64 yeai's 2.4 2.3
65-74 years 2.4 2.1
75-84 years 2.2 1.9
84 years 2.0 1.9
Deprivation quintile
1-least deprived 2.23 1.74
2 2.06 1.48
3 2.23 1.74
4 2.52 2.02
5-most deprived 2.19 1.72
Year of admission
1990 1.0 1.0
1991 1.6 1.4
1992 2.0 1.3
1993 2.3 1.7
1994 2.8 1.8
1995 2.9 2.1
1996 2.9 3.2
1997 3.7 2.8
1998 3.4 2.8
1999 2.9 2.1
2000 2.5 1.7
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9.2 Discussion of second AMI baseline characteristics
Whilst there is an extensive literature that describes the baseline chaiacteristics in men and 
women hospitalised with first AMI, there are very few studies that have distinguished 
between fiist and recurrent AMI and no other studies that have specifically examined 
second AML Consequently there are no other studies with which to compaie many of the 
findings reported from the cuiTent study. The findings from the description and analyses 
of first AMI in the current study were compared to the literature and it would therefore not 
be appropriate to repeat this process for second AMI. The findings from the current study 
relating to second AMI will therefore be discussed briefly and in context of the findings 
regarding fii'st AMI and where appropriate any relevant literature.
9.2.1 Age and sex
Between 1990 and 2000, 9,664 individuals were hospitalised in Scotland with a second 
AMI. Women comprised 39.8% of the cohort and had a mean age of 74.2 years, which is 
just over two years older than at the time of their first AMI. Men were on average three 
years older at the time of admission with their second AMI than with their first AMI. This 
represents a substantial shift in age distribution, especially in men. Men and women 
hospitalised with a second AMI were on average older than individuals hospitalised with a 
first AMI. Nearly three quarters of individuals hospitalised with a second AMI were aged 
greater than 64 years. The age distribution of men and women presenting with a first and 
second AMI are therefore different. The majority of studies examining epidemiological 
aspects of AMI do not discern between first and subsequent AMI, although it would be 
useful to do so because of their differing characteristics which have considerable 
implications in terms of survival. The proportion of men and women in each cohort was 
similar for first and second AMI (41.4% women with first AMI versus 39.8% with second 
AMI). There aie few studies with which to compare these data and no population based 
studies tliat have looked specifically at second AMI as oppose to recunent AMI. The 60 
Minutes Myocardial Infarction Project did describe the characteristics of patients with re­
infarction compared to patients with a first infarction in 14,980 patients hospitalised in 
Germany between 1992 and 1994.^^“^ The mean age of patients admitted with re-infarction 
was 69 years which was four years older than individuals hospitalised with a first AMI. 
Women accounted for 28% of patients with a re-infarction and 33% o f patients with a first 
infarction. Sex specific data were not reported.
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9.2.2Socioeconomic characteristics
As for first AMI, there was a socio-economic gradient with a greater proportion of men 
and women who were hospitalised with a second AMI belonging to the most deprived 
categories compared to the least deprived categories. The socioeconomic gradient was 
stronger for second AMI than for first AMI, so that the association between hospitalisation 
with AMI and socioeconomic deprivation was slightly greater for second than for first 
AMI. Overall 42.2% of men and 44.5% of women hospitalised with a second AMI came 
from the two most deprived deprivation categories, compared to 41% of men and 43.2% of 
women with a first AMI. There is no literature with which to compare these findings. The 
implication is that men and women fiom deprived areas are more likely to be readmitted 
with a subsequent AMI. However it is not reasonable to draw this conclusion. Individuals 
hospitalised witlr a first and second AMI are two separate cohorts and also subsequent 
AMIs can only occur in survivors which introduces an iimnediate bias. The association 
between socioeconomic deprivation and recuixent AMI is interesting but is not something 
that can be examined in this study.
9.2.3Comorbid diagnoses
No previous studies have examined tire distribution of comorbid diagnoses in individuals 
hospitalised with a second AMI. In the current study 65.5% of men and 71.3% of women 
hospitalised with a second AMI had one or more comorbid diagnoses. This is substantially 
higher than the proportions for first AMI which were 44.3% and 51.5% of men and women 
respectively. As for first AMI, heart failure was the most commonly recorded 
comorbidity. The prevalence of heart failure almost doubled fiorn first to second AMI. 
Large relative increases were also seen with cancer, cerebrovascular disease, renal failure 
and coronary heart disease. Men and women hospitalised with a second AMI are on 
average two to three year's older than individuals hospitalised with a first AMI and because 
there is a strong association between age and the prevalence of comorbid conditions, one 
would expect to see some increase in the prevalence of comorbid diagnoses. Overall there 
was a stronger association between age and prevalence of comorbid diagnoses with first 
AMI than with second AMI. The prevalence of one or more comorbid diagnoses more 
than doubled in men and increased by 70% in women hospitalised with a first AMI 
between the youngest and oldest age groups. In individuals hospitalised with a second 
AMI the prevalence of any comorbid diagnosis mcreased by 48% in men and by 19% in
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women between the youngest and oldest age groups. In younger individuals hospitalised 
with a second AMI there was a striking excess of women compared to men who had 
comorbid diagnoses of diabetes, cerebrovascular disease and renal failure. This may 
reflect the fact that coronaiy heart disease is relatively inflequent in young women and that 
young women hospitalised with a second AMI are likely to have particularly adverse risk 
profiles and high levels of comoibid illness.
9.2.4Median time since first AMI
The median inteival between infarctions was greater in men than in women (2.3 and 1.8 
years in men and women, respectively) but remained relatively consistent across different 
age groups. The median intei-val between infarctions in men increased from one year in 
1990 to 3.7 years in 1997 and then decreased to 2.5 years in 2000 (P<0,001). The pattern 
was similar in women, rising flrom one year to 3.2 years in 1996 and then falling back to 
1.7 years in 2000 (P<0.001). Second infarctions represented a decreasing proportion of all 
infarctions over the duration of the study. It is not clear why the median time since a 
previous AMI would decline over time and then increase in recent years. One possibility is 
that the improving short term survival seen following a first AMI has resulted in 
individuals surviving who might have previously died. Such individuals are likely to have 
severe disease and may then be at higher risk of subsequent events.
9.2.5Summary
Patients with a second MI were older (3 years on average) and had more cardiovascular 
risk factors (e.g. diabetes and hypertension) than patients witli a first AMI, presumably 
demonstrating the potential of these factors to increase the likelihood of a recurrent event. 
Patients with a second MI also had more cardiovascular co-morbidity, probably reflecting 
the consequences of greater cardiac injury. For example, these patients had more atrial 
fibrillation and a notable excess of heart failure. In addition, individuals with a second MI 
had more non-cardiovascular co-morbidity, presumably reflecting common aetiological 
factors (e.g. smoking in relation to COPD) and their older age.
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10 Temporal trends in baseline characteristics of individuals 
admitted to hospital following a second AMI 1990-2000
Temporal trends in the distribution of prognostic factors may affect the prognosis of men 
and women following admission to hospital with a second AML It is therefore important 
to examine the distribution of these factors over time. Variation in the age and the 
presence of comorbid diagnoses may contribute to observed trends in survival and need to 
be taken into account when considering trends in survival.
lO.lResults
10.1.1 Age
As for first AMI, year of admission was categorised into tliree time periods, 1990-1992, 
1993-1996 and 1997-2000. The age distribution of men and women admitted to hospital 
following a second AMI has undergone modest changes which are similar to those seen for 
first AMI. The proportion of younger individuals aged less than 75 years has declined in 
men and in women. In men the proportion of individuals aged less than 75 years fell firom 
72% in 1990-1992 to 65.3% in 1997-2000. A similar decline was seen in women in whom 
the proportion fell fi-om 49.1% in 1990-1992 to 40.0% in 1997-2000. There has been a 
conesponding rise in the number of elderly men and women. In 1990-1992, 4.1% of men 
and 12% of women were aged over 84 years. By 1997-2000 these figures had risen to 8% 
and 21% respectively. These trends were all highly significant, p<0.001. The average age 
of men and women on admission has also increased. In men the median age increased 
from 68 to 70 years and in women from 75 to 77 years. These data are shown in Table 86. 
Figure 23 shows a scatterplot of mean age on admission in men against year of admission. 
A linear trend line has been fitted to the data. The sample correlation coefficient 
suggests that 70% of the variability in mean age can be explained by its relationship with 
year of admission and there is consequently a strong relationship between the two 
variables. As for first AMI, the strength of the relationship is greater in women in whom 
the is 83% (Figure 24).
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Table 86 Temporal trends in age distribution of men and women
viii. Age group distribution
Number of cases 
(%)
MEN WOMEN
Year of 1990- 1993- 1997- 1990- 1993- 1997-
admission 1992 1996 2000 1992 1996 2000
Age-group <55 275 334 181 65 65 38
years (13.3%) (24.0%) (12.6%) (4.6%) (4.3%) (4.1%)
55-64 533 552 313 208 193 98
years (25.7%) (24.0%) (21.7%) (14.7%) (12.7%) (10.7%)
65-74 685 778 447 422 447 231
years (33.0%) (33.8%) (31.0%) (29.8%) (29.5%) (25.2%)
75-84 495 523 384 552 589 358
years (23.9%) (22.7%) (26.7%) (39.0%) (38.9%) (39%)
>84 85 115 115 170 220 193
years (4.1%) (5.0%) (8.0%) (12.0%) (14.5%) (21.0%)
Total 2073 2302 1440 1417 1514 918
ix. Summaiy Statistics
MEN WOMEN
Year of 
admission
1990-1992 1993-1996 1997-2000 1990-1992 1993-1996 1997-2000
Mean age 
(years)
67.3
(66.8-
67.7)
67.4
(66.9-
67.8)
68,8
(68.2-
69.4)
73.3
(72.7-
73.8)
74.2
(73.7-
74.8)
75.6
(74.9-
76.3)
Standard
deviation
11.0 11.2 11.5 10.2 10.1 10.7
Median age 
(years)
68 68 70 75 75 77
Interquartile
range
16 15 16 13 14 13
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Figure 23 Mean age on admission to hospital following a second AMI in men 1990-
2000
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Figure 24 Mean age on admission to hospital following a second AMI in women 1990- 
2000
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10.1.2 Comorbidity
As for first AMI, the proportion of men and women with comorbid conditions increased 
over the study period for most diagnoses and in most age gi'oups (Figure 25). However, 
fewer of the trends reached statistical significance, especially in younger age groups (Table 
88).
The proportion of men with a diagnosis of diabetes increased across all age groups 
between 1990-1992 and 1997-2000. 4% of men aged less than 55 years had a diagnosis of 
diabetes in 1990-1992. By 1997-2000 this had risen to 8.8%. Other age groups 
demonstrated changes of a similar magnitude. These trends were all significant. In 
women the proportion of individuals with a diagnosis of diabetes was greater than in men 
and increased in all but the very elderly. These trends did not however reach statistical 
significance.
The proportion of individuals with a diagnosis of cancer increased in men in all but the 
very elderly. These trends did not reach significance except in the under 55 year olds in 
whom the relative change was greatest. In this age group, 2.9% of men had a cancer 
diagnosis in 1990-1992 and this rose to 7.7% in 1997-2000. In women, the greatest 
changes occurred between 1993-1996 and 1997-2000. In 1993-1996, 8.3% of women aged 
55-64 years had a diagnosis of cancer and this rose to 19.4% in 1997-2000. Trends over 
time however were not statistically significant.
As for fii'st AMI, cerebrovascular disease and peripheral vascular disease exliibited less 
clear trends in prevalence over tune in both men and women. There were no obvious 
patterns for cerebrovascular disease and changes were not significant except in men and 
women aged 75 to 84 years in whom the prevalence rose. In women the prevalence of 
cerebrovascular disease increased from 8.2% to 13.4% over the study period. None of the 
trends were significant for peripheral vascular disease.
The prevalence of heait failure increased substantially in men except in those aged less 
than 55 years. 23.1% of men aged 65-74 years had a diagnosis of heait failure in 1990- 
1992. By 1997-2000 this had risen to 34.9%. Similar increases were seen for fii'st AMI. 
In women the trends were less clear. Only women aged 65-74 years experienced a 
significant increase in the prevalence of heart failure. In this age group the proportion with
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a heart failure diagnosis increased horn 26.8% to 42%. This contrasted with first AMI in 
which similar increases were seen in men and in women.
Coding for atrial fibrillation increased substantially over the study period. In 1990-1992 
7.8% of women aged 65-74 years had a diagnosis of atrial fibrillation. By 1997-2000 this 
figure had risen to 18.6%. Increases were seen across all age groups although these were 
greater in the elderly and did not reach statistical significance in those aged less than 65 
years. In men the relative changes were more consistent across age groups and the trends 
all reached significance. The proportion of men aged 65-74 years with a diagnosis of atrial 
fibrillation increased fi’om 8.6% in 1990-1992 to 14.5% in 1997-2000. These changes 
were similar to those observed for first AMI.
Hypertension also increased in prevalence over time. The changes occuned across all age 
groups except in women aged less than 55 years. Again this pattern was similar to that 
obseiwed for fifst AMI, For example the proportion of women aged 75-84 years with a 
diagnosis of hypertension increased from 9.8% in 1990-1992 to 24.9 in 1997-2000. The 
equivalent figures in men were 5.7% and 17.4%.
As for fii'st AMI, trends in previous coronary heart disease excluding AMI were smaller in 
magnitude when compared to other diagnoses. Prevalence of previous coronary heart 
disease decreased in women aged less than 55 years, falling from 35.4% in 1990-1992 to 
23.7% in 1997-2000. In older women prevalence demonstrated modest increases. For 
example in women aged 65-74 years the prevalence increased fr om 21.8% to 26.4%. None 
of these trends were significant in women. In men, older age groups experienced 
significant increases in the prevalence of previous coronary heart disease, especially in 
men aged greater than 84 years in whom the prevalence rise from 9.4% in 1990-1992 to 
34.8% in 1997-2000.
Overall the proportion of men and women with at least one comorbid diagnosis increased 
in men and women of all ages although these trends were not significant in women aged 
less than 65 years and m men aged less than 55 years. In 1990-1992, 55.3% of men aged 
greater than 84 years had one or more comorbid diagnoses. By 1997-2000, this figure had 
increased to 85.2%. The equivalent figures m women were 75.9% and 81.3%.
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Figure 25 Distribution of comorbid diagnoses by age group and time period for men
and women
S.
25
20
15
10
5
0+-
Diabetes □ 1990-1992 Diabetes □ 1990-1992□ 1993-1996 □ 1993-1996men women□ 1997-2000 □ 1997-2000
Q
55 64 65-74 75-84
Age group- years
18
16
0  14S* 121 5^ »i :
4
20
55-64 65-74 75-84
Age group- years
20
18
16m 14S* 12I  Ü «.I :
4
2
0
Cancer
men
□ 1990-1992 Cancer □ 1990-1992□ 1993-1996 □ 1993-1996women□ 1997-2000 □ 1997-2000
rD
55-64 65-74 75-84
Age group- years
18
16
0> 14
I*' * I :
420
55-64 65-74 75-84
Age group- years
Cerebrovascular disease 
men
20
•95 55-64
□ 1990-1992 Cerebrovascular disease □ 1990-1992□ 1993-1996 women □ 1993-1996□ 1997-2000 □ 1997-2000
65-74 75-84
Age group- years
s.
55-64 65-74 75-84
Age group- years
261
20
18
16
a, M
I ' -I ;
4
2
0
Hype rtension 
men
□ 1990-1992
□ 1993-1996
□ 1997-2000
Q
55-64 65-74 75-84
Age group- years
Hype rtension 
women
□ 1990-1992
□ 1993-1996
□ 1997-2000
n
75-84
Age group- years
Peripheral vascular disease 
men
□ 1990-1992
□ 1993-1996
□ 1997-2000
55-64 65-74 75-84
Age group- years
Peripheral vascular disease 
women
14
12Î  10
S  3i 'I  '
2
0
□ 1990-1992
□ 1993-1996
□ 1997-2000
55-64 65-74 75-84
Age group- years
§
Renal Failure 
men
rlTi i-TT r
□ 1990-1992 Renal failure □ 1990-1992□ 1993-1996 women □ 1993-1996
□ 1997-2000 □ 1997-2000
n
75-84 75-84
Age group- years Age group- years
262
1 ^ '
Atrial fibrillation 
men
j - n  r f
□ 1990-1992 Atrial fibrillation □ 1990-1992
□ 1993-1996 women □ 1993-1996
□ 1997-2000
30
□ 1997-2000
S5-M 65-74 75-84
Age group- years
25
0> 20
« 10
ml..
55-64 65-74 75-84
Age group- years
so
45
40
Q) 35
«  30
g ^ 25
P  20
Heart failure □ 1990-1992 Heart failure O 1990-1992
men □ 1993-1996 women □ 1993-1996
□ 1997-2000 □ 1997-2000
A
r&
55-64 65-74 75-84
Age group- years
te 20
55-64 65-74 75-84
Age group- years
Coronary heart disease 
men
35
30
o 25O)
1 ^ 2015
«0. 10
5
0
□ 1990-1992
□ 1993-1996
□ 1997-2000
55-64 65-74 75-84
Age group- years
Coronary heart disease 
women
§  ^ 20
:
5
0
□ 1990-1992
□ 1993-1996
□ 1997-2000
55-64 65-74 75-84
Age group- years
263
R e s p ira to ry  d isease  
m en
(0 15
10
Æ
rh
□ 1990-1992 R es p ira to ry  d is ea se □ 1990-1992□ 1993-1996 w o m en □ 1993-1996□ 1997-2000 □ 1997-2000
55-64 65-74 75-84
Age group- years
20I e 
I** «
55-64 65-74 75-84
Age group- years
Any com orb id  d iag n o s is  
m en
□ 1990-1992
□ 1993-1996
□ 1997-2000
55-64 65-74 75-84
Age group- years
Any com orb id  d iagn o s is  
w om en
□ 1990-1992
□ 1993-1996
□ 1997-2000
90
80
70
60
50 k
40
302010 -0
55-64 65-74 75-84
Age group- years
264
I
»
IIIg
■s■s
5
%
i
0>X!1
M
i
g.
ur-00IH
o\o Io W1Os(NO O<NOgO 8O ooooo o o
00 o
oo io VOoomoo 8O Ooo ooo' 8o 8o'o o o o
P h
8O
Ooo
ooo 8o
ooo'
moooo
oooo
00 oo 8o'
VOooo 8o
<N
Oo8o'
ooo o 8o 8O 8Omo
ooooo'
moooo
ooo8o' 8o’8O 8OO
P h
i o 8Oooo'ooo' ooo 8o ooo ooo ooo'o o
CZ3 Io rnrooooo 8oooo'o o o
P h
oooooo'
soo m<No' ooo\mo' soo' ooooo 8o oooooo o
VO
COo Ioio'COo (No'
o
go
VOso' gOvo oooCOo oo COOOwo oO ooo O O
csJ
U
(U
in
10.2Discussion regarding temporal trends in baseline 
characteristics of second AMI
10.2.1 Age and sex
Individuals hospitalised with a second AMI increased in age between 1990 and 2000. The 
median age on admission increased from 68 to 70 years in men and from 75 to 77 years in 
women. The increase in age was therefore similar in men and women and comparable to 
the change observed in individuals hospitalised with a first AMI. In 1997-2000, 85.2% of 
women and 65.7% of men hospitalised with a second AMI were aged 65 years and over. 
This is a relatively elderly cohort and highlights the importance of population based studies 
and the limitations of age restricted studies in the description and analysis of AMI 
epidemiology. There are no other studies with which to compare these data. The SPRINT 
Registry compai'ed the baseline characteristics and prognosis of patients hospitalised with a 
recurrent AMI in 1981-3 and 1992-6.^^  ^ The mean age of patients in this study did not 
change significantly over time, although sex specific results were not reported. The 
registry only includes individuals admitted to coronaiy care units who are younger and 
more likely to be men than in a population based study. The registry is therefore subject to 
selection bias making it difficult to generalise results. The proportion of women decreased 
slightly over the study period from 40.6% in 1990 to 38.9% in 2000. Again there are no 
other population based studies with which to compaie these results. In the SPRINT 
Registry the proportion of women remained stable at 21-22%, which is substantially lower 
than seen in the current study.^^^
10.2.2 Comorbidity
As with first AMI the proportion of men and women diagnosed with comorbid conditions 
increased over the study period. Overall in 1990, 59.1% of men and 66.3% of women had 
one or more comorbid diagnosis. By 2000 this had increased to 72.5% and 76.9% in men
and women respectively. Increases occurred in most age groups and for all diagnoses.
The greatest relative increases occuiTed with atrial fibrillation, hypertension and renal 
failure in both men and women and diabetes in men. The prevalence of all these diagnoses 
more than doubled between 1990 and 2000. These diagnoses also demonstrated the largest 
relative increases in prevalence over time for first AMI. The only study to report changing 
baseline characteristics over time in individuals hospitalised with recurrent AMI is the
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SPRINT Registry/^^ This study found that patients hospitalised in 1992-1996 had a higher 
prevalence of diabetes and hypertension but less frequently had prior angina than 
individuals hospitalised in 1981-1983. Overall the prevalence o f diabetes increased from 
21% in 1981-1983 to 30% in 1992-1996. The reported prevalences of diabetes and 
hypertension were substantially higher than those reported in the current study. As 
discussed previously it is likely that comorbid diagnoses are underrecorded in the Scottish 
Morbidity Record discharge forms used in the current study. In addition the SPRINT 
Registry only includes individuals admitted to coronary care units and is not representative 
of the general population.
10.2.3 Summary
In the current study, individuals hospitalised with a second AMI increased in age between 
1990 and 2000. They also were increasingly likely to be diagnosed with other comorbid 
conditions. These changes affected men and women of all ages and were similar to the 
changes observed in individuals hospitaUsed with a first AMI between 1990 and 2000.
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11 SECOND AMI: BURDEN OF DISEASE 
11.1 Results
11.1.1 Population rates for admission to hospital following a second 
AMI 1990-2000
The aim of this section is to describe the burden that individuals hospitalised with a second 
AMI place on the National Health Service. It describes the incidence of second AMI in 
men and women and in different age groups, their length of stay and occupied bed days as 
well as the proportion of individuals that undergo revascularisation procedures during their 
index stay.
Sex
Between 1990 and 2000, the population discharge rate for second AMI fell by 58% in men, 
from 37 to 15 per 100,000, and by 58% m women, from 22 to 9 per 100,000 (Table 88 and 
Figure 26). These trends were highly significant in men and women, p<0.001. Population 
admission rates for fri'st AMI declined by 28% in men and 30% in women and the declines 
obseiwed for second AMI were therefore greater than the declines observed for first AMI.
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Table 88 Annual number of cases and population rates per 100,000 for men and
women admitted to hospital following a second AMI
Number of cases Population rates (per 100,000)
Men Women Men Women
1990 693 455 37 22
1991 714 480 38 23
1992 666 482 36 23
1993 671 406 36 19
1994 601 419 32 20
1995 555 377 30 18
1996 475 312 26 15
1997 441 239 24 11
1998 385 248 21 12
1999 325 239 17 11
2000 289 192 15 9
Crude % change -58.30 -57.80 -58.58 -58.16
Average annual 
change (95% Cl)
"46 ( " 39-"52) "2.5 C2.1-" 
2.8)
"31 ( ■ 24-"38) ■ 1 . 5 ( “ 1.2- 
"1.8)
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Figure 26 Age and sex specific population rates for admission to hospital following a
second AMI
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Age and sex
Age and sex specific temporal trends in population rates are shown in Table 89,Tab le 90, 
Table 91, Table 92, Table 93, and Figure 27. The greatest absolute change in the number 
of individuals admitted to hospital following a second AMI occurred in those aged 55 to 64 
years and 65-74 years, and was greater in men than in women. Between 1990 and 2000, 
the number of men aged 65-74 years with a discharge diagnosis of second AMI decreased 
by 127, a relative decline of 60%. In women the number of second AMI diagnoses in 
individuals aged 65-74 years, declined by 89, a relative decline of 67%. These trends were 
all highly significant.
Smaller absolute and relative changes were seen in men and women aged >84 years. In 
this age group, population rates for AMI hospitalisation declined by 39% in men and 46% 
in women. These trends were significant, although they represented a small reduction in 
second AMIs in absolute terms, a decline of only 3 cases in men and 7 cases in women. A 
similar pattern was observed in individuals aged <55 years. There was a decline of 61% in 
population rates for second AMI in men aged <55 years and a decline of 46% in women 
aged <55 years. These significant trends represented small changes in absolute terms.
The sex differences in population rates for second AMI hospitalisation decreased with 
increasing age so that the large discrepancy seen in younger people was no longer as 
apparent in men and women aged 75 and over. This was because the absolute decline in 
population rates was substantially higher in men although the relative changes were 
similar.
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Table 89 Annual number of cases and population rates per 100,000 for men and
women aged <55 years admitted to hospital following a second AMI
Aged < 55 years Number of cases Population rates (per 100,000)
Men Women Men Women
1990 110 22 8 2
1991 85 23 7 2
1992 80 20 6 2
1993 85 15 7 1
1994 99 19 8 1
1995 88 16 7 1
1996 62 15 5 1
1997 63 12 5 1
1998 41 7 3 1
1999 35 7 3 1
2000 42 12 3 1
Crude % change -61.82 -45.45 -61.18 -45.90
Average annual "6.7 ( " 9-"4) "1 .5 (“ 2~“ 1) " 0.5 fO.7- “ "0.1 ( "  0.2-
change (95% Cl) 0.3) "0.1)
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Table 90 Annual number of cases and population rates per 100,000 for men and
women aged 55-64 years admitted to hospital following a second AMI
Number of cases Population rates 
(per 100,000)
Men Women Men Women
1990 174 78 68 27
1991 198 62 78 22
1992 161 68 63 24
1993 177 57 70 20
1994 126 57 49 20
1995 132 39 52 14
1996 117 40 46 14
1997 102 35 40 13
1998 84 23 33 8
1999 68 23 26 8
2000 59 17 22 6
Crude % change -66.09 -78.21 -67.08 -78.09
Average annual 
change (95% Cl)
" 1 4 ( “ 16-“11) "6 ( " 7-"5) “5 ( " 7-"4) "2("2.5-"1.8)
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Table 91 Annual number of cases and population rates per 100,000 for men and
women aged 65-74 years admitted to hospital following a second AMI
Number of cases Population rates 
(per 100,000)
Men Women Men Women
1990 211 133 112 54
1991 234 153 122 61
1992 240 136 124 54
1993 211 126 107 50
1994 209 127 104 49
1995 190 110 96 44
1996 168 84 85 34
1997 133 55 67 22
1998 128 72 65 29
1999 102 60 51 24
2000 84 44 42 18
Crude % change -60.19 -66.92 -62.19 -66.65
Average annual 
change (95% Cl)
“1 5 ( “ 19-"11) “11 (■ 14--3) “8 ( - 10-“6) “4 ( “ 5-“3)
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Table 92 Annual number of cases and population rates per 100,000 for men and
women aged 75-84 years admitted to hospital following a second AMI
Number of cases Population rates 
(per 100,000)
Men Women Men Women
1990 166 170 182 101
1991 171 191 187 114
1992 158 191 175 116
1993 166 154 188 96
1994 140 155 162 99
1995 115 152 128 94
1996 102 128 110 78
1997 112 85 118 51
1998 108 90 112 54
1999 89 99 91 60
2000 75 84 75 50
Crude % change -54.82 -50.59 -58.77 -49.84
Average annual 
change (95% Cl))
"10 ("  12-"8) "121 ( "  15- "12(~ 15-“9) -7(-9 -"5 )
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Table 93 Annual number of cases and population rates per 100,000 for men and
women aged >84 years admitted to hospital following a second AMI
Number o f cases Population rates 
(per 100,000)
Men Women Men Women
1990 32 52 210 100
1991 26 51 163 94
1992 27 67 161 120
1993 32 54 184 94
1994 27 61 149 104
1995 30 60 158 99
1996 26 45 132 73
1997 31 52 152 83
1998 24 56 112 88
1999 31 50 141 78
2000 29 35 128 54
Crude % change -9.38 -32.69 -39.10 -46.02
Average annual 
change (95% Cl)
■ 0.06 fO.7- 
0.6) NS
"1.3 ( “ 3-0.4) 
NS
"7 ( “ 10-"3) “4 ( “ 7-" 1.4)
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Figure 27 Age and sex specific population rates for admission to hospital following a
second AMI
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11.1.2 Length of stay and bed days occupied following admission to
hospital with a second AM I 1990-2000
Length o f  stay in days in men and women
As for fii’st AMI, length of stay declined steadily in men and women between 1990 and 
2000 (Table 94). In 1990 the mean length of stay was 13.0 days in men and 14.1 days in 
women. This difference was highly significant. By 2000 the mean length of stay had 
declined to 8,8 days in men and 11.3 days in women. Again these changes were highly 
significant. These figures were very similar to those observed for first AMI. Median 
length of stay differed substantially firom mean and was therefore a more appropriate 
summary measure. The median length of stay was 8 days in men and women in 1990 and 
declined to 6 days in men and 7 days in women by 2000. The interquartile range was 
greater in women than in men in each yeai' suggesting that the distribution of length of stay 
was more widely spread.
T ab le  94 L en g th  o f s tay  in  m en  a n d  w om en follow ing a second A M I 1990-2000
MEN WOMEN
year of 
admission
M ean M e d ia n IQ  ran g e M ean M e d ia n IQ  ra n g e
1990 13.0 8 5-8 14.1 8 6-13
1991 9.9 7 5-7 14.4 8 6-13
1992 10.8 7 5-7 13.9 8 5-12
1993 9.0 7 5-7 18.0 8 5,75-11
1994 10.0 7 5-7 13.2 8 5-14
1995 9.1 6 5-6 11.6 8 6-13
1996 8.8 7 5-7 12.3 7 5-13
1997 8.9 6 5-6 9.3 7 4-10
1998 8.1 6 4-6 10.3 7 4-11.75
1999 9.4 6 5-6 10.1 7 5-12
2000 8.8 6 4-6 11.3 7 4-14
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Bed days in men and women
Figure 28 shows the bed days per 1000 population occupied by men and women following 
a second AMI between 1990 and 2000. As for first AMI, bed days declined substantially 
in men and in women. In men the number of bed days occupied per 1000 head o f  
population fell fi-om 4.9 in 1990 to 1.4 in 2000, a decline of 72%. The fall was slightly less 
in women in whom the bed days declined from 3.1 in 1990 and 1.0 in 2000, a fall o f 67%. 
Since 1995, the occupied bed days per 1000 population has been greater in men than in 
women except for 1993 when occupied bed days in women exceeded that seen in men.
Figure 28 Bed days occupied by men and women following a second AMI 1990-2000
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11.1.3 In-hospital revascularisation rates in men and women
following a second AM I 1990-2000
Table 95 shows the number and proportion of men and women with a second AMI 
undergoing a revascularisation procedure duiing their inpatient stay.
Table 95 Numbers and rates of men and women with a second AMI undergoing 
revascularisation during their index hospital admission 1990-2000
MEN WOMEN
Revasc CABG PICA Revasc CABG PTCA
1990 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
1991 3 (0.4%) 2 (0.3%) 1 (0.1%) 1 (0.2%) 1 (0.2%) 0 (0%)
1992 3 (0,5%) 0 (0%) 3 (0.5%) 1 (0.2%) 1 (0.2%) 0 (0%)
1993 2 (0.3%0 1 (0.1%) 1 (0.1%) 1 (0.2%) 1 (0.2%) 0 (0%)
1994 3 (0.5%) 1 (0.2%) 2 (0.3%) 1 (0.2%) 1 (0.2%) 0 (0%)
1995 3 (0.5%) 1 (0.2%) 2 (0.4%) 5(1.3%) 2 (0.5%) 3 (0.8%)
1996 4 (0.8%) 2 (0.4%) 2 (0.4%) 4(1.3%) 2 (0.6%) 2 (0.6%)
1997 7 (1.6%) 2 (0.5%) 5(1.1%) 2 (0.8%) 0 (0%) 2 (0.8%)
1998 8 (2.1%) 1 (0.3%) 7(1.8%) 5 (2.0%) 3 (1.2%) 3 (1.2%)
1999 10(3.1%) 1 (0.3%) 9 (2.8%) 3 (1.3%) 0 (0%) 3 (1.3%)
2000 13 (4.5%) 0 (0%) 13 (4.5%) 7 (3.6%) 0 (0%) 7 (3.6%)
Total 56 (1.0%) 11 (0.2%) 45 (8%) 30 (0.8%) 11 (0.3%) 20 (3.6%)
2 8 1
Figure 29 Proportion of men and women undergoing a revascularisation procedure
during admission following a second AMI 1990-2000
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Table 96 Proportion of men and women in different age groups undergoing a 
revascularisation procedure during admission following a second AMI
Age group men women
< 55 years 18 (2.3%) 4 (2.4%)
55-64 years 20(1.4%) 8(1.6%)
56-74 years 14 (0.7%) 16(1.5%)
75-84 years 3 (0.2%) 2(0.1%)
>84 years 1 (0.3%) 0 (0%)
Total 56(1.0%) 30 (0.8%)
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11.1.4 Second AM I as a proportion of all emergency medical
admissions
In 1990 hospitalisations for second AMI accounted for 0.9% of all emergency medical 
admissions in men and 0.7% of all emergency medical admissions in women. By 2000 
these figures had fallen to 0.3% and 0.2% in men and women respectively. Second AMI 
accounted for a higher proportion of medical admissions in men than in women and this 
sex difference remained relatively stable between 1990 and 2000.
Figure 30 Barchart showing admissions for second AMI as a proportion of ail 
emergency medical admissions in men and women 1990-2000
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11.2Discussion regarding burden of disease for second AMI
11.2.1 Population discharge rates for second AMI 1990-2000
In the cuiTent study population discharge rates for second AMI more than halved in men 
and women between 1990 and 2000. The relative reduction in second AMI hospitalisation 
rates were therefore greater than the changes obsei-ved for first AMI hospitalisation rates 
which declined by 28% in men and by 30% in women. Significant declines were observed 
in all age groups although the magnitude of these changes was slightly greater in younger 
compared to older individuals. The relative changes in hospitalisation rates within age 
gi'oups were similar in men and women. Although there are no studies that have examined 
temporal trends in population rates for second AMI, a number of studies have examined 
temporal trends in population rates for recurrent AMI. The literature surrounding temporal 
trends in incidence of recurrent AMI is not consistent in its findings. The ARIC Study 
showed reductions in recunent event rates in men and women although these trends only 
reached significance in men.^  ^ The Toulouse-Monica Study and NHANES Study reported 
declines only in men and in NHANES incidence rates of recurrent AMI increased in 
w o m e n . T h e  disagreement is therefore mainly centred around women. In the current 
study both men and women have experienced similar declines in the incidence of recurrent 
events. Recurrence rates should fall as a result of effective secondary prevention. It has 
been suggested that the less marked reductions in recurrent rates in women obseiwed in 
some studies may be due to either a lower level of secondary prevention in this group or 
more severe coronary disease in women than in In addition none of these
studies included individuals over the age of 74 years. Given that in the cunent study over 
70% of women hospitalised with a second AMI were aged 75 years and over, these studies 
aie likely to have excluded the majority of theii- target population making it difficult to 
generalise results to the general population. The lai'ger decline in numbers of second, 
compared to first, infarctions may reflect a greater benefit fi'om population-based 
secondary, compared to primary, prevention measures.
11.2.2 Length of stay and bed days in men and women
Median length of stay declined significantly in men and women between 1990 and 2000. 
Median length of stay was 8 days in men and women in 1990 and declined to 6 days in
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men and 7 days in women in 2000. The declines were very similar to those observed for 
first AMI. Median length of stay for second AMI was also similar to the length of stay 
observed for first AML This is perhaps surprising given that individuals hospitalised with 
a second AMI are on average older and more likely to have other comorbid conditions than 
individuals hospitalised with a first AMI. It may in part reflect a bias arising as a result o f 
the increased in-hospital case fatality that occurs in individuals hospitalised with a second 
AMI. This could offset an increased length of stay occurring in a smaller proportion of 
individuals resulting in a similar overall length of stay.
11.2.3 In-hospital revascularisation rates in men and women 1990- 
2000
In contrast to the declining incidence of second AMI there was a dramatic increase in the 
number of men and women undergoing a revascularisation procedure between 1990 and 
2000. In 1990 less than 1 % of men or women underwent revascularisation whilst in 2000 
this figure had increased to 4.5% in men and 3.7% in women. Most of this increase was 
accounted for by a rising rate of percutaneous angioplasty procedures. As with first AMI 
there was a strong age effect and revasculaiisation was more likely to be carried out in 
younger men and women than in older men and women. As discussed for first AMI these 
intervention rates are much lower than those reported by other studies. These findings are 
not felt to be representative of clinical practice and are thought to reflect deficiencies in the 
coding or the extraction of the data
11.2.4 Proportion of all emergency medical admissions
In 1990 hospitalisations for second AMI accounted for less than 1% of all emergency 
medical admissions. This figure was much lower than for first AMI which accounted for 
9% of all emergency medical admissions in men and 7% of all emergency medical 
admissions in women. By 2000 these figures had fallen in line with first AMI and 
accounted for only 0.3% of male emergency medical admissions and 0.2% of female 
emergency medical admissions. There are no other studies with which to compare these 
data.
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11.2.5 Summary
The incidence of first MI has fallen substantially in recent years in Scotland, as in most 
other industrialised countries and the current study confirms this ubiquitous trend. In 
addition, however, we have now shown that there has been an even more striking reduction 
in admissions for second infarctions, falling by nearly 60% in both men and women. 
Length o f stay has also declined and hence the burden of second AMI on the health service 
has fallen between 1990 and 2000. Revascularisation rates have however increased so that 
a smaller number of individuals are exerting a greater pressure on the health service.
2 8 6
12 SURVIVAL FOLLOWING ADMISSION TO HOSPITAL 
WITH A SECOND AMI
12.1Results of unadjusted survival analyses
This section describes the unadjusted case fatality of men and women hospitalised in 
Scotland with a second AML As for first AMI case fatality has been examined at 30 days, 
six months, one yeai’, two years and five years in men and women. Analyses have also 
been stratified according to age, socioeconomic deprivation, yeai* of admission and the 
presence of comorbid diagnoses. The aim is to provide detailed mortality data and to gain 
insight into the survival of men and women and the factors that affect survival before 
eaiTying out more sophisticated multivariate analyses.
12.1.1 Unadjusted case fatality from life tables
As for first AMI, the overall unadjusted case fatality rates were higher in women than in 
men at all of the time periods examined. In men the overall case fatality rates at 30 days, 
six months, one year, two years and five years were 22.4%, 30.2%, 35.1%, 41.4% and 
55.9% respectively. In women the equivalent rates were 27.7%, 37.6%, 43.2%, 51.1% and 
66.7%. These sex differences were all statistically significant. As for fii'st AMI, prognosis 
following a second AMI was worse in women than in men. Case fatality was also 
substantially higher than for first AMI, and this excess was most apparent in men and in 
the elderly. For example in men, case fatality following a first AMI was 16.3% in those 
aged <55 years and 39.0% in those aged >84 years. Case fatality rose to 22.4% and 55.9% 
respectively in men following their second AML
Table 97 Unadjusted case fatality rates in men and women following admission to 
hospital with a second AMI
CASE FATALn Y % (95%CI)
' /M EN : WOMEN
30 days 22.4 27.7
Six months 30.2 37.6
One year 35.1 43.2
Two years 41.4 51.1
Five years 55.9 66.7
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12.1.1.1 Age
30 day and six months case fatality
The effect of age on case fatality was powerful in men and in women. 30 day case fatality 
was 6.6% in men and 9.5% in women aged less than 55 years. It increased to 40.0% in 
men and 38.9% in women aged greater than 84 years (Table 98Table 97). By six months 
case fatality had risen to 10.0% in men and 12.5% in women aged <55 years (Table 99). 
There was an interaction between age and sex so that case fatality was greater in young 
women than in young men but less in older women than in older men at 30 days and six 
months. The effect of age on case fatality was slightly less marked than for first AMI, 
especially in the very elderly. In all but the very elderly, case fatality following a second 
AMI was significantly greater than case fatality following a first AMI, although this excess 
was more marked in younger age groups. For example, 30 day ease fatality in men aged 
<55 years was 3.7% following a fii'st AMI and 6.6% following a second AMI. In men 
aged >84 years however, the figures were 42.6% and 40.0% respectively.
One, two and five  years case fatality
By one year case fatality following a second AMI had increased to 35.1% in men and 
43.2% in women. Case fatality was therefore higher than the figures seen following a first 
AMI; 23.9% in men and 39.3% in women. The age sex interaction remained as age 
appeared to have a lesser effect in women than in men (Table lOOTable 100). At five years 
case fatality remained higher in women than in men in younger age groups, but was fairly 
equivocal in the older age groups. At five years, case fatality following a second AMI 
remained higher than case fatality following a first AMI. Again, the discrepancy was 
greater in younger age groups. In men aged < 55 years, case fatality was 26.6% following 
a second AMI and 11.5% following a first AMI, but in men aged >84 year the figures were 
87.8% and 85.8% respectively.
12.1.1.2 Socioeconomic deprivation 
30 day and six months case fatality
Socio-economic deprivation appeared to have a minimal effect on short-tei*m case fatality. 
As for fii'st AMI, there was a reverse socioeconomic gradient, more so in men, so that 
fatality was higher in the least deprived groups and lower in the most deprived categories. 
For example, 30 day case fatality was 24.8% in the least deprived category compared to
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21.2% ill the most deprived category. This gradient was not as apparent in women. The 
effect was not consistent however, and by six months this trend was less apparent. This 
was in contrast to fiist AMI where the reverse socioeconomic effect was greater in women 
than in men. Case fatality was higher in all categories in women than in men at 30 days 
and at six months.
One, two and five  years case fatality
Socio-economic deprivation had a similar effect in the longer term. Again, there was a 
reverse socioeconomic gradient that was stronger in men than in women, in whom the 
effect of socioeconomic deprivation was less consistent. For example, five year case 
fatality in men decreased fi*om 57.8% in the least deprived group to 55.1% in the most 
deprived group. In women, case fatality was higher in the least deprived category but 
similar in the remaining deprivation categories and there was no evidence of any 
significant differences or of trends.
12.1.1.3 Comorbidity
30 day and six months case fatality
As for first AMI, the effect of prior and concurrent diagnoses had a marked effect on case 
fatality at 30 days and six months. The presence of one or more diagnoses increased six 
month case fatality fiom 19.9% to 35.6% in men and fiom 29.4% to 41.0% in women. The 
greatest effects were seen with renal failure, respiratory disease, cerebrovascular disease, 
peripheral vascular disease and heart failure. For example, six month case fatality was 
58.1% in men and 59.4% in women with a coding for renal failure, compared to an overall 
rate of 30.2% in men and 37.6% in women. Heart failure was associated with a six month 
case fatality rate of 45.5% in men and 48,8% in women. There was no consistent sex 
effect as it varied according to diagnosis. The magnitude of effect of different comorbid 
diagnoses was similar for first and second AMI. Cancer however, had less of an effect on 
case fatality following a second AMI than it did following a first AMI. At 30 days 
following a second AMI, case fatality was 21.5% in men and 29.7% in women with a 
coding for cancer. Following a first AMI, the figures were 34.2% and 36.0% respectively. 
Again, hypertension had a small effect on case fatality which increased to 28.1% in men 
and 36.6% in women at six months. As for first AMI, none of the comorbidies coded 
appeared to have a protective effect and to reduce case fatality.
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One, two and five years case fatality
Similar patterns to those seen at 30 days and six months were seen at one, two and five 
years. Respiratory disease, renal failure, heart failure and cerebrovascular and peripheral 
vascular disease again caiTied the worst prognosis. 89.5% of men and women with renal 
failure and 78.1% of men and 82.6% of women with heart failure were dead within five 
years. The presence of any comorbid diagnosis significantly increased case fatality at five 
years. In men, five year case fatality was 65.3% with any comorbidity compared to 38.6% 
with none. The effect was not quite as marked in women; 73.2% compared to 51.0%. As 
for shorter temi case fatality, cancer had a lesser effect following a second AMI than it did 
following a first AMI, especially in men. Again, hypertension and coronary heart disease 
appeared to have the least effect on case fatality, especially in men. For example, men 
with a previous admission for coronary heart disease had a five year* case fatality of 58.1% 
compared to 66.6% in women.
12.1.1.4 Trends in unadjusted case fatality in men and women 
30 day and six months case fatality
Between 1990 and 2000, in men, case fatality following a second AMI fell fiom 24.0% to 
23.2%, a marginal decline of only 3.2%. In women, case fatality declined by 2.6%, falling 
fi'om 28,4% in 1990 to 27.6% in 2000 (Table 103). Larger declines were seen at six 
months, when case fatality declined by 7.2% in men and by 7.6% in women. These 
changes contrasted with those seen for first AMI. 30 day case fatality following a fii'st 
AMI declined by 19% in men and by 8% in women between 1990 and 2000.
One, two and five  years case fatality
At one year case fatality in men declined fiom 39.5% in 1990 to 35.3% in 2000, a decline 
of 10.7% (Table 104). In women one year- case fatality fell by 7.1%, fiom 43.7% to 
40.6%. These falls were comparable to those seen following a first AMI. At two years 
however, case fatality fell by 15.9% in men but remained stable in women. Five years case 
fatality fell by 8.6% in men, from 59.2% to 54.1% and by 10.6% in women, fiom 69.5% to 
65.4% (Table 105). The trends in longer term case fatality following a second AMI were 
therefore similar to those seen following a first AMI.
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Table 98 Unadjusted 30 day ease fatality rates in men and women following
admission to hospital with a second AMI
30 DAY CASE FATALITY (95%CI)
ME1\,:,:::^ ■ WOMEN
Overall 22.4 27.7
Age group
<55 6.6 (6.6-6.6) 9.5 (9.5-9.6)
55-64 13.0(12.9-13.0) 16.8(16.8-16.9)
65-74  ^ < 23.6 (23.5-23.6) 23.6 (23.5-23.6)
75-84 35.3 (35.3-35.3) 31.9 (31.9-31.9)
>84 40.0 (39.9-40.1) 38.9 (38.9-39.0)
Deprivation quin tile
Irleast deprived 24.8 (24.7-24.8) 29.2 (29.2-29.3)
2 23.6 (23.5-23.6) 27.4 (27.3-27.4)
23.4 (23.3-23.4) 27.5 (27.5-27.6)
4 v 19.8(19.7-19.8) 27.4 (27.4-27.4)
5-most deprived 21.2 (21.1-21.2) 27.1 (27.1-27.1)
Comorbidity
Any comorbidity 26,0 (26.0-26.0) 26.0 (26.0-26.0)
No comorbidity 15.6(15.6-15.7) 22.9 (22.9-22.9)
Diabetes 28.7 (28.7-28.8) 28.1 (28.0-28.1)
Cancer 21.5(21.5-21.5) 29.7 (29.7-29.8)
Respiratory disease 28.8 (28.8-28.9) 31.4 (31.4-31.4)
Cerebrovascular disease 32.1 (32.1-32.1) 34.5 (34.4-34.5)
Peripheral vascular 
disease 31.6 (31.5-31.6) 30.7 (30.7-30.8)
Atrial fibrillation 29.1 (29.0-29.1) 27.7 (27.7-27.7)
Hypertension 19.9 (19.8-19.9) 26.0 (25.9-26.0)
Renal failure - 42.3 (42.2-42.3) 43.7 (43.6-43.7)
Heart failure 32.5 (32.4-32.5) 35.0(35.0-35.1)
Coronary heart disease 21.1 (21.1-21.1) 27.3 (27.2-27.3)
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Table 99 Unadjusted six month case fatality rates in men and women following
admission to hospital with a second AMI
SIX MONTH CASE FAPALITY (?5%GI)
MEN ■ WOMEN
Overall 30.2 37.6
Age group
<55 10.0(10.0-10.0) 12.5 (12.5-12.5)
17.8(17.8-17.8) 21.8 (21.8-21.9)
65-74 31.5 (31.5-31.5) 31.7 (31.7-31.8)
75-84 46.7 (46.7-46.7) 44.4 (44.4-44.5)
>84 , ' 54.0 (53.9-54.0) 52.1 (52.1-52.2)
Deprivation quintile
1-least deprived 33.3 (33.3-33.4) 39.8 (39.8-39.9)
■2 ' 29.8 (29.8-29.9) 37.6 (37.6-37.6)
3 30.7(30.7-30.7) 35.6 (35.6-35.7)
4 28.7 (28.7-28.7) 38.1 (38.1-38.1)
5-most deprived 28.8 (28.8-28.8) 37.6 (37.5-37.6)
Comorbidity
Any comorbidity 35.6 (35.6-35.6) 41.0(41.0-41.0)
No comorbidity 19.9(19.9-19.9) 29.4 (29.3-29.4)
Diabetes 37.7 (37.6-37.7) 41.7(41.7-41.8)
Cancer 41.8(41.7-41.8) 43.3 (43.3-43.4)
Respiratory disease 41.4 (41.3-41.4) 43.6 (43.6-43.6)
Cerebrovascular disease 44.3 (44.2-44.3) 46.6 (46.6-46.7)
Peripheral vascular 
disease 42.5 (42.4-42.5) 44.2 (44.1-44.2)
Atrial fibrillation 42.6 (42.6-42.7) 44.4 (44.3-44.4)
Hypertension 28.1 (28.0-28.1) 36.6 (36.6-36.6)
Renal failure 58.1 (58.1-58.2) 59.4 (59.3-59.5)
Heart failure 45.5 (45.4-45.5) 48.8 (48.7-48.8)
Coronary heart disease 30.0 (29.9-30.0) 36.7 (36.7-36.7)
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Table 100 Unadjusted one year case fatality rates in men and women following
admission to hospital with a second AMI
ONE YEAR CASE FATALl l Y (95%C1)
. ; M EN : ; < ; WOMEN
Overall 35.1 43.2
Age group
<55, 12.3 (12.3-12.3) 15.5 (15.4-15.5)
55-64 21.0 (21.0-21.1) 25.5 (25.4-25.5)
65-74 36.7 (36.6-36.7) 37.0 (37.0-37.0)
75-84 53.1 (53.0-53.1) 50.5 (50.5-50.5)
>84 64.8 (64.7-64.8) 59.4 (59.3-59.4)
Deprivation quintile f
1-least deprived 37.4 (37.4-37.5) 46.1 (46.0-46.1)
7^ : 35.4 (35.4-35.4) 43.3 (43.3-43.3)
36.3 (36.3-36.3) 40.8 (40.8-40.8)
4 33.3 (33.3-33.3) 44.0 (44.0-44.1)
5-most deprived 33.3 (33.3-33.3) 42.4 (42.4-42.4)
Comorbidity
Any comorbidity 41.6(41.6-41.6) 47.1 (47.1-47.2)
No comorbidity 22.7 (22.6-22.7) 33.4 (33.4-33.4)
Diabetes 44.8 (44.8-44.8) 49.7 (49.7-49.8)
Cancer 33.4 (33.3-33.4) 50.9 (50.8-50.9)
Respiratory disease 49.0 (49.0-49.1) 52.3 (52.3-52.4)
Cerebrovascular disease 52.5 (52.4-52.5) 52.1 (52.0-52.1)
Peripheral vascular 
disease 51.1 (51.1-51.2) 49.8 (49.2-50.4)
Atrial fibrillation 51.4 (51.3-51.4) 51.0 (50.6-51.5)
Hypertension 33.8 (33.8-33.9) 45.0 (44.9-45.0)
Renal failure 66.0 (66.0-66.1) 67.5 (67.4-67.6)
Heart failure 52.9 (52.8-52.9) 55.2 (55.0-55.5)
Coronary heart disease 34.5 (34.5-34.5) 42.8 (42.8-42.9)
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Table 101 Unadjusted two years case fatality rates in men and women following
admission to hospital with a second AMI
TWO YEAR CASE FATALITY (95%CI)
MEN WOMEN
Overall 41.4 51.1
Age group
<55 ; 15.8(15,8-15.8) 19.3 (19.2-19.3)
55-64 26.9 (26.9-26.9) 31.1 (31.1-31.2)
65-74 42.9 (42.9-42.9) 43.6 (43.6-43.6)
46.7 (46.7-46.7) 59.2 (59.2-59.2)
>84 54.0 (53.9-54.0) 70.6 (70.5-70.6)
Deprivation quintile
1-least deprived 43.3 (43.2-43.3) 53.4 (53.4-53.4)
41.5 (41.5-41.5) 52.3 (52.3-52.4)
3 42.8 (42.8-42.8) 48.9 (48.9-49.0)
4 " 40.2 (40.1-40.2) 50.8 (50.7-50.8)
5-most deprived 39.3 (39.3-39.4) 50.8 (50.8-50.9)
Comorbidity
Any comorbidity 49.0 (49.0-49.0) 53.4 (53.4-53.4)
No comorbidity 27.0 (27.0-27.0) 38.3 (38.3-38.3)
Diabetes 52.5 (52.4-52.5) 65.4 (65.3-65.4)
Cancer 56.4 (56.3-56.4) 50.8 (50.8-50.9)
Respiratory disease 56.0 (55.9-56.0) 56.3 (56.2-56.3)
Cerebrovascular disease 59.6 (59.5-59.6) 38.3 (38.3-38.3)
Peripheral vascular disease 59.1 (59.1-59.2) 60.0(59.9-60.1)
Atrial fibrillation 59.3 (59.3-59.4) 68.4 (68.3-68.4)
Hypertension 41.6(41.6-41.7) 63.80 (63.7-63.8)
Renal failure 73.9 (73.8-73.9) 59.2 (59.1-59.2)
Heart failure 61.2(61.2-61.2) 59.9 (59.8-59.9)
Coronary heart disease 42.3 (42.3-42.3) 61.9(61.9-62.0)
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Table 102 Unadjusted five years case fatality rates in men and women following
admission to hospital with a second AMI
FIVE YEAR c a s e  FATALITY (95%CI)
. WOMEN7^
Overall 55.9 66.7
Age group
<55 26.6 (26.6-26.6) 31.1 (31.0-31.1)
55-64 38.9 (38.9-38.9) 43.4 (43.3-43.4)
65-74 58.7 (58.7-58.7) 58.1 (58.1-58.2)
75-84 79.2 (79.2-79.3) 77.0 (76.9-77.0)
>84 87.8 (87.8-87.9) 88.2 (88.1-88.2)
Deprivation quintile
1-least deprived 57.8 (57.8-57.9) 71.1 (71.0-71.1)
2 . 56.6 (56.6-56.7) 66.7 (66.6-66,7)
3 . ■ 55.8 (55.7-55.8) 64.5 (64.4-64.5)
4 55.1 (55.0-55.1) 65.8 (65.7-65.8)
5-most deprived 55.1 (55.0-55.1) 67.0 (66.9-67.0)
Comorbidity
Any comorbidity 65.3 (65.3-65.3) 73.2 (73.2-73.3)
No comorbidity 38.6 (38.6-38.6) 51.0 (51.0-51.0)
Diabetes 69.6 (69.6-69.7) 77.4 (77.4-77.5)
Cancer 53.7 (53.7-53.7) 81.7 (81.6-81.7)
Respiratory disease 73.4 (73.3-73.4) 80.3 (80.3-80.4)
Cerebrovascular disease 76.8 (76.8-76.8) 78.0 (78.0-78.1)
Peripheral vascular 
disease 74.9 (74.9-74.9) 78.1 (77.6-78.6)
Atrial fibrillation 75.6 (75.6-75.7) 79.1 (79.1-79.1)
HypeWension. 55.8 (55.7-55.8) 73.4 (73.4-73.5)
Renal failure 89.5 (89.5-89.5) 89.5 (89.4-89.5)
Heart failure 78.1 (78.0-78.1) 82.6 (82.6-82.7)
Coronary heart disease 58.1 (58.0-58.1) 66.6 (66.6-66.6)
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Table 103 Trends in unadjusted 30 day and six months case fatality rates in men and
women following admission to hospital with a second AMI
30 DAY CASE FATALITY % SIX MONTHS CASE FATALITY 
%
MEN WOMEN MEN WOMEN
1990 24.0 (23.9-24.0) 28.4 (28.3-28.4) 33.9 (33.9-34.0) 38.9 (38.9-38.9)
1991 25.8 (25.7-25.8) 29.0 (28.9-29.0) 33.9 (33.9-33.9) 37.9 (37.9-38.0)
1992 23.3 (23.2-23.3) 29,5 (29.4-29.5) 29.0 (28.9-29.0) 42.3 (42.3-42.4)
1993 22.7 (22.6-22.7) 27.1 (27.1-27.1) 30.7 (30.7-30.7) 36.5 (36.4-36.5)
1994 19.6(19.6-19.7) 27.2 (27.2-27.3) 26.6 (26.6-26.7) 39.1 (39.1-39.2)
1995 19.5 (19.4-19.5) 24.9 (24.9-25.0) 28.1 (28.1-28.1) 34.8 (34.7-34.8)
1996 22.3 (22.3-22.4) 25.3 (25.3-25.4) 31.0 (30.9-31.0) 35.6 (35.5-35.6)
1997 20.4 (20.4-20.4) 29.7 (29.7-29.8) 28.3 (28.3-28.4) 36.0 (35.9-36.0)
1998 22.3 (22.3-22.4) 27.4 (27.4-27.5) 29.1 (29.0-29.1) 37.1 (37.0-37.2)
1999 24.9 (24.9-25.0) 27.6 (27.6-27.7) 28.9 (28.9-29.0) 35.6 (35.5-35.6)
2000 23.2 (23.1-23.2) 27.6 (27.5-27.7) 31.5 (31.4-31.5) 35.9(35.5-35.6)
Crude % 
change
"3.2 "2.6 "7.2 "7.6
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Table 104 Trends in unadjusted one year and two year case fatality rates in men and
women following admission to hospital with a second AMI 1990-2000
ONE YEAR CASE FATALITY % TWO YEARS CASE FATALITY 
%
MEN WOMEN MEN WOMEN
1990 39.5 (39.5-39.6) 43.7 (43.7-43.8) 45.7 (45.7-45.8) 52.8 (52.7-52.8)
1991 38.5 (38.5-38.6) 44.0 (43.9-44.0) 45.2 (45.2-45.3) 52.7 (52.7-52.8)
1992 33.9 (33.9-34.0) 48.3 (47.9-48.8) 42.5 (42.5-42.5) 57.5 (57.4-57.5)
1993 35.5 (35.4-35.5) 41.4(41.3-41.4) 41.7 (41.7-41.8) 47.0(47.0-47.1)
1994 32.3 (32.2-32.3) 44.9 (44.8-44.9) 38.4 (38.4-38.5) 53.0 (52.9-53.0)
1995 32.8 (32.8-32.8) 40.9 (40.8-40.9) 38.6 (40.2-40.3) 47.5 (47.4-47.5)
1996 34.1 (34.1-34.2) 41.4(41,3-41.4) 40.2 (40.2-40.3) 47.8 (47.7-47.8)
1997 32.2 (32.2-32.2) 41.8(41.8-41.9) 38.8 (38.4-38.5) 47.7 (47.6-47.8)
1998 35.6 (35.6-35.6) 42.7 (42.7-42.8) 40.3 (40.2-40.3) 50.8 (50.7-50.9)
1999 32.9 (32.9-33.0) 40.6 (40.5-40.7) 38.5 (38.4-38.5) 52.7 (52.7-52.8)
2000 35.3 (35.2-35.3) 40.6 (40.6-40.7)
% change “ 10.7 "7.1 " 15.9 "0.1
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Table 105 Trends in unadjusted five year case fatality rates in men and women
following admission to hospital with a second AMI 1990-2000
FIVE YEARS CASE f a t a l it y  %
MEN WOMEN
1990 59.2 (59.1-59.2) 69.5 (69.4-69.5)
1991 59.2 (59.2-59.3) 68.3 (68.3-68.4)
1992 57.2 (57.2-57.2) 72.2 (72.2-72.2)
1993 56.8 (56.7-56.8) 66.5 (66.5-66.5)
1994 54.7 (54.7-54.8) 68.5 (68.5-68.5)
1995 54.1(54.0-54.1) 62.1 (62.0-62.1)
1996 54.1 (54.1-54.2) 65.4 (65.4-65.5)
Crude % change "8.6 ~ 10.6
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12.1.2 Kaplan-M eier Survival Curves and median survival time
12.1.2.1 O v e ra ll
The Kaplan Meier survival curve for men and women showed an initial sharp drop in 
survival followed by a progressive decline in cumulative survival in both men and women 
(Figure 31). Survival was consistently higher in men and this difference was statistically 
significant (p<0.001). The results o f the log rank tests are shown in Table 108. Median 
survival times for men and women are shown in Table 106 and in Table 107. Median 
survival following a second AMI was 3.6 years in men and 1.8 years in women. This 
compared to a median survival following a first AMI of 8.8 years in men and 4.3 years in 
women.
12.1.2.2 Age
Figure 31 shows the Kaplan Merer survival curves for men and women in different age 
groups. As demonstrated in the life tables, age had a powerful effect on prognosis. 
Median survival was greater than 10 years in both inerr and women aged <55 years, but 
decreased to 0.3 years in men and 0.4 years in women aged >84 years. Prognosis was 
better for men than for women up to the age o f 65 years, after which prognosis was better 
in women than in men. The interaction seen in the life table analyses was therefore evident 
in median survival and in the Kaplan Meier Suivival Curves. In the longer tenn and 
especially in older age groups, prognosis appeared similar in men and women. The effect 
o f sex on prognosis therefore seemed to change as survival time increased. Overall the 
survival cuives were not significantly different in men and women in any o f the age 
groups.
12.1.2.3 Soc io-econom ic d ep r iv a tio n
Figure 32 shows Kaplan Meier survival curves in men and women within deprivation 
categories. The effect of sex on survival was similar in each o f the deprivation categories. 
Survival was significantly worse in women in all groups (p<0.001). In men, median 
suivival was shorter in the least deprived category (3.2 years) when compared to other 
deprivation groups (3.7 years in most deprived group). There was little variation in median 
suivival in the other categories. In women, median survival was significantly longer in the 
most deprived categoiy (1.9 years) when compared to the least deprived categoiy (1.4 
years).
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Figure 31 Survival by sex for all ages and by age group for second AMI
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Kaplan Meier Survival Curve, age 55-64 years in
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Kaplan Meier Survival Curve, age 75-84 years In
men and women
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Figure 32 Survival by sex within deprivation categories for second AMI
Kaplan Meier Survival Curve, least deprived 
category in men and women
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Kaplan Meier Survival Curve, deprivation category
3 in men and women
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Table 106 Median survival time in years in men and women following a second AMI
M E D IA N  SU R V IV A L IN  Y E A R S (95%  C l)
M E N : : W O M E N
Overall 3.6 (3.3-3.S) 1.8(1.6-2.0)
Age group
<55 >10 11.6 (no Cl)
55-64 8.6 (7.6-9.6) 7.6 (5.8-9.4)
65-74 3.1 (2.7-3.5) 3.1 (2.5-3.6)
75-84 0.7 (Q.5-0.9) 0.9 (0.7-1.2)
>84 0.3 (0.1-0.5) 0.4 (0.2-0.6)
Deprivation quintile
1-least dep riv ed 3.2 (2.S-3.9) 1.4 (0.9-2.0)
2 3.4 (2.8-4.1) 1.7(1.2-2.2)
3.7(3.1-4.4) 2.2(1.7-2.7)
4 3.7 (3.1-4.3) 1.9(1.3-2.4)
5-m ost dep riv ed 3.7 (3.1-4.4) 1.9 (1.5-2.4)
Comorbidity
A ny com orb id ity 2.1 (1.9-2.4) 1.3 (1.1-1.5)
No com orb id ity 8.1 (7.4-8,7) 4.7 (3.9-5.Ô)
D iabetes 1.5 (0.8-2.0) 1.1 (0.7-1.4)
C an c e r 1.1 (0.8-1.4) 0.9(0.6-1.3)
R e sp ira to ry  d isease 1.1 (0.7-1.6) 0.8 (0.5-1.1)
C e re b ro v a sc u la r  d isease 0.8 (0.5-1.1) 0.8 (0.4-1.3)
P e r ip h e r a l  v a scu la r  d isease 0.9 (0.6-1.2) 1.0 (0.4-1.6)
A tr ia l  fib r illa tio n 0.9(0.6-1.2) 0.9 (0.6-1.2)
H y p erten s io n 3.7 (2.S-4.5) 1.5 (1.0-2.0)
R e n a l fa ilu re 0.2 (0.1-0.3) 0.2(0.1-0.3)
H e a r t  fa ilu re 0.8 (0.6-0.9) 0.6 (0.4-0.7)
C o ro n a ry  h e a f t  d isease 3.3 (2.7-3.8) 1.9(1.4-2.3)
306
Table 107 Trends in median survival time in years in men and women following a
second AMI
M E D IA N  SU R V IV A L IN  Y E A R S (95%  C l)
M E N W O M E N
1990 2.9 (2.1-3.6) 1.7(1.2-2.2)
1991 2.8 (2.0-3.5) 1.7 (1.2-2.2)
1992 3.4 (2.7-4.2) 1.1 (0.7-1.6)
1993 3.4 (2.6-7.0) 2.5 (1.7-3.2)
1994 4.2 (3.5-4.9) 1.5 (0.9-2.2)
1995 3.9 (2.9-4.S) 2.3 (1.4-3.2)
1996 4.0(2.9-5.1) 2.3 (1.4-3.2)
1997 4.1 No Cl 2.7 (1.0-4.3)
1998 >3 1.9 (1.2-2.7)
1999 >2 1.7 (1.2-2.3)
2000 >1 >1
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Table 108 Results of log rank tests from Kaplan Meier Survival comparing men and
women with a second AMI
LOG RANK TEST^ P-VALUE
Sex P<0.001
Age group
<55 P=0.2157
55-64 P^O.2361
65-74 P=^0.3495
75-84 P^O.0879
>84 P=0.4719
Deprivation quintile
1-least deprived P<0.001
2 P<0.001
3 P=0.0001
4 P<0,001
5-most deprived P<0.001
Comorbidity
Any comorbidity P<0.001
No comorbidity P<0.001
Diabetes P=0.0015
Cancer P-0.0447
Respiratory disease P-0.0075
Cerebrovascular disease P==0.6718
Peripheral vascular disease P=0,5465
Atrial fibrillation P=0.5166
Hypertension P<0.001
Renal failure P^O.7931
Heart failure P=0.0061
Coronary heart disease P<0.001
Continued over,
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Table 109 continued
LOG RANK TEST, P-VALUE
1990 P-0.0004
1991 P=0.0014
1992 P<0.001
1993 P=0.046
1994 P<0.001
1995 P-0.0028
1996 P-0.0029
1997 P=0,0720
1998 P=0.0041
1999 P-0.0007
2000 P=0.2313
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12.1.2.4 C om orb id ity
The presence o f any comorbid diagnosis substantially reduced median survival in men and 
women followmg a second AML Median survival was 8.1 years in men and 4.7 years in 
women who had no comorbid diagnosis but only 2.1 years in men and 1.3 year's in women 
who had one or more comorbid diagnoses. Each of the comorbid diagnoses appeared to 
substantially reduce median survival. Kaplan Meier Survival Curves are shown in Figure 
33. As seen in the life table analyses, the strongest effects were with renal failure, heart 
failure, cerebrovascular and peripheral vascular disease. Survival with any of these 
diagnoses was not significantly different between men and women. Sex differences in 
overall survival were significant with some o f the comorbid diagnoses that appeared to 
have a lesser effect on survival. For example, hypertension and coronary heart disease 
(p<0.001). The effect of sex did not always remain constant over time so that with a 
cancer diagnosis, short term survival appeared similar and men and women, whilst middle 
and longer term survival were worse in women.
12.1.2.5 T ren d s  in  m ed ian  su rv iv a l follow ing a second A M I
Median survival increased in men from 2.9 years in 1990 to 4.2 years in 1994, after which 
it then started to decline. A similar pattern was seen in women in whom median survival 
increased from 1.7 years in 1990 to 2.5 years in 1993, after which it declined reaching 1.7 
years in 1999. Sex differences were not consistent and overall survival was not always 
significantly different in men and women.
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Figure 33 Kaplan Meier Survival Curves by sex within comorbid diagnoses
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12.2 Results of adjusted survival analyses
The aim o f this section is to examine the independent effect o f sex on short and longer 
tenn survival following hospitalisation with a second AML Men and women differ in their 
baseline characteristics such as age and comorbid diagnoses and in order to determine 
whether sex has an independent effect, these varying distributions need to be accounted for 
using multivariate modelling techniques. The analyses also aim to examine and to quantify 
the independent effect o f other factors such as age and comorbid diagnoses on the risk o f 
death in men and women at different time periods.
12.2.1 Logistic regression at 30 days in men and women following a 
second AMI
12.2.1.1 O v era ll
Table 109 shows the effect o f other factors on sex as a predictor o f prognosis at 30 days 
following a second AMI. The model started with sex and added other variables, in order o f 
decreasing significance. Without adjusting for any factors, women’s odds o f death at 30 
days were 33% greater than for men. This sex difference was less than that seen for first 
AMI, where women’s odds o f  death at 30 days were 77% greater than for men. 
Accounting for age differences between men and women removed almost all o f  this sex 
difference so that women’s odds o f death were 2% less than that o f men. This difference 
was not statistically significant. Addition o f  other variables into the model slightly altered 
the sex difference in the odds o f dying at 30 days, although sex continued to be non­
significant and was not therefore a significant predictor o f outcome at 30 days. The final 
model excluded yeai' of admission, deprivation category, cancer, resphatoiy disease and 
previous coronary heart disease, none o f which were significant predictors o f outcome at 
30 days. After all the variables had been included in the model, women had a non­
significant sui-vival advantage o f 2% in the odds o f death at 30 days. These findings 
contrast with first AMI where women’s odds o f death at 30 days were 20% greater than for 
men and all variables remained significant predictors o f outcome and were retained in the 
final model. An age sex interaction term was tested but was non-significant, p=0.155.
Table 110 shows the logistic regression models earned out in men and women separately. 
Age was the most powerful predictor of outcome at 30 days and, as for first AMI, appeared
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to have a stronger effect in men than in women. Men aged 85 yeais and over had a seven 
fold increase in the risk o f death when compared to men aged < 55 years (odds ratio 7.63, 
95%CI 5.27-11.05). In women the equivalent odds ratio was 6.43 (95% Cl 3.59-11.51). 
The effect o f age was not therefore as marked as for first AMI, following which men aged 
85 years and over had a 15 fold increase in the risk o f death when compared to men aged 
<55 years. Socioeconomic deprivation was not a significant predictor o f outcome at 30 
days in men or in women. Again this was in contrast to first AMI where socioeconomic 
deprivation was a significant predictor o f outcome in men and in women and appeared to 
have a more marked effect on the odds o f death in men than in women. In general, the 
effect o f comorbid conditions on the risk of death at 30 days following a second AMI was 
less than that seen following a first AMI. For example a diagnosis o f cancer caiTied an 
11% increase in the odds o f death in men following a second AMI and a 63% increase in 
the odds o f death in men following a first AMI. As for first AMI, heart failure and renal 
failure had the strongest effect on outcome in men and in women. Previous coronary heart 
disease was not a significant predictor o f 30 day outcome in men or in women. Atrial 
fibrillation and hypertension both decreased the odds o f death at 30 days. Atrial 
fibrillation was associated a 24% reduction in the odds o f death in women. The effect o f 
atrial fibrillation did not reach significance in men. In contrast, hypertension reduced the 
risk o f death by 28% in men and 16% in women, though this effect was only significant in 
men. The adjusted odds o f death at 30 days decreased in men and women between 1990 
and 2000, although these changes were not significant.
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T ab le  109 E ffect on sex o f stepw ise  a d d itio n  o f o th e r  s ign ifican t v a riab les  in  log istic 
reg ress ion  a t  30 days
S T E P V A R IA B L E  IN  M O D E L OD DS R A T IO  (95% C I)
M E N ■ . W O M E N
E n te r Sex 1.00 1.33 (1.21-1.46)
1 + age g roup 1.00 0.98 (0.89-1.08)
2 + h e a r t  fa ilu re 1.00 0.96 (0.87-1.06)
3 + re n a l  fa ilu re 1.00 0.97 (0.87-1.07)
4 + tim e since p rev ious A M I 1.00 0.95 (0.86-1.05)
+ ce reb ro v asc u la r  d isease 1.00 0.96 (0.87-1.07)
6 + h y p erten s io n 1.00 0.97 (0.88-1.08)
7 t  d iabetes 1.00 0.97 (0.88-1.07)
8 + atirial f ib r illa tio n 1.00 0.97 (0.88-1.07)
9 + p e r ip h e ra l v a scu la r  
d isease
1.00 0.98 (0.88-1.08)
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Table 110 Adjusted odds of death at 30 days in men and women admitted to hospital
following a second AMI
ODDS RATIO (95% Cl)
m e n W OMEN
Sex 1.00 0.98 (0.88-1.08)
Age group
<55 1.00 1.00
55-64 1.85 (1.34-2.55) 2.22 (1.22-4.04)
65-74 3.57 (2.63-4.83) 3.27 (1.85-5.78)
75-84 5.93 (4.36-8.07) 4.81 (2.74-8.46)
>84 7.63 (5.27-11.05) 6.43 (3.59-11.51)
Depr^ation quintile
1-least deprived 1.00 1.00
2 1.01 (0.81-1.26) 0.95 (0.74-1.22)
3 1.12(0.90-1.38) 1.01 (0.79-1.22)
4 0.94 (0.76-1.17) 1.01 (0.80-1.29)
5-most deprived 1.01 (0.81-1.27) 1.00 (0.78-1.27)
Comorbidity
Diabetes 1.41 (1.16-1.71) 1.02 (0.83-1.27)
Cancer 1.11 (0.91-1.36) 1.03 (0.80-1.31)
Resp iratory disease 1.10(0.91-1.33) 1.07 (0.86-1.33)
Cerebrovascular disease 1.36(1.12-1.65) 1.49(1.18-1.89)
Peripheral vascular 
disease 1.30 (1.05-1.62) 1.04 (0.79-1.36)
A trial fibrillation 0.98 (0.79-1.22) 0.76 (0.60-0.95)
Hypertension 0.72 (0.58-0.89) 0.84 (0.68-1.04)
Renal failure 1.83 (1.39-2.41) 1.84(1.35-2.51)
H eart failure 1.56 (1.35-1.80) 1,52(1.30-1.77)
Coronary heart disease 0.93 (0.80-1.09) 0.99 (0.83-1.18)
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Table 111 Trends in adjusted odds of death at 30 days in men and women admitted to
hospital following a second AMI
OD D S R A T IO  (95%  C l)
M E N W O M E N
Year o f  admission
1990 1.00 1.00
1991 1.14(0.88-1.48) 1.00 (0.75-1.35)
1992 0.94 (0.72-1.23) 1.01 (0.75-1.35)
1993 0.88 (0.67-1.15) 0.91 (0.67-12.4)
1994 0.75 (0.57-1.00) 0.92 (0.68-1.25)
1995 0.76 (0.56-1.01) 0.78 (0.56-1.08)
1996 0.87 (0.65-1.18) 0.84 (0.59-1.18)
1997 0.75 (0.55-1.03) 1.04 (0.72-1.49)
1998 0.80 (0.58-1.10) 0.89 (0.62-1.28)
1999 0.72 (0.51-1.01) 0.83 (0.57-1.20)
2000 0.79 (0.55-1.12) 0.83 (0.56-1.23)
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12.2.1.2 L og istic  reg ress ion  a t  30 days follow ing a second A M I age <65 years
After adjusting for other factors, sex was not a significant predictor o f outcome at 30 days 
in individuals aged less than 65 years hospitalised following a second AMI, p=0.17 (Table 
112). This was in contrast to 30 day survival following a first AMI, in which women had a 
29% mcrease in the odds o f death after adjusting for other factors. Socioeconomic 
deprivation was not a significant predictor o f outcome in men or women in this age group. 
However, in women the odds o f death was greatest in the least deprived category 
compared to the other categories, and was significantly less in deprivation categoiy two 
than in the least deprived group. This again was in contrast to outcome following a first 
AMI, where socioeconomic deprivation had the strongest effect in the younger age group. 
The presence o f comorbid conditions had a more marked effect on 30 day survival in this 
younger age group, than in the whole cohort, however the effect o f a number o f these 
diagnoses was not significant. A diagnosis o f diabetes increased the odds o f death by 97% 
in men, p=0.001. Women with renal failure were more than six times likely to die at 30 
days (odds ratio in women 46.41 95%CI 2.09-19.61). Hypertension had a protective effect 
but only in women in whom the odds o f dying were 0.43 (0.19-0.96). Time since first 
AMI was a significant predictor o f outcome but only in men in whom the odds o f death at 
30 days decreased by 6% for each additional year since the first AMI (p=0.015). Odds o f 
dying at 30 days showed no consistent trend over time in men or in women, although year 
o f admission was a significant predictor o f outcome at 30 days in both sexes (p=0.033 in 
men p=0.014 in women). This contrasted with first AMI in which the odds o f death fell by 
59% in men and 47% in women in this younger age group.
12.2.1.3 Log istic  reg ress ion  a t  30 days follow ing a second A M I age 65-74 years
Sex remained a non-significant predictor o f outcome in this age group (Table 114). This 
contrasted to first AMI in which women had a 13% increase in the odds o f death at 30 days 
when compared to men o f a similar age. Socio-economic deprivation did not have a 
significant effect on outcome in this age group in men or in women. The effect o f 
comorbid diagnoses differed according to the natur e o f the diagnosis and sex and fewer o f 
the diagnoses had a significant effect on outcome than demonstrated in survival followmg 
first AMI. The only diagnoses in men that were significant predictors o f outcome at 30 
days were heart failure, renal failure, cerebrovascular disease, hypertension and diabetes. 
As in the younger age group, heart failure and renal failure continued to have the strongest 
effects, for example men with a diagnosis o f heart failure had a 70% increase in the odds o f 
death at 30 days, whilst in women the risk was increased more than two-fold. In women,
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heart failure was the only diagnosis that canied a significantly increased risk in the odds o f 
death. Hypertension had a protective effect and lowered the odds o f death by 40%, but 
only in men. Time since previous AMI had a similar effect as seen in the younger age 
group, with a 5% reduction in the odds o f death at 30 days for each additional year since 
the first AMI. Again this was only significant in men, p=0.006. Year o f admission was 
not a significant predictor o f outcome in men or women at 30 days following a second 
AMI (Table 115).
12.2.1.4 Log istic reg ress ion  a t  30 days follow ing a second A M I age >74 years
Sex continued to be a non-significant predictor o f outcome at 30 days in this older age 
group (Table 116). Again this contrasts with first AMI where women had a 12% increase 
in the odds o f death at 30 days. Socio-economic deprivation did not have a significant 
effect on outcome in men or in women in this older age group and this was similar to the 
effect seen following a first AMI. In general the presence o f comorbid conditions had a 
lesser effect on the odds o f death in this older age group than in the two younger groups. 
Only heart failure, renal failure and atrial fibrillation had a significant effect on outcome in 
men and in women. For example, heart failure increased the odds o f death by 34% in men 
aged greater than 74 years and by 22% in women aged >74 years. In women, 
cerebrovascular disease also increased the odds o f death, by 41%. Atrial fibrillation had a 
protective effect and lowered the odds o f death at 30 days in men and women, by 29% in 
men and by 25% in women. Year if admission was not a significant predictor o f outcome 
in men or in women (Table 117).
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Table 112 Adjusted odds of death at 30 days in men and women aged < 65 years
admitted to hospital following a second AMI 1990-2000
ODDS RATIO (95% Cl)
, MEN ' W O M E N .
Sex 1.00 1.21 (0.92-1.59)
Deprivation quintile
1-least deprived 1.00 1.00
■2 1.46(1.46-0.83) 0.26 (0.09-0.71)
3 1.35 (0.78-2.33) 0.65 (0.29-1.49)
. .1 :'/ 1.08 (0.62-1.86) 0.61 (0.27-1.37)
5-most deprived 1.39 (0.80-2.40) 0.52 (0.24-1.15)
Comorbidity
Diabetes 1.97 (1.34-1.88) 1.42 (0.75-2.70)
Cancer 1.00 (0.58-1.74) 0.73 (0.31-1.70)
Resp iratory disease 1.34 (0.83-2.14) 0.99 (0.43-2.27)
Cerebrovascular disease 1.21 (0.73-1.99) 1.77 (0.89-3.54)
Peripheral vascular disease 1.67 (0.97-2.88) 1.36(0.50-3.70)
A trial fibrillation 1.33 (0.73-2.44) 0.80 (0.29-2.19)
Hypertension 1.06 (0.69-1.63) 0.43 (0.19-0.96)
Renal failure 2.06 (1.00-4.23) 6.41 (2.09-19.61)
H eart failure 2.06(1.31-2.59) 2.44(1.41-4.21)
Coronary heart disease 0.94 (0.68-1.30) 1.63 (0.97-2.74)
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Table 113 Trends in adjusted odds of death at 30 days in men and women aged <65
years admitted to hospital following a second AMI
OD DS R A T IO  (95%  C l)
A . . . m e n ; . : , W O M E N
Year o f  admission
1990 1.00 1.00
1991 1.78 91.04-3.05) 1.90 (0.82-4.40)
1992 1.41 (0.79-2.51) 1.04 (0.42-2.55)
1993 1.02 (0.57-1.83) 0.90 (0.33-2.44)
1994 0.81 (0.42-1.57) 2.90(1.25-6.71)
1995 0.63 (0.32-1.25) 0.34 (0.08-1.41)
1996 0.85 (0.43-1.69) 1.19(0.43-3.28)
1997 1.40 (0.74-2.67) 0.55 (0.14-2.19)
1998 0.79 (0.37-1.72) 0.54 (0.13-2.25)
1999 0.70 (0.28-1.72) 0.23 (0.03-1.93)
2000 1.36(0.66-2.81) 1.40 (0.39-5.10)
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Table 114 Adjusted odds of death at 30 days in men and women aged 65-74 years
admitted to hospital following a second AMI 1990-2000
ODDS RATIO X95% Cl)
; MEN \ ■ WOMEN
Sex 1.00 0.96 (0.80-1.15)
Deprivation quintile
1-least deprived 1.00 1.00
2 - 0.89 (0.61-1.29) 1.41 (0.83-2.42)
3 1.01 (0.71-1.44) 1.23 (0.73-2.06)
4 0.71 (0.49-1.02) 1.39 (0.84-2.30)
5-most deprived 0.86 (0.59-1.26) 1.67(1.01-2.77)
Comorbidity
D iabetes 1.52 (1.12-2.07) 0.90 (0.60-1.34)
Cancer 1.07 (0.76-1.49) 1.03 (0.64-1.65)
Resp iratory disease 0.90 (0.64-1.24) 1.07 (0.70-1.64)
Cerebrovascular disease 1.72 (1.27-2.32) 1.30 (0.82-2.06)
Peripheral vascular disease 1.20 (0.83-1.74) 1.15(0.65-2.01)
A trial fibrillation 1.30 (0.92-1.85) 0.76 (0.47-1.24)
Hypertension 0.60 (0.41-0.88) 1.12(0.75-1.68)
Renal failure 1.96(1.19-3.21) 1.78 (0.92-3.44)
H eart failure 1.70(1.34-2.16) 2.02 (1.48-2.75)
Coronary heart disease 0.92 (0.71-1.19) 0.92 (0.65-1.30)
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Table 115 Trends
years admitted to
in adjusted odds of death at 30 days in men and women aged 65-74
hospital following a second AMI
ODDS R A T IO  (95%  C l)
M E N  . W O M E N
Year o f  admission
1990 1.00 1.00
1991 0.96 (0.62-1.48) 0.89 (0.52-1.54)
1992 0.76 (0.49-1.19) 0.95 (0.54-1.67)
1993 0.91 (0.58-1.43) 0.75 (0.42-1.35)
1994 0.57 (0.35-0.92) 0.44 (0.24-0.84)
1995 0.77 (0.48-1.24) 0.53 (0.28-1.00)
1996 0.75 (0.46-1.22) 0.96 (0.50-1.84)
1997 0.51 (0.29-0.91) 0.95 (0.46-1.96)
1998 0.55 (0.31-0.97) 0.46 (0.21-0.97)
1999 0.70 (0.39-1.25) 0.61 (0.29-1.30)
2000 0.85 (0.47-1.56) 0.58 (0.24-1.37)
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Table 116 Adjusted odds of death at 30 days in men and women aged >74 years
admitted to hospital following a second AMI 1990-2000
OD DS R A T IO  (95%  C l)
W O M E N
Sex LOO 0.88 (0.77-1.07)
Deprivation quintile
1-least dep riv ed LOO 1.00
2 V. /A.  . 0.95 (0.70-1.31) 0.94 (0.69-1.26)
3 1.09 (0.80-1.50) 0.99 (0.74-1.33)
1.17 (0.84-1,61) 1.01 (0.75-1.36)
5-m ost dep rived 1.04 (0.74-1.45) 0.88 (0.65-1.19)
Comorbidity
D iabetes 1.01 (0.73-1.41) 0.97 (0.73-1.29)
C an ce r 1.15 (0.86-1.54) 1.08 (0.78-1.47)
R e sp ira to ry  d isease 1.16 (0.88-1.54) 1.08 (0.82-1.41)
C e re b ro v a sc u la r  d isease 1.14 (0.85-1.53) 1.41 (1.04-1.93)
P e r ip h e ra l  v ascu la r  d isease 1.25 (0.92-1.70) 0.93 (0.67-1.31)
A tr ia l  f ib r illa tio n 0.71 (0.52-0.96) 0.75 (0.58-0.98)
H y pertens ion 0.70 (0.49-1.00) 0.80 (0.61-1.06)
R en a l fa ilu re 1.61 (1.11-2.33) 1.60(1.10-2.34)
H e a r t  fa ilu re 1.34(1.08-1.66) 1.22 (1.01-1.48)
C o ro n a ry  h e a r t  d isease 0.91 (0.71-1.17) 0.94 (0.75-1.19)
324
Table 117 Trends
years admitted to
in adjusted odds of death at 30 days in men and women aged >74
hospital following a second AMI
OD D S R A T IO  (95%  C l)
, : M E N W O M E N
Year o f  admission
1990 1.00 1.00
1991 0.9 (0.65-1.50) 0.95 (0.64-1.41)
1992 0.87 (0.57-1.34) 1.09 (0.75-1.61)
1993 0.73 (0.48-1.12) 1.01 (0.67-1.52)
1994 0.85 (0.54-1.33) 1.00 (0.67-1.51)
1995 0.73 (0.46-1.17) 0.98 (0.65-1.48)
1996 0.88 (0.54-1.43) 0.73 (0.46-1.14)
1997 0.69 (0.43-1.12) 1.24 (0.78-1.96)
1998 0.98 (0.61-1.59) 1.13 (0.72-1.79)
1999 0.73 (0.44-1.20) 0.99 (0.62-1.56)
2000 0.52 (0.30-0.90) 0.92 (0.56-1.51)
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12.2.2 Cox’s Proportional Hazards Regression in men and wom en at
one year excluding 30 days
12.2.2.1 O ve ra ll
When no other variables were included in the model, sex was a significant predictor of 
outcome at one year following a first AMI (p<0.001) and the unadjusted hazard o f death 
was 1.35 in women relative to men. Adjusting for age alone accounted for all o f this sex 
difference and sex was no longer a significant independent predictor of outcome, p=0.66. 
Addition o f other variables into the model had little effect on the hazard o f death and did 
not therefore appear to account for initial sex differences. In the final model, the risk of 
death was similar in men and women. The adjusted hazard o f death was 0.94 (0.84-1,05) 
so that there was no significant difference in survival between the sexes. As for survival at 
30 days, not all variables were included in the final model. The model excluded; 
deprivation categoiy, hypertension and previous coronary heart disease. All other 
variables remained significant and were included in the final model. The variables that 
were excluded were therefore different from those excluded from the model at 30 days 
which comprised: year o f admission, cancer, previous coronary heart disease, respiiatory 
disease and deprivation categoiy. An age sex interaction teim was included in the model 
and was not found to be significant, p=0.44.
Table 118 shows the Cox Proportional Hazard regression models carried out in men and 
women separately. Age had a less powerfiil effect on prognosis than at 30 days, so that the 
hazard o f death was 5.90 times greater in men aged >84 when compared to men age <55 
years. A similar effect was seen m women. The effect o f age was again considerably less 
powerful than seen in one year survival following a first AMI. For example the hazard o f 
death at one years was 11.61 times greater in men aged >84 years than in men aged <55 
years followmg a first AMI. Socioeconomic deprivation was not an independent predictor 
o f one year outcome in men or in women following a second AMI. This was in-keeping 
with that seen for 30 day suiwival following second AMI, but in contrast to one year 
suiwival following a first AMI where socioeconomic deprivation was an independent 
predictor o f outcome in men but not in women. In general, the presence o f comorbid 
conditions increased the hazard o f death in men and women though the magnitude o f effect 
varied according to the diagnosis and by sex. Heart failure and renal failure had the 
greatest effects. For example, the hazard o f death was 86% greater in men and 55% 
greater in women who had a diagnosis of heart failure than in those individuals who did 
not. Hypertension, previous coronary heart disease and caneer did not have a significant
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effect on prognosis in either men or women. None o f the comorbid conditions had a 
significant protective effect. In general, the magnitude of the effect o f comorbid 
conditions was greater at one year following a second AMI than at 30 days. For example, 
hazard o f death was 10% greater in men with resphatory disease than in men without 
respiratory disease compared to 48% greater at one year. Atrial fibrillation had a 
protective effect on 30 day outcome which was significant in women. By one year 
however atrial fibrillation had an adverse effect on outcome which was significant in men 
and in women. Time since first AMI was a highly significant predictor o f one year 
outcome and the hazard o f death was reduced by 7% in men and 8% in women for each 
additional year since the first AMI. Year o f admission was a significant independent 
predictor o f outcome at one year in men and women. The adjusted hazar d o f death at one 
year fell by 50% in men and by 37% in women (Table 119). This compared to falls o f 
33% in men and 31% in women at one year following a first AMI. This sex difference was 
not significant, p=0.180.
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Table 118 Hazard ratios for death at one year excluding 30 days in men and women
admitted to hospital following a second AMI
HAZARD RATIO (95% Cl)
MEN WOMEN
1.00 0.94 (0.84-1.05)
Age group
<55 1.00 1.00
55-64 1.39 (0.98-1.98) 1.57 (0.79-3.13)
65-74 2.47 (1.78-3.42) 2.41 (1.27-4.59)
75-84 3.67 (2.64-5.11) 4.02 (2.13-7.59)
>84 5.90(4.01-8.70) 4.82 (2.50-9.29)
Deprivation quintile
1-least deprived 1.00 1.00
,2 0.95 (0.74-1.23) 0.93 (0.71-1.39)
3 1.17(0.91-1.49) 0.80 (0.61-1.05)
4 1.14(0.90-1.46) 1.04 (0.80-1.35)
5-most deprived 1.02 (0.79-1.31) 0.99 (0.76-1.29)
Comorbidity
Diabetes 1.17(0.95-1.45) 1.38 (1.12-1.71)
Cancer 1.17(0.95-1.44) 1.24 (0.97-1.59)
Respiratory disease 1.48 (1.22-1.79) 1.26(1.01-1.59)
Cerebrovascular disease 1.52 (1.25-1.85) 1,15 (0.88-1.51)
Peripheral vascular 
disease 1.40(1.12-1.75) 1.15 (0.86-1.54)
Atrial fibrillation 1.40(1.13-1.73) 1.31 (1.05-1.63)
Hypertension 0.82 (0.65-1.04) 1.07 (0.86-1.34)
Renal failure 1.77(1.34-2.34) 1.74 (1.27-2.37)
Heart failure 1.86(1.59-2.18) 1.55 (1.31-1.84)
Coronary heart disease 1.04 (0.88-1.23) 0.90 (0.74-1.09)
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Table 119 Trends in hazard ratio for death at one year excluding 30 days in men and
women admitted to hospital following a second AMI
HAZAÏU) RATIO (95% Cl)
/M EN ; WOMEN
Year o f admission
1990 1.00 1.00
1991 0.79 (0.60-1.06) 0.99 (0.71-1.39)
1992 0.57 (0.42-0.78) 1.14(0.83-1.57)
1993 0.72 (0.54-0.96) 0.77 (0.54-1.10)
1994 0.67 (0.50-0.91) 1.12(0.81-1.57)
1995 0.71 (0.52-0.96) 0.88 (0.62-1.25)
1996 0.59 (0.42-0.83) 0.93 (0.64-1.35)
1997 0.60 (0.43-0.85) 0.72 (0.46-1.11)
1998 0.65 (0.46-0.92) 0.83 (0.55-1.25)
1999 0.47 (0.32-0.70) 0.63 (0.41-0.96)
2000 0.50 (0.33-0.74) 0.63 (0.39-1.00)
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12.2.2.2 Cox’s Proportional Hazards Regression at one year following a second AMI 
age <65 years excluding 30 days
Survival was similar in men and women aged less than 65 years and sex was not an 
independent predictor of prognosis at one yeai* in this age group following a second AMI 
(Table 120). This finding was consistent with one year outcome following a first AMI. 
The adjusted hazard of death in women relative to men was 1.02 (0.74-1.40). As 
demonstrated in the whole cohort, socioeconomic deprivation was not a significant 
predictor of outcome in men or in women aged <65 years. Few of the comorbid conditions 
were significant predictors of one year outcome though the effect of these comorbid 
diagnoses on prognosis appeared greater in this age group than in the overall cohort. For 
example, heart failure was associated with 2.44 times the risk of death in the under 65 year 
old men compared to an increased risk of 86% in the whole cohort. In women, only heart 
failure earned a significant adverse effect on outcome, whilst in men, heait failure, renal 
failure, atrial fibrillation and diabetes were all associated with an increase in the hazard of 
death at one year. The adjusted hazard of death fell by 67% in men and 71% in women, 
though these declines were not significant (Table 121).
12.2.2.3 Cox’s Proportional Hazards Regression at one year following a second AMI 
age 65-74 years excluding 30 days
Again, sex was not a significant predictor of one year survival in this age group (Table 
122). This finding is in contrast to first AMI where the hazard of death was 8% lower in 
women relative to men at one year in this age group. As in the younger age group, 
socioeconomic deprivation was not a significant predictor of death in men or in women. 
Comorbid diagnoses showed similar effects to those seen in the younger age gi’oup, 
although the magnitude of these effects varied slightly. Heart failure, renal failure and 
atrial fibrillation had the strongest impact on prognosis, especially in men. For example, 
heart failure was associated with more than twice the risk of death in men (hazaid ratio 
2.02 in men and 1.63 in women). Men and women with a diagnosis of atrial fibrillation 
were almost twice as likely to die at one year as those without tliis diagnosis. Hazard of 
death was 1.91 in men and 1.95 in women. Following a frst AMI, atrial fibrillation 
increased the hazard of death by 48% in men and by 53% in women in the same age group. 
Between 1990 and 2000 the risk of death fell by 46% in men and by 80% in women, 
though these trends did not reach statistical significance in men or in women (Table 123).
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12.2.2.4 Cox’s Proportional Hazards Regression at one year following a second AMI
age >74 years excluding 30 days
As in the younger age groups, sex was not a significant predictor of outcome at one year in 
men and women following a second AMI, p=0.156 (Table 124). This finding was 
consistent with that seen at one year following a &st AMI. As in the two younger age 
groups, socioeconomic deprivation was not a significant predictor of outcome in men or in 
women. Comorbid diagnoses continued to have a significant effect on prognosis, though 
the magnitude of these effects was generally less than that seen in younger age groups. For 
example, heart failure was associated with a 33% in the risk of death in women aged >74 
years compaied to an excess risk of 3.38 times in women aged <65 years. Atrial 
fibrillation continued to have an adverse effect on prognosis, but only in women. 
Respiratoiy disease, cerebrovascular disease and peripheral vascular disease all increased 
the risk of death in men but not in women. Time since fh'st AMI was a significant 
predictor of outcome at one year in men and in women. The hazard of death declined by 
6% in men and by 9% in women for each additional year since the first AMI. Year of 
admission was a significant predictor of one year outcome in this age group, and the hazard 
of death declined by 50% in men and by 12% in women (Table 125). This sex difference 
was significant, p=0.033.
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Table 120 Hazard ratios for death one year excluding 30 days in men and women
aged < 65 years admitted to hospital following a second AMI 1990-2000
HAZARD RATIO (95% Cl)
■'.MEN WOMEN
Sex 1.00 1.02 (0.74-1.40)
Deprivation quintile
1-least deprived 1.00 1.00
2 1.73 (0.83-3.60) 0.99 (0.32-3.04)
3 1.46 (0.71-3.00) 0.89 (0.29-2.69)
4 2.00 (1.00-3.97) 0.96 (0.32-2.85)
5-most deprived 1.86 (0.92-3.77) 0.72 (0.25-2.09)
Comorbidity
Diabetes 1.60 (1.03-2.49) 1.51 (0.75-3.05)
Cancer 1.66 (0.96-2.86) 1.51 (0.67-3.43)
Respiratory disease 1.09 (0.63-1.88) 1.21 (0.49-2.98)
Cerebrovascular disease 1.34 (0.80-2.24) 1.83 (0.81-4.16)
Peripheral vascular 
disease 1.37 (0.74-2.54) 1.21 (0.49-2.98)
Atrial fibrillation 1.97 (1.08-3.54) 0.31 (0.07-1.47)
Hypertension 0.62 (0.35-1.09) 0.82 (0.36-1.86)
Renal failure 3.29 (1.67-6.45) 2.82 (0.81-9.77)
Heart failure 2.44 (1.70-3.50) 3.38 (1.74-6.57)
Coronary heart disease 1.07 (0.75-1.53) 1.01 (0.53-1.91)
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Table 121 Trends in hazard ratios of death at one year excluding 30 days in men and
women aged <65 years admitted to hospital following a second AMI
■ h a z a r d  r a t io  (95% Cl) ^
V MEN • " WOMEN
Year o f admission
1990 1.00 1.00
1991 0.86 (0.47-1.57) 0.63 (0.21-1.87)
1992 0.64 (0.33-1.23) 0.62 (0.22-1.72)
1993 1.14(0.66-1.97) 1.03 (0.38-2.78)
1994 0.69 (0.36-1.30) 0.44 (0.11-1.67)
1995 0.57 (0.29-1.12) 1.17(0.39-3.49)
1996 0.60 (0.30-1.20) 0.58 (0.16-2.13)
1997 0.53 (0.23-1.18) 0.58 (0.16-2.13)
1998 0.53 (0.23-1.20) 0.82 (0.21-3.20)
1999 0.21 (0.05-0.90) 0.46 (0.09-2.25)
2000 0.33 (0.11-0.96) 0.29 (0.03-2.50)
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Table 122 Adjusted hazard ratios for death at one year excluding 30 days in men and
women aged 65-74 years admitted to hospital following a second AMI 1990-2000
HAZARD RATIO (95% Cl)
MEN WOMEN
Sex 1.00 0.88 (0.72-1.09)
Deprivation quintile
1-least deprived 1.00 1.00
2 0.71 (0.44-1.14) 0.99 (0.55-1.76)
3 1.12(0.72-1.73) 0.97 (0.56-1.68)
4 1.22 (0.80-1.86) 1.20 (0.71-2.04)
5-most deprived 1.15 (0.73-1.80) 0.83 (0.47-1.47)
Comorbidity
Diabetes 1.02 (0.70-1.47) 1.69 (1.14-2.50)
Cancer 0.98 (0.69-1.41) 1.22 (0.73-2.03)
Respiratory disease 1.42(1.03-1.95) 1.69 (1.09-2.63)
Cerebrovascular disease 1.57 (1.13-2.47) 1.18 (0.70-2.00)
Peripheral vascular disease 1.41 (0,94-2.09) 1.59 (0.89-2.85)
Atrial fibrillation 1.91 (1.36-2.71) 1.95 (1.25-3.02)
Hypertension 0.82 (0.55-1.22) 1.15(0.73-1.81)
Renal failure 1.87 (1.12-3.12) 1.56 (0.76-3.20)
Heart failure 2.02 (1.56-2.63) 1.63 (1.14-2.31)
Coronary heart disease 1.13 (0.85-1.50) 0.83 (0.56-1.24)
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Table 123 Trends in adjusted hazard ratios for death at one year excluding 30 days m
men and women aged 65-74 years admitted to hospital following a second AMI
HAZARD RATIO (95% Cl)
MEN WOMEN
Year o f  admission
1990 1.00 1.00
1991 0.65 (0.39-1.07) 0.63 (0.30-1.32)
1992 0.52 (0.31-0.87) 1.19(0.63-2.28)
1993 0.59 (0.35-0.99) 0.90 (0.45-1.80)
1994 0.63 (0.38-1.03) 1.08 (0.56-2.08)
1995 0.74 (0.45-1.23) 0.71 (0.34-1.48)
1996 0.81(0.48-1.34) 0.78 (0.34-1.48)
1997 0.53 (0.28-0.99) 0.99 (0.43-2.26)
1998 0.59 (0.32-1.07) 0.80 (0.36-1.79)
1999 0.37(0.18-0.76) 0.66 (0.28-1.58)
2000 0.54 (0.26-1.11) 0.20 (0.05-0.91)
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Table 124 Adjusted hazard ratios for death at one year excluding 30 days in men and
women aged >74 years admitted to hospital following a second AMI 1990-2000
HAZARD RATIO (95% Cl)
; MEN WOMEN
1.00 0.89 (0.77-1.04)
Deprivation quintile
1-least deprived 1.00 1.00
0.90 (0.64-1.26) 0.94 (0.68-1.30)
3 . 1.12(0.81-1.56) 0.73 (0.52-1.02)
0.93 (0.65-1.34) 1.09 (0.79-1.50)
5-most deprived 0.80(0.55-1.15) 1.14(0.83-1.56)
Comorbidity
Diabetes 1.09 (0.77-1.54) 1.15 (0.86-1.52)
Cancer 1.20 (0.89-1.63) 1.25 (0.91-1.71)
Respiratory disease 1.65 (1.25-2.18) 1.17(0.88-1.56)
Cerebrovascular disease 1.46(1.09-1.94) 1.05 (0.74-1.49)
Peripheral vascular disease 1.45 (1.06-1.98) 0.99 (0.69-1.43)
Atrial fibrillation 1.06 (0.79-1.44) 1.30(1.01-1.68)
Hypertension 0.99 (0.70-1.44) 1.12(0.85-1.48)
Renal failure 1.37(0.70-1.41) 1.67(1.15-2.43)
Heart failure 1.53 (1.21-1.92) 1.33 (1.08-1.64)
Coronary heart disease 0.88 (0.67-1.16) 0.90 (0.70-1.15)
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Table 125 Trends in adjusted hazard ratios for death at one year excluding 30 days in
men and women aged >74 years admitted to hospital following a second AMI
HAZARD RATIO (95% Cl)
-MEN WOMEN
Year o f  adm ission
1990 1.00 1.00
1991 0.82 (0.53-1.27) 1.25 (0.83-1.90)
1992 0.51 (0.32-0.83) 1.29 (0.86-1.93)
1993 0.55 (0.35-0.87) 0.68 (0.42-1.10)
1994 0.63 (0.39-1.02) 1.34 (0.88-2.03)
1995 0.72 (0.45-1.17) 0.98 (0.63-1.530
1996 0.32 (0.17-0.59) 1.02 (0.65-1.62)
1997 0.68 (0.41-1.11) 0.66 (0.37-1.18)
1998 0.75 (0.45-1.24) 0.89 (0.53-1.49)
1999 0.57 (0.34-0.97) 0.66 (0.38-1.12)
2000 0.50 (0.28-0.87) 0.88 (0.52-1.50)
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12.2.3 Cox’s Proportional Hazards in men and wom en at five years
following a second AM I excluding 30 days
12.2.3.1 Overall
At five years and excluding the first 30 days, women had an increased risk of death at five 
years (hazard ratio 1.39) before adjusting for any other prognostic factors. Accounting for 
the age differences between men and women removed this sex difference and sex was no 
longer a significant independent predictor of outcome (hazard ratio 1.01, 95% Cl 0.93- 
1.09, p=0.82). Addition of other variables into the model had a maiginal effect on this 
hazard ratio, and men and women continued to have a similar prognosis after adjusting for 
other prognostic factors (hazard ratio 0.97, 95% Cl 0.89-1.05). Socioeconomic deprivation 
and previous coronary heart disease excluding AMI were not significant predictors of 
outcome and were not retained in the final model. All other variables were retained in the 
final model.
Table 126 shows the result of the Cox Proportional Hazard regression models carried out 
in men and women separately at five years following a second AMI and excluding the first 
30 days. Age had a similar effect in men and women and again was the most powerful 
predictor of outcome. As at 30 days and one year, age had a less powerful effect on 
prognosis than following first AMI. At five years the hazard of death in men aged greater 
than 84 years was 5.07 following a second AMI compared to 11.38 following a first AMI. 
Socioeconomic deprivation was not a significant predictor of outcome in men or in women 
at five years. This was in contrast to five yeai* suivival following first AMI in which 
socioeconomic deprivation was a significant predictor of outcome in men and in women 
and men in the most deprived category had a 26% increase in the hazard of death at five 
years than men in the least deprived category. The presence of comorbid diagnoses had a 
similar effect in men and women, but was more likely to be significant in men than in 
women. Heart failure had the most powerful effect and increased the hazard of death by 
78% in men and by 67% in women. In men, cancer was the only diagnosis that that did 
not have a significant effect on outcome. Hypertension had a protective effect in men and 
reduced the hazard of death at five years (hazard ratio 0.73 95%CI 0.61-0.88). All other 
diagnoses significantly increased the hazaid of death in men. Excluding hypertension and 
cancer, the effect of comorbid diagnoses was similar in men following a first and second 
AMI. In women, fewer comorbid diagnoses had a significant effect on prognosis. 
Diabetes, cancer, respiratory disease, cerebrovascular disease, renal failure and heart
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failure all significantly increased the hazard of death at five years. Heart failure and 
diabetes had the most powerful effect on prognosis. Between 1990 and 1996, the five year 
hazard of death declined significantly by 29% in men. There was a non-significant decline 
of 17% in women over the same time period (Table 127). This sex difference was not 
significant, p=0.316. These declines were similar to those seen following a first AMI 
(27% in men and 23% in women).
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Table 126 Hazard ratios for death at five years excluding 30 days in men and women
admitted to hospital following a second AMI
HAZARD RATIO (95% CI>
MEN WOMEN
1.00 0.97 (0.89-1.05)
Age group
<55 1.00 1.00
55 64 1.36 (1.10-1.68) 1.21 (0.81-1.80)
65-74 2.27(1.86-2.77) 1.76(1.21-2.56)
75-84 3.38 (2.75-4.17) 3.22 (2.23-4.65)
>84 5.07 (3.83-6.72) 4.34 (2.94-6.40)
Deprivation quintile
1-least deprived 1.00 1.00
2 : 0.92 (0.77-1.10) 0.90 (0.74-1.10)
3 1.03 (0.86-1.22) 0.89 (0.73-1.08)
 ^ , ' : ' , V 1.05 (0.89-1.25) 0.92 (0.76-1.12)
5-most deprived 1.06 (0.88-1.26) 1.02 (0.84-1.23)
Comorbidity
Diabetes 1.40 (1.19-1.64) 1.45 (1.24-1.70)
Cancer 1.11 (0.94-1.32) 1.37(1.13-1.66)
Respiratory disease 1.32(1.12-1.54) 1.37(1.15-1.62)
Cerebrovascular disease 1.54(1.32-1.80) 1.33 (1.10-1.61)
Peripheral vascular 
disease 1.44(1.21-1.71) 1.09 (0.87-1.36)
Atrial fibifillation 1.39(1.17-1.66) 1.14(0.96-1.36)
Hypertension 0.73 (0.61-0.88) 1.10(0.93-1.3)
Renal failure 1.70 (1.32-2.19) 1.38 (1.03-1.84)
Heart failure 1.78 (1.59-2.00) 1.67 (1.47-1.89)
Coronary heart disease 1.17(1.04-1.32) 0.92 (0.80-1.06)
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Table 127 Trends in hazard ratio for death at five years excluding 30 days in men and
women admitted to hospital following a second AMI
HAZARD RATIO (95% Cl)
MEN. - ' ' WOMEN
Year of admission
1990 1.00 1.00
1991 0.95 (0.79-1.14) 0.97 (0.79-1.19)
1992 0.85 (0.71-1.02) 1.00 (0.82-1.23)
1993 0.83 (0.69-1.00) 0.78 (0.63-0.97)
1994 0.84 (0.69-1.02) 0.95 (0.77-1.18)
1995 0.83 (0.68-1.01) 0.73 (0.59-0.92)
1996 0.71 (0.58-0.88) 0.83 (0.66-1.06)
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12.2.3.2 Cox’s Proportional Hazards Regression at five years following a second 
AMI age <65 years excluding 30 days
As in the whole cohort, sex was not a significant independent predictor of outcome at five 
years in individuals aged less than 65 years, p=0.97. Socioeconomic deprivation remained 
non-significant in men and in women (Table 128). This contrasted with first AMI in which 
socioeconomic deprivation was a relatively powerful predictor of outcome especially in 
younger men. As seen in shorter term survival, the presence of comorbid conditions had a 
marked impaet on prognosis at five years in this younger age group, especially in men. 
Men and women with renal failure and heart failure had almost twice the increased risk of 
death at five years as those without these conditions. For example, the hazard of death at 
five years in individuals with a diagnosis of heart failure was increased 2.12 times in 
women aged less than 65 years and by 96% in men. Hypertension had a protective effect 
in men with a hazard ratio of 0.56 (95% Cl interval, 0.38-0.81, p<0.001). All other 
diagnoses carxied an adverse effect. Comorbid diagnoses were more likely to cany a 
significant adverse effect in men than in women. In women only heart failure, diabetes, 
respiratory disease and cerebrovascular disease were significant independent predictors of 
outcome. The magnitude of effect was however greater in women than in men for a 
number of diagnoses including cerebrovascular disease and respiratory disease. In men 
respiratory disease was not a significant predictor of outcome but in women the hazard 
ratio was 2.32 (95% Cl 1.40-3.83, P=0.001). Time since previous AMI was not a 
significant predictor in women but was m men in whom the risk of death decreased by 7% 
for each additional year smce the first AMI. The risk of death fell by 41 % in men and 50% 
in women between 1990 and 1996 (Table 129). This decline was only significant in men, 
p=0.009.
12.2.3.3 Cox’s Proportional Hazards Regression at five years following a second 
AMI age 65-74 years excluding 30 days
Hazard of death at five years and excluding the fir st 30 days was 16% lower in women 
than in men in this age group following a second AMI (Table 130). This sex effect was 
significant, p=0.020. Sex was not a significant predictor of outcome in younger men and 
women or in the whole cohort. It was however significant in this age group at five years 
following a first AMI. The effect of socioeconomic deprivation was significant but only in 
men in whom the overall effect was significant, p=0.027 although individual deprivation 
categories did not vary significantly firorn the reference category. Men in the most 
deprived category had a 27% increase in the hazard of death relative to individuals in the
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least deprived category. The presence of comorbid diagnoses had a variable effect on 
outcome which differed in men and women. Heart failure again carried the worst 
prognosis. In men the hazard of death was increased two-fold and in women by 76% in 
those with a diagnosis of heart failure compared to those without. Renal failure and 
previous coronary heart disease were not significant independent predictors of outcome in 
men or in women. In women diabetes, cancer, respiratoiy disease, hypertension and heart 
failure were all significant predictors of outcome at five years in this age group. A 
diagnosis of diabetes increased the hazard of death by 68% (95% Cl 1.36-2.24). In men, 
the conditions that had a significant association with outcome included respiratoiy disease, 
cerebrovascular disease, peripheral vascular disease, atrial fibrillation and heart failure. 
Time since fii’st AMI was a significant predictor of outcome in men and in women and 
each additional year decreased the hazard of death by 8% in men and by 5% in women. 
This sex difference was not statistically significant. The temporal decline in the risk of 
death at five years was only significant in women, (hazard ratio 0.51, 95% Cl 0.30-0.88) 
(Table 131).
12.2.3,4 Cox’s Proportional Hazards Regression at five years following a second 
AMI age >74 years excluding 30 days
In this age group, as in the youngest age gioup, sex was not a significant predictor of 
outcome at five yeai's, p=0.997. This contrasted with fii’st AMI where sex was a 
significant predictor of outcome in all three age groups. Socioeconomic deprivation did 
not have a significant effect on prognosis in men or women in this age gioup (Table 132). 
Comorbid diagnoses had a less powerful effect in men and women in this age group 
compared to the younger age groups. The magnitude of the effects was less than that 
observed in younger age groups. These findings were similar* to that obseiwed following a 
first AMI. In women only cancer and heait failure were associated with a significant 
adverse prognosis. As in younger age groups, heart failure had the most powerful effect 
and was associated with a 58% increase in the hazard of death at five years. In men, 
diabetes, heart failure, peripheral vascular disease and cerebrovascular disease were all 
associated with a significant adverse outcome at five years. Again heart failure had the 
most powerful effect with a hazard ratio of 1.53. Time since first AMI was a significant 
predictor of outcome in men and women. Each additional year was associated with a 
reduction in the hazard of death of 5% in men and 10% in women. This sex difference was 
not significant, p=0.324. There was a significant decline in the risk of death of 47% in
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men. In women, although year of admission was a significant predictor of outcome there 
was no clear trend in the hazard of death at five years (Table 133).
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Table 128 Hazard ratios for death five years excluding 30 days in men and women
aged < 65 years admitted to hospital following a second AMI 1990-2000
HAZARD RATIO (95% Cl)
- : u- MEN WOMEN
Sex 1.00 0.97 (0.79-1.19)
Deprivation quintile
1-least deprived 1.00 1.00
■2 _ ■ ■ , • . 1.60(1.05-2.43) 0.76 0.40-1.45)
3 1.45 (0.97-2.17) 0.69 (0.36-1.32)
4 ' 1.59(1.08-2.36) 0.62 (0.32-1.19)
5-most deprived 1.49(1.00-2.24) 0.77 (0.42-1.38)
Comorbidity
Diabetes 1.85 (1.38-2.48) 1.92 (1.21-3.06)
Cancer 1.63 (1.12-2.35) 1.36 (0.79-2.32)
Respiratory disease 1.16(0.81-1.65) 2.32 (1.40-3,83)
Cerebrovascular disease 1.45 (1.04-2.02) 2.39 (1.45-3.94)
Peripheral vascular disease 1.54 (1.04-2.27) 1.17(0.61-2.26)
Atrial fibrillation 1.60(1.02-2.51) 1.48 (0.74-2.97)
Hypertension 0.56 (0.38-0.81) 1.03 (0.63-1.70)
Rénal faxlure 3.87 (2.36-6.35) 1.74 (0.67-4.54)
Heart failure 1.96(1.54-2.48) 2.12(1.33-3.38)
Coronary heart disease 1.24(1.00-1.54) 0.97 (0.65-1.46)
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Table 129 Trends in hazard ratios of death at five years excluding 30 days in men and
women aged <65 years admitted to hospital following a second AMI
HAZARD RATIO (95% Cl)
■ WOMEN
Year o f  adniission
1990 1.00 1.00
1991 1.01 (0.73-1.41) 0.92 (0.51-1.66)
1992 0.84 (0.60-1.19) 0.95 (0.54-1.66)
1993 0.89 (0.64-1.23) 0.89 (0.49-1.59)
1994 0.63 (0.43-0.91) 0.39(0.18-0.83)
1995 0.61 (0.42-0.87) 0.44 (0.20-0.95)
1996 0.59 (0.39-0.88) 0.50 (0.23-1.06)
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Table 130 Adjusted hazard ratios for death at five years excluding 30 days in men
and women aged 65-74 years admitted to hospital following a second AMI 1990-2000
HAZARD RATIO (95% Cl)
MEN WOMEN
Sex 1.00 0.84 (0.73-0.97)
Deprivation quintile
1-least deprived 1.00 1.00
2 0.83 (0.60-1.15) 0.83 (0.55-1.26)
3 1.04 (0.77-1.41) 0.93 (0.63-1.35)
4 1.23 (0.92-1.64) 0.96 (0.66-1.40)
5-most deprived 1.27 (0.94-1.72) 0.95 (0.64-1.40)
Comorbidity
Diabetes 1.06 (0.81-1.40) 1.68 (1.36-2.24)
Cancer 1.02(0.78-1.33) 1.49 (1.02-2.18)
Respiratory disease 1.44 (1.13-1.84) 1.71 (1.23-2.39)
Cerebrovascular disease 1.57 (1.22-2.00) 1.38 (0.95-2.02)
Peripheral vascular disease 1.53 (1.15-2.05) 1.01 (0.63-1.62)
Atrial fibrillation 1.42 (1.06-1.90) 1.33 (0.92-1.93)
Hypertension 0.79 (0.59-1.07) 1.39 (1.00-1.93)
Renal failure 1.51 (0.99-2.31) 1.58 (0.87-2.84)
Heart failure 2.00 (1.65-2.41) 1.76 (1.37-2.26)
Coronary heart disease 1.11 (0.90-1.36) 0.95 (0.72-1.25)
347
Table 131 Trends in adjusted hazard ratios for death at five years excluding 30 days
in men and women aged 65-74 years admitted to hospital following a second AMI
HAZARD RATIO (95% Cl)
WOMEN
Year o f  admission
1990 1.00 1.00
1991 1.05 (0.76-1.45) 0.79 (0.53-1.18)
1992 0.83 (0.60-1.16) 1.00 (0.67-1.48)
1993 0.87 (0.62-1.23) 0.74 (0.48-1.14)
1994 0.89 (0.64-1.23) 0.82 (0.55-1.23)
1995 0.97 (0.69-1.37) 0.52 (0.33-0.84)
1996 0.91 (0.64-1.29) 0.51 (0.30-0.88)
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Table 132 Adjusted hazard ratios for death at five years excluding 30 days in men
and women aged >74 years admitted to hospital following a second AMI 1990-2000
HAZARD RATIO (95% Cl)
MEN : WOMEN
Sex 1.00 1.00 (0.89-1.12)
Deprivation quintile
1-least deprived 1.00 1.00
2 0.76 (0.58-0.99) 0.94 (0.74-1.20)
3 0.94 (0.72-1.23) 0.86 (0.67-1.10)
4 0.75 (0.57-1.00) 1.02 (0.81-1.30)
5-most deprived 0.79 (0.59-1.06) 1.08 (0.85-1.37)
Comorbidity
Diabetes 1.42(1.06-1.90) 1.22 (0.98-1.52)
Cancer 1.03 (0.78-1.35) 1.44(1.12-1.85)
Respiratory disease 1.27 (0.98-1.65) 1.13 (0.90-1.42)
Cerebrovascular disease 1.41 (1.09-1.84) 1.10(0.84-1.43)
Peripheral vascular disease 1.40 (1.06-1.84) 0.97 (0.74-1.28)
Atrial fibrillation 1.25 (0.97-1.61) 1.15 (0.93-1.43)
Hypertension 0.92 (0.66-1.28) 0.92 (0.73-1.16)
Renal failure 1.30 (0.85-2.01) 1.16(0.80-1.68)
Heart failure 1.53 (1.27-1.84) 1.58 (1.35-1.85)
Coronary heart disease 1.20 (0.97-1.50) 0.92 (0.76-1.11)
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Table 133 Trends in adjusted hazard ratios for death at five years excluding 30 days
in men and women aged >74 years admitted to hospital following a second AMI
HAZARD RATIO (95% Cl)
MEN WOMEN
Year o f  admission
1990 1.00 1.00
1991 0.80 (0.58-1.09) 1.10(0.84-1.45)
1992 0.80 (0.59-1.09) 1.08 (0.82-1.41)
1993 0.67 (0.49-0,92) 0.75 (0.56-1.00)
1994 0.86 (0.62-1.19) 1.19(0.90-1.57)
1995 0.85 (0.61-1.20) 0.93 (0.70-1.24)
1996 0.53 (0.36-0.78) 1.03 (0.77-1.38)
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12.3Discussion regarding unadjusted and adjusted survival in 
men and women following a second AMI
Prognosis following hospitalisation with a second AMI is poor and is worse than the 
prognosis seen in individuals hospitalised with a first AMI. In the current study 
approximately one quarter of individuals died within one month of admission and almost 
40% within one year. As for first AMI, unadjusted short and long tenn case fatality rates 
were lower in men than in women. Median survival was only 1.8 years in women and 3.6 
years in men compared with 4.3 years in women and 8.8 years in men following a first 
AMI. Long term case fatality improved in men hospitalised with a second AMI between 
1990 and 1996 and displayed a non-significant trend in women. Short term case fatality 
following hospitalisation with a second AMI did not demonstrate similar trends over the 
study period.
12.3.1 Sex
Short term case fatality
In the current study overall 30 day case fatality in individuals hospitalised with a second 
AMI was 22.4% in men and 27.7% in women. One-yeai’ case fatality was also higher in 
individuals hospitalised with a second AMI compared to those with a first AMI. There are 
few other data with which to compare these figures. In the 60 Minutes Myocardial 
Infarction Project unadjusted in-hospital case fatality was significantly higher in 
individuals hospitalised with a recurrent AMI compaied to those with a first AMI (23% 
versus 15%). Sex specific figures were not reported. The findings from the cuiTent study 
are not surprising given that individuals hospitalised with a second AMI are on average 
older and are more likely to have other comorbid diagnoses than individuals hospitalised 
with a first AMI. As for first AMI, short-term ease fatality was consistently higher in 
women than in men. Whilst a number of other studies have compared survival in 
individuals who do and do not experience a subsequent AMI, no other studies have 
reported case fatality in men and women hospitalised with a second AMI. This is 
important because many of these studies have compared survival using a different stalling 
point, so that for example one year case fatality rates are calculated fi'om the date of the 
fii'st AMI, rather than the reinfarction date. This means that their findings are not 
comparable with the findings fr om the current study. In the current study after adjusting 
for the effects of other factors, sex was not a significant predictor of short term case
351
fatality. The fact that women were older than men at the time of their second AMI 
accounted for most of the sex difference seen in unadjusted short term suiwival rates. 
There was no age sex interaction in short term survival following second AMI and sex 
remained a non-significant predictor of outcome m different age groups. This finding 
contrasted to first AMI from which women were 20% more likely to die at 30 days after 
adjusting for other factors, and the effect of sex was greater in younger age groups. This is 
a new finding and it is not cleai* why sex should be an independent predictor of case 
fatality following first AMI but not following second AML It is likely that some of the 
hypotheses that have been put forward to explain sex differences in survival following a 
first AMI would also be relevant to second AMI and would therefore result in similar sex 
differences in survival in first and second AMI. For example the suggestion that the higher 
risk of death seen in younger women following a first AMI may be due to a lower rate of 
use of established treatments for AMI in women than in men would also be relevant for 
second AMI. Other hypotheses are perhaps more likely therefore. For example it has been 
suggested that women are more likely to delay seeking treatment, thereby resulting in 
higher short-term case fatality. Delay in seeking treatment is less likely to occur in 
individuals who have already been hospitalised with a previous AMI and are more likely to 
recognise their symptoms.
Longer term case fatality
By two yeai's case fatality had increased to 41.4% in men and 51.1% in women 
hospitalised with a second AMI. By five years these figures had risen to 55.9% and 66.7% 
in men and women respectively. Suiwival was therefore substantially worse in men and 
women hospitalised with a second AMI compared to those hospitalised with a first AMI. 
There are few data with which to compare these findings. In the Minnesota Heaif Survey 
three year case fatality in 1990 was 27% in men and 36% in women hospitalised with a 
recurrent AMI compared to 18% in men and 24% in women hospitalised with a first AMI.
The Minnesota Heart Survey only included individuals up to the age of 74 years and
was therefore a substantially younger population than the population described in the
cuiTcnt study. In the cuirent study men and women hospitalised with a second AMI had a
similar long tenn prognosis after accounting for the effect of age and other factors. Sex
was not therefore a significant independent predictor of long tenn outcome following a
second AMI. This again contrasts with first AMI where women had a long tenn survival
advantage and were less likely to die than men. If greater natural longevity is thought to
contribute to the better long term survival of women following fiist AMI then this is also
likely to apply following a second AML It may be that those individuals who go on to
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experience subsequent AMI are a select group with particularly severe disease who are not 
representative of the majority of individuals who are hospitalised with an AML In addition 
those individuals who experience a second AMI are more likely to have other comorbid 
diagnoses and suiwival might therefore be worse because of competing causes that may 
offset women’s natural survival advantage.
12.3.2 Age
Short term case fatality
As for first AMI, age was the most powerfiil predictor of suivival in men and women 
hospitalised with a second AML 30 day case fatality rose from 6.6% in men and 9.5% in 
women aged less than 55 years to 40.0% in men and 38.9% in women aged greater than 84 
years. There are no other data with which to compare these figures. 30 day case fatality 
following a first AMI rose from 3.7% in men and 5.9% in women aged less than 55 years 
to 42.6% in men and 44.7% in women aged greater than 84 yeais. Short tenn case fatality 
was therefore worse following a second AMI than following a first AMI, but only in 
younger patients and not in the very elderly. It is not clear why second AMI should carry a 
particularly adverse prognosis in younger individuals. These individuals have high rates of 
comorbid diagnoses which will contribute to their poor prognosis. In keeping with these 
findings, age had a less powerful effect on prognosis in second AMI than in first AMI, 
after adjusting for the effects of other factors. The risk of death was increased 7.6 times in 
men and 6.4 times in women aged greater than 84 years hospitalised with a seeond AMI, 
eompared to 15.3 times in men and 12.1 times in women hospitalised with a first AML
Longer term case fatality
In the current study, over one half of men and two thfrds of women hospitalised with a 
second AMI were dead within five years. As for short term case fatality, the excess risk 
associated with second AMI was greater in younger age groups. At five years the effect of 
age on prognosis was less powerful than the effect seen at 30 days. Again this contrasts 
with first AMI in which age continued to have a similar effect on short and longer term 
prognosis. This may reflect the fact that the severity of disease in these individuals is such 
that other factors have less of an impact on prognosis.
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12.3,3 Socioeconomic deprivation
Short term case fatality
Unadjusted short teim case fatality was higher in the least deprived groups and lower in the 
most deprived groups. This is likely to be due to the increased age of individuals in less 
deprived groups compared to those in more deprived groups. After adjusting for other 
factors in the multivariate analyses, socioeconomic deprivation was not a significant 
predictor of 30 day outcome in men or women or in different age groups. This finding 
contrasted with fii'st AMI where socioeconomic deprivation was a significant predictor of 
prognosis and increased the risk of death especially in younger individuals and in men. It 
is not clear why socioeconomic deprivation should adversely affect outcome following a 
first but not a second AMI. It has been suggested that socioeconomic status may affect 
access to specialised cardiac services and effective secondary prevention 
treatments. (74;20?;208 ^  delay in the diagnosis of coronary heart disease and failure to 
institute appropriate treatment might be associated with an adverse prognosis following a 
first but not a second AMI. If the suivival differences seen in different socioeconomic 
groups following fiist AMI were wholly attributable to less effective treatment during 
hospitalisation then it would seem likely that these differences would also be present in 
survival following a second AMI. There are no studies that have compared the effects of 
socioeconomic deprivation on fii'st and subsequent AMI.
Longer term case fatality
In the cuiTcnt study socioeconomic deprivation had a similar effect on short and long term 
case fatality following a second AMI. In the multivariate analyses socioeconomic 
deprivation was not a significant predictor of long term outcome in men or in women. 
Again this contrasted with first AMI in which socioeconomic deprivation was a significant 
predictor of long term outcome in men and women and men in the most deprived category 
had a 26% increased risk of death than men in the least deprived categoiy. As mentioned 
previously it has been suggested that the longer term effects of socioeconomic deprivation 
may arise as a result of less efficient secondary prevention in these individuals. It
seems likely that these effects would apply to second as well as first AMI. It is however 
possible that the severity of disease in individuals hospitalised with a second AMI is such 
that they represent a more homogenous group with less potential for survival to be affected 
by individual factors such as sex, socioeconomic deprivation and comorbid diagnoses.
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12.3.4 Comorbid diagnoses
Short term case fatality
In the current study, as for tirst AMI, comorbid diagnoses were associated with a 
substantially increased unadjusted case fatality in individuals hospitalised with a second 
AMI. Unadjusted case fatality was increased particularly in individuals with diagnoses of 
renal failure, heart failure, respiratoiy disease and cerebrovascular and peripheral vascular 
disease. After adjusting for the effects of other factors in the multivariate analyses, not all 
comorbid diagnoses were significant predictors of outcome, unlike in fii'st AMI where all 
comorbid diagnoses were significant independent predictors of survival. At 30 days, only 
heart failure, cerebrovascular disease and renal failure were significantly associated with 
reduced suiwival in men and women and the magnitude of effect was smaller than for first 
AMI. In general the presence o f comorbid diagnoses had a lesser effect on prognosis 
following hospitalisation with second than with first AMI. Again this may be due to the 
fact that individuals hospitalised with a second AMI have severe disease and a poor 
prognosis and consequently have less scope for other factors such as comorbid disease to 
impact upon suiwival. The comorbid diagnoses that remained significant predictors of 
outcome following hospitalisation with a second AMI were those that were associated 
particularly adverse outcomes following hospitalisation with a first AMI. There are no 
other studies with which to compare these data. Atrial fibrillation had a protective effect 
and was associated with a reduction in the risk of death at 30 days but only in women. 
Hypertension was also associated with a reduction in the risk of death although this effect 
was only significant in men. These findings were similar to those seen in first AMI in 
which both hypertension and atrial fibrillation were associated with a reduction in the risk 
of death at 30 days. It is not clear why atrial fibrillation should be associated with a 
reduction in short tenn case fatality following AMI. As mentioned previously there is 
some evidence to suggest that the prognosis following AMI may be influenced by the 
temporal relationship between atrial fibrillation and AMI, and whether atrial fibrillation is 
a pre-existing condition or whether it develops as a complication of the AMI.^^’^ ’^^ ^^  Pre­
existing atrial fibrillation is less likely to be associated with an adverse outcome following 
AMI than atrial fibrillation that develops as a complication of an AMI. It is not possible 
to determine from the cun ent study whether the atrial fibrillation was a new or pre-existing 
diagnosis. It is also not clear why hypertension should be associated with a reduction in 
the risk of death at 30 days following a second AMI. Although the literature is not 
consistent in its findings, most studies have found that hypertension has an adverse effect 
on prognosis following AMI. '^^  ^ It is likely that the prevalence of hypertension is
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underestimated in the current study and that those individuals with this recorded diagnosis 
represent a biased sample, perhaps including those who have been targeted for secondary 
prevention measures. Again there are no data with which to compare these findings. In 
general the magnitude of effect of different comorbid diagnoses on suiwival was greater in 
younger than in older individuals hospitalised with a second AMI. This finding was 
similar to that seen in first AMI.
Longer term case fatality
In the current study, comorbid diagnoses again had a marked effect on unadjusted suiwival 
and most were associated with a substantial reduction in longer teim survival. In the 
multivariate analyses most comorbid diagnoses were significant predictors of outcome and 
were associated with an mcrease in case fatality. As for short tenn case fatality, heart 
failure and renal failure were associated with a paiticularly adverse prognosis. These 
findings aie consistent with first AMI in the cunent study and with other studies in which 
these diagnoses have been consistently associated with a poor prognosis in individuals 
hospitalised with Hypertension was associated with a decreased risk of
death at five years but only in men hospitalised with a second AMI. Hypertension was not 
a significant independent predictor of long term outcome following a first AMI. Atrial 
fibrillation increased the risk of death at five years in men and women hospitalised with a 
second AMI. This contrasted with the effect on 30 day survival where atrial fibrillation 
was found to have a protective effect. Diabetes had a greater effect on long term survival 
than on short tenn survival. As for short term suiwival, the presence of comorbid 
diagnoses had a greater impact on prognosis in younger than in older individuals. The 
effect of different comorbid diagnoses on survival was not consistent between men and 
women or between different age groups.
12.3.5 Temporal trends in case fatality in men and women following 
a second AMI
Short term case fatality
In the current study there were modest declines in unadjusted 30 day case fatality in men 
and women which were smaller than those observed in fiist AMI. In the multivariate 
analyses there was a trend towards declining case fatality, though this did not reach 
statistical significance. The difference in the trends between first and second AMI may 
reflect the lesser potential to salvage myocardium in patients with prior ventriculai' 
damage.
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Longer term case fatality
The trends in longer teim case fatality following second AMI were more encouraging. In 
the multivariate analyses there was a significant reduction in the risk o f death at five years 
in men overall and in women aged 65-74 years. These changes were compai'ahle to those 
declines seen in case fatality following hospitalisation with first AMI.
12.3.6 Summary
In the current study, as expected, the prognosis of men and women following 
hospitalisation with a second AMI was worse than following a first AMI. Approximately 
one quarter o f individuals died within one month o f admission and almost 40% within one 
year. Unadjusted short and longer term case fatality rates were lower in men than in 
women. However, differences in age and baseline characteristics explained all o f the 
differences between men and women in short and long term case fatality and sex was not 
therefore a significant predictor o f outcome. Age was the most powerful predictor o f 
outcome, though none o f the factors examined had as strong as effect on second AMI 
suiwival as on first AMI survival. Socioeconomic deprivation was not a significant 
predictor o f outcome. Comorbid diagnoses in general had an adverse effect on prognosis 
which again was not as pronounced as in first AMI. There were modest declines in short 
term case fatality between 1990 and 2000 which did not reach statistical significance in the 
multivariate analyses. There was however a significant reduction in the risk o f death at 
five years in men overall and in women aged 65-74 years which was similar to the declines 
obseiwed in longer term survival following a fii'st AMI.
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13 OVERALL DISCUSSION AND CONCLUSION
I have described and compared the baseline characteristics and survival o f women and also 
men hospitalised with a first and a second AMI in Scotland between 1990 and 2000. 
Although there is ali'eady a vast literature suiTounding the epidemiology o f AMI, there are 
gaps in this literature and limitations exist regarding the generalisation o f research findings 
to men and women in the general population. Studies examining the prognosis o f 
individuals who have experienced an AMI date back to the 1950s. Most studies, however, 
have focussed on short term survival. Eaily studies also often focussed exclusively on 
men. Some later studies included women, but most did not examine characteristics or 
outcome in men and women separately. There has been a growing awareness in the last 
ten years that important sex differences in cai’diovascular epidemiology exist. 
Consequently studies have begun to examine and report on baseline characteristics and 
survival in men and women separately. This is very important because those individuals 
who experience an AMI represent a priority target gioup for primary and secondary 
prevention. In order to reduce the incidence of AMI, we need to have a good 
understanding o f the risk factors as well as the baseline characteristics o f the men and 
women affected. The occurrence o f AMI as well as survival following AMI is largely 
dependent upon the success o f population and individual based prevention and treatment 
strategies. It is therefore crucial to be able to describe these in men and women separately. 
Over the past ten years there have been dramatic changes in treatment o f AMI. Clinical 
trials provide valuable information but generally on a selected and biased sample o f the 
population. Population based studies are essential to determine whether the benefits 
realised in clinical trials translate into clinical practice, and how these benefits might affect 
men and women o f different ages.
13.1 What is already known
The existing literature provides consistent evidence o f an age discrepancy between men 
and women hospitalised with AMI. It is well known that women are on average six to ten 
years older than men at the time of presentation with their first AMI. AMI is therefore 
relatively uncommon in young women compaied to young men. The risk o f AMI 
increases dramatically with age and the majority of individuals are over the age o f 65 years 
at the time o f presentation with their first AMI. Although an important cause o f premature
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mortality, especially in men, AMI is occurring in mcreasmgly older individuals. The 
average age o f individuals hospitalised with AMI is mcreasing steadily in men and in 
women. Most studies have demonstrated declining incidence rates o f first AMI. Such 
declines have been more cleai'ly established in men than in women in whom reports are 
conflicting. In terms o f baseline characteristics, it is known that both men and women 
hospitalised with AMI have a higher than expected prevalence rate o f hypertension and 
diabetes when compared to the general population and that the prevalence o f these factors 
is especially high in younger men and women.
There is significant variation in reports o f prognosis following AMI. The actual survival 
figures vary substantially between studies although the majority of studies have shown that 
short term survival is worse in women compared to men. There is also a growing literature 
that suggests that the female survival disadvantage is confined to younger women. Longer 
tenn survival is less consistent in teims o f absolute risk and sex differences. There is clear 
evidence of declining short tenn case fatality following hospitalisation with AMI in men 
and in women.
There are very little population based data available with which to compare the 
demographic characteristics o f these patient cohorts. The current analysis is the only one 
available that allows the description o f the age, sex and socioeconomic characteristics o f 
all individuals fi'om one countiy that have been hospitalised with a fihst or second AMI.
13.2Findings from current study
Between 1990 and 2000, 110,226 individuals were hospitalised in Scotland with a first 
AMI. 9,664 men and women were hospitalised with a second AMI. This does not 
represent the total burden o f hospitalisation for AMI which would also include individuals 
with more than two hospitalisations with AMI. Over half o f all men and three quarters o f 
women were aged greater than 64 yeai's at the time o f theii' fii'st AMI admission. 
Individuals hospitalised with a second AMI were significantly older (three years on 
average) so that by the time o f their second AMI over 60% o f men and 80% o f women 
were aged 65 year's or over. Individuals hospitalised with both a first and a second AMI 
were more likely to come from more deprived areas than from more affluent areas and this 
was especially tme of younger women.
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ïn terms o f baseline characteristics, almost half o f all men and women hospitalised with a 
first AMI had one or more comorbid diagnosis. The prevalence rate o f comorbid illness 
increased with age and younger women had high levels o f comorbid illness than younger 
men. The most commonly recorded conditions were heart failure, hypertension, 
respiratory disease and diabetes. However the prevalence o f different comorbid conditions 
varied according to age and sex. Individuals hospitalised with a second AMI had an even 
higher prevalence o f comorbid illness. Almost three quarters o f men and women 
hospitalised with a second AMI had one or more comorbid diagnosis. The most 
commonly recorded diagnoses were similar: heart failure, previous coronary heart disease 
(excluding AMI), diabetes, hypertension and respiratory disease. As with first AMI, 
younger women had particularly high levels o f comorbid illness compared to younger men. 
The median time between first and second AMIs was 2.3 years in men and 1.8 years in 
women. Many o f these findings are new, and very few studies have examined the 
distribution and prevalence o f non-cardiac comorbidity in men and women hospitalised 
with AMI.
The average age o f men and women hospitalised with a fii’st and second AMI increased by 
one to two years between 1990 and 2000. Over the same period, the prevalence o f 
comorbid illness also increased. For both first and second AMI, absolute changes over 
time were gieater in older age groups and the diagnoses that demonstrated the greatest 
relative increase in prevalence were hypertension, atrial fibrillation and renal failure. No 
other studies have reported sex specific trends in the prevalence o f cardiac and non-cardiac 
comorbidity in men and women hospitalised with AMI.
AMI hospitalisation rates fell dramatically over the study period, declining by about 30% 
in individuals hospitalised with a first AMI and by more than 50% in individuals 
hospitalised with a second AMI. Length o f stay also demonstrated substantial declines for 
individuals hospitalised with both fir st and second AMIs. The burden placed on the health 
seiwice in Scotland has consequently fallen between 1990 and 2000. There has however 
been a dramatic increase in the proportion and number of individuals hospitalised with a 
fii'st and second AMI who underwent a coronary revascularisation procedure.
In the current study, the prognosis o f men and women hospitalised with a first AMI was 
much worse than indicated by clinical trials. One fifth of patients died within one month 
o f admission and almost one half by five years. Unadjusted survival was substantially 
better in men than in women. Much but not all o f the excess short term risk in women
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could be explained by the fact that women were older than men at the time o f theii' first 
AML Women however remained at a 20% increased risk o f death at 30 days after 
adjusting for age and other factors. There was an age sex interaction in short term survival 
and the excess short term risk seen in women compared to men was gieater in younger 
women. This finding is in keeping with a giowing literature that reports similar 
observations. After excluding early deaths, adjusted longer term case fatality was slightly 
greater in men than in women. The short tenn survival advantage seen in men was 
therefore no longer present. Age was the most powerful predictor o f survival in men and 
women. Socioeconomic deprivation also had a powerful effect on survival, especially on 
longer term suiwival, in younger age groups and in men. Most comorbid diagnoses 
substantially increased the risk o f death m the short and longer term. Heart failure, renal 
failure and cancer had the most powerful effects. Comorbid diagnoses tended to have a 
greater effect on longer term suiwival than on short term suiwival and in younger men and 
women than in older individuals. Atrial fibrillation and hypertension reduced the risk o f 
death in the short term but not in the longer teim. The risk of death at 30 days fell by more 
than one tliird in men and a quarter in women between 1990 and 2000. Declines were 
greater in younger than in older age groups.
In the current study, as expected, the prognosis of men and women following 
hospitalisation with a second AMI was even worse than the prognosis following a first 
AMI. Approximately one quarter o f individuals died within one month o f admission and 
almost 40% within one year. Unadjusted short and longer term case fatality rates were 
lower in men than in women. Differences in age and baseline characteristics explained all 
of the differences between men and women in short and long term case fatality and sex 
was not a significant predictor o f outcome. Age was the most powerful predictor o f 
outcome. Interestingly, none o f the factors examined had as strong as effect on second 
AMI survival as on first AMI survival. Socioeconomic deprivation was not a significant 
predictor o f outcome. Comorbid diagnoses in general had an adverse effect on prognosis 
which again was not as pronounced as in first AMI. There were modest declines in short 
term case fatality which did not reach statistical significance in the multivariate analyses. 
There was however a significant reduction in the risk o f death at five years in men overall 
and in women aged 65-74 years which was similar to the declines observed in longer term 
survival following a second AMI.
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13.3Limitations of data used in current study
The current study has relied on hospital discharge coding to identify cases diagnosed with 
AML Discharge coding has been found to be quite accurate in Scotland. The Information 
and Statistics Division, Scotland has a Scottish Morbidity Record Standards Unit, which 
checks a one percent sample o f Scottish Morbidity Record 1 forms and compares the 
information with that recorded in the clinical case notes. In 1994, the accuracy o f AMI as 
a principal diagnosis was 94 percent. The extraction method that was used to identify 
individuals with a principal diagnosis of AMI is likely to have missed a small number o f 
individuals in whom AMI was coded in a secondary position. During a continuous 
inpatient stay, individuals may be coded with a number o f different diagnostic codes. In 
the cunent study the principal diagnosis was based on the last cardiovascular diagnosis in 
this continuous inpatient stay. This should ensure that individuals, who are diagnosed as 
chest pain or angina before a definitive diagnosis of AMI is made, are included in the 
study. It will also ensure that those individuals, who have a non-cardiovascular diagnosis 
at any point during their admission, are also included in the analysis. It will however 
exclude those individuals hospitalised with an AMI who are subsequently transferred with 
a diagnosis o f angina. The reason for this is that the AMI data was extracted as part o f a 
larger cardiovascular database that included chest pain and angina as well as AMI. In 
order to avoid double counting of patients, each individual can be given only one 
diagnosis. The current study only includes patients admitted to hospital. However very 
few individuals with a diagnosis of AMI are now managed in the c o m m u n i t y . A  
substantial proportion o f individuals experiencing an AMI will not survive to reach 
hospital and these individuals have not been included in the current study.^ As recording 
o f secondary diagnoses can be poor, co-morbidity in this study was based on both the 
principal diagnoses recorded in previous admissions, and secondary diagnoses in the index 
admission. People with milder forms o f the comorbid disease, which did not result in 
admission, might be missed if this condition was not recorded as a secondary diagnosis. 
This selection bias might therefore overestimate the true impact of the comorbid 
conditions. A further limitation is that population-based data fi*om hospital discharge at 
present lacks treatment and clinical detail. There is currently no way o f knowing whether 
an individual received thrombolysis or other pharmacogical therapies. Lastly, though 
some losses to follow-up might be expected, emigration o f people o f "pensionable age" 
fi'om Scotland was less than 2% per decade.^^^
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13.4Remaining deficits in knowledge
I believe that my work has made a number o f potentially important new additions to the 
existing literature regarding sex differences in the epidemiology of AMI, as well as 
consolidating and confirming existing findings. It has also highlighted the lack o f 
infonnation and data pertaining to particular issues.
There are surprisingly few data describing the baseline characteristics of men and women 
hospitalised with AMI. Concurrent cardiac diagnoses are well described but non-cardiac 
diagnoses have been rarely reported. Consequently, it is not easy to assemble a realistic 
picture o f these patients that includes other diagnoses they are likely to have other than 
their presenting AMI. Sex-specific information is rarely reported, so that when baseline 
characteristics have been more fully described, it is usually on an aggregate basis.
There is virtually no information available regarding the socioeconomic background of 
men and women hospitalised with an AMI. Numerous studies have looked at the 
population prevalence o f cardiac risk factors and the relationship between specific risk 
factors and cardiac outcomes. There is however very little information describing the 
distribution o f socioeconomic factors including distribution o f deprivation in population 
cohorts o f men and women hospitalised with AMI. Many o f those studies that have 
attempted to describe the broader socioeconomic cir cumstances o f individuals hospitalised 
with AMI have excluded women or the elderly, or have looked at men and women 
together."':'''-'"'':'^)'
Coronary heart disease has evolved considerably over the last decade or so in terms of 
diagnosis and treatment, as have the risk factors and baseline characteristics o f individuals 
presenting with AMI. Despite this, there is minimal data available describing evolving 
patient chamcteristics and changes in risk factors over time.
The health service burden o f AMI and coronary heart disease is poorly defined. This may 
partly reflect a difficulty in making comparisons across different health care systems. It is 
however surprising how little is known about the contribution o f these diagnoses to the 
total health care burden and whether this has changed over time with the introduction o f 
new therapies and prevention strategies.
In terms o f survival, a growing literature has explored potential sex differences following
hospitalisation with AMI. Most o f this literature has concentrated on short term survival
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and studies have adjusted for different baseline factors in their multivariate analyses. This 
makes comparison across studies difficult. Very few studies have described and examined 
longer teim survival in men and women hospitalised with AMI. An idea that has begun to 
evolve is the realisation that men and women o f different ages who are hospitalised with an 
AMI are different entities in temis of their baseline characteristics and prognosis. The 
reasons for this have not yet been well explored, and there are very few studies that have 
examined the distribution o f risk factors and baseline characteristics in these subgroups and 
have attempted to determine the importance o f these factors in the prognosis following 
hospitalisation. So for example whilst a number o f studies have adjusted for diagnoses 
such as atrial fibrillation in their attempt to quantify sex differences in 30 day survival, 
very few have examined the effect of these diagnoses on survival in men and women 
separately. From analyses carried out in the current study it seems highly likely that 
interaction between different comorbid diagnoses exist and that these interactions will 
influence prognosis. It also seems clear that comorbid diagnoses may have a different 
impact upon suiwival o f individuals depending upon their age and sex. Trends in survival 
following AMI have also been described but it is not clear in which groups the 
improvements have occuiTed and if disparities exist why that should be.
Most studies that have explored the epidemiology of AMI have included all AMIs. A 
relatively small number have looked specifically at first AMI. From the findings o f the 
cunent study it is clear that the baseline characteristics, survival and prognostic factors 
differ in individuals presenting with first and second AMIs. It would therefore seem 
appropriate to examine these groups separately. Wliilst there is information available 
describing the additional risk that previous AMI presents in individuals hospitalised with 
any AMI, there is viitually no information available describing the characteristics and 
prognosis o f patients presenting with second AMIs.
13.5Further research
Using the existing dataset
Had time not been a constraining factor then some o f gaps that have been identified could 
have been explored further using the existing dataset. It would be possible to explore the 
prevalence of comorbid diagnoses in different socioeconomic groups and to look at the 
interaction between specific comorbid diagnoses and their relationship to short and longer 
term suiwival. The relationship between comorbid diagnoses and suiwival in men and
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women is undoubtedly a complex issue but it is an issue that is amenable to ftiither 
exploration especially using large datasets that are suitable for subgroup analysis. It would 
also be possible to look at the role o f socioeconomic deprivation in more detail. 
Socioeconomic deprivation appeal's to be related to the incidence and survival o f 
individuals hospitalised with AMI. The relationship varies according to age and sex and is 
different in first and second AMI. It would be interesting to examine some o f these issues 
further in order to gain a better understanding and overview of the role o f socioeconomic 
deprivation and AMI epidemiology. This thesis has explored the epidemiology o f first and 
second AMI. It has not however looked at the small number o f individuals who experience 
more than two AMIs. Whilst these individuals account for a small proportion o f all 
individuals hospitalised with AMI, they make a greater contribution to the number o f 
episodes of AMI and to the total burden arising as a result o f AMI. It would be useful to 
look at these individuals in more detail. The current study has only examined all cause 
death in the survival analysis. It would be interesting to look at coronary heart disease 
death as well as all cause death and also to explore the natural history o f men and women 
hospitalised with AMI in terms of future hospitalisations and diagnoses.
With further development o f  dataset
More accurate and more detailed secondary coding on hospital discharge forms would 
enable researchers to gain a better understanding of the characteristics o f individuals 
hospitalised with AMI. It would be usefiil if  the coding could incorporate information that 
would indicate whether the condition is a new or long-standing diagnosis. This would 
allow researchers to determine the temporal relationship between diagnoses and the 
importance o f these diagnoses to the prognosis o f the patient. It would also be valuable to 
expand the coding o f secondary diagnoses to include information on risk factors including 
smoking, obesity and cholesterol. Such information would allow an ongoing and detailed 
analysis o f these factors to the development and survival fiom coronary heart disease. It 
would also allow a more accurate assessment o f trends in risk factors and changing 
characteristics of individuals presenting with coronary heart disease.
It would be useful to routinely record information regarding the results o f diagnostic tests 
for AMI. Development o f new, more sensitive tests, such as cardiac troponins and creatine 
kinase (CK) - MB mass, have meant that it is now possible to identify patients who have 
had very small infarcts, that would not previously been considered an AMI. This means 
that people who were fonnally given a diagnosis o f angina pectoris might today be 
diagnosed as having had a small AMI. The redefinition o f myocardial infarction has
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implications for individuals, for clinical practice and for the study o f the epidemiology o f 
AMI. It is estimated that the new definition for AMI will increase the number o f non-ST 
elevation acute coronary syndromes by about 40%.^ In theory, widespread use o f a 
standardised definition should allow more valid epidemiological comparisons between 
different populations and within populations over time. Information regarding the 
diagnosis o f AMI and results o f troponin tests will be vital in order to continue monitoring 
trends in incidence and survival o f AMI in the context o f a changing diagnostic tlireshold.
The cuiTent study only includes information derived from secondary care. Access to 
primary care data would be extremely valuable, especially if linked to hospital admission 
data. This would enable a greater understanding of the predictors o f AMI and 
identification o f high risk groups. It would also allow greater exploration o f the 
relationship between different diagnoses and the complex interactions that exist between 
them.
Information on prescribing in both primary and secondary care would be extremely useful 
to determine how widely available therapies are prescribed in the general population and 
whether their use has been associated with a reduction in incidence and case fatality 
following AMI across the Scottish population. It is important to know whether the benefits 
seen in clinical trials translate into the general population and also the factors that have 
contributed to declining incidence and case fatality. A number o f studies have attempted 
to estimate the contribution o f different factors, however these are estimates and analysis 
of real data would be preferable.
Priorities regarding data
Coding of secondary diagnoses is poor. It is clear from the literature that the majority o f 
secondary diagnoses are under-recorded, leading to an underestimation o f their prevalence. 
In order to maximise the potential uses of the Scottish Morbidity Record database there 
needs to be more accurate and more complete coding o f secondary diagnoses on the 
hospital dischai’ge records. In addition it is apparent that revascularisation procedures are 
under-recorded in this current study. It is not known whether this has arisen as a result o f 
the extraction process or whether these procedures are under-recorded in the Scottish 
Morbidity Record data.
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Priorities regarding clinical questions
As ali'eady mentioned there is scope to gain a better understanding as to the role o f 
socioeconomic deprivation in the epidemiology o f coronary heart disease and its 
association with incidence and sui'vival. Surprisingly few studies have examined these 
issues in men and women and greater clarity is required.
The importance o f comorbid diagnoses and the relationship between different diagnoses in 
men and women also requires further exploration and clarification. There is a growing 
interest in the relationship between abnormal renal function and coronary heai't disease but 
suiprisingly this issue has not been looked at in men and women separately.
Finally from the findings o f this cunent study and from existing literature it is apparent 
that younger women represent an especially high risk group in terms o f short tenn case 
fatality following AMI. The reasons for this are as yet unclear and require frirther 
investigation.
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Background to Record Linkage within ISD
The main linked data set contains linked SMRl, SMR6, SMR4 and Registrar General’s 
death. SMRl (Scottish Morbidity Records 1) cover all non-obstetric and non-psychiatric 
discharges from NHS hospitals in Scotland. SMR6 are cancer registration records and 
SMR4 are mental health inpatient records. All patient records including deaths for each 
patient are linked together using 'probability matching’. The ‘probability matching’ 
algorithm uses all available identifying information (name, date o f birth, postcode, hospital 
patient reference number etc.) to link the records.
Within these 'patient record sets', the SMRl records are gi'ouped into continuous stays. A 
continuous stay is a continuous period o f time spent as an inpatient or day case in hospital 
regardless o f any transfers between specialties or hospitals. For example, a patient may be 
admitted with an Acute Myocardial Infarction in a specialty o f General Medicine, be 
transferred to Cardiology then transferred again to Geriatric Assessment before discharge. 
This single continuous stay would have generated three separate SMRl discharge records 
which linkage can bring together.
This linked data set currently contains SMRl, SMR6, SMR4 and death records for the 
period 1981 onwai’ds and holds data on over 5 million patients with over 20 million 
contacts within the acute hospital sector.
Accuracy o f the data
It is estimated that the probability matching algorithm links the SMRl, SMR4, SMR6 and 
Registrar General's death records with an accuracy of 98%.
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ISD Scotland has a Data Quality Unit that checks a 1% sample of SMRl forms and 
compares the information recorded on SMRl/01 with that recorded in the clinical case 
notes. For example, from the 1998/1999 checks it was found that the accuracy o f tliree 
digit principal diagnosis and main operation coding are approximately 90% and 91% 
respectively.
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Request Specification -  Emergency chest pain, Angina, AMI & ‘Other CHD’
1. Define INDEX events
For the period 1986 to 2000 (inclusive) select emergency diagnoses (principal 
diagnostic position only) o f AMI, Chest Pain, Angina and ‘Other CHD’ (see table 
below for diagnostic codes) as defined by last named (of the above) diagnoses in CIS. 
For example a patient admitted as an emergency for chest pain, transferred as AMI 
and transferred again with hip fi’acture will be classified as emergency AMI.
Data
number
Principal diagnosis ICD-9 code 
(up to 31®* March 
1996)
ICD-10 code 
(from 1®* April 
1996)
1 AMI 410 121,122
2 Chest Pain 786.5 R07
3 Angina 411,413 120,124.9
4 Other CHD 412,414 123,124.0-I24.8,125
All continuous inpatient stays for each diagnosis within this period, 1986-2000 will 
be included.
The following fields will be included in the final data extract: 
the episode of the CIS:
- Link number (to identify same individual patients)
- Month & year o f admission
- Month & year o f discharge
- Hospital code
- Type o f admission - Emergency only
- Type o f facility 
" Specialty
- Length of stay
- Postcode Sector
390
- Deprivation category 5 (quintiles)
- Deprivation category 7
- Health Board o f Residence
- Principal Diagnosis
the ‘index’ SMRl(s) record
- Month & year o f admission
- Month & year of discharge
- Hospital code
- Age
- Sex
- Type o f admission 
" Type o f facility
- Specialty
- Length o f stay
- Postcode Sector
- Deprivation category 5 (quintiles)
- Deprivation categoiy 7
- Health Board o f Residence 
“ Diagnoses 1-6
- Operations 1-4
- Month & year o f main operation
- Yeai' o f admission
Markers for the index record
marker for a diagnosis o f diabetes on diagnosis positions 2-6 o f index record (see 
table below for codes)
marker for a diagnosis o f cancer on diagnosis positions 2-6 o f index record (see 
table below for codes)
marker for a diagnosis o f respiratory on diagnosis positions 2-6 o f index record (see 
table below for codes)
marker for a diagnosis o f cerebrovascular on diagnosis positions 2-6 o f index 
record (see table below for codes)
marker for a diagnosis of PVD on diagnosis positions 2-6 o f index record (see table 
below for codes)
marker for a diagnosis of Atrial fibrillation on diagnosis positions 2-6 o f index 
record (see table below for codes)
marker for a diagnosis of Hypertension on diagnosis positions 2-6 o f index record 
(see table below for codes)
marker for a diagnosis o f Renal failure on diagnosis positions 2-6 o f index record 
(see table below for codes)
marker for a diagnosis of Heart failure on diagnosis positions 2-6 of index record 
(see table below for codes)
marker for a diagnosis of Cardiogenic shock on diagnosis positions 2-6 o f index 
record (see table below for codes)
Diagnosis in Variable ICD-9 code ICD-10 code
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positions 2-6 of 
index record
name
Diabetes comorbOl 250 E10-E14
Cancer comorb02 140-208 C00-C99
Respiratory comorbOS 480-496 J10-J18,
J40-J47
Cerebrovascular
disease
comorb04 430-438 160-169,
G45
Peripheral vascular 
disease
comorbOS 440-448 170-178
Atrial fibrillation comorbOb 427.3 148
Essential
hypertension
comorbOV 401 110-113
Renal Failure comorbOS 584-586 N17-N19
Heart failure comorb09 425.4, 425.5, 
425.9, 428.0, 
428.1,428.9, 402
150,
142.0,142.6, 
I l l l .O
Cardiogenic shock comorblO 785.5 R57.0
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the last episode in the CIS
- Month & year of admission
- Month & year o f discharge
- Hospital code
- Type o f admission
- Type o f facility
- Specialty
- Length o f stay
- Diagnoses 1-6
- Health B o ard o f  Residence
14. L 1.1.1 1.1.1 Summary details (within CIS)
Marker for CABG operation in continuous stay (see table below for codes)
Date o f CABG operation in continuous stay
Marker for PTC A operation in continuous stay (see table below for codes)
Date for PTC A operation in continuous stay
Marker for Angiography operation in continuous stay (see table below for codes) 
Date for Angiography operation in continuous stay
Operation OPCS3 code 
(up to 31®* Dec 1988)
OPCS4 code 
(from 1®* Jan 1989)
CABG 304.3 K40-K46
PTCA 884.5, 884.9 K49, K50.1
Angiography 306 K63, K65
Total Length o f continuous stay (Date o f Admission on 1®‘ episode -  Date of 
Discharge on last episode
Marker to denote if patient was discharged dead using discharge code from last 
episode in the continuous stay.
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2. Prior Events
Screen back to 1981 for the following in a different continuous stay from the index event:
a) total number o f episodes with AMI in prineipal position (elective, emergency and 
transfer together)
b) total number o f episodes with angina in principal position (elective, emergency 
and transfer together)
c) total number o f episodes with chest pain in principal position (elective, emergency 
and transfer together)
d) total number o f episodes with other CHD in principal position (elective, 
emergency and transfer together)
e) total number o f episodes with AMI in principal position (elective, emergency and 
transfer together) within five years o f index event
Q total number o f episodes with angina in principal position (elective, emergency 
and transfer together) within five years o f index event
g) total number o f episodes with chest pain in principal position (elective, emergency 
and transfer together) within five years o f index event
h) total number o f episodes with other CHD in principal position (elective, 
emergency and transfer together) within five years o f index event
i) total number o f episodes with AMI in principal position (elective, emergency and 
transfer together) within ten years o f index event
j) total number o f episodes with angina in principal position (elective, emergency 
and transfer together) within ten years o f index event
k) total number o f episodes with chest pain in principal position (elective, emergency 
and transfer together) within ten years o f index event
1) total number o f episodes with other CHD in principal position (elective, 
emergency and transfer together) within ten years o f index event.
m) Mai'ker to denote if patient had any of the diagnoses specified in the table below 
within 5 years o f index event -  flag (0-no, 1-yes). Diagnosis could be in any 
position.
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Prior admission 
within 5 years
ICD-9 code ICD-10 code
Diabetes 250 E10-E14
Cancer 140-208 C00-C99
Respiratory 480-496 J10-J18,
J40-J47
Cerebrovascular 430-438 160-169,
disease G45
Peripheral vascular 
disease
440-448 170-178
Essential hypertension 401 110-113
Atrial fibrillation 427.3 148
Other forms of heart 415-427 126-151
disease 429
Heart failure 425.4, 425.5, 425.9, 150,
428.0, 428.1, 428.9, 142.0,142.6,
402 Illl.O
Renal Failure 584-586 N17-N19
Cardiogenic shock 785.5 R570
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3. Prior or secondary Events
Marker to denote if patient had specified diagnosis in the 5 years prior to the index 
record or in diagnostic positions 2-6 o f the index record -  flag (0-no, 1-yes). Prior 
diagnoses could be in any position. See table below for codes.
Prior admission within 5 years 
or secondary diagnosis
Variable
name
ICD-9 code ICD-10 code
Diabetes copriorOl 250 E10-E14
Cancer coprior02 140-208 C00-C99
Respiratory coprio03 480-496 J10-J18,
J40-J47
Cerebrovascular disease coprio04 430-438 160-169,
G45
Peripheral vascular disease coprio05 440-448 170-178
Atrial fibrillation coprio06 427.3 148
Essential hypertension coprio07 401 110-113
Renal Failure coprioOS 584-586 N17-N19
Heart failure coprio09 425.4, 425.5,
425.9, 428.0,
428.1.428.9, 
402
150,
142.0,142.6, 
I l l l .O
Cardiogenic shock copriolO 785.5 14.1.1.2 R570
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4. Subsequent Events (different CIS)
a) Count of the number o f episodes after the index continuous stay with a principal 
diagnosis o f AMI, chest pain, Angina or other CHD.
AMI
- Count o f all episodes for AMI after the index cis.
- Date of first episode for AMI after the index cis.
Chest pain
- Count o f all episodes for chest pain after the index cis.
- Date of first episode for chest pain after the index cis.
Angina
- Count o f all episodes for Angina after the index cis.
- Date o f first episode for Angina after the index cis.
Other CHD
- Count of all episodes for other CHD after the index cis.
- Date of first episode for other CHD after the index cis.
b) Marker to denote if  patient had specified operations after the index continuous 
stay and the date o f the operation. If  patient had more than operation o f the same 
type the date o f the first operation will be provided.
CABG (codes as before)
- Marker to denote if patient had a CABG operation after the index cis.
- Date of CABG operation.
» Number o f days between date of admission on index record and date o f CABG 
operation.
PTCA (codes as before)
“ Marker to denote if patient had a PTCA operation after the index cis.
- Date of PTCA operation.
- Number o f days between date o f admission on index record and date o f PTCA 
operation
Angiography(codes as before)
Marker to denote if  patient had an Angiography operation after the index cis,
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- Date of angiography operation.
“ Number o f days between date o f admission on index record and date o f 
angiography operation
c) Other subsequent events and time to. Markers to denote if the patient had
specified principal diagnoses and the time to these diagnoses.
- Marker to denote if patient had an episode with a diagnosis of Heart failure 
after the index cis (0-no, 1-yes).
- Number o f days between date of admission on index record and date o f 
admission for first subsequent heart failure episode.
- Marker to denote if  patient had an episode with a diagnosis of Cerebrovascular 
disease after the index cis (0-no, 1-yes).
- Number o f days between date o f admission on index record and date o f 
admission for fii'st subsequent cerebrovascular disease episode.
- Marker to denote if patient had an episode with a diagnosis of atrial fibrillation 
after the index cis (0-no, 1-yes).
- Number o f days between date o f admission on index record and date o f
admission for first subsequent atrial fibrillation episode
- Marker to denote if patient had an episode with a diagnosis of peripheral 
vascular disease after the index cis (0-no, 1-yes).
- Number o f days between date o f admission on index record and date o f 
admission for first subsequent peripheral vasculai* disease episode
- Marker to denote if patient had an episode with a diagnosis of lung cancer after 
the index cis (0-no, 1-yes).
- Number o f days between date o f admission on index record and date o f 
admission for first subsequent lung cancer episode.
” Marker to denote if patient had an episode with a diagnosis o f breast cancer 
after the index cis (0-no, 1-yes).
- Number o f days between date o f admission on index record and date o f 
admission for fii'st subsequent breast cancer episode.
- Marker to denote if patient had an episode with a diagnosis o f large bowel 
cancer after the index cis (0-no, 1-yes).
- Number o f days between date o f admission on index record and date o f 
admission for first subsequent large bowel cancer episode.
- Marker to denote if patient had an episode with a diagnosis o f prostate cancer 
after the index cis (0-no, 1-yes).
- Number o f days between date o f admission on index record and date o f 
admission for fii'st subsequent prostate cancer episode
- Marker to denote if patient had an episode with a diagnosis of oesophageal 
cancer after the index cis (0-no, 1-yes).
- Number o f days between date o f admission on index record and date o f 
admission for first subsequent oesophageal cancer episode
- Marker to denote if  patient had an episode with a diagnosis o f gastric cancer 
after the index cis (0-no, 1-yes).
- Number o f days between date o f admission on index record and date o f 
admission for first subsequent gastric cancer episode
- Marker to denote if patient had an episode with a diagnosis of cancer after the 
index cis (0-no, 1-yes).
- Number o f days between date o f admission on index record and date o f 
admission for first subsequent cancer episode
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Marker to denote if patient had an episode with any other diagnosis after the 
index cis (0-no, 1-yes).
Date of first diagnosis after the index cis.
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Diagnostic codes to be used are provided in the table below.
Diagnosis ICD-9 code 
(up to 31*“ Mar 
1996)
ICD-10 code 
(from 1®* Apr 1996)
Heart failure 425.4, 425.5, 425.9, 
428.0, 428.1,428.9, 
402
150,1420,1426,1110
Cerebrovascular disease 430-438 160-169, G45
Atrial fibrillation 427.3 148
Peripheral vascular disease 440-448 170-178
Lung Cancer 162 C33, C34
Breast Cancer 174 C50
Large Bowel Cancer 153-154 CIS
Prostate Cancer 185 C61
Oesophageal Cancer 150 C15
Gastric Cancer 151 C16
Any Cancer 140-208 C00-C99
Any other diagnosis Any ICD9 code 
except those listed 
above
Any ICDIO code 
except those listed 
above
d) Subsequent non-fatal event.
- Marker to denote if  the patient had a subsequent principal diagnosis o f AMI 
and/or a PTCA operation and/or a CABG operation (codes as before).
- Number o f days between date o f admission on index record and date o f 
admission o f subsequent non-fatal event.
e) Subsequent events within 5 and 10 yeai's of index admission
- Marker to denote if  patient had a subsequent AMI admission diagnosis (codes as
before) within 5 years o f date o f admission o f index record.
- Number o f days between date o f admission on index record and date o f 
admission o f first subsequent principal AMI diagnosis (codes as before).
- Marker to denote if  the patient had a subsequent AMI diagnosis (codes as 
before) either fatal or non-fatal within 5 yeais o f date o f admission o f index 
record.
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- Number o f days between date o f admission on index record and date o f 
subsequent non-fatal or fatal AMI diagnosis.
- Marker to denote if the patient had a subsequent fatal AMI diagnosis (codes as 
before) witliin 5 years o f date o f admission o f index record.
- Number o f days between date o f admission on index record and date o f 
subsequent fatal AMI diagnosis
- Marker to denote if the patient had a subsequent CABG or PTCA operation 
(codes as before) within 5 years o f date o f admission o f index record.
- Number o f days between date o f admission on index record and date o f 
subsequent CABG or PTCA operation.
- Marker to denote if the patient had a subsequent non-fatal event (definition as 
above) within 5 years o f date o f admission of index record.
- Number o f days between date o f admission on index record and date o f 
subsequent non-fatal event.
- Marker to denote if  the patient had a subsequent AMI diagnosis (codes as 
before) or died (any cause) within 5 years o f date of admission o f index record.
- Number o f days between date o f admission on index record and date o f 
admission/death o f fii'st subsequent principal AMI diagnosis (codes as before) 
or death (any cause).
- Mai'ker to denote if  the patient had a subsequent AMI diagnosis (codes as 
before) or had a cerebrovascular event or died (any cause) within 5 years o f 
date o f admission o f index record.
- Number o f days between date o f admission on index record and date o f 
admission/death o f first subsequent principal AMI diagnosis (codes as before) 
or cerebrovascular event or death (any cause).
- Marker to denote if  the patient had a subsequent AMI diagnosis (codes as 
before) or had a revascularisation (CABG or PTCA) or died (any cause) within 
5 years o f date o f admission o f index record.
- Number o f days between date o f admission on index record and date o f 
admission/death o f first subsequent principal AMI diagnosis (codes as before) 
or revascularisation (CABG or PTCA) or death (any cause).
- Marker to denote if the patient had a subsequent AMI diagnosis (codes as 
before) or cerebrovasculai’ event or had a revascularisation (CABG or PTCA) 
or died (any cause) within 5 years o f date o f admission o f index record.
- Number o f days between date o f admission on index record and date o f 
admission/death o f first subsequent principal AMI diagnosis (codes as before) 
or cerebrovascular event or revascularisation (CABG or PTCA) or death (any 
cause).
Repeat the 5 yeai* markers for 10 years.
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f) Death information as at 31 December 2001.
- Death marker (0-no, 1 -yes) as at 3 December 2001
- Month & year o f death
- Cause o f death
- Number of days to death or censor. Censor date is 3 December 2001.
- Markers to denote if  the patient died of the specified prhnary causes of death 
flag (0-no, 1-yes). See table below for codes:
Prior admission within 5 years 
or secondary diagnosis
Variable
name
ICD-9 code ICD-10
code
Acute myocardial infarction dthcatOl 410 121,122
Other Coronaiy Heart Disease dthcat02 411-414 120,123, 
124,125
Heart failure dthcat03 425.4,425.5, 
425.9,428.0, 
428.1,428.9, 
402
150,
1420,1426, 
1110
Cancer dthcat04 140-208 C00-C99
Lung Cancer dthcat05 162 C33, C34
Breast Cancer dthcat06 174 C50
Large Bowel Cancer dthcatO? 153-154 C18
Prostate Cancer dthcatOS 185 C61
Gastric Cancer dthcat09 151 C16
Oesophageal Cancer dthcatlO 150 C15
Respiratory Disease dthcatl 1 480-496 J10-J18,
J40-J47
Cerebrovascular Disease dthcatl2 430-438 160-169,
G45
g) Patient’s status at 30 days, 1 year, 5years and 10 years.
- Marker to denote if  the patient was dead or alive/censored within 30 days o f
date o f admission o f index record (0-alive/censored, 1-dead)
- Mai'ker to denote if  the patient was dead or alive/censored within 1 year o f date 
o f admission o f index record (0-alive/censored, 1-dead)
- Marker to denote if the patient was dead or alive/censored within 5 years o f  
date o f admission o f index record (0-alive/censored, 1-dead)
- Marker to denote if  the patient was dead or alive/censored within 10 years o f
date o f admission o f index record (0-alive/censored, 1 -dead)
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5. Information added in SPSS
In addition to the fields extracted in FORTRAN the following fields were created in SPSS 
and added to the file.
AMI
Number o f days between date o f admission (index) and first episode for AMI after the 
index cis.
Chest pain
Number o f days between date o f admission (index) and first episode for chest pain 
after the index cis.
Angina
Number o f days between date of admission (index) and first episode for Angina after 
the index cis.
Other CHD
Number o f days between date o f admission (index) and first episode for other CHD 
after the index cis.
Any subsequent admission
Number o f days between date o f admission (index) and first subsequent episode after 
the index cis.
Other fields
Marker to denote which condition.
1 = AMI
2 = Chest Pain
3 = Angina
4 = Other CHD
Counter within each o f the 4 data sets
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